Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_001199107.2(TBC1D24):c.965+1G>A	TBC1D24		Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Jul 10, 2020)	no assertion criteria provided	VCV000977227	16	2547115	16	2497114	977227	965354	rs1390045914	NC_000016.10:2497113:G:A
NM_001031679.3(MSRB3):c.391-1G>A	MSRB3		Deafness, autosomal recessive 74	Pathogenic	criteria provided, single submitter	VCV000562077	12	65856934	12	65463154	562077	553269	rs751906778	NC_000012.12:65463153:G:A
NM_016239.4(MYO15A):c.6178-2A>G	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242335	17	18047809	17	18144495	242335	243889	rs878854415	NC_000017.11:18144494:A:G
NM_004230.4(S1PR2):c.419A>G (p.Tyr140Cys)	S1PR2	Y140C	Deafness, autosomal recessive 68	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000219249	19	10335163	19	10224487	219249	217271	rs869312750	NC_000019.10:10224486:T:C
NM_138691.3(TMC1):c.1143C>G (p.Tyr381Ter)	TMC1	Y381*	Deafness, autosomal recessive|Deafness, autosomal recessive 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562098	9	75404152	9	72789236	562098	553259	rs757327146	NC_000009.12:72789235:C:G
NM_000260.4(MYO7A):c.5856+5G>C	MYO7A		Deafness, autosomal recessive|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562097	11	76918452	11	77207407	562097	553268	rs1386887007	NC_000011.10:77207406:G:C
NM_001256317.3(TMPRSS3):c.783-1G>T	TMPRSS3		Deafness, autosomal recessive|Deafness, autosomal recessive 8	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562094	21	43802344	21	42382235	562094	553272	rs1237955948	NC_000021.9:42382234:C:A
NM_000260.4(MYO7A):c.3728C>G (p.Pro1243Arg)	MYO7A	P1243R, P1232R	Deafness, autosomal recessive|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562092	11	76901162	11	77190117	562092	553267	rs750358148	NC_000011.10:77190116:C:G
NM_016239.4(MYO15A):c.4570C>T (p.Gln1524Ter)	MYO15A	Q1524*	Deafness, autosomal recessive 3|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562083	17	18039112	17	18135798	562083	553270	rs1209665716	NC_000017.11:18135797:C:T
NM_001384140.1(PCDH15):c.788C>A (p.Pro263Gln)	PCDH15	P263Q, P226Q, P241Q, P268Q	Deafness, autosomal recessive|Deafness, autosomal recessive 23	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562080	10	56077119	10	54317359	562080	553261	rs1564949059	NC_000010.11:54317358:G:T
NM_016239.4(MYO15A):c.5005C>T (p.Gln1669Ter)	MYO15A	Q1669*	Deafness, autosomal recessive 3|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562078	17	18041558	17	18138244	562078	553271	rs1567641234	NC_000017.11:18138243:C:T
NM_001199799.2(ILDR1):c.1384C>T (p.Arg462Ter)	ILDR1	R462*, R373*, R418*	Deafness, autosomal recessive 42|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562073	3	121712212	3	121993365	562073	553254	rs775062249	NC_000003.12:121993364:G:A
NM_016239.4(MYO15A):c.4528C>T (p.Gln1510Ter)	MYO15A	Q1510*	Deafness, autosomal recessive|Deafness, autosomal recessive 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000375675	17	18039070	17	18135756	375675	362515	rs779077039	NC_000017.11:18135755:C:T
NM_000260.4(MYO7A):c.2115C>A (p.Cys705Ter)	MYO7A	C705*, C694*	Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000228377	11	76886438	11	77175392	228377	231387	rs782255281	NC_000011.10:77175391:C:A
NM_001146079.2(CLDN14):c.694G>A (p.Gly232Arg)	CLDN14-AS1|CLDN14	G232R	Deafness, autosomal recessive 29	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000189333	21	37833300	21	36461002	189333	187221	rs786204841	NC_000021.9:36461001:C:T
NM_004208.4(AIFM1):c.1265G>A (p.Arg422Gln)	AIFM1|RAB33A	R422Q, R83Q, R418Q	Deafness, X-linked 5	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000162480	X	129270060	X	130136085	162480	172150	rs724160021	NC_000023.11:130136084:C:T
NM_005422.4(TECTA):c.2736C>A (p.Cys912Ter)	TBCEL-TECTA|TECTA	C912*, C1231*	Deafness, autosomal recessive|Deafness, autosomal recessive 21	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562089	11	121000715	11	121130006	562089	553263	rs368050948	NC_000011.10:121130005:C:A
NM_005422.4(TECTA):c.6162+5G>A	TBCEL-TECTA|TECTA		Deafness, autosomal recessive|Deafness, autosomal recessive 21	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562088	11	121058708	11	121187999	562088	553264	rs1565541888	NC_000011.10:121187998:G:A
NM_182548.4(LHFPL5):c.452G>T (p.Gly151Val)	LHFPL5	G151V	Deafness, autosomal recessive 67|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2020)	no assertion criteria provided	VCV000562086	6	35782362	6	35814585	562086	553258	rs762876554	NC_000006.12:35814584:G:T
NM_194248.3(OTOF):c.5714G>T (p.Gly1905Val)	OTOF	G1905V, G1215V, G1138V	Deafness, autosomal recessive|Deafness, autosomal recessive 9	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562085	2	26683614	2	26460746	562085	553252	rs1558464965	NC_000002.12:26460745:C:A
NM_194248.3(OTOF):c.1904T>A (p.Val635Asp)	OTOF	V635D	Deafness, autosomal recessive|Deafness, autosomal recessive 9	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562082	2	26703079	2	26480211	562082	553253	rs1558488902	NC_000002.12:26480210:A:T
NM_194248.3(OTOF):c.*19C>T	OTOF	R1172W, R1939W	Deafness, autosomal recessive|Deafness, autosomal recessive 9	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562079	2	26681087	2	26458219	562079	553251	rs530821443	NC_000002.12:26458218:G:A
NM_032119.4(ADGRV1):c.1055C>T (p.Pro352Leu)	ADGRV1	P352L	Deafness, autosomal recessive|Autosomal recessive sensorineural hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562081	5	89923410	5	90627593	562081	553257	rs765574676	NC_000005.10:90627592:C:T
NM_002700.3(POU4F3):c.374C>T (p.Pro125Leu)	POU4F3	P125L	Autosomal recessive sensorineural hearing loss|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562074	5	145719364	5	146339801	562074	553256	rs1561590396	NC_000005.10:146339800:C:T
NM_016239.4(MYO15A):c.3505C>T (p.Arg1169Ter)	MYO15A	R1169*	Deafness, autosomal recessive 3|Deafness, autosomal recessive|not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000498654	17	18025619	17	18122305	498654	490078	rs781546107	NC_000017.11:18122304:C:T
NM_001038603.3(MARVELD2):c.1331+1G>A	MARVELD2		Rare genetic deafness|Deafness, autosomal recessive 49	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000228359	5	68728503	5	69432676	228359	229307	rs762352115	NC_000005.10:69432675:G:A
NM_016239.4(MYO15A):c.5531+1G>A	MYO15A		Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000164528	17	18044458	17	18141144	164528	176599	rs727503309	NC_000017.11:18141143:G:A
NM_001080476.3(GRXCR1):c.229C>T (p.Gln77Ter)	GRXCR1	Q77*	Deafness, autosomal recessive 25|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000000195	4	42895512	4	42893495	195	15234	rs267606855	NC_000004.12:42893494:C:T
NM_001354604.2(MITF):c.1129C>T (p.Arg377Ter)	MITF	R270*, R371*, R264*, R319*, R354*, R355*, R370*, R208*, R376*, R377*	Waardenburg syndrome type 2A|Rare genetic deafness	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228363	3	70008521	3	69959370	228363	229152	rs876657699	NC_000003.12:69959369:C:T
NM_006941.4(SOX10):c.424T>C (p.Trp142Arg)	POLR2F|SOX10	W142R	Waardenburg syndrome type 2E|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505653	22	38379368	22	37983361	505653	497803	rs1555939408	NC_000022.11:37983360:A:G
NM_001199107.2(TBC1D24):c.533C>T (p.Ser178Leu)	TBC1D24	S178L	not provided|Deafness, autosomal dominant 65|Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000133246	16	2546682	16	2496681	133246	136991	rs483352866	NC_000016.10:2496680:C:T
NM_001354604.2(MITF):c.1198C>T (p.Arg400Ter)	MITF	R231*, R287*, R293*, R342*, R377*, R378*, R393*, R394*, R399*, R400*	Nonsyndromic hearing loss and deafness|not provided|Waardenburg syndrome type 2A	Pathogenic(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000995923	3	70014016	3	69964865	995923	983627	rs1464157509	NC_000003.12:69964864:C:T
NM_138691.3(TMC1):c.236+1G>A	TMC1		Deafness, autosomal dominant 36|Deafness, autosomal recessive 7|Rare genetic deafness	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504715	9	75309631	9	72694715	504715	497055	rs775428246	NC_000009.12:72694714:G:A
NM_004004.6(GJB2):c.9G>A (p.Trp3Ter)	GJB2	W3*	Rare genetic deafness|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044767	13	20763712	13	20189573	44767	53934	rs111033401	NC_000013.11:20189572:C:T
NM_004208.4(AIFM1):c.1264C>T (p.Arg422Trp)	RAB33A|AIFM1	R422W, R418W, R83W	Combined oxidative phosphorylation deficiency|Charcot-Marie-Tooth Neuropathy X|not provided|Deafness, X-linked 5	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000162479	X	129270061	X	130136086	162479	172151	rs724160020	NC_000023.11:130136085:G:A
NM_000441.2(SLC26A4):c.109G>T (p.Glu37Ter)	SLC26A4|SLC26A4-AS1	E37*	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000627471	7	107302195	7	107661750	627471	615796	rs371544695	NC_000007.14:107661749:G:T
NM_000441.2(SLC26A4):c.589G>A (p.Gly197Arg)	SLC26A4	G197R	Pendred syndrome|not provided|Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043562	7	107314782	7	107674337	43562	52731	rs111033380	NC_000007.14:107674336:G:A
NM_000260.4(MYO7A):c.1258A>T (p.Lys420Ter)	MYO7A	K420*, K409*	Usher syndrome type 1|Deafness, autosomal recessive|not provided|Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504508	11	76872076	11	77161030	504508	497812	rs782539587	NC_000011.10:77161029:A:T
NM_000441.2(SLC26A4):c.235C>T (p.Arg79Ter)	SLC26A4	R79*	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188950	7	107303811	7	107663366	188950	186726	rs786204581	NC_000007.14:107663365:C:T
NM_001384140.1(PCDH15):c.2785C>T (p.Arg929Ter)	PCDH15	R929*, R934*, R858*, R941*, R892*, R907*, R936*	Usher syndrome type 1F|Deafness, autosomal recessive 23|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370242	10	55755492	10	53995732	370242	357856	rs1057516342	NC_000010.11:53995731:G:A
NM_000441.2(SLC26A4):c.1262A>C (p.Gln421Pro)	SLC26A4	Q421P	not provided|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000556159	7	107330681	7	107690236	556159	544382	rs201660407	NC_000007.14:107690235:A:C
NM_001614.5(ACTG1):c.766C>T (p.Arg256Trp)	ACTG1	R256W	not provided|Baraitser-Winter Syndrome 2|Lissencephaly|Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000029590	17	79478250	17	81511224	29590	38544	rs281875329	NC_000017.11:81511223:G:A
NM_138691.3(TMC1):c.100C>T (p.Arg34Ter)	TMC1	R34*	not provided|Deafness, autosomal recessive|Rare genetic deafness|Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004103	9	75309494	9	72694578	4103	19142	rs121908073	NC_000009.12:72694577:C:T
NM_000441.2(SLC26A4):c.2027T>A (p.Leu676Gln)	SLC26A4	L676Q	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043533	7	107342495	7	107702050	43533	52702	rs111033318	NC_000007.14:107702049:T:A
NM_004004.6(GJB2):c.439G>A (p.Glu147Lys)	GJB2	E147K	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Rare genetic deafness|Nonsyndromic hearing loss and deafness|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371709	13	20763282	13	20189143	371709	358131	rs767178508	NC_000013.11:20189142:C:T
NM_001384140.1(PCDH15):c.7C>T (p.Arg3Ter)	PCDH15	R3*	Rare genetic deafness|Usher syndrome type 1F|Deafness, autosomal recessive 23|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004931	10	56424016	10	54664256	4931	19970	rs137853001	NC_000010.11:54664255:G:A
NM_000441.2(SLC26A4):c.1614+1G>A	SLC26A4		Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043516	7	107338557	7	107698112	43516	52685	rs111033312	NC_000007.14:107698111:G:A
NM_000441.1(SLC26A4):c.578C>T	SLC26A4	T193I	Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004830	7	107314771	7	107674326	4830	19869	rs111033348	NC_000007.14:107674325:C:T
NM_000441.2(SLC26A4):c.1225C>T (p.Arg409Cys)	SLC26A4	R409C	Pendred syndrome|not provided|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371421	7	107330644	7	107690199	371421	357540	rs147952620	NC_000007.14:107690198:C:T
NM_000441.2(SLC26A4):c.1707+5G>A	SLC26A4		Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: May 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000446457	7	107340625	7	107700180	446457	439906	rs192366176	NC_000007.14:107700179:G:A
NM_000441.2(SLC26A4):c.2086C>T (p.Gln696Ter)	SLC26A4	Q696*	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189164	7	107344827	7	107704382	189164	186741	rs752807925	NC_000007.14:107704381:C:T
NM_000441.2(SLC26A4):c.1174A>T (p.Asn392Tyr)	SLC26A4	N392Y	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000446453	7	107330593	7	107690148	446453	439902	rs201562855	NC_000007.14:107690147:A:T
NM_022124.6(CDH23):c.5237G>A (p.Arg1746Gln)	CDH23	R1746Q	Usher syndrome type 1|Rare genetic deafness|Usher syndrome type 1D|CDH23-Related Disorders|Retinal dystrophy|Childhood onset hearing loss|Deafness, autosomal recessive 12|Usher syndrome type 1D|Pituitary adenoma 5, multiple types|not provided	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004916	10	73539073	10	71779316	4916	19955	rs111033270	NC_000010.11:71779315:G:A
NM_206933.4(USH2A):c.3309C>A (p.Tyr1103Ter)	USH2A|USH2A-AS1	Y1103*	Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Usher syndrome, type 2A	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048499	1	216380622	1	216207280	48499	57661	rs397518011	NC_000001.11:216207279:G:T
NM_000441.2(SLC26A4):c.2162C>T (p.Thr721Met)	SLC26A4	T721M	not provided|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Rare genetic deafness|Pendred syndrome	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004826	7	107350571	7	107710126	4826	19865	rs121908363	NC_000007.14:107710125:C:T
NM_000441.2(SLC26A4):c.1079C>T (p.Ala360Val)	SLC26A4	A360V	not provided|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188793	7	107329575	7	107689130	188793	186734	rs786204474	NC_000007.14:107689129:C:T
NM_000441.2(SLC26A4):c.85G>C (p.Glu29Gln)	SLC26A4|SLC26A4-AS1	E29Q	not provided|Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Wolff-Parkinson-White pattern|Pendred syndrome|SLC26A4-Related Disorders	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004839	7	107302171	7	107661726	4839	19878	rs111033205	NC_000007.14:107661725:G:C
NM_000441.2(SLC26A4):c.919-2A>G	SLC26A4		Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Deafness, autosomal recessive|not provided|Rare genetic deafness	Pathogenic(Last reviewed: Sep 20, 2018)	reviewed by expert panel	VCV000004840	7	107323898	7	107683453	4840	19879	rs111033313	NC_000007.14:107683452:A:G
NM_004004.6(GJB2):c.-23+1G>A	GJB2		Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|not provided|Hearing loss|Nonsyndromic hearing loss and deafness|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Deafness, X-linked 2|Deafness, autosomal dominant 3a|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|none provided|Deafness, autosomal recessive|Hearing impairment|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017029	13	20766921	13	20192782	17029	32068	rs80338940	NC_000013.11:20192781:C:T
NM_000441.2(SLC26A4):c.1226G>A (p.Arg409His)	SLC26A4	R409H	Pendred syndrome|not provided|Rare genetic deafness|not specified|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Deafness, autosomal recessive	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043496	7	107330645	7	107690200	43496	52666	rs111033305	NC_000007.14:107690199:G:A
NM_004004.6(GJB2):c.427C>T (p.Arg143Trp)	GJB2	R143W	Hearing loss|Rare genetic deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not provided|Hearing impairment|none provided	Pathogenic(Last reviewed: Jun 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017009	13	20763294	13	20189155	17009	32048	rs80338948	NC_000013.11:20189154:G:A
NM_004004.6(GJB2):c.109G>A (p.Val37Ile)	GJB2	V37I	Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Nonsyndromic hearing loss and deafness|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Deafness, X-linked 2|Deafness, autosomal dominant 3a|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Nonsyndromic Deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|not provided|Hearing impairment|none provided|Rare genetic deafness	Pathogenic(Last reviewed: Jun 24, 2019)	reviewed by expert panel	VCV000017023	13	20763612	13	20189473	17023	32062	rs72474224	NC_000013.11:20189472:C:T
NM_000441.2(SLC26A4):c.1229C>T (p.Thr410Met)	SLC26A4	T410M	not provided|Pendred syndrome|Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Deafness, autosomal recessive|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	reviewed by expert panel	VCV000043498	7	107330648	7	107690203	43498	52668	rs111033220	NC_000007.14:107690202:C:T
NM_000441.2(SLC26A4):c.2168A>G (p.His723Arg)	SLC26A4	H723R	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided|Rare genetic deafness|SLC26A4-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004825	7	107350577	7	107710132	4825	19864	rs121908362	NC_000007.14:107710131:A:G
NM_000441.2(SLC26A4):c.1975G>C (p.Val659Leu)	SLC26A4	V659L	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188889	7	107342443	7	107701998	188889	186740	rs200455203	NC_000007.14:107701997:G:C
NM_018150.4(RNF220):c.1088G>A (p.Arg363Gln)	RNF220	R363Q, R105Q, R150Q, R389Q	LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY	Pathogenic(Last reviewed: Jan 10, 2022)	no assertion criteria provided	VCV001333094	1	45101796	1	44636124	1333094	1323850		NC_000001.11:44636123:G:A
NM_018150.4(RNF220):c.1094G>A (p.Arg365Gln)	RNF220	R365Q, R107Q, R152Q, R391Q	LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY	Pathogenic(Last reviewed: Jan 10, 2022)	no assertion criteria provided	VCV001333093	1	45101802	1	44636130	1333093	1323849		NC_000001.11:44636129:G:A
NM_001002295.2(GATA3):c.779-1G>C	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Mar 9, 2020)	no assertion criteria provided	VCV001322981					1322981	1313275		
NM_001174089.2(SLC4A11):c.1658C>A (p.Ser553Ter)	SLC4A11	S515*, S553*, S569*, S596*	Corneal dystrophy-perceptive deafness syndrome	Pathogenic	no assertion criteria provided	VCV001184523	20	3210254	20	3229608	1184523	1174379		NC_000020.11:3229607:G:T
NM_005548.3(KARS1):c.1573G>A (p.Glu525Lys)	KARS1	E525K, E369K, E553K	Leukoencephalopathy, progressive, infantile-onset, with or without deafness	Pathogenic(Last reviewed: Mar 1, 2021)	no assertion criteria provided	VCV000997977	16	75662589	16	75628691	997977	985697	rs770522582	NC_000016.10:75628690:C:T
NM_005548.3(KARS1):c.1312C>T (p.Arg438Trp)	KARS1	R438W, R282W, R466W	Leukoencephalopathy, progressive, infantile-onset, with or without deafness	Pathogenic(Last reviewed: Mar 1, 2021)	no assertion criteria provided	VCV000997976	16	75665092	16	75631194	997976	985696	rs761527468	NC_000016.10:75631193:G:A
NM_000304.4(PMP22):c.449G>T (p.Gly150Val)	PMP22	G150V	Charcot-Marie-Tooth disease and deafness|Dejerine-Sottas disease	Pathogenic	no assertion criteria provided	VCV000433198	17	15134268	17	15230951	433198	426772	rs879253954	NC_000017.11:15230950:C:A
NM_004004.6(GJB2):c.66G>T (p.Lys22Asn)	GJB2	K22N	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	VCV000242831	13	20763655	13	20189516	242831	243935	rs879253741	NC_000013.11:20189515:C:A
NM_000260.4(MYO7A):c.620A>G (p.Asn207Ser)	MYO7A	N207S, N196S	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236051	11	76867935	11	77156889	236051	237613	rs878853235	NC_000011.10:77156888:A:G
NM_001378609.3(OTOGL):c.6064G>T (p.Glu2022Ter)	OTOGL	E1977*, E2022*	Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Dec 12, 2019)	no assertion criteria provided	VCV001323401					1323401	1313686		
NM_001378609.3(OTOGL):c.2391-2A>G	OTOGL		Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV001323400					1323400	1313685		
NM_001292063.2(OTOG):c.4309C>T (p.Gln1437Ter)	OTOG	Q1437*, Q1449*	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Dec 19, 2019)	no assertion criteria provided	VCV001323392					1323392	1313677		
NM_000245.4(MET):c.4068T>A (p.Tyr1356Ter)	MET	Y1356*, Y1374*, Y926*	Deafness, autosomal recessive 97	Pathogenic(Last reviewed: Sep 11, 2019)	no assertion criteria provided	VCV001323275					1323275	1313561		
NM_016366.3(CABP2):c.232G>A (p.Glu78Lys)	CABP2	E84K, E78K	Deafness, autosomal recessive 93	Pathogenic(Last reviewed: Jul 6, 2019)	no assertion criteria provided	VCV000917515	11	67289435	11	67521964	917515	905844	rs1391730624	NC_000011.10:67521963:C:T
NM_001080476.3(GRXCR1):c.385-2A>G	GRXCR1		Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522426	4	42964907	4	42962890	522426	513051	rs771844359	NC_000004.12:42962889:A:G
NM_206933.4(USH2A):c.11048-1G>A	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 13, 2010)	no assertion criteria provided	VCV000048365	1	215933186	1	215759844	48365	57527	rs111033414	NC_000001.11:215759843:C:T
NM_022124.6(CDH23):c.5712+1G>A	CDH23		Rare genetic deafness	Pathogenic(Last reviewed: Feb 20, 2012)	no assertion criteria provided	VCV000045988	10	73544858	10	71785101	45988	55153	rs397517341	NC_000010.11:71785100:G:A
NM_022124.6(CDH23):c.5272C>T (p.Gln1758Ter)	CDH23	Q1758*	Rare genetic deafness	Pathogenic(Last reviewed: Feb 20, 2012)	no assertion criteria provided	VCV000045972	10	73539108	10	71779351	45972	55137	rs397517337	NC_000010.11:71779350:C:T
NM_000260.4(MYO7A):c.6029A>G (p.Asp2010Gly)	MYO7A	D2010G, D1972G, D1961G	Rare genetic deafness	Pathogenic(Last reviewed: Oct 28, 2006)	no assertion criteria provided	VCV000043314	11	76919826	11	77208781	43314	52484	rs111033175	NC_000011.10:77208780:A:G
NM_080680.3(COL11A2):c.109G>T (p.Ala37Ser)	COL11A2	A37S	Deafness, autosomal recessive 53|Nonsyndromic Deafness	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000160366	6	33157220	6	33189443	160366	170211	rs606231410	NC_000006.12:33189442:C:A
NM_000260.4(MYO7A):c.4297C>T (p.Gln1433Ter)	MYO7A	Q1422*, Q1433*	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001334123	11	76905543	11	77194498	1334123	1324890		NC_000011.10:77194497:C:T
NM_001692.4(ATP6V1B1):c.925G>T (p.Glu309Ter)	ATP6V1B1	E309*	Renal tubular acidosis with progressive nerve deafness	Pathogenic	no assertion criteria provided	VCV001329994	2	71190307	2	70963177	1329994	1320678		NC_000002.12:70963176:G:T
NM_001692.4(ATP6V1B1):c.67C>T (p.Arg23Ter)	ATP6V1B1	R23*	Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Jan 17, 2020)	no assertion criteria provided	VCV001323856					1323856	1314136		
NM_001256317.3(TMPRSS3):c.679C>T (p.Gln227Ter)	TMPRSS3	Q100*, Q227*	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Mar 19, 2020)	no assertion criteria provided	VCV001323697					1323697	1313978		
NM_016239.4(MYO15A):c.4606C>T (p.Arg1536Ter)	MYO15A	R1536*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Dec 4, 2020)	no assertion criteria provided	VCV001323311					1323311	1313597		
NM_016239.4(MYO15A):c.9400C>T (p.Arg3134Ter)	MYO15A	R3134*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 30, 2020)	no assertion criteria provided	VCV001301978	17	18064644	17	18161330	1301978	1292260		NC_000017.11:18161329:C:T
NM_001135022.2(ELMOD3):c.512A>G (p.His171Arg)	ELMOD3	H171R	Deafness, autosomal dominant 81	Pathogenic(Last reviewed: Aug 24, 2021)	no assertion criteria provided	VCV001210213	2	85598590	2	85371467	1210213	1200213		NC_000002.12:85371466:A:G
NM_144672.4(OTOA):c.346C>T (p.Gln116Ter)	OTOA	Q116*, Q37*	Deafness, autosomal recessive	Pathogenic(Last reviewed: Jul 29, 2021)	no assertion criteria provided	VCV001192296	16	21696629	16	21685308	1192296	1182306		NC_000016.10:21685307:C:T
NM_001080516.2(GRXCR2):c.323C>T (p.Ala108Val)	GRXCR2	A108V	Deafness, autosomal recessive	Pathogenic(Last reviewed: Aug 5, 2021)	no assertion criteria provided	VCV001192284	5	145252209	5	145872646	1192284	1182294		NC_000005.10:145872645:G:A
NM_001256317.3(TMPRSS3):c.242C>G (p.Ser81Ter)	TMPRSS3	S81*	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, single submitter	VCV001185592	21	43809118	21	42389009	1185592	1175565		NC_000021.9:42389008:G:C
NM_004100.5(EYA4):c.580+2T>C	EYA4		Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, single submitter	VCV001185589	6	133783617	6	133462479	1185589	1175561		NC_000006.12:133462478:T:C
NM_170741.4(KCNJ16):c.191C>T (p.Thr64Ile)	KCNJ16		HYPOKALEMIC TUBULOPATHY AND DEAFNESS	Pathogenic(Last reviewed: Jun 28, 2021)	no assertion criteria provided	VCV001174521	17	68128419	17	70132278	1174521	1163801		NC_000017.11:70132277:C:T
NM_170741.4(KCNJ16):c.404G>C (p.Gly135Ala)	KCNJ16		HYPOKALEMIC TUBULOPATHY AND DEAFNESS	Pathogenic(Last reviewed: Jun 28, 2021)	no assertion criteria provided	VCV001174520	17	68128632	17	70132491	1174520	1163800		NC_000017.11:70132490:G:C
NM_170741.4(KCNJ16):c.749C>T (p.Pro250Leu)	KCNJ16		HYPOKALEMIC TUBULOPATHY AND DEAFNESS	Pathogenic(Last reviewed: Jun 28, 2021)	no assertion criteria provided	VCV001174519	17	68128977	17	70132836	1174519	1163799		NC_000017.11:70132835:C:T
NM_170741.4(KCNJ16):c.395T>G (p.Ile132Arg)	KCNJ16		HYPOKALEMIC TUBULOPATHY AND DEAFNESS	Pathogenic(Last reviewed: Jun 29, 2021)	no assertion criteria provided	VCV001174518	17	68128623	17	70132482	1174518	1163798		NC_000017.11:70132481:T:G
NM_170741.4(KCNJ16):c.526C>T (p.Arg176Ter)	KCNJ16		HYPOKALEMIC TUBULOPATHY AND DEAFNESS	Pathogenic(Last reviewed: Jun 29, 2021)	no assertion criteria provided	VCV001174517	17	68128754	17	70132613	1174517	1163797		NC_000017.11:70132612:C:T
NM_170741.4(KCNJ16):c.409C>T (p.Arg137Cys)	KCNJ16		HYPOKALEMIC TUBULOPATHY AND DEAFNESS	Pathogenic(Last reviewed: Jun 28, 2021)	no assertion criteria provided	VCV001174516	17	68128637	17	70132496	1174516	1163796		NC_000017.11:70132495:C:T
NM_001002295.2(GATA3):c.864C>G (p.Cys288Trp)	GATA3	C287W	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jun 26, 2021)	no assertion criteria provided	VCV001174139	10	8106041	10	8064078	1174139	1163349		NC_000010.11:8064077:C:G
NM_005548.3(KARS1):c.795+1G>A	KARS1		LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH DEAFNESS	Pathogenic(Last reviewed: Mar 1, 2021)	no assertion criteria provided	VCV000997984	16	75669577	16	75635679	997984	985704	rs2082153181	NC_000016.10:75635678:C:T
NM_001145026.2(PTPRQ):c.4006C>T (p.Gln1336Ter)	PTPRQ	Q1336*	Deafness, autosomal recessive 84	Pathogenic	criteria provided, single submitter	VCV000973493	12	80940467	12	80546688	973493	961806	rs1896318374	NC_000012.12:80546687:C:T
NM_001256317.3(TMPRSS3):c.1192-1G>C	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828127	21	43795978	21	42375869	828127	816510	rs1601514990	NC_000021.9:42375868:C:G
NM_177398.4(LMX1A):c.290G>C (p.Cys97Ser)	LMX1A	C97S	Deafness, autosomal dominant 7	Pathogenic(Last reviewed: Feb 12, 2020)	no assertion criteria provided	VCV000812516	1	165218851	1	165249614	812516	800759	rs1571177726	NC_000001.11:165249613:C:G
NM_001127.4(AP1B1):c.2374G>T (p.Glu792Ter)	AP1B1	E792*, E765*, E785*, E723*, E728*, E735*	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805798	22	29727841	22	29331852	805798	794118	rs780548317	NC_000022.11:29331851:C:A
NM_001127.4(AP1B1):c.430T>C (p.Cys144Arg)	AP1B1	C144R, C87R	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 17, 2020)	no assertion criteria provided	VCV000805796	22	29754810	22	29358821	805796	794116	rs1602749299	NC_000022.11:29358820:A:G
NM_001127.4(AP1B1):c.38-1G>A	AP1B1		Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805795	22	29759096	22	29363107	805795	794115	rs1602761438	NC_000022.11:29363106:C:T
NM_005612.5(REST):c.983-2247C>G	REST		Deafness, autosomal dominant 27	Pathogenic(Last reviewed: Jul 17, 2020)	no assertion criteria provided	VCV000694373	4	57793760	4	56927594	694373	682299	rs1720770872	NC_000004.12:56927593:C:G
NM_130837.3(OPA1):c.556+1G>A	OPA1		Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000692000	3	193335075	3	193617286	692000	679822	rs1577162868	NC_000003.12:193617285:G:A
NM_016239.4(MYO15A):c.4879G>T (p.Glu1627Ter)	MYO15A	E1627*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Aug 28, 2019)	no assertion criteria provided	VCV000691339	17	18041432	17	18138118	691339	679025	rs1597787868	NC_000017.11:18138117:G:T
NM_033284.2(TBL1Y):c.206A>T (p.Asp69Val)	TBL1Y	D69V	Deafness, Y-linked 2	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000625467	Y	6931939	Y	7063898	625467	613772	rs199659121	NC_000024.10:7063897:A:T
NM_016239.4(MYO15A):c.6638G>A (p.Trp2213Ter)	MYO15A	W2213*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000599164	17	18051471	17	18148157	599164	590324	rs1567649945	NC_000017.11:18148156:G:A
NM_003672.4(CDC14A):c.839-3C>G	CDC14A		Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000559438	1	100933509	1	100467953	559438	550162	rs1553191001	NC_000001.11:100467952:C:G
NM_004004.6(GJB2):c.175G>C (p.Gly59Arg)	GJB2	G59R	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000496215	13	20763546	13	20189407	496215	487604	rs104894410	NC_000013.11:20189406:C:G
NM_006996.3(SLC19A2):c.1082G>A (p.Trp361Ter)	SLC19A2	W361*, W160*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000492807	1	169438023	1	169468785	492807	485690	rs1553211899	NC_000001.11:169468784:C:T
NM_006996.3(SLC19A2):c.428C>T (p.Ser143Phe)	SLC19A2	S143F	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Sep 3, 2013)	no assertion criteria provided	VCV000492806	1	169446772	1	169477534	492806	485691	rs761957186	NC_000001.11:169477533:G:A
NM_005548.3(KARS1):c.1513C>T (p.Pro505Ser)	KARS1	P505S, P533S, P349S	Deafness, congenital, and adult-onset progressive leukoencephalopathy	Pathogenic(Last reviewed: Mar 1, 2021)	no assertion criteria provided	VCV000437930	16	75663351	16	75629453	437930	431552	rs1555512658	NC_000016.10:75629452:G:A
NM_002473.6(MYH9):c.5137A>G (p.Ser1713Gly)	MYH9	S1713G	Deafness, autosomal recessive	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402285	22	36681924	22	36285878	402285	389253	rs764139009	NC_000022.11:36285877:T:C
NM_001256317.3(TMPRSS3):c.582T>A (p.Cys194Ter)	TMPRSS3	C194*, C67*	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402283	21	43804113	21	42384004	402283	389252	rs1060499811	NC_000021.9:42384003:A:T
NM_138691.3(TMC1):c.1532C>T (p.Pro511Leu)	TMC1	P511L	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402278	9	75407234	9	72792318	402278	389230	rs727503483	NC_000009.12:72792317:C:T
NM_016239.4(MYO15A):c.1223C>T (p.Ala408Val)	MYO15A	A408V	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402261	17	18023337	17	18120023	402261	389248	rs191710555	NC_000017.11:18120022:C:T
NM_016239.4(MYO15A):c.9572G>A (p.Arg3191His)	MYO15A	R3191H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402260	17	18065953	17	18162639	402260	389250	rs373520843	NC_000017.11:18162638:G:A
NC_012920.1:m.14692A>G	MT-TE		Diabetes-deafness syndrome maternally transmitted	Pathogenic(Last reviewed: Oct 25, 2016)	no assertion criteria provided	VCV000267298	MT	14692	MT	14692	267298	262350	rs879192165	NC_012920.1:14691:A:G
NM_016239.4(MYO15A):c.6146C>A (p.Pro2049His)	MYO15A	P2049H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242334	17	18047283	17	18143969	242334	243888	rs878854414	NC_000017.11:18143968:C:A
NM_016239.4(MYO15A):c.4780G>C (p.Asp1594His)	MYO15A	D1594H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242331	17	18040898	17	18137584	242331	243885	rs878854412	NC_000017.11:18137583:G:C
NM_016239.4(MYO15A):c.3944G>A (p.Gly1315Glu)	MYO15A	G1315E	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242329	17	18030391	17	18127077	242329	243883	rs878854410	NC_000017.11:18127076:G:A
NM_016239.4(MYO15A):c.742C>G (p.Arg248Gly)	MYO15A	R248G	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 6, 2016)	no assertion criteria provided	VCV000242328	17	18022856	17	18119542	242328	243882	rs878854409	NC_000017.11:18119541:C:G
NM_001199107.2(TBC1D24):c.194G>T (p.Arg65Leu)	TBC1D24	R65L	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236046	16	2546343	16	2496342	236046	237618	rs878853232	NC_000016.10:2496341:G:T
NM_016239.4(MYO15A):c.8340G>A (p.Thr2780=)	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236038	17	18058539	17	18155225	236038	237622	rs878853228	NC_000017.11:18155224:G:A
NM_001039213.4(CEACAM16):c.505G>A (p.Gly169Arg)	CEACAM16	G169R	Deafness, autosomal dominant 4b	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000235136	19	45207410	19	44704140	235136	236870	rs876661405	NC_000019.10:44704139:G:A
NM_006016.6(CD164):c.574C>T (p.Arg192Ter)	CD164	R192*, R173*, R158*, R179*	Deafness, autosomal dominant 66	Pathogenic(Last reviewed: Jul 30, 2019)	no assertion criteria provided	VCV000235130	6	109690074	6	109368871	235130	236864	rs876661402	NC_000006.12:109368870:G:A
NM_004526.4(MCM2):c.130C>T (p.Arg44Cys)	MCM2	R44C	Deafness, autosomal dominant 70	Pathogenic(Last reviewed: Feb 18, 2021)	no assertion criteria provided	VCV000235129	3	127318284	3	127599441	235129	236863	rs375851208	NC_000003.12:127599440:C:T
NM_130837.3(OPA1):c.1817G>A (p.Cys606Tyr)	OPA1	C551Y, C606Y, C427Y, C533Y, C552Y, C569Y, C515Y, C570Y, C588Y, C428Y	Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	VCV000225120	3	193364916	3	193647127	225120	227006	rs879255592	NC_000003.12:193647126:G:A
NM_080680.3(COL11A2):c.2662C>A (p.Pro888Thr)	COL11A2	P888T, P781T, P802T	Deafness, autosomal recessive 53	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000218349	6	33141299	6	33173522	218349	215057	rs864309523	NC_000006.12:33173521:G:T
NM_001286445.3(RIPOR2):c.189-1G>A	RIPOR2		Deafness, autosomal recessive 104	Pathogenic(Last reviewed: Jul 8, 2014)	no assertion criteria provided	VCV000208145	6	24874028	6	24873800	208145	204406	rs875989828	NC_000006.12:24873799:C:T
NM_001039141.3(TRIOBP):c.6598C>T (p.Arg2200Ter)	TRIOBP	R2200*, R487*	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	VCV000165613	22	38165057	22	37769050	165613	176305	rs727503528	NC_000022.11:37769049:C:T
NM_016929.5(CLIC5):c.96T>A (p.Cys32Ter)	CLIC5	C32*, C191*	Deafness, autosomal recessive 103	Pathogenic(Last reviewed: Apr 30, 2014)	no assertion criteria provided	VCV000160365	6	45922949	6	45955212	160365	170210	rs606231308	NC_000006.12:45955211:A:T
NM_170682.4(P2RX2):c.1057G>C (p.Gly353Arg)	P2RX2	G353R, G281R, G261R, G319R, G329R	Deafness, autosomal dominant 41	Pathogenic(Last reviewed: Jan 25, 2014)	no assertion criteria provided	VCV000155763	12	133198121	12	132621535	155763	165516	rs202138002	NC_000012.12:132621534:G:C
NM_004447.6(EPS8):c.88C>T (p.Gln30Ter)	EPS8	Q30*	Deafness, autosomal recessive 102	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000155761	12	15834208	12	15681274	155761	165514	rs587777691	NC_000012.12:15681273:G:A
NM_001079866.2(BCS1L):c.901T>A (p.Tyr301Asn)	BCS1L	Y301N, Y181N, Y134N	Pili torti-deafness syndrome	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000126497	2	219527617	2	218662894	126497	132021	rs587777278	NC_000002.12:218662893:T:A
NM_033641.4(COL4A6):c.1768G>A (p.Gly590Ser)	COL4A6	G591S, G590S	Deafness, X-linked 6	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000102425	X	107430509	X	108187279	102425	108167	rs779748859	NC_000023.11:108187278:C:T
NM_198999.3(SLC26A5):c.209G>A (p.Trp70Ter)	SLC26A5	W70*	Deafness, autosomal recessive 61	Pathogenic(Last reviewed: Oct 28, 2013)	no assertion criteria provided	VCV000097021	7	103061268	7	103420821	97021	102926	rs431905518	NC_000007.14:103420820:C:T
NM_198999.3(SLC26A5):c.390A>C (p.Arg130Ser)	SLC26A5	R130S	Deafness, autosomal recessive 61	Pathogenic(Last reviewed: Oct 28, 2013)	no assertion criteria provided	VCV000097020	7	103053462	7	103413015	97020	102925	rs431905517	NC_000007.14:103413014:T:G
NM_002160.4(TNC):c.5386A>T (p.Thr1796Ser)	TNC	T1796S	Deafness, autosomal dominant 56	Pathogenic(Last reviewed: Jul 30, 2013)	no assertion criteria provided	VCV000097009	9	117803226	9	115040947	97009	102918	rs431905513	NC_000009.12:115040946:T:A
NM_002160.4(TNC):c.5317G>A (p.Val1773Met)	TNC	V1773M	Deafness, autosomal dominant 56	Pathogenic(Last reviewed: Jul 30, 2013)	no assertion criteria provided	VCV000097008	9	117803295	9	115041016	97008	102917	rs137933052	NC_000009.12:115041015:C:T
NM_001135022.2(ELMOD3):c.794T>C (p.Leu265Ser)	ELMOD3	L265S	Deafness, autosomal recessive 88	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000065464	2	85616929	2	85389806	65464	76380	rs587777040	NC_000002.12:85389805:T:C
NM_001292063.2(OTOG):c.6311C>T (p.Pro2104Leu)	OTOG	P2116L, P2104L	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039818	11	17634185	11	17612638	39818	48417	rs397514607	NC_000011.10:17612637:C:T
NM_033109.5(PNPT1):c.1424A>G (p.Glu475Gly)	PNPT1	E475G	Deafness, autosomal recessive 70	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039802	2	55883283	2	55656148	39802	48401	rs397514599	NC_000002.12:55656147:T:C
NM_001378609.3(OTOGL):c.5265+5G>A	OTOGL		Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039780	12	80735947	12	80342167	39780	48379	rs902734999	NC_000012.12:80342166:G:A
NM_001378609.3(OTOGL):c.574C>T (p.Arg192Ter)	OTOGL	R192*	Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039779	12	80623121	12	80229341	39779	48378	rs397514588	NC_000012.12:80229340:C:T
NM_006383.4(CIB2):c.368T>C (p.Ile123Thr)	CIB2	I123T, I74T, I80T, I128T	Deafness, autosomal recessive 48	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039687	15	78398255	15	78105913	39687	48286	rs397515412	NC_000015.10:78105912:A:G
NM_001031679.3(MSRB3):c.55C>T (p.Arg19Ter)	MSRB3	R19*	Deafness, autosomal recessive 74	Pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000031056	12	65702414	12	65308634	31056	40013	rs149258390	NC_000012.12:65308633:C:T
NM_001199799.2(ILDR1):c.1135G>T (p.Glu379Ter)	ILDR1	E379*, E335*, E290*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000030796	3	121712461	3	121993614	30796	39753	rs387907015	NC_000003.12:121993613:C:A
NM_133261.3(GIPC3):c.565C>T (p.Arg189Cys)	GIPC3	R189C	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030758	19	3586965	19	3586967	30758	39715	rs387907002	NC_000019.10:3586966:C:T
NM_133261.3(GIPC3):c.136G>A (p.Gly46Arg)	GIPC3	G46R	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030757	19	3585731	19	3585733	30757	39714	rs946085339	NC_000019.10:3585732:G:A
NM_133261.3(GIPC3):c.903G>A (p.Trp301Ter)	GIPC3	W301*	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Feb 15, 2011)	no assertion criteria provided	VCV000030754	19	3590152	19	3590154	30754	39711	rs387907000	NC_000019.10:3590153:G:A
NM_130837.3(OPA1):c.2894T>A (p.Val965Asp)	OPA1	V910D, V965D, V874D, V892D, V911D, V787D, V947D, V786D, V928D, V929D	Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000030463	3	193384980	3	193667191	30463	39420	rs387906901	NC_000003.12:193667190:T:A
NM_130837.3(OPA1):c.1481G>T (p.Gly494Val)	OPA1	G439V, G494V, G403V, G440V, G421V, G476V, G316V, G457V, G458V, G315V	Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000030462	3	193361767	3	193643978	30462	39419	rs387906900	NC_000003.12:193643977:G:T
NM_000260.4(MYO7A):c.1184G>A (p.Arg395His)	MYO7A	R395H, R384H	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000029926	11	76871312	11	77160266	29926	38881	rs387906700	NC_000011.10:77160265:G:A
NM_001002295.2(GATA3):c.1025G>A (p.Cys342Tyr)	GATA3	C342Y, C341Y	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000029693	10	8111536	10	8069573	29693	38648	rs387906621	NC_000010.11:8069572:G:A
NM_004004.6(GJB2):c.218A>G (p.His73Arg)	GJB2	H73R	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Apr 17, 1999)	no assertion criteria provided	VCV000017037	13	20763503	13	20189364	17037	32076	rs121912968	NC_000013.11:20189363:T:C
NM_004004.6(GJB2):c.162C>A (p.Asn54Lys)	GJB2	N54K	Knuckle pads, deafness AND leukonychia syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000017030	13	20763559	13	20189420	17030	32069	rs104894412	NC_000013.11:20189419:G:T
NM_004004.6(GJB2):c.50C>T (p.Ser17Phe)	GJB2	S17F	Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000017022	13	20763671	13	20189532	17022	32061	rs28929485	NC_000013.11:20189531:G:A
NM_004004.6(GJB2):c.34G>C (p.Gly12Arg)	GJB2	G12R	Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000017021	13	20763687	13	20189548	17021	32060	rs104894408	NC_000013.11:20189547:C:G
NM_004004.6(GJB2):c.176G>C (p.Gly59Ala)	GJB2	G59A	Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000017015	13	20763545	13	20189406	17015	32054	rs104894404	NC_000013.11:20189405:C:G
NM_001376256.1(CRYM):c.941A>C (p.Lys314Thr)	CRYM	K314T	Deafness, autosomal dominant 40	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000016935	16	21270106	16	21258785	16935	31974	rs104894512	NC_000016.10:21258784:T:G
NM_001376256.1(CRYM):c.945A>T (p.Ter315Tyr)	CRYM		Deafness, autosomal dominant 40	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000016934	16	21270102	16	21258781	16934	31973	rs104894509	NC_000016.10:21258780:T:A
NM_001002295.2(GATA3):c.1059A>T (p.Arg353Ser)	GATA3	R353S, R352S	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016630	10	8115710	10	8073747	16630	31669	rs104894165	NC_000010.11:8073746:A:T
NM_001002295.2(GATA3):c.823T>A (p.Trp275Arg)	GATA3	W275R, W274R	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000016624	10	8106000	10	8064037	16624	31663	rs104894163	NC_000010.11:8064036:T:A
NM_001002295.2(GATA3):c.829C>T (p.Arg277Ter)	GATA3	R277*, R276*	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jul 27, 2000)	no assertion criteria provided	VCV000016623	10	8106006	10	8064043	16623	31662	rs104894162	NC_000010.11:8064042:C:T
NM_000222.3(KIT):c.2386A>G (p.Arg796Gly)	KIT	R796G, R792G, R791G, R793G, R795G, R797G	Piebaldism with sensorineural deafness	Pathogenic(Last reviewed: Jan 6, 1998)	no assertion criteria provided	VCV000013858	4	55599260	4	54733094	13858	28897	rs121913684	NC_000004.12:54733093:A:G
NM_004568.6(SERPINB6):c.733G>T (p.Glu245Ter)	SERPINB6	E245*, E249*, E259*, E264*, E201*	Deafness, autosomal recessive 91	Pathogenic(Last reviewed: May 14, 2010)	no assertion criteria provided	VCV000013601	6	2948930	6	2948696	13601	28640	rs267607037	NC_000006.12:2948695:C:A
NM_000328.3(RPGR):c.517G>C (p.Gly173Arg)	RPGR	G173R, G172R, G183R	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with deafness	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000009916	X	38176671	X	38317418	9916	24955	rs137852550	NC_000023.11:38317417:C:G
m.12183G>A	MT-TH		Pigmentary retinopathy and sensorineural deafness	Pathogenic(Last reviewed: Apr 8, 2003)	no assertion criteria provided	VCV000009609	MT	12183	MT	12183	9609	24648	rs121434473	NC_012920.1:12182:G:A
NM_024009.3(GJB3):c.497A>G (p.Asn166Ser)	GJB3	N166S	Deafness, digenic, GJB2/GJB3	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000006492	1	35250860	1	34785259	6492	21531	rs121908851	NC_000001.11:34785258:A:G
NM_130837.3(OPA1):c.1910A>G (p.Tyr637Cys)	OPA1	Y582C, Y637C, Y546C, Y600C, Y619C, Y458C, Y583C, Y459C, Y564C, Y601C	Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000005090	3	193365898	3	193648109	5090	20129	rs121908376	NC_000003.12:193648108:A:G
NM_031475.3(ESPN):c.2321G>A (p.Arg774Gln)	ESPN	R774Q, R744Q, R753Q	Deafness, without vestibular involvement, autosomal dominant	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000004422	1	6512152	1	6452092	4422	19461	rs121908136	NC_000001.11:6452091:G:A
NM_031475.3(ESPN):c.2155A>C (p.Ser719Arg)	ESPN	S719R, S689R, S698R	Deafness, without vestibular involvement, autosomal dominant	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000004420	1	6511986	1	6451926	4420	19459	rs121908134	NC_000001.11:6451925:A:C
NM_001174089.2(SLC4A11):c.589T>C (p.Ser197Pro)	SLC4A11	S213P, S197P, S240P	Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001319	20	3214583	20	3233937	1319	16358	rs121909395	NC_000020.11:3233936:A:G
NM_001174089.2(SLC4A11):c.2518A>G (p.Met840Val)	SLC4A11	M856V, M840V, M802V, M883V	Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001315	20	3208945	20	3228299	1315	16354	rs121909396	NC_000020.11:3228298:T:C
NM_001174089.2(SLC4A11):c.1415G>A (p.Arg472Lys)	SLC4A11	R488K, R472K, R434K, R515K	Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001314	20	3211161	20	3230515	1314	16353	rs121909393	NC_000020.11:3230514:C:T
NM_001080476.3(GRXCR1):c.412C>T (p.Arg138Cys)	GRXCR1	R138C	Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000196	4	42964936	4	42962919	196	15235	rs267606856	NC_000004.12:42962918:C:T
NM_001080476.3(GRXCR1):c.628-9C>A	GRXCR1		Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000193	4	43022362	4	43020345	193	15232	rs606231120	NC_000004.12:43020344:C:A
NM_017433.5(MYO3A):c.4587-1G>A	MYO3A		Deafness, autosomal recessive 30	Pathogenic(Last reviewed: Aug 23, 2019)	no assertion criteria provided	VCV001323315					1323315	1313601		
NM_001384474.1(LOXHD1):c.1228C>T (p.Gln410Ter)	LOXHD1	Q410*	Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Apr 15, 2021)	no assertion criteria provided	VCV001323244					1323244	1313530		
NM_001042702.5(PJVK):c.550-2A>T	PJVK		Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Sep 1, 2020)	no assertion criteria provided	VCV001322205					1322205	1312519		
NM_002691.4(POLD1):c.3199G>A (p.Glu1067Lys)	POLD1	E1067K, E1093K	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	Pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, single submitter	VCV001301641	19	50920507	19	50417250	1301641	1291924		NC_000019.10:50417249:G:A
NM_001199799.2(ILDR1):c.820C>T (p.Gln274Ter)	ILDR1	Q185*, Q230*, Q274*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001299309	3	121712776	3	121993929	1299309	1289168		NC_000003.12:121993928:G:A
NM_033109.5(PNPT1):c.1619A>G (p.Asn540Ser)	PNPT1	N540S	Deafness, autosomal recessive 70	Pathogenic	criteria provided, single submitter	VCV000972897	2	55873605	2	55646470	972897	961219	rs202190573	NC_000002.12:55646469:T:C
NM_001292063.2(OTOG):c.379C>T (p.Gln127Ter)	OTOG	Q127*, Q139*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000930109	11	17574752	11	17553205	930109	918352	rs1851981434	NC_000011.10:17553204:C:T
NM_001001331.4(ATP2B2):c.1033C>T (p.Gln345Ter)	ATP2B2	Q345*	Autosomal dominant non-syndromic sensorineural deafness type DFNA	Pathogenic(Last reviewed: Jul 6, 2019)	no assertion criteria provided	VCV000917514	3	10420936	3	10379252	917514	905842	rs2061464108	NC_000003.12:10379251:G:A
NM_001199799.2(ILDR1):c.942C>A (p.Cys314Ter)	ILDR1	C225*, C270*, C314*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000695027	3	121712654	3	121993807	695027	683136	rs752714222	NC_000003.12:121993806:G:T
NM_194248.3(OTOF):c.3864+1G>A	OTOF		Rare genetic deafness	Pathogenic(Last reviewed: Feb 24, 2018)	criteria provided, single submitter	VCV000667426	2	26695386	2	26472518	667426	654272	rs758918226	NC_000002.12:26472517:C:T
NM_181458.4(PAX3):c.1166C>G (p.Ser389Ter)	PAX3	S389*, S388*	Rare genetic deafness	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000667018	2	223084866	2	222220147	667018	654244	rs758136826	NC_000002.12:222220146:G:C
NM_153700.2(STRC):c.259C>T (p.Gln87Ter)	STRC	Q87*	Rare genetic deafness	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000666998	15	43910360	15	43618162	666998	654775	rs1344019160	NC_000015.10:43618161:G:A
NM_153700.2(STRC):c.4375+1G>A	STRC		Rare genetic deafness	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000666997	15	43896193	15	43603995	666997	654768	rs766595464	NC_000015.10:43603994:C:T
NM_001378609.3(OTOGL):c.6122-1G>A	OTOGL		Deafness, autosomal recessive 84b	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522356	12	80752450	12	80358670	522356	512934	rs952235302	NC_000012.12:80358669:G:A
NM_016239.4(MYO15A):c.8341-2A>C	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000517420	17	18058626	17	18155312	517420	497703	rs778404517	NC_000017.11:18155311:A:C
NM_144672.4(OTOA):c.268-2A>G	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000505849	16	21696549	16	21685228	505849	497686	rs770892393	NC_000016.10:21685227:A:G
NM_001384474.1(LOXHD1):c.3148G>T (p.Glu1050Ter)	LOXHD1	E1050*	Rare genetic deafness	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000505330	18	44139479	18	46559516	505330	497581	rs1555679863	NC_000018.10:46559515:C:A
NM_000503.6(EYA1):c.241C>T (p.Gln81Ter)	EYA1	Q81*, Q110*	Rare genetic deafness	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000504996	8	72234465	8	71322230	504996	496931	rs1554550637	NC_000008.11:71322229:G:A
NM_032119.4(ADGRV1):c.2302G>T (p.Glu768Ter)	ADGRV1	E768*	Rare genetic deafness	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000504947	5	89938514	5	90642697	504947	496392	rs1554068885	NC_000005.10:90642696:G:T
NM_001039141.3(TRIOBP):c.3055G>A (p.Gly1019Arg)	TRIOBP	G1019R	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402281	22	38121618	22	37725611	402281	389255	rs549095193	NC_000022.11:37725610:G:A
NM_001039141.3(TRIOBP):c.1447C>T (p.Gln483Ter)	TRIOBP	Q483*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402280	22	38120010	22	37724003	402280	389254	rs1060499809	NC_000022.11:37724002:C:T
NM_144672.4(OTOA):c.1025A>T (p.Asp342Val)	OTOA	D342V, D18V, D263V	Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402269	16	21716534	16	21705213	402269	389247	rs1060499804	NC_000016.10:21705212:A:T
NM_001384474.1(LOXHD1):c.4843G>A (p.Gly1615Arg)	LOXHD1	G1615R, G408R, G504R	Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402259	18	44104462	18	46524499	402259	389251	rs768835732	NC_000018.10:46524498:C:T
NM_001379180.1(ESRRB):c.850G>A (p.Gly284Ser)	ESRRB	G263S, G284S	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402255	14	76949102	14	76482759	402255	389246	rs375916159	NC_000014.9:76482758:G:A
NM_001379180.1(ESRRB):c.608G>A (p.Arg203His)	ESRRB	R182H, R203H	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402254	14	76948389	14	76482046	402254	389245	rs1060499794	NC_000014.9:76482045:G:A
NM_022124.6(CDH23):c.3181G>A (p.Glu1061Lys)	CDH23	E1061K	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402253	10	73468929	10	71709172	402253	389236	rs1060499793	NC_000010.11:71709171:G:A
NM_004004.6(GJB2):c.400T>C (p.Trp134Arg)	GJB2	W134R	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236061	13	20763321	13	20189182	236061	237615	rs878853241	NC_000013.11:20189181:A:G
NM_206933.4(USH2A):c.13711G>T (p.Glu4571Ter)	USH2A	E4571*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000228412	1	215847542	1	215674200	228412	228300	rs751411512	NC_000001.11:215674199:C:A
NM_138691.3(TMC1):c.1677G>A (p.Trp559Ter)	TMC1	W559*	Rare genetic deafness	Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	VCV000228407	9	75420408	9	72805492	228407	229706	rs876657729	NC_000009.12:72805491:G:A
NM_153700.2(STRC):c.3493C>T (p.Gln1165Ter)	STRC	Q1165*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000228403	15	43902515	15	43610317	228403	230571	rs876657726	NC_000015.10:43610316:G:A
NM_153700.2(STRC):c.3217C>T (p.Arg1073Ter)	STRC	R1073*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000228402	15	43903435	15	43611237	228402	230574	rs876657725	NC_000015.10:43611236:G:A
NM_153700.2(STRC):c.1086C>A (p.Tyr362Ter)	STRC	Y362*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000228401	15	43908678	15	43616480	228401	230579	rs876657724	NC_000015.10:43616479:G:T
NM_016239.4(MYO15A):c.9303+1G>T	MYO15A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000228374	17	18062994	17	18159680	228374	230750	rs876657708	NC_000017.11:18159679:G:T
NM_001354604.2(MITF):c.704C>G (p.Ser235Ter)	MITF	S128*, S235*, S219*, S72*, S218*, S234*, S183*	Rare genetic deafness	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000228364	3	69990424	3	69941273	228364	229148	rs876657700	NC_000003.12:69941272:C:G
NM_001354604.2(MITF):c.1043G>A (p.Trp348Ter)	MITF	W241*, W342*, W325*, W341*, W347*, W290*, W348*, W179*, W235*, W326*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000228362	3	70008435	3	69959284	228362	229151	rs876657698	NC_000003.12:69959283:G:A
NM_013296.5(GPSM2):c.1063-1G>T	GPSM2		Rare genetic deafness	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000228354	1	109446746	1	108904124	228354	228256	rs773068151	NC_000001.11:108904123:G:T
NM_032119.4(ADGRV1):c.14885G>A (p.Trp4962Ter)	ADGRV1	W4962*	Rare genetic deafness	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000228351	5	90103467	5	90807650	228351	229362	rs876657694	NC_000005.10:90807649:G:A
NM_133261.3(GIPC3):c.411+1G>A	GIPC3		Rare genetic deafness	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	VCV000228349	19	3586679	19	3586681	228349	230991	rs876657692	NC_000019.10:3586680:G:A
NM_000503.6(EYA1):c.896C>A (p.Ser299Ter)	EYA1	S299*, S177*, S293*, S328*, S322*, S323*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000228347	8	72184063	8	71271828	228347	229628	rs876657691	NC_000008.11:71271827:G:T
NM_000503.6(EYA1):c.1090G>T (p.Glu364Ter)	EYA1	E364*, E393*, E242*, E358*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000228345	8	72156888	8	71244653	228345	229627	rs876657689	NC_000008.11:71244652:C:A
NM_022124.6(CDH23):c.9556C>T (p.Arg3186Ter)	CDH23	R3186*, R946*, R83*	Rare genetic deafness	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000228330	10	73572570	10	71812813	228330	229908	rs773464867	NC_000010.11:71812812:C:T
NM_022124.6(CDH23):c.7483-1G>C	CDH23		Rare genetic deafness	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	VCV000228329	10	73562654	10	71802897	228329	229896	rs876657682	NC_000010.11:71802896:G:C
NM_194248.3(OTOF):c.2818C>T (p.Gln940Ter)	OTOF	Q940*, Q193*, Q250*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 30, 2014)	criteria provided, single submitter	VCV000179539	2	26699044	2	26476176	179539	173511	rs727504936	NC_000002.12:26476175:G:A
NM_206933.4(USH2A):c.632G>A (p.Trp211Ter)	USH2A	W211*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 23, 2013)	criteria provided, single submitter	VCV000179482	1	216591875	1	216418533	179482	172924	rs727504893	NC_000001.11:216418532:C:T
NM_206933.4(USH2A):c.14248C>T (p.Gln4750Ter)	USH2A	Q4750*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 12, 2013)	criteria provided, single submitter	VCV000179439	1	215824029	1	215650687	179439	172515	rs727504867	NC_000001.11:215650686:G:A
NM_032119.4(ADGRV1):c.12631C>T (p.Arg4211Ter)	ADGRV1	R4211*	Rare genetic deafness	Pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	VCV000179305	5	90073825	5	90778008	179305	174459	rs727504777	NC_000005.10:90778007:C:T
NM_016239.4(MYO15A):c.10136C>A (p.Ser3379Ter)	MYO15A	S3379*	Rare genetic deafness	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000179222	17	18075005	17	18171691	179222	176488	rs546575046	NC_000017.11:18171690:C:A
NM_206933.4(USH2A):c.11145T>A (p.Tyr3715Ter)	USH2A	Y3715*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	VCV000179075	1	215933088	1	215759746	179075	172750	rs727504608	NC_000001.11:215759745:A:T
NM_000503.6(EYA1):c.428G>A (p.Trp143Ter)	EYA1	W143*, W172*	Rare genetic deafness	Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	VCV000178857	8	72229915	8	71317680	178857	174401	rs727504494	NC_000008.11:71317679:C:T
NM_194248.3(OTOF):c.2991+2T>G	OTOF		Rare genetic deafness	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000178509	2	26698780	2	26475912	178509	173510	rs370132645	NC_000002.12:26475911:A:C
NM_144672.4(OTOA):c.1688+1G>T	OTOA		Rare genetic deafness	Pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	VCV000164824	16	21730513	16	21719192	164824	175925	rs727503350	NC_000016.10:21719191:G:T
NM_022124.6(CDH23):c.7873-2A>T	CDH23		Rare genetic deafness	Pathogenic(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	VCV000162945	10	73565561	10	71805804	162945	174998	rs727502933	NC_000010.11:71805803:A:T
NM_022124.6(CDH23):c.945+1G>T	CDH23		Rare genetic deafness	Pathogenic(Last reviewed: Jul 24, 2014)	criteria provided, single submitter	VCV000162876	10	73375374	10	71615617	162876	174680	rs727502919	NC_000010.11:71615616:G:T
NM_206933.4(USH2A):c.9159T>G (p.Tyr3053Ter)	USH2A	Y3053*	Rare genetic deafness	Pathogenic(Last reviewed: Mar 12, 2012)	criteria provided, single submitter	VCV000048613	1	216017735	1	215844393	48613	57775	rs397518042	NC_000001.11:215844392:A:C
NM_206933.4(USH2A):c.12714T>G (p.Tyr4238Ter)	USH2A	Y4238*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 30, 2011)	criteria provided, single submitter	VCV000048405	1	215848539	1	215675197	48405	57567	rs397517981	NC_000001.11:215675196:A:C
NM_000503.6(EYA1):c.1361-1G>T	EYA1		Rare genetic deafness	Pathogenic(Last reviewed: Nov 24, 2010)	criteria provided, single submitter	VCV000048102	8	72127964	8	71215729	48102	57266	rs397517917	NC_000008.11:71215728:C:A
NM_032119.4(ADGRV1):c.7406G>A (p.Trp2469Ter)	ADGRV1	W2469*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 30, 2013)	criteria provided, single submitter	VCV000046371	5	89989979	5	90694162	46371	55536	rs397517436	NC_000005.10:90694161:G:A
NM_032119.4(ADGRV1):c.11253C>G (p.Tyr3751Ter)	ADGRV1	Y3751*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 25, 2013)	criteria provided, single submitter	VCV000046254	5	90049522	5	90753705	46254	55419	rs376689763	NC_000005.10:90753704:C:G
NM_022124.6(CDH23):c.8781C>A (p.Tyr2927Ter)	CDH23	Y2927*, Y687*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 26, 2012)	criteria provided, single submitter	VCV000046053	10	73569635	10	71809878	46053	55218	rs397517362	NC_000010.11:71809877:C:A
NM_022124.6(CDH23):c.5923+1G>A	CDH23		Rare genetic deafness	Pathogenic(Last reviewed: Sep 27, 2010)	criteria provided, single submitter	VCV000045995	10	73548800	10	71789043	45995	55160	rs397517346	NC_000010.11:71789042:G:A
NM_015404.4(WHRN):c.1267C>T (p.Arg423Ter)	WHRN	R423*, R40*, R72*	Rare genetic deafness	Pathogenic(Last reviewed: Aug 4, 2010)	criteria provided, single submitter	VCV000045645	9	117186763	9	114424483	45645	54810	rs397517255	NC_000009.12:114424482:G:A
NM_006005.3(WFS1):c.2141A>C (p.Asn714Thr)	WFS1	N714T	Rare genetic deafness	Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	VCV000045447	4	6303663	4	6301936	45447	54614	rs397517196	NC_000004.12:6301935:A:C
NM_000441.2(SLC26A4):c.2188C>T (p.Gln730Ter)	SLC26A4	Q730*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 6, 2010)	criteria provided, single submitter	VCV000043542	7	107350597	7	107710152	43542	52711	rs397516428	NC_000007.14:107710151:C:T
NM_000307.5(POU3F4):c.499C>T (p.Arg167Ter)	POU3F4	R167*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 10, 2008)	criteria provided, single submitter	VCV000043347	X	82763831	X	83508823	43347	52517	rs111033345	NC_000023.11:83508822:C:T
NM_000260.4(MYO7A):c.6498C>A (p.Tyr2166Ter)	MYO7A	Y2166*, Y2126*, Y2117*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 21, 2011)	criteria provided, single submitter	VCV000043330	11	76924964	11	77213919	43330	52500	rs397516331	NC_000011.10:77213918:C:A
NM_000260.4(MYO7A):c.2094+1G>A	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: Dec 23, 2010)	criteria provided, single submitter	VCV000043171	11	76885961	11	77174915	43171	52341	rs111033404	NC_000011.10:77174914:G:A
NM_000260.4(MYO7A):c.141G>A (p.Trp47Ter)	MYO7A	W47*, W36*	Rare genetic deafness	Pathogenic(Last reviewed: May 14, 2012)	criteria provided, single submitter	VCV000043146	11	76858852	11	77147806	43146	52316	rs397516285	NC_000011.10:77147805:G:A
NM_001084.5(PLOD3):c.668A>G (p.Asn223Ser)	PLOD3	N223S	Bone fragility with contractures, arterial rupture, and deafness	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000006643	7	100858381	7	101215100	6643	21682	rs121434414	NC_000007.14:101215099:T:C
NM_138691.3(TMC1):c.1259G>A (p.Cys420Tyr)	TMC1	C420Y	Deafness, autosomal recessive|Deafness, autosomal recessive 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000619172	9	75406836	9	72791920	619172	610566	rs1564556995	NC_000009.12:72791919:G:A
NM_022124.6(CDH23):c.6083A>C (p.Asp2028Ala)	CDH23	D2028A	Deafness, autosomal recessive|Deafness, autosomal recessive 12	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000619171	10	73550922	10	71791165	619171	610567	rs762226905	NC_000010.11:71791164:A:C
NM_153700.2(STRC):c.379C>T (p.Arg127Ter)	STRC	R127*	Rare genetic deafness|Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000505325	15	43910240	15	43618042	505325	497466	rs771264491	NC_000015.10:43618041:G:A
NM_000245.4(MET):c.2521T>G (p.Phe841Val)	MET	F841V, F859V, F411V	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive|Deafness, autosomal recessive 97	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000183686	7	116403260	7	116763206	183686	181585	rs794728016	NC_000007.14:116763205:T:G
NM_016239.4(MYO15A):c.8714-1G>A	MYO15A		Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	VCV000178449	17	18060469	17	18157155	178449	176480	rs377015931	NC_000017.11:18157154:G:A
NM_016356.5(DCDC2):c.1271A>C (p.Gln424Pro)	DCDC2	Q424P	Deafness, autosomal recessive 66|Nonsyndromic Deafness	Pathogenic(Last reviewed: Jan 18, 2015)	no assertion criteria provided	VCV000161160	6	24178613	6	24178385	161160	171004	rs794729665	NC_000006.12:24178384:T:G
NM_016239.4(MYO15A):c.9517+2T>C	MYO15A		Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000666995	17	18064763	17	18161449	666995	654829	rs1322423998	NC_000017.11:18161448:T:C
NM_016239.4(MYO15A):c.996C>G (p.Tyr332Ter)	MYO15A	Y332*	Deafness, autosomal recessive 3|Rare genetic deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000505185	17	18023110	17	18119796	505185	497482	rs759523751	NC_000017.11:18119795:C:G
NM_016239.4(MYO15A):c.5896C>T (p.Arg1966Ter)	MYO15A	R1966*	Rare genetic deafness|Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228373	17	18046140	17	18142826	228373	230729	rs765468034	NC_000017.11:18142825:C:T
NM_153700.2(STRC):c.4195G>T (p.Glu1399Ter)	STRC	E1399*	Rare genetic deafness|Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000165310	15	43896582	15	43604384	165310	176112	rs371513959	NC_000015.10:43604383:C:A
NM_153700.2(STRC):c.4701+1G>A	STRC		Deafness, autosomal recessive 16|Rare genetic deafness	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000165305	15	43893593	15	43601395	165305	175965	rs199839039	NC_000015.10:43601394:C:T
NM_194248.3(OTOF):c.4799+1G>A	OTOF		Deafness, autosomal recessive|Rare genetic deafness	Pathogenic(Last reviewed: Jan 30, 2014)	criteria provided, single submitter	VCV000164841	2	26688539	2	26465671	164841	173640	rs200147906	NC_000002.12:26465670:C:T
NM_144672.4(OTOA):c.1352G>A (p.Gly451Asp)	OTOA	G451D, G127D, G372D	Deafness, autosomal recessive|Deafness, autosomal recessive 22	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000100654	16	21726337	16	21715016	100654	106526	rs200656442	NC_000016.10:21715015:G:A
NM_006383.4(CIB2):c.297C>G (p.Cys99Trp)	CIB2	C99W, C104W, C50W, C56W	Deafness, autosomal recessive 48|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039686	15	78401626	15	78109284	39686	48285	rs370965183	NC_000015.10:78109283:G:C
NM_006383.4(CIB2):c.272T>C (p.Phe91Ser)	CIB2	F91S, F96S, F42S, F48S	Deafness, autosomal recessive 48|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039685	15	78401651	15	78109309	39685	48284	rs397515411	NC_000015.10:78109308:A:G
NM_004999.4(MYO6):c.2545C>T (p.Arg849Ter)	MYO6	R849*, R844*	Rare genetic deafness|Autosomal dominant nonsyndromic deafness 22	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000008582	6	76596598	6	75886881	8582	23621	rs121912561	NC_000006.12:75886880:C:T
NM_022124.6(CDH23):c.6133G>A (p.Asp2045Asn)	CDH23	D2045N	Deafness, autosomal recessive 12|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000004919	10	73550972	10	71791215	4919	19958	rs121908348	NC_000010.11:71791214:G:A
NM_138691.3(TMC1):c.1543T>C (p.Cys515Arg)	TMC1	C515R	Deafness, autosomal recessive|Deafness, autosomal recessive 7	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000004107	9	75407245	9	72792329	4107	19146	rs121908076	NC_000009.12:72792328:T:C
NM_001128228.3(TPRN):c.1239G>A (p.Trp413Ter)	TPRN	W413*	Deafness, autosomal recessive 79|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000134	9	140093925	9	137199473	134	15173	rs267607135	NC_000009.12:137199472:C:T
NM_000260.4(MYO7A):c.2557C>T (p.Arg853Cys)	MYO7A	R842C, R853C	Deafness, autosomal dominant 11	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV001333565	11	76890970	11	77179924	1333565	1324336		NC_000011.10:77179923:C:T
NM_194248.3(OTOF):c.1392+1G>A	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Dec 16, 2019)	no assertion criteria provided	VCV001323390					1323390	1313675		
NM_001127453.2(GSDME):c.1102C>G (p.Gln368Glu)	GSDME	Q368E, Q204E	Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Oct 1, 2021)	no assertion criteria provided	VCV001298356	7	24745884	7	24706265	1298356	1288218		NC_000007.14:24706264:G:C
NM_000441.2(SLC26A4):c.415+2T>C	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	no assertion criteria provided	VCV001065211	7	107312695	7	107672250	1065211	1053519		NC_000007.14:107672249:T:C
NM_000441.2(SLC26A4):c.1264-12T>A	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	no assertion criteria provided	VCV001065209	7	107334836	7	107694391	1065209	1053521		NC_000007.14:107694390:T:A
NM_001080476.3(GRXCR1):c.469G>T (p.Glu157Ter)	GRXCR1	E157*	Deafness, autosomal recessive 25	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000987829	4	42964993	4	42962976	987829	975781	rs774844858	NC_000004.12:42962975:G:T
NM_031475.3(ESPN):c.1916-1G>C	ESPN		Deafness, autosomal recessive 36, with or without vestibular involvement	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV000984702	1	6511662	1	6451602	984702	972779	rs1643944047	NC_000001.11:6451601:G:C
NM_016239.4(MYO15A):c.5673C>G (p.Tyr1891Ter)	MYO15A	Y1891*	Deafness, autosomal recessive 3	Pathogenic	criteria provided, single submitter	VCV000973491	17	18045416	17	18142102	973491	961804	rs2046392476	NC_000017.11:18142101:C:G
NM_177398.4(LMX1A):c.721G>C (p.Val241Leu)	LMX1A|LMX1A-AS2	V241L	Deafness, autosomal dominant 7	Pathogenic(Last reviewed: Feb 12, 2020)	no assertion criteria provided	VCV000812515	1	165179962	1	165210725	812515	800758	rs1571147567	NC_000001.11:165210724:C:G
NM_000260.4(MYO7A):c.1708C>T (p.Arg570Ter)	MYO7A	R559*, R570*	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000802705	11	76877119	11	77166073	802705	791176	rs1591310948	NC_000011.10:77166072:C:T
NM_016239.4(MYO15A):c.488C>A (p.Ser163Ter)	MYO15A	S163*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000694390	17	18022602	17	18119288	694390	682318	rs773729617	NC_000017.11:18119287:C:A
NM_138691.3(TMC1):c.885-2A>C	TMC1		Deafness, autosomal recessive 7	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000620585	9	75403253	9	72788337	620585	611985	rs1564554148	NC_000009.12:72788336:A:C
NM_001199107.2(TBC1D24):c.1131C>G (p.Tyr377Ter)	TBC1D24	Y377*, Y371*	Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000569501	16	2548386	16	2498385	569501	570225	rs1567413218	NC_000016.10:2498384:C:G
NM_020971.3(SPTBN4):c.7303C>T (p.Arg2435Cys)	SPTBN4	R2435C	Myopathy, congenital, with neuropathy and deafness	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000559548	19	41076618	19	40570712	559548	550271	rs777273785	NC_000019.10:40570711:C:T
NM_020971.3(SPTBN4):c.1511G>A (p.Arg504Gln)	SPTBN4	R504Q	Myopathy, congenital, with neuropathy and deafness	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000559547	19	41009885	19	40503978	559547	550270	rs765087147	NC_000019.10:40503977:G:A
NM_004004.6(GJB2):c.172C>G (p.Pro58Ala)	GJB2	P58A	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424853	13	20763549	13	20189410	424853	413168	rs1064797090	NC_000013.11:20189409:G:C
NM_004004.6(GJB2):c.164C>A (p.Thr55Asn)	GJB2	T55N	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424852	13	20763557	13	20189418	424852	413169	rs1064797089	NC_000013.11:20189417:G:T
NM_004004.6(GJB2):c.136G>A (p.Asp46Asn)	GJB2	D46N	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424851	13	20763585	13	20189446	424851	413170	rs1064797088	NC_000013.11:20189445:C:T
NM_000260.4(MYO7A):c.4153-2A>G	MYO7A		Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000402268	11	76905397	11	77194352	402268	389241	rs1060499803	NC_000011.10:77194351:A:G
NM_000260.4(MYO7A):c.6211C>T (p.Gln2071Ter)	MYO7A	Q2071*, Q2022*, Q2033*	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000402266	11	76922356	11	77211311	402266	389243	rs1060499802	NC_000011.10:77211310:C:T
NM_194248.3(OTOF):c.1111G>C (p.Gly371Arg)	OTOF	G371R	Deafness, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000252378	2	26707436	2	26484568	252378	246783	rs879255246	NC_000002.12:26484567:C:G
NM_000307.5(POU3F4):c.235C>T (p.Gln79Ter)	POU3F4	Q79*	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236062	X	82763567	X	83508559	236062	237626	rs878853242	NC_000023.11:83508558:C:T
NM_005422.4(TECTA):c.2887G>A (p.Ala963Thr)	TBCEL-TECTA|TECTA	A963T, A1282T	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236059	11	121000866	11	121130157	236059	237609	rs753896285	NC_000011.10:121130156:G:A
NM_016239.4(MYO15A):c.6340G>A (p.Val2114Met)	MYO15A	V2114M	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236040	17	18049252	17	18145938	236040	237620	rs377385081	NC_000017.11:18145937:G:A
NM_016239.4(MYO15A):c.7207G>T (p.Asp2403Tyr)	MYO15A	D2403Y	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000236037	17	18052889	17	18149575	236037	237621	rs878853227	NC_000017.11:18149574:G:T
NM_004839.4(HOMER2):c.554G>C (p.Arg185Pro)	HOMER2	R185P, R196P	Deafness, autosomal dominant 68	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000218351	15	83523493	15	82854741	218351	215059	rs864309524	NC_000015.10:82854740:C:G
NM_004208.4(AIFM1):c.778A>G (p.Thr260Ala)	AIFM1|RAB33A	T260A, T256A	Deafness, X-linked 5	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000218110	X	129274511	X	130140536	218110	214765	rs863225432	NC_000023.11:130140535:T:C
NM_005982.4(SIX1):c.373G>A (p.Glu125Lys)	SIX1	E125K	Deafness, autosomal dominant 23	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000208361	14	61115535	14	60648817	208361	204589	rs797044960	NC_000014.9:60648816:C:T
NM_001693.4(ATP6V1B2):c.1516C>T (p.Arg506Ter)	ATP6V1B2	R506*	Deafness, congenital, with onychodystrophy, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000203442	8	20077893	8	20220382	203442	199855	rs794729667	NC_000008.11:20220381:C:T
NM_001146079.2(CLDN14):c.167G>A (p.Trp56Ter)	CLDN14|CLDN14-AS1	W56*	Deafness, autosomal recessive 29	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000189332	21	37833827	21	36461529	189332	187220	rs371100799	NC_000021.9:36461528:C:T
NM_138691.3(TMC1):c.1253T>A (p.Met418Lys)	TMC1	M418K	Deafness, autosomal dominant 36	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000183668	9	75406830	9	72791914	183668	181568	rs786201027	NC_000009.12:72791913:T:A
NM_001145026.2(PTPRQ):c.837T>A (p.Tyr279Ter)	PTPRQ	Y279*	Deafness, autosomal recessive 84	Pathogenic(Last reviewed: Apr 9, 2010)	no assertion criteria provided	VCV000156333	12	80849348	12	80460829	156333	166113	rs183258549	NC_000012.12:80460828:T:A
NM_001145026.2(PTPRQ):c.715A>G (p.Arg239Gly)	PTPRQ	R239G	Deafness, autosomal recessive 84	Pathogenic(Last reviewed: Apr 9, 2010)	no assertion criteria provided	VCV000156332	12	80849470	12	80460707	156332	166112	rs281865414	NC_000012.12:80460706:A:G
NM_170682.4(P2RX2):c.178G>T (p.Val60Leu)	P2RX2	V60L, R37L	Deafness, autosomal dominant 41	Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000155762	12	133196029	12	132619443	155762	165515	rs587777692	NC_000012.12:132619442:G:T
NM_144672.4(OTOA):c.1879C>T (p.Pro627Ser)	OTOA	P627S, P548S, P303S	Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000100655	16	21734298	16	21722977	100655	106527	rs587777133	NC_000016.10:21722976:C:T
NM_002700.3(POU4F3):c.977G>A (p.Arg326Lys)	POU4F3	R326K	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000096710	5	145719967	5	146340404	96710	102599	rs398123070	NC_000005.10:146340403:G:A
NM_024915.4(GRHL2):c.1258-1G>A	GRHL2		Deafness, autosomal dominant 28	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000092126	8	102643864	8	101631636	92126	97553	rs398123006	NC_000008.11:101631635:G:A
NM_001130823.3(DNMT1):c.1816G>T (p.Val606Phe)	DNMT1	V606F, V485F, V590F	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	Pathogenic(Last reviewed: May 15, 2012)	no assertion criteria provided	VCV000050919	19	10265278	19	10154602	50919	65578	rs397509391	NC_000019.10:10154601:C:A
NM_001283.5(AP1S1):c.183-2A>G	AP1S1		Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000039854	7	100800656	7	101157375	39854	48453	rs751430853	NC_000007.14:101157374:A:G
NM_001039213.4(CEACAM16):c.418A>C (p.Thr140Pro)	CEACAM16	T140P	Deafness, autosomal dominant 4b	Pathogenic(Last reviewed: Mar 8, 2011)	no assertion criteria provided	VCV000031238	19	45207323	19	44704053	31238	40195	rs387907149	NC_000019.10:44704052:A:C
NM_001199799.2(ILDR1):c.583C>T (p.Gln195Ter)	ILDR1	Q195*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Oct 23, 2020)	no assertion criteria provided	VCV000030798	3	121720218	3	122001371	30798	39755	rs387907017	NC_000003.12:122001370:G:A
NM_133261.3(GIPC3):c.767G>A (p.Gly256Asp)	GIPC3	G256D	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030756	19	3589890	19	3589892	30756	39713	rs387907001	NC_000019.10:3589891:G:A
NM_133261.3(GIPC3):c.785T>G (p.Leu262Arg)	GIPC3	L262R	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Feb 15, 2011)	no assertion criteria provided	VCV000030753	19	3589908	19	3589910	30753	39710	rs387906999	NC_000019.10:3589909:T:G
NM_001256317.3(TMPRSS3):c.308A>G (p.Asp103Gly)	TMPRSS3	D103G	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000030493	21	43809052	21	42388943	30493	39450	rs387906915	NC_000021.9:42388942:T:C
NM_014332.3(SMPX):c.214G>T (p.Glu72Ter)	SMPX	E72*	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029947	X	21755734	X	21737616	29947	38902	rs387906708	NC_000023.11:21737615:C:A
NM_014332.3(SMPX):c.109G>T (p.Glu37Ter)	SMPX	E37*	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029946	X	21761891	X	21743773	29946	38901	rs387906707	NC_000023.11:21743772:C:A
NM_001384140.1(PCDH15):c.1583T>A (p.Val528Asp)	PCDH15	V528D, V491D, V535D, V506D, V533D, V540D	Deafness, autosomal recessive 23	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000018429	10	55943211	10	54183451	18429	33468	rs267606932	NC_000010.11:54183450:A:T
NM_001614.5(ACTG1):c.833C>T (p.Thr278Ile)	ACTG1	T278I	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000018319	17	79478104	17	81511078	18319	33358	rs28999112	NC_000017.11:81511077:G:A
NM_001614.5(ACTG1):c.994C>G (p.Pro332Ala)	ACTG1	P332A	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000018317	17	79477850	17	81510824	18317	33356	rs104894545	NC_000017.11:81510823:G:C
NM_001614.5(ACTG1):c.266C>T (p.Thr89Ile)	ACTG1	T89I	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000018315	17	79479026	17	81512000	18315	33354	rs28999111	NC_000017.11:81511999:G:A
NM_080680.3(COL11A2):c.2423G>A (p.Gly808Glu)	COL11A2	G701E, G722E, G808E	Deafness, autosomal dominant 13	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000017125	6	33142311	6	33174534	17125	32164	rs121912948	NC_000006.12:33174533:C:T
NM_004004.6(GJB2):c.175G>A (p.Gly59Ser)	GJB2	G59S	Knuckle pads, deafness AND leukonychia syndrome	Pathogenic(Last reviewed: Jul 30, 2005)	no assertion criteria provided	VCV000017034	13	20763546	13	20189407	17034	32073	rs104894410	NC_000013.11:20189406:C:T
NM_004004.6(GJB2):c.148G>T (p.Asp50Tyr)	GJB2	D50Y	Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000017028	13	20763573	13	20189434	17028	32067	rs28931594	NC_000013.11:20189433:C:A
NM_014208.3(DSPP):c.49C>A (p.Pro17Thr)	DSPP	P17T	Deafness, autosomal dominant nonsyndromic sensorineural 39, with dentinogenesis imperfecta 1	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000016855	4	88532109	4	87610957	16855	31894	rs121912986	NC_000004.12:87610956:C:A
NM_000601.6(HGF):c.495G>A (p.Ser165=)	HGF		Deafness, autosomal recessive 39	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014949	7	81381566	7	81752250	14949	29988	rs137853235	NC_000007.14:81752249:C:T
NM_002906.4(RDX):c.698+1G>A	RDX		Deafness, autosomal recessive 24	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000013187	11	110128491	11	110257766	13187	28226	rs1191259480	NC_000011.10:110257765:C:T
NM_002906.4(RDX):c.463C>T (p.Gln155Ter)	RDX	Q155*, Q123*	Deafness, autosomal recessive 24	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000013186	11	110134689	11	110263964	13186	28225	rs121918380	NC_000011.10:110263963:G:A
NM_002906.4(RDX):c.1732G>A (p.Asp578Asn)	RDX	D578N, D231N, D174N, D442N	Deafness, autosomal recessive 24	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000013184	11	110102614	11	110231889	13184	28223	rs121918379	NC_000011.10:110231888:C:T
ATP6V1B1, IVS12DS, G-C, +1	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Oct 15, 2008)	no assertion criteria provided	VCV000012230					12230	27269		
NM_001692.4(ATP6V1B1):c.585+1G>A	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000012227	2	71187209	2	70960079	12227	27266	rs782723581	NC_000002.12:70960078:G:A
NM_000260.4(MYO7A):c.731G>C (p.Arg244Pro)	MYO7A	R244P, R233P	Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011853	11	76868046	11	77157000	11853	26892	rs121965081	NC_000011.10:77156999:G:C
NM_004085.4(TIMM8A):c.133-23A>C	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011325	X	100601671	X	101346683	11325	26364	rs869320666	NC_000023.11:101346682:T:G
NM_004085.4(TIMM8A):c.238C>T (p.Arg80Ter)	TIMM8A	R80*	Deafness dystonia syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000011324	X	100601543	X	101346555	11324	26363	rs1054894	NC_000023.11:101346554:G:A
NM_004085.4(TIMM8A):c.70G>T (p.Glu24Ter)	TIMM8A	E24*	Deafness dystonia syndrome	Pathogenic(Last reviewed: Apr 20, 2016)	no assertion criteria provided	VCV000011320	X	100603583	X	101348595	11320	26359	rs111033631	NC_000023.11:101348594:C:A
NM_004999.4(MYO6):c.2417-1758T>G	MYO6		Autosomal dominant nonsyndromic deafness 22	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000008583	6	76593963	6	75884246	8583	23622	rs1562283089	NC_000006.12:75884245:T:G
NM_000085.5(CLCNKB):c.1929+1G>A	CLCNKB|LOC106501713		BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000007601	1	16382254	1	16055759	7601	22640	rs1191726071	NC_000001.11:16055758:G:A
NM_005219.5(DIAPH1):c.3661+1G>T	DIAPH1		Deafness, autosomal dominant 1	Pathogenic(Last reviewed: Nov 14, 1997)	no assertion criteria provided	VCV000007528	5	140903709	5	141524142	7528	22567	rs1476157529	NC_000005.10:141524141:C:A
NM_001379180.1(ESRRB):c.392C>T (p.Ala131Val)	ESRRB	A110V, A131V	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007499	14	76906025	14	76439682	7499	22538	rs121909110	NC_000014.9:76439681:C:T
NM_002700.3(POU4F3):c.668T>C (p.Leu223Pro)	POU4F3	L223P	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000007080	5	145719658	5	146340095	7080	22119	rs121909057	NC_000005.10:146340094:T:C
NM_002700.3(POU4F3):c.865C>T (p.Leu289Phe)	POU4F3	L289F	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000007079	5	145719855	5	146340292	7079	22118	rs121909056	NC_000005.10:146340291:C:T
NM_005422.4(TECTA):c.2941+1G>A	TBCEL-TECTA|TECTA		Deafness, neurosensory autosomal recessive 21	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000007015	11	121000921	11	121130212	7015	22054	rs966621865	NC_000011.10:121130211:G:A
NM_016239.4(MYO15A):c.8968-1G>C	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 15, 2007)	no assertion criteria provided	VCV000006960	17	18061836	17	18158522	6960	21999	rs746051220	NC_000017.11:18158521:G:C
NM_016239.4(MYO15A):c.5492G>T (p.Gly1831Val)	MYO15A	G1831V	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 15, 2007)	no assertion criteria provided	VCV000006959	17	18044418	17	18141104	6959	21998	rs121908972	NC_000017.11:18141103:G:T
NM_016239.4(MYO15A):c.3313G>T (p.Glu1105Ter)	MYO15A	E1105*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000006957	17	18025427	17	18122113	6957	21996	rs121908971	NC_000017.11:18122112:G:T
NM_016239.4(MYO15A):c.8148G>T (p.Gln2716His)	MYO15A	Q2716H	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006955	17	18057504	17	18154190	6955	21994	rs121908969	NC_000017.11:18154189:G:T
NM_016239.4(MYO15A):c.3756+1G>T	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006954	17	18028546	17	18125232	6954	21993	rs748108031	NC_000017.11:18125231:G:T
NM_016239.4(MYO15A):c.3685C>T (p.Gln1229Ter)	MYO15A	Q1229*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000006953	17	18027872	17	18124558	6953	21992	rs121908968	NC_000017.11:18124557:C:T
NM_016239.4(MYO15A):c.7801A>T (p.Lys2601Ter)	MYO15A	K2601*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000006952	17	18055173	17	18151859	6952	21991	rs121908967	NC_000017.11:18151858:A:T
NM_016239.4(MYO15A):c.6331A>T (p.Asn2111Tyr)	MYO15A	N2111Y	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000006951	17	18049243	17	18145929	6951	21990	rs121908966	NC_000017.11:18145928:A:T
NM_024009.3(GJB3):c.421A>G (p.Ile141Val)	GJB3	I141V	Deafness, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006488	1	35250784	1	34785183	6488	21527	rs74315320	NC_000001.11:34785182:A:G
NM_006996.3(SLC19A2):c.152C>T (p.Pro51Leu)	SLC19A2	P51L	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Mar 15, 2004)	no assertion criteria provided	VCV000005964	1	169454853	1	169485615	5964	21003	rs121908540	NC_000001.11:169485614:G:A
NM_006996.3(SLC19A2):c.1074G>A (p.Trp358Ter)	SLC19A2	W358*, W157*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005963	1	169438031	1	169468793	5963	21002	rs74315375	NC_000001.11:169468792:C:T
NM_006996.3(SLC19A2):c.750G>A (p.Trp250Ter)	SLC19A2	W250*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005958	1	169446450	1	169477212	5958	20997	rs74315374	NC_000001.11:169477211:C:T
NM_006996.3(SLC19A2):c.484C>T (p.Arg162Ter)	SLC19A2	R162*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005955	1	169446716	1	169477478	5955	20994	rs74315373	NC_000001.11:169477477:G:A
NM_153676.4(USH1C):c.1019+5G>C	USH1C		Deafness, autosomal recessive 18	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000005147	11	17544326	11	17522779	5147	20186	rs1592002789	NC_000011.10:17522778:C:G
NM_001256317.3(TMPRSS3):c.647G>T (p.Arg216Leu)	TMPRSS3	R216L, R89L	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000004946	21	43803277	21	42383168	4946	19985	rs137853000	NC_000021.9:42383167:C:A
TMPRSS3, IVS4AS, G-A, -6	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000004943					4943	19982		
NM_001384140.1(PCDH15):c.785G>A (p.Gly262Asp)	PCDH15	G262D, G240D, G267D, G225D	Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Dec 15, 2003)	no assertion criteria provided	VCV000004935	10	56077122	10	54317362	4935	19974	rs137853002	NC_000010.11:54317361:C:T
NM_181458.4(PAX3):c.141C>G (p.Asn47Lys)	PAX3	N47K	Craniofacial-deafness-hand syndrome	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000004213	2	223161877	2	222297158	4213	19252	rs104893652	NC_000002.12:222297157:G:C
NM_138691.3(TMC1):c.16+1G>T	TMC1		Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000004106	9	75263581	9	72648665	4106	19145	rs1169090943	NC_000009.12:72648664:G:T
NM_138691.3(TMC1):c.1714G>C (p.Asp572His)	TMC1	D572H	Deafness, autosomal dominant 36	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000004105	9	75431077	9	72816161	4105	19144	rs121908072	NC_000009.12:72816160:G:C
NM_138691.3(TMC1):c.1960A>G (p.Met654Val)	TMC1	M654V	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004104	9	75435954	9	72821038	4104	19143	rs121908074	NC_000009.12:72821037:A:G
NM_017433.5(MYO3A):c.732-2A>G	MYO3A		Deafness, autosomal recessive 30	Pathogenic(Last reviewed: May 28, 2002)	no assertion criteria provided	VCV000004016	10	26312949	10	26024020	4016	19055	rs1023746725	NC_000010.11:26024019:A:G
NM_017433.5(MYO3A):c.1777-12G>A	MYO3A		Deafness, autosomal recessive 30	Pathogenic(Last reviewed: May 28, 2002)	no assertion criteria provided	VCV000004015	10	26409593	10	26120664	4015	19054	rs1564568849	NC_000010.11:26120663:G:A
NM_147196.3(TMIE):c.170G>A (p.Trp57Ter)	TMIE	W57*, W4*	Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000003394	3	46747356	3	46705866	3394	18433	rs267607120	NC_000003.12:46705865:G:A
NM_001145809.2(MYH14):c.3049C>T (p.Leu1017Phe)	MYH14	L976F, L1017F, L984F	Deafness, autosomal dominant 4	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000002197	19	50774681	19	50271424	2197	17236	rs28940306	NC_000019.10:50271423:C:T
NM_001145809.2(MYH14):c.20C>A (p.Ser7Ter)	MYH14	S7*	Deafness, autosomal dominant 4	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000002196	19	50713642	19	50210385	2196	17235	rs119103279	NC_000019.10:50210384:C:A
NM_004403.3(GSDME):c.1183+4A>G	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000002093	7	24745799	7	24706180	2093	17132	rs1562687295	NC_000007.14:24706179:T:C
NM_004403.3(GSDME):c.991-6C>G	GSDME		Deafness, autosomal dominant 5	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000002092	7	24746001	7	24706382	2092	17131	rs1562687726	NC_000007.14:24706381:G:C
NM_182548.4(LHFPL5):c.494C>T (p.Thr165Met)	LHFPL5	T165M	Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001697	6	35782404	6	35814627	1697	16736	rs104893976	NC_000006.12:35814626:C:T
NM_182548.4(LHFPL5):c.380A>G (p.Tyr127Cys)	LHFPL5	Y127C	Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000001695	6	35773827	6	35806050	1695	16734	rs104893975	NC_000006.12:35806049:A:G
NM_001039141.3(TRIOBP):c.3202C>T (p.Arg1068Ter)	TRIOBP	R1068*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001494	22	38121765	22	37725758	1494	16533	rs118204030	NC_000022.11:37725757:C:T
NM_001039141.3(TRIOBP):c.2362C>T (p.Arg788Ter)	TRIOBP	R788*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001493	22	38120925	22	37724918	1493	16532	rs118204029	NC_000022.11:37724917:C:T
NM_001039141.3(TRIOBP):c.889C>T (p.Gln297Ter)	TRIOBP	Q297*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001492	22	38119452	22	37723445	1492	16531	rs118204028	NC_000022.11:37723444:C:T
NM_001039141.3(TRIOBP):c.1741C>T (p.Gln581Ter)	TRIOBP	Q581*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001491	22	38120304	22	37724297	1491	16530	rs118204027	NC_000022.11:37724296:C:T
NM_001042702.5(PJVK):c.161C>T (p.Thr54Ile)	PJVK	T54I, T57I, T89I	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001298	2	179318297	2	178453570	1298	16337	rs118203988	NC_000002.12:178453569:C:T
NR_029512.1(MIR96):n.14C>A	MIR96		Deafness, autosomal dominant 50	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000000866	7	129414596	7	129774756	866	15905	rs587776523	NC_000007.14:129774755:G:T
NM_182548.4(LHFPL5):c.*16+1G>A	LHFPL5		Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001334122	6	35787241	6	35819464	1334122	1324889		NC_000006.12:35819463:G:A
NM_002700.3(POU4F3):c.694G>T (p.Glu232Ter)	POU4F3	E232*	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001334110	5	145719684	5	146340121	1334110	1324877		NC_000005.10:146340120:G:T
NM_001042702.5(PJVK):c.880C>G (p.His294Asp)	PJVK	H135D, H294D, H296D, H297D	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Dec 23, 2021)	criteria provided, single submitter	VCV001329506	2	179325822	2	178461095	1329506	1320192		NC_000002.12:178461094:C:G
NM_001042702.5(PJVK):c.671T>G (p.Leu224Arg)	PJVK	L224R, L227R, L65R	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Dec 23, 2021)	criteria provided, single submitter	VCV001329504	2	179325078	2	178460351	1329504	1320190		NC_000002.12:178460350:T:G
NM_153700.2(STRC):c.3958G>T (p.Glu1320Ter)	STRC	E1320*	Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV001323655					1323655	1313936		
NM_144672.4(OTOA):c.399+2T>C	OTOA		Deafness, autosomal recessive 22	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV001323389					1323389	1313674		
NM_001384474.1(LOXHD1):c.3351-1G>C	LOXHD1		Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319170	18	44127022	18	46547059	1319170	1309423		NC_000018.10:46547058:C:G
NM_004100.5(EYA4):c.1154C>A (p.Ser385Ter)	EYA4	S331*, S337*, S362*, S385*, S391*	Deafness, autosomal dominant 10	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210331	6	133804216	6	133483078	1210331	1200331		NC_000006.12:133483077:C:A
NM_002906.4(RDX):c.1108C>T (p.Arg370Ter)	RDX	R23*, R234*, R370*	Deafness, autosomal recessive 24	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000982441	11	110108360	11	110237635	982441	970560	rs1463925107	NC_000011.10:110237634:G:A
NM_006941.4(SOX10):c.426G>A (p.Trp142Ter)	POLR2F|SOX10	W142*	Rare genetic deafness	Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, single submitter	VCV000505252	22	38379366	22	37983359	505252	497802	rs1555939403	NC_000022.11:37983358:C:T
NM_001378609.3(OTOGL):c.1585C>T (p.Gln529Ter)	OTOGL	Q520*, Q529*	Deafness, autosomal recessive 84b|not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000503724	12	80648963	12	80255183	503724	495308	rs371465450	NC_000012.12:80255182:C:T
NM_001292063.2(OTOG):c.294C>G (p.Tyr98Ter)	OTOG	Y110*, Y98*	Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV000496812	11	17574667	11	17553120	496812	488236	rs574007567	NC_000011.10:17553119:C:G
NM_001292063.2(OTOG):c.5056C>T (p.Gln1686Ter)	OTOG	Q1698*, Q1686*	not provided|Deafness, autosomal recessive 18b	Pathogenic(Last reviewed: Mar 31, 2021)	criteria provided, single submitter	VCV000489359	11	17631903	11	17610356	489359	481983	rs930688767	NC_000011.10:17610355:C:T
NM_022124.6(CDH23):c.7312G>A (p.Glu2438Lys)	CDH23	E2438K, E198K	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446449	10	73559336	10	71799579	446449	439917	rs1264310782	NC_000010.11:71799578:G:A
NM_022124.6(CDH23):c.6712+1G>A	CDH23		Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446448	10	73553398	10	71793641	446448	439916	rs1554874900	NC_000010.11:71793640:G:A
NM_022124.6(CDH23):c.6085C>T (p.Arg2029Trp)	CDH23	R2029W	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446446	10	73550924	10	71791167	446446	439914	rs750880909	NC_000010.11:71791166:C:T
NM_022124.6(CDH23):c.5147A>C (p.Gln1716Pro)	CDH23	Q1716P	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446445	10	73538025	10	71778268	446445	439913	rs758382198	NC_000010.11:71778267:A:C
NM_022124.6(CDH23):c.4877A>C (p.Asp1626Ala)	CDH23	D1626A	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446444	10	73537468	10	71777711	446444	439912	rs1554871816	NC_000010.11:71777710:A:C
NM_022124.6(CDH23):c.1934A>G (p.Asp645Gly)	CDH23	D645G	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446443	10	73442277	10	71682520	446443	439911	rs1390562340	NC_000010.11:71682519:A:G
NM_182548.4(LHFPL5):c.575T>C (p.Leu192Pro)	LHFPL5	L192P	Autosomal recessive non-syndromic intellectual disability|Deafness, autosomal recessive 67	Pathogenic(Last reviewed: Feb 12, 2017)	criteria provided, single submitter	VCV000375705	6	35782485	6	35814708	375705	362595	rs1554147220	NC_000006.12:35814707:T:C
NM_004086.3(COCH):c.1159C>T (p.Leu387Phe)	LOC100506071|COCH	L387F, L452F	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236036	14	31355200	14	30885994	236036	237616	rs878853226	NC_000014.9:30885993:C:T
NM_032119.4(ADGRV1):c.7129C>T (p.Arg2377Ter)	ADGRV1	R2377*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000228353	5	89988599	5	90692782	228353	229335	rs758718347	NC_000005.10:90692781:C:T
NM_022124.6(CDH23):c.1449+1G>T	CDH23	V484L	Rare genetic deafness	Pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, single submitter	VCV000228327	10	73406375	10	71646618	228327	229851	rs876657680	NC_000010.11:71646617:G:T
NM_001256317.3(TMPRSS3):c.1189C>T (p.Gln397Ter)	TMPRSS3	Q398*, Q397*, Q271*	Rare genetic deafness	Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	VCV000177740	21	43796652	21	42376543	177740	176240	rs727504304	NC_000021.9:42376542:G:A
NM_206933.4(USH2A):c.2541C>A (p.Cys847Ter)	LOC122152296|USH2A	C847*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	VCV000166516	1	216420195	1	216246853	166516	172916	rs727503736	NC_000001.11:216246852:G:T
NM_000503.6(EYA1):c.1475+1G>C	EYA1		Rare genetic deafness	Pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	VCV000163427	8	72127848	8	71215613	163427	174396	rs727503042	NC_000008.11:71215612:C:G
NM_022124.6(CDH23):c.5712G>A (p.Thr1904=)	CDH23		Rare genetic deafness	Pathogenic(Last reviewed: Oct 10, 2011)	no assertion criteria provided	VCV000045989	10	73544857	10	71785100	45989	55154	rs397517342	NC_000010.11:71785099:G:A
NM_022124.6(CDH23):c.3628C>T (p.Gln1210Ter)	C10orf105|CDH23	Q1210*	Rare genetic deafness	Pathogenic(Last reviewed: Sep 25, 2011)	criteria provided, single submitter	VCV000045926	10	73490274	10	71730517	45926	55091	rs397517326	NC_000010.11:71730516:C:T
NM_006005.3(WFS1):c.2054G>C (p.Arg685Pro)	WFS1	R685P	Rare genetic deafness	Pathogenic(Last reviewed: Feb 28, 2012)	criteria provided, single submitter	VCV000045446	4	6303576	4	6301849	45446	54613	rs142668478	NC_000004.12:6301848:G:C
NM_004004.6(GJB2):c.426C>A (p.Phe142Leu)	GJB2	F142L	Rare genetic deafness	Pathogenic(Last reviewed: Sep 2, 2011)	criteria provided, single submitter	VCV000044750	13	20763295	13	20189156	44750	53917	rs397516877	NC_000013.11:20189155:G:T
NM_153700.2(STRC):c.4219-1G>A	STRC		Deafness-infertility syndrome|Spermatogenic failure 7|Deafness, autosomal recessive 16|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000505435	15	43896351	15	43604153	505435	497248	rs748854592	NC_000015.10:43604152:C:T
NM_022124.6(CDH23):c.3481C>T (p.Arg1161Ter)	C10orf105|CDH23	R1161*	Rare genetic deafness|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2011)	no assertion criteria provided	VCV000045920	10	73485179	10	71725422	45920	55085	rs397517323	NC_000010.11:71725421:C:T
NM_000260.4(MYO7A):c.1200+1G>A	MYO7A		Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043138	11	76871329	11	77160283	43138	52308	rs397516283	NC_000011.10:77160282:G:A
NM_001031679.3(MSRB3):c.244T>G (p.Cys82Gly)	MSRB3	C89G, C82G	Deafness, autosomal recessive|Deafness, autosomal recessive 74	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2011)	no assertion criteria provided	VCV000031055	12	65722364	12	65328584	31055	40012	rs387907088	NC_000012.12:65328583:T:G
NM_001199799.2(ILDR1):c.3G>A (p.Met1Ile)	ILDR1	M1I	Deafness, autosomal recessive|Deafness, autosomal recessive 42	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000030797	3	121740922	3	122022075	30797	39754	rs387907016	NC_000003.12:122022074:C:T
NM_001042702.5(PJVK):c.499C>T (p.Arg167Ter)	PJVK	R167*, R170*, R202*, R8*	Deafness, autosomal recessive 59|Rare genetic deafness	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000001300	2	179320828	2	178456101	1300	16339	rs118203989	NC_000002.12:178456100:C:T
NM_001042702.5(PJVK):c.406C>T (p.Arg136Ter)	PJVK	R136*, R139*, R171*	Deafness, autosomal recessive 59|Deafness|Deafness, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000560905	2	179319253	2	178454526	560905	551997	rs367688416	NC_000002.12:178454525:C:T
NM_004004.6(GJB2):c.516G>C (p.Trp172Cys)	GJB2	W172C	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jul 28, 2019)	reviewed by expert panel	VCV000590799	13	20763205	13	20189066	590799	581737	rs1302739538	NC_000013.11:20189065:C:G
NM_138691.2(TMC1):c.1939T>C	TMC1	S647P	Rare genetic deafness|Deafness, autosomal recessive 7|not provided	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000228408	9	75435933	9	72821017	228408	229709	rs138527651	NC_000009.12:72821016:T:C
NM_153700.2(STRC):c.4351C>T (p.Arg1451Ter)	STRC	R1451*	Deafness, autosomal recessive 16|Deafness-infertility syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212742	15	43896218	15	43604020	212742	209355	rs778909195	NC_000015.10:43604019:G:A
NM_000441.2(SLC26A4):c.284G>A (p.Gly95Glu)	SLC26A4	G95E	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001334127	7	107303860	7	107663415	1334127	1324894		NC_000007.14:107663414:G:A
NM_024063.3(SPATA5L1):c.1398T>G (p.Ile466Met)	SPATA5L1	I466M	DEAFNESS, AUTOSOMAL RECESSIVE 119|NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY	Pathogenic(Last reviewed: Nov 17, 2021)	no assertion criteria provided	VCV001275860	15	45702692	15	45410494	1275860	1265738		NC_000015.10:45410493:T:G
NM_000441.2(SLC26A4):c.317C>A (p.Ala106Asp)	SLC26A4	A106D	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	criteria provided, single submitter	VCV001065204	7	107312595	7	107672150	1065204	1053517		NC_000007.14:107672149:C:A
NM_000441.2(SLC26A4):c.1786C>T (p.Gln596Ter)	SLC26A4	Q596*	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	criteria provided, single submitter	VCV001065203	7	107341624	7	107701179	1065203	1053524		NC_000007.14:107701178:C:T
NM_004357.5(CD151):c.493C>T (p.Arg165Ter)	CD151	R165*	Nephropathy with pretibial epidermolysis bullosa and deafness	Pathogenic(Last reviewed: Jan 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV001028736	11	837496	11	837496	1028736	1017536	rs759213580	NC_000011.10:837495:C:T
NM_005548.3(KARS1):c.1702C>T (p.Leu568Phe)	KARS1	L596F, L412F, L568F	LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH DEAFNESS	Pathogenic(Last reviewed: Mar 1, 2021)	no assertion criteria provided	VCV000997983	16	75661885	16	75627987	997983	985703	rs768349236	NC_000016.10:75627986:G:A
NM_004357.5(CD151):c.[19A>T;622_630del]	CD151	K7*	Nephropathy with pretibial epidermolysis bullosa and deafness	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000982373	11|11	836088	11|11	836088	982373	970501|970502	rs1846753757|rs1846841530	NC_000011.10:836087:A:T|NC_000011.10:837946:CTGCATCACC:C
NM_194248.3(OTOF):c.5788G>T (p.Glu1930Ter)	OTOF	E1163*, E1240*, E1930*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 11, 2020)	criteria provided, single submitter	VCV000977921	2	26683540	2	26460672	977921	966050	rs953404925	NC_000002.12:26460671:C:A
NM_194248.3(OTOF):c.*196T>C	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	no assertion criteria provided	VCV000916017	2	26680910	2	26458042	916017	904241	rs1157997148	NC_000002.12:26458041:A:G
NM_194248.3(OTOF):c.4362+1G>C	OTOF		Deafness, autosomal recessive 9	Pathogenic	criteria provided, single submitter	VCV000634822	2	26689966	2	26467098	634822	622685	rs1274464930	NC_000002.12:26467097:C:G
NM_001283.5(AP1S1):c.186T>G (p.Tyr62Ter)	AP1S1	Y62*	not provided|Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620377	7	100800661	7	101157380	620377	611668	rs981747624	NC_000007.14:101157379:T:G
NM_002804.5(PSMC3):c.1127+337A>G	PSMC3		DEAFNESS, CATARACT, IMPAIRED INTELLECTUAL DEVELOPMENT, AND POLYNEUROPATHY|Developmental cataract|Neurodevelopmental delay|Severe sensorineural hearing impairment	Pathogenic(Last reviewed: Jun 1, 2021)	no assertion criteria provided	VCV000599398	11	47441478	11	47419927	599398	590734	rs1177898071	NC_000011.10:47419926:T:C
NM_000307.5(POU3F4):c.975G>A (p.Trp325Ter)	POU3F4	W325*	Deafness, X-linked 2	Pathogenic(Last reviewed: Sep 10, 2017)	criteria provided, single submitter	VCV000599350	X	82764307	X	83509299	599350	590644	rs1569280385	NC_000023.11:83509298:G:A
NM_022124.6(CDH23):c.4210-2A>G	CDH23		Usher syndrome type 1D|Deafness, autosomal recessive 84	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000585306	10	73498253	10	71738496	585306	576352	rs557620034	NC_000010.11:71738495:A:G
NM_003672.4(CDC14A):c.1033C>T (p.Arg345Ter)	CDC14A	R345*, R52*, R287*	Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000559439	1	100949903	1	100484347	559439	550163	rs549556142	NC_000001.11:100484346:C:T
NM_194248.3(OTOF):c.*20G>A	OTOF	R1939Q, R1172Q	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000548986	2	26681086	2	26458218	548986	539468	rs201326023	NC_000002.12:26458217:C:T
NM_194248.3(OTOF):c.897+5G>A	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446442	2	26717805	2	26494937	446442	439898	rs1553356452	NC_000002.12:26494936:C:T
NM_194248.3(OTOF):c.5466C>G (p.Tyr1822Ter)	OTOF	Y1822*, Y1055*, Y1132*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446440	2	26684631	2	26461763	446440	439895	rs753580324	NC_000002.12:26461762:G:C
NM_194248.3(OTOF):c.1422T>A (p.Tyr474Ter)	OTOF	Y474*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446438	2	26705431	2	26482563	446438	439897	rs1403112959	NC_000002.12:26482562:A:T
NM_001110219.3(GJB6):c.119C>T (p.Ala40Val)	GJB6	A40V	Deafness, autosomal dominant 3b	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000424855	13	20797501	13	20223362	424855	413171	rs780320724	NC_000013.11:20223361:G:A
NM_016239.4(MYO15A):c.4519C>T (p.Arg1507Ter)	MYO15A	R1507*	not provided|Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000421664	17	18039061	17	18135747	421664	409850	rs549138385	NC_000017.11:18135746:C:T
NM_001354604.2(MITF):c.970A>G (p.Arg324Gly)	MITF	R318G, R217G, R155G, R211G, R317G, R323G, R301G, R302G, R324G, R266G	Waardenburg syndrome type 2A|Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000375216	3	70005620	3	69956469	375216	361917	rs1057519326	NC_000003.12:69956468:A:G
NM_001354604.2(MITF):c.939G>C (p.Lys313Asn)	MITF	K307N, K206N, K312N, K313N, K144N, K306N, K200N, K255N, K291N, K290N	Waardenburg syndrome type 2A|Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000375215	3	70001021	3	69951870	375215	361916	rs1057519325	NC_000003.12:69951869:G:C
NM_003672.4(CDC14A):c.1015C>T (p.Arg339Ter)	CDC14A	R339*, R281*, R46*	Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000235146	1	100949885	1	100484329	235146	236878	rs777112652	NC_000001.11:100484328:C:T
NM_004208.4(AIFM1):c.1352G>A (p.Arg451Gln)	AIFM1|RAB33A	R451Q, R447Q, R112Q	Deafness, X-linked 5	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000218108	X	129267384	X	130133409	218108	214763	rs863225431	NC_000023.11:130133408:C:T
NM_032229.3(SLITRK6):c.541C>T (p.Arg181Ter)	SLITRK6	R181*	Deafness and myopia	Pathogenic(Last reviewed: Nov 24, 2014)	no assertion criteria provided	VCV000088862	13	86370103	13	85795968	88862	94431	rs587777071	NC_000013.11:85795967:G:A
NM_032229.3(SLITRK6):c.890C>A (p.Ser297Ter)	SLITRK6	S297*	Deafness and myopia	Pathogenic(Last reviewed: Nov 24, 2014)	no assertion criteria provided	VCV000088861	13	86369754	13	85795619	88861	94430	rs587777070	NC_000013.11:85795618:G:T
NM_001371333.1(DIABLO):c.377C>T (p.Ser126Leu)	DIABLO	S126L, S82L, S29L, S73L, S53L	Deafness, autosomal dominant 64|not provided	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV000030449	12	122701355	12	122216808	30449	39406	rs387906893	NC_000012.12:122216807:G:A
NM_014332.3(SMPX):c.175G>T (p.Gly59Ter)	SMPX	G59*	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029945	X	21755773	X	21737655	29945	38900	rs387906706	NC_000023.11:21737654:C:A
NM_005247.4(FGF3):c.317A>G (p.Tyr106Cys)	FGF3	Y106C	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000029817	11	69631095	11	69816327	29817	38772	rs281860306	NC_000011.10:69816326:T:C
NM_001614.5(ACTG1):c.1109T>C (p.Val370Ala)	ACTG1	V370A	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000018320	17	79477735	17	81510709	18320	33359	rs104894547	NC_000017.11:81510708:A:G
NM_005247.4(FGF3):c.196G>T (p.Gly66Cys)	FGF3|LOC109115964	G66C	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Dec 13, 2021)	no assertion criteria provided	VCV000013840	11	69633506	11	69818738	13840	28879	rs121917705	NC_000011.10:69818737:C:A
NM_005247.4(FGF3):c.466T>C (p.Ser156Pro)	FGF3	S156P	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000013837	11	69625327	11	69810559	13837	28876	rs121917703	NC_000011.10:69810558:A:G
NM_001692.4(ATP6V1B1):c.91C>T (p.Arg31Ter)	ATP6V1B1	R31*	Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Apr 7, 2021)	no assertion criteria provided	VCV000012225	2	71163175	2	70936045	12225	27264	rs121964879	NC_000002.12:70936044:C:T
NM_000307.5(POU3F4):c.990A>T (p.Arg330Ser)	POU3F4	R330S	Deafness, X-linked 2	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000011683	X	82764322	X	83509314	11683	26722	rs104894923	NC_000023.11:83509313:A:T
NM_000307.5(POU3F4):c.935C>T (p.Ala312Val)	POU3F4	A312V	Deafness, X-linked 2	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000011682	X	82764267	X	83509259	11682	26721	rs387906502	NC_000023.11:83509258:C:T
NM_000307.5(POU3F4):c.950T>G (p.Leu317Trp)	POU3F4	L317W	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000011679	X	82764282	X	83509274	11679	26718	rs104894921	NC_000023.11:83509273:T:G
NM_002764.4(PRPS1):c.193G>A (p.Asp65Asn)	PRPS1	D65N	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009938	X	106882595	X	107639365	9938	24977	rs180177151	NC_000023.11:107639364:G:A
NM_004999.4(MYO6):c.1325G>A (p.Cys442Tyr)	MYO6	C442Y, C437Y	Autosomal dominant nonsyndromic deafness 22	Pathogenic(Last reviewed: Jul 9, 2004)	no assertion criteria provided	VCV000008577	6	76566915	6	75857198	8577	23616	rs121912557	NC_000006.12:75857197:G:A
NM_000304.4(PMP22):c.82T>C (p.Trp28Arg)	PMP22	W28R	Charcot-Marie-Tooth disease and deafness	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000008440	17	15162507	17	15259190	8440	23479	rs104894626	NC_000017.11:15259189:A:G
NM_001379180.1(ESRRB):c.1087G>T (p.Val363Leu)	ESRRB	V342L, V363L	Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007500	14	76958026	14	76491683	7500	22539	rs121909111	NC_000014.9:76491682:G:T
NM_002241.5(KCNJ10):c.581C>A (p.Pro194His)	KCNJ10	P194H	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000007469	1	160011742	1	160041952	7469	22508	rs137853073	NC_000001.11:160041951:G:T
NM_005422.4(TECTA):c.5331G>A (p.Leu1777=)	TBCEL-TECTA|TECTA		Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000007024	11	121036040	11	121165331	7024	22063	rs1591462832	NC_000011.10:121165330:G:A
NM_005422.4(TECTA):c.5509T>C (p.Cys1837Arg)	TECTA|TBCEL-TECTA	C1837R, C2151R	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000007023	11	121037412	11	121166703	7023	22062	rs121909061	NC_000011.10:121166702:T:C
NM_005422.4(TECTA):c.5509T>G (p.Cys1837Gly)	TBCEL-TECTA|TECTA	C1837G, C2151G	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000007020	11	121037412	11	121166703	7020	22059	rs121909061	NC_000011.10:121166702:T:G
NM_005422.4(TECTA):c.4856G>C (p.Cys1619Ser)	TBCEL-TECTA|TECTA	C1619S, C1938S	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000007017	11	121031010	11	121160301	7017	22056	rs121909060	NC_000011.10:121160300:G:C
NM_005422.4(TECTA):c.3169T>A (p.Cys1057Ser)	TBCEL-TECTA|TECTA	C1057S, C1376S	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000007016	11	121008357	11	121137648	7016	22055	rs121909059	NC_000011.10:121137647:T:A
NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe)	MYO15A	I2113F	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000006950	17	18049249	17	18145935	6950	21989	rs121908965	NC_000017.11:18145934:A:T
NM_004086.3(COCH):c.1535T>C (p.Met512Thr)	COCH|LOC100506071	M512T, M577T	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000006616	14	31358879	14	30889673	6616	21655	rs121908934	NC_000014.9:30889672:T:C
NM_004086.3(COCH):c.1625G>A (p.Cys542Tyr)	COCH|LOC100506071	C542Y, C607Y	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000006615	14	31358969	14	30889763	6615	21654	rs121908932	NC_000014.9:30889762:G:A
NM_004086.3(COCH):c.349T>C (p.Trp117Arg)	COCH|LOC100506071	W117R, W182R	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000006610	14	31348126	14	30878920	6610	21649	rs121908929	NC_000014.9:30878919:T:C
NM_004086.3(COCH):c.263G>A (p.Gly88Glu)	COCH|LOC100506071	G88E, G153E	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000006609	14	31348040	14	30878834	6609	21648	rs121908928	NC_000014.9:30878833:G:A
NM_004100.5(EYA4):c.1282-12T>A	EYA4|TARID		Deafness, autosomal dominant 10	Pathogenic(Last reviewed: Jul 15, 2007)	no assertion criteria provided	VCV000006240	6	133833847	6	133512709	6240	21279		NC_000006.12:133512708:T:A
OTOF, IVS5, G-A, +1	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000006135					6135	21174		
NM_001256317.3(TMPRSS3):c.1208C>T (p.Pro403Leu)	TMPRSS3	P404L, P403L, P277L	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000004945	21	43795961	21	42375852	4945	19984	rs28939084	NC_000021.9:42375851:G:A
NM_022124.6(CDH23):c.5663T>C (p.Phe1888Ser)	CDH23	F1888S	Deafness, autosomal recessive 12	Pathogenic(Last reviewed: Apr 14, 2005)	no assertion criteria provided	VCV000004924	10	73544808	10	71785051	4924	19963	rs121908352	NC_000010.11:71785050:T:C
NM_001243133.2(NLRP3):c.1705G>C (p.Gly569Arg)	NLRP3	G569R, G571R	Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000004375	1	247588456	1	247425154	4375	19414	rs121908151	NC_000001.11:247425153:G:C
NM_017433.5(MYO3A):c.3129T>G (p.Tyr1043Ter)	MYO3A	Y1043*	Deafness, autosomal recessive 30	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000004014	10	26457658	10	26168729	4014	19053	rs193919333	NC_000010.11:26168728:T:G
NM_144672.4(OTOA):c.1320+2T>C	OTOA		Deafness, autosomal recessive 22	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000003560	16	21721426	16	21710105	3560	18599	rs1567381218	NC_000016.10:21710104:T:C
NM_015404.4(WHRN):c.2332C>T (p.Arg778Ter)	WHRN	R778*, R395*, R427*, R777*	Deafness, autosomal recessive 31	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000002689	9	117166262	9	114403982	2689	17728	rs137852839	NC_000009.12:114403981:G:A
NM_001145809.2(MYH14):c.2299C>A (p.Arg767Ser)	MYH14	R726S, R767S, R734S	Deafness, autosomal dominant 4	Pathogenic(Last reviewed: Jun 17, 2005)	no assertion criteria provided	VCV000002198	19	50762467	19	50259210	2198	17237	rs28940307	NC_000019.10:50259209:C:A
MARVELD2, IVS4DS, T-C, +2	MARVELD2		Deafness, autosomal recessive 49	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000001197					1197	16236		
NR_029512.1(MIR96):n.13G>A	MIR96		Deafness, autosomal dominant 50	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000000865	7	129414597	7	129774757	865	15904	rs587776522	NC_000007.14:129774756:C:T
NM_001145308.5(LRTOMT):c.333C>G (p.Tyr111Ter)	LRTOMT|TOMT	Y71*, Y111*, Y78*	Deafness, autosomal recessive 63	Pathogenic(Last reviewed: Sep 23, 2008)	no assertion criteria provided	VCV000000546	11	71817231	11	72106185	546	15585	rs137853188	NC_000011.10:72106184:C:G
NM_001145308.5(LRTOMT):c.328G>A (p.Glu110Lys)	LRTOMT|TOMT	E110K, E70K, E77K	Deafness, autosomal recessive 63	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000545	11	71817226	11	72106180	545	15584	rs137853187	NC_000011.10:72106179:G:A
NM_001145308.5(LRTOMT):c.313T>C (p.Trp105Arg)	LRTOMT|TOMT	W105R, W65R, W72R	Deafness, autosomal recessive 63	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000544	11	71817211	11	72106165	544	15583	rs137853186	NC_000011.10:72106164:T:C
NM_005422.4(TECTA):c.1705C>T (p.Gln569Ter)	TBCEL-TECTA|TECTA	Q569*, Q888*	Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001334118	11	120996512	11	121125803	1334118	1324885		NC_000011.10:121125802:C:T
NM_004086.3(COCH):c.341T>C (p.Leu114Pro)	COCH|LOC100506071	L114P, L179P	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001174533	14	31348118	14	30878912	1174533	1163808		NC_000014.9:30878911:T:C
NM_002906.4(RDX):c.129G>A (p.Trp43Ter)	RDX	W43*	Deafness, autosomal recessive 24	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000983525	11	110135567	11	110264842	983525	971590		NC_000011.10:110264841:C:T
NM_004086.3(COCH):c.1115T>C (p.Ile372Thr)	LOC100506071|COCH	I437T, I372T	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Nov 21, 2019)	no assertion criteria provided	VCV000813819	14	31355156	14	30885950	813819	802077	rs1594385065	NC_000014.9:30885949:T:C
NM_001614.5(ACTG1):c.94C>T (p.Pro32Ser)	ACTG1	P32S	not provided|Deafness, autosomal dominant 20	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000807364	17	79479287	17	81512261	807364	798726	rs1598551290	NC_000017.11:81512260:G:A
NM_001292063.2(OTOG):c.4984G>T (p.Gly1662Ter)	OTOG	G1674*, G1662*	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623765	11	17631831	11	17610284	623765	612902	rs1407028917	NC_000011.10:17610283:G:T
NM_001384140.1(PCDH15):c.4671+1217C>T	PCDH15	Q1576*, Q1569*	Deafness, autosomal recessive 23	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000402273	10	55569099	10	53809339	402273	389231	rs1056396947	NC_000010.11:53809338:G:A
NM_206933.4(USH2A):c.13313G>A (p.Trp4438Ter)	USH2A	W4438*	Retinal dystrophy|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048416	1	215847940	1	215674598	48416	57578	rs111033417	NC_000001.11:215674597:C:T
NM_016239.4(MYO15A):c.8767C>T (p.Arg2923Ter)	MYO15A	R2923*	Rare genetic deafness	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	VCV000045771	17	18060523	17	18157209	45771	54936	rs373462792	NC_000017.11:18157208:C:T
NM_000441.2(SLC26A4):c.1149+3A>G	SLC26A4		Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000043493	7	107329648	7	107689203	43493	52663	rs111033314	NC_000007.14:107689202:A:G
NM_016239.4(MYO15A):c.6046+1G>A	MYO15A		Deafness, autosomal recessive 3|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000164536	17	18047111	17	18143797	164536	176604	rs201978571	NC_000017.11:18143796:G:A
NM_001614.5(ACTG1):c.353A>T (p.Lys118Met)	ACTG1	K118M	Deafness, autosomal dominant 20|Nonsyndromic hearing loss and deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000018316	17	79478939	17	81511913	18316	33355	rs104894544	NC_000017.11:81511912:T:A
NM_080680.3(COL11A2):c.3100C>T (p.Arg1034Cys)	COL11A2	R1034C, R927C, R948C	Deafness, autosomal dominant 13|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017124	6	33139540	6	33171763	17124	32163	rs121912947	NC_000006.12:33171762:G:A
NM_153700.2(STRC):c.4027C>T (p.Gln1343Ter)	STRC	Q1343*	Deafness, autosomal recessive 16|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448908	15	43896948	15	43604750	448908	442483	rs144948296	NC_000015.10:43604749:G:A
NM_173477.5(USH1G):c.511G>T (p.Glu171Ter)	USH1G	E171*, E68*	Usher syndrome, type 1G|Deafness|Deafness, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000560918	17	72916420	17	74920325	560918	552027	rs201866631	NC_000017.11:74920324:C:A
NM_005548.3(KARS1):c.1430G>A (p.Arg477His)	KARS1	R477H, R505H, R321H	LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH DEAFNESS|Deafness, congenital, and adult-onset progressive leukoencephalopathy|Deafness, autosomal recessive 89	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000437931	16	75663434	16	75629536	437931	431553	rs778748895	NC_000016.10:75629535:C:T
NM_016239.4(MYO15A):c.4198G>A (p.Val1400Met)	MYO15A	V1400M	Deafness, autosomal recessive 3|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632271	17	18034837	17	18131523	632271	620574	rs749136456	NC_000017.11:18131522:G:A
NM_001384474.1(LOXHD1):c.3169C>T (p.Arg1057Ter)	LOXHD1	R1057*	Rare genetic deafness|not provided|Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179755	18	44139458	18	46559495	179755	176706	rs727505104	NC_000018.10:46559494:G:A
NM_005422.4(TECTA):c.5668C>T (p.Arg1890Cys)	TBCEL-TECTA|TECTA	R1890C, R2204C	Deafness, autosomal dominant 12|Nonsyndromic hearing loss and deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007022	11	121038844	11	121168135	7022	22061	rs121909063	NC_000011.10:121168134:C:T
NM_194248.3(OTOF):c.4491T>A (p.Tyr1497Ter)	OTOF	Y730*, Y1497*, Y807*	Deafness, autosomal recessive 9|Rare genetic deafness	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	VCV000006133	2	26689591	2	26466723	6133	21172	rs80356600	NC_000002.12:26466722:A:T
NM_005219.5(DIAPH1):c.3022C>T (p.Arg1008Ter)	DIAPH1	R1008*, R999*	Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001076722	5	140908146	5	141528579	1076722	1060302		NC_000005.10:141528578:G:A
NM_000441.2(SLC26A4):c.1991C>T (p.Ala664Val)	SLC26A4	A664V	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	no assertion criteria provided	VCV001065212	7	107342459	7	107702014	1065212	1053525		NC_000007.14:107702013:C:T
NM_016239.4(MYO15A):c.2456C>A (p.Ser819Ter)	MYO15A	S819*	Deafness, autosomal recessive|not provided	Pathogenic(Last reviewed: Sep 30, 2021)	criteria provided, single submitter	VCV000996594	17	18024570	17	18121256	996594	984414	rs767378045	NC_000017.11:18121255:C:A
NM_133261.3(GIPC3):c.662C>T (p.Thr221Ile)	GIPC3	T221I	Deafness, autosomal recessive|not provided	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000871900	19	3589510	19	3589512	871900	860551	rs761543680	NC_000019.10:3589511:C:T
NM_005219.5(DIAPH1):c.1549C>T (p.Gln517Ter)	DIAPH1	Q508*, Q517*	Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000839955	5	140954626	5	141575059	839955	830414	rs2099895754	NC_000005.10:141575058:G:A
NM_016239.4(MYO15A):c.1615C>T (p.Gln539Ter)	MYO15A	Q539*	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803330	17	18023729	17	18120415	803330	791683	rs1597752877	NC_000017.11:18120414:C:T
NM_000441.2(SLC26A4):c.2108T>C (p.Leu703Pro)	SLC26A4	L703P	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000691518	7	107350517	7	107710072	691518	679204	rs1584344549	NC_000007.14:107710071:T:C
NM_000441.2(SLC26A4):c.641A>G (p.Tyr214Cys)	SLC26A4	Y214C	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000691509	7	107315430	7	107674985	691509	679195	rs773861155	NC_000007.14:107674984:A:G
NM_001145319.2(PLS1):c.383T>C (p.Phe128Ser)	PLS1	F128S	Hearing loss, autosomal dominant 76|Bilateral sensorineural hearing impairment|Autosomal dominant non-syndromic sensorineural deafness type DFNA	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000633603	3	142395017	3	142676175	633603	622035	rs1577876794	NC_000003.12:142676174:T:C
NM_020971.3(SPTBN4):c.3820G>T (p.Glu1274Ter)	SPTBN4	E1274*	Myopathy, congenital, with neuropathy and deafness|not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000559545	19	41029509	19	40523602	559545	550268	rs1555818396	NC_000019.10:40523601:G:T
NM_002039.4(GAB1):c.347G>A (p.Gly116Glu)	GAB1	G116E	Deafness, autosomal recessive 26	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000545492	4	144336904	4	143415751	545492	535752	rs1553950635	NC_000004.12:143415750:G:A
NM_016239.4(MYO15A):c.9083+6T>A	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jan 31, 2021)	criteria provided, single submitter	VCV000520436	17	18061958	17	18158644	520436	511041	rs1555547112	NC_000017.11:18158643:T:A
NM_032861.4(SERAC1):c.1159C>T (p.Arg387Ter)	SERAC1	R387*	not provided|3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000445812	6	158541464	6	158120432	445812	439084	rs1220930025	NC_000006.12:158120431:G:A
NM_001191057.4(PDE1C):c.778G>T (p.Ala260Ser)	PDE1C	A320S, A395S, A260S	Hearing loss, autosomal dominant 74|Autosomal dominant non-syndromic sensorineural deafness type DFNA	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	VCV000433528	7	31890328	7	31850714	433528	427102	rs775633137	NC_000007.14:31850713:C:A
NM_194248.3(OTOF):c.4030C>T (p.Arg1344Ter)	OTOF	R1344*, R577*, R654*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000402271	2	26691336	2	26468468	402271	389220	rs1060499805	NC_000002.12:26468467:G:A
NM_013296.5(GPSM2):c.977G>A (p.Trp326Ter)	GPSM2	W326*	Deafness, autosomal recessive|Chudley-McCullough syndrome	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000402258	1	109445771	1	108903149	402258	389218	rs1060499797	NC_000001.11:108903148:G:A
NM_020971.3(SPTBN4):c.1597C>T (p.Gln533Ter)	SPTBN4	Q533*	Myopathy, congenital, with neuropathy and deafness|not provided	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000375254	19	41009971	19	40504064	375254	361955	rs1114167445	NC_000019.10:40504063:C:T
NM_016239.4(MYO15A):c.8467G>A (p.Asp2823Asn)	MYO15A	D2823N	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000236053	17	18059516	17	18156202	236053	237623	rs878853238	NC_000017.11:18156201:G:A
NM_003672.4(CDC14A):c.1126C>T (p.Arg376Ter)	CDC14A	R376*, R318*, R83*	Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000235145	1	100949996	1	100484440	235145	236877	rs876661408	NC_000001.11:100484439:C:T
NM_004230.4(S1PR2):c.323G>C (p.Arg108Pro)	S1PR2	R108P	Deafness, autosomal recessive 68	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000219259	19	10335259	19	10224583	219259	217338	rs869312749	NC_000019.10:10224582:C:G
NM_032861.4(SERAC1):c.1126C>T (p.Gln376Ter)	SERAC1	Q376*	not provided|3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215142	6	158541497	6	158120465	215142	211211	rs199632531	NC_000006.12:158120464:G:A
NM_002764.4(PRPS1):c.337G>T (p.Ala113Ser)	PRPS1		Deafness, X-linked 1	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140571	X	106884162	X	107640932	140571	150245	rs587781261	NC_000023.11:107640931:G:T
NM_021116.4(ADCY1):c.3112C>T (p.Arg1038Ter)	ADCY1	R1038*	Deafness, autosomal recessive 44	Pathogenic(Last reviewed: Nov 20, 2014)	no assertion criteria provided	VCV000139587	7	45753346	7	45713747	139587	143212	rs587777497	NC_000007.14:45713746:C:T
NM_194248.3(OTOF):c.1621G>A (p.Gly541Ser)	OTOF	G541S	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000040177	2	26703836	2	26480968	40177	48674	rs397515435	NC_000002.12:26480967:C:T
NM_005247.4(FGF3):c.146A>G (p.Tyr49Cys)	FGF3|LOC109115964	Y49C	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000029816	11	69633556	11	69818788	29816	38771	rs281860300	NC_000011.10:69818787:T:C
NM_001614.5(ACTG1):c.354G>C (p.Lys118Asn)	ACTG1	K118N	Deafness, autosomal dominant 20|not provided	Pathogenic(Last reviewed: Aug 15, 2009)	no assertion criteria provided	VCV000018321	17	79478938	17	81511912	18321	33360	rs267606630	NC_000017.11:81511911:C:G
NM_004004.6(GJB2):c.131G>C (p.Trp44Ser)	GJB2	W44S	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000017031	13	20763590	13	20189451	17031	32070	rs104894413	NC_000013.11:20189450:C:G
NM_004004.6(GJB2):c.535G>A (p.Asp179Asn)	GJB2	D179N	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000017026	13	20763186	13	20189047	17026	32065	rs28931595	NC_000013.11:20189046:C:T
NM_001002295.2(GATA3):c.1099C>T (p.Arg367Ter)	GATA3	R367*, R366*	not provided|Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jun 28, 2021)	criteria provided, single submitter	VCV000016626	10	8115750	10	8073787	16626	31665	rs104894164	NC_000010.11:8073786:C:T
NM_005247.4(FGF3):c.17T>C (p.Leu6Pro)	LOC109115964|FGF3	L6P	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000013841	11	69633685	11	69818917	13841	28880	rs121917706	NC_000011.10:69818916:A:G
NM_000307.5(POU3F4):c.604A>T (p.Lys202Ter)	POU3F4	K202*	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000011678	X	82763936	X	83508928	11678	26717	rs104894920	NC_000023.11:83508927:A:T
NM_002764.4(PRPS1):c.869T>C (p.Ile290Thr)	PRPS1	I290T, I86T	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009941	X	106893174	X	107649944	9941	24980	rs180177153	NC_000023.11:107649943:T:C
NM_002764.4(PRPS1):c.916G>A (p.Gly306Arg)	PRPS1	G306R, G102R	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009940	X	106893221	X	107649991	9940	24979	rs180177154	NC_000023.11:107649990:G:A
NM_002764.4(PRPS1):c.259G>A (p.Ala87Thr)	PRPS1	A87T	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009939	X	106882661	X	107639431	9939	24978	rs180177152	NC_000023.11:107639430:G:A
m.12258C>A	MT-TS2		Cerebellar ataxia, cataract, and diabetes mellitus|Retinitis pigmentosa-deafness syndrome	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000009560	MT	12258	MT	12258	9560	24599	rs118203888	NC_012920.1:12257:C:A
NM_004999.4(MYO6):c.3496C>T (p.Arg1166Ter)	MYO6	R1166*, R1153*, R1134*, R1175*, R1138*, R1143*	Deafness, autosomal recessive 37|not provided	Pathogenic(Last reviewed: Jun 25, 2020)	criteria provided, single submitter	VCV000008579	6	76623836	6	75914119	8579	23618	rs121912558	NC_000006.12:75914118:C:T
NM_004086.3(COCH):c.197T>G (p.Val66Gly)	COCH|LOC100506071	V66G, V131G	Deafness, autosomal dominant 9	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000006608	14	31346892	14	30877686	6608	21647	rs121908927	NC_000014.9:30877685:T:G
NM_194248.3(OTOF):c.5473C>G (p.Pro1825Ala)	OTOF	P1825A, P1135A, P1058A	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006138	2	26684624	2	26461756	6138	21177	rs28937591	NC_000002.12:26461755:G:C
NM_194248.3(OTOF):c.766-2A>G	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006134	2	26717943	2	26495075	6134	21173	rs80356584	NC_000002.12:26495074:T:C
NM_001039141.3(TRIOBP):c.3349C>T (p.Arg1117Ter)	TRIOBP	R1117*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV000001495	22	38121912	22	37725905	1495	16534	rs118204031	NC_000022.11:37725904:C:T
NM_005982.4(SIX1):c.396G>C (p.Lys132Asn)	SIX1	K132N	Branchiootic syndrome 3|Deafness, autosomal dominant 23	Pathogenic(Last reviewed: Dec 7, 2021)	no assertion criteria provided	VCV001327579	14	61115512	14	60648794	1327579	1318183		NC_000014.9:60648793:C:G
NM_153700.2(STRC):c.3460C>T (p.Arg1154Ter)	STRC	R1154*	not provided|Deafness, autosomal recessive 16	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000618399	15	43902548	15	43610350	618399	609916	rs576724182	NC_000015.10:43610349:G:A
NM_005422.4(TECTA):c.2139C>A (p.Cys713Ter)	TBCEL-TECTA|TECTA	C713*, C1032*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000505476	11	120998825	11	121128116	505476	496965	rs768295360	NC_000011.10:121128115:C:A
NM_001378609.3(OTOGL):c.1940G>A (p.Trp647Ter)	OTOGL	W638*, W647*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000498660	12	80655799	12	80262019	498660	490084	rs377708973	NC_000012.12:80262018:G:A
NM_005422.4(TECTA):c.4857C>A (p.Cys1619Ter)	TBCEL-TECTA|TECTA	C1619*, C1938*	Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000402279	11	121031011	11	121160302	402279	389239	rs764153521	NC_000011.10:121160301:C:A
NM_001384474.1(LOXHD1):c.894T>G (p.Tyr298Ter)	LOXHD1	Y298*	not provided|Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Feb 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000286635	18	44181420	18	46601457	286635	270872	rs886043441	NC_000018.10:46601456:A:C
NM_206933.4(USH2A):c.8681+1G>A	USH2A		Retinitis pigmentosa 39|Usher syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	VCV000228416	1	216051099	1	215877757	228416	228321	rs876657733	NC_000001.11:215877756:C:T
NM_138691.3(TMC1):c.1676G>A (p.Trp559Ter)	TMC1	W559*	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000228406	9	75420407	9	72805491	228406	229705	rs876657728	NC_000009.12:72805490:G:A
NM_001122659.3(EDNRB):c.618G>A (p.Trp206Ter)	EDNRB|EDNRB-AS1	W206*, W296*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	VCV000228342	13	78477474	13	77903339	228342	230451	rs876657688	NC_000013.11:77903338:C:T
NM_144672.4(OTOA):c.1880+1G>A	OTOA		Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000164826	16	21734300	16	21722979	164826	175926	rs148690740	NC_000016.10:21722978:G:A
NM_016239.4(MYO15A):c.7893+1G>A	MYO15A		Rare genetic deafness|not provided	Pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	VCV000164552	17	18055266	17	18151952	164552	176477	rs727503316	NC_000017.11:18151951:G:A
NM_018060.4(IARS2):c.2726C>T (p.Pro909Leu)	IARS2	P909L	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia|growth hormone deficiency with short stature|partial sensorineural deafness|Cataract|Peripheral neuropathy	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000156553	1	220316451	1	220143109	156553	166347	rs587783070	NC_000001.11:220143108:C:T
NM_206933.4(USH2A):c.10724G>A (p.Cys3575Tyr)	USH2A	C3575Y	Rare genetic deafness|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048356	1	215955400	1	215782058	48356	57518	rs111033265	NC_000001.11:215782057:C:T
NM_000260.4(MYO7A):c.4293G>A (p.Trp1431Ter)	MYO7A	W1431*, W1420*	Rare genetic deafness|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043236	11	76905539	11	77194494	43236	52406	rs397516308	NC_000011.10:77194493:G:A
NM_000260.4(MYO7A):c.3724C>T (p.Gln1242Ter)	MYO7A	Q1242*, Q1231*	Deafness, autosomal recessive 2|Usher syndrome type 1|not provided|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372560	11	76901158	11	77190113	372560	360049	rs1057517857	NC_000011.10:77190112:C:T
NM_001692.4(ATP6V1B1):c.785+1G>A	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000179259	2	71188824	2	70961694	179259	178267	rs727504746	NC_000002.12:70961693:G:A
NM_001145308.5(LRTOMT):c.242G>A (p.Arg81Gln)	LRTOMT|TOMT	R81Q, R41Q, R48Q	Deafness, autosomal recessive 63|Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000543	11	71817140	11	72106094	543	15582	rs137853185	NC_000011.10:72106093:G:A
NM_000260.4(MYO7A):c.285+2T>C	MYO7A		Deafness, autosomal recessive 2|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000489095	11	76858998	11	77147952	489095	482004	rs782292032	NC_000011.10:77147951:T:C
NM_000441.2(SLC26A4):c.1554G>A (p.Trp518Ter)	SLC26A4	W518*	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Rare genetic deafness|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000165257	7	107338496	7	107698051	165257	174163	rs727503428	NC_000007.14:107698050:G:A
NM_194248.3(OTOF):c.2153G>A (p.Trp718Ter)	OTOF	W718*	Bilateral sensorineural hearing impairment|Deafness, autosomal recessive 9|Rare genetic deafness	Pathogenic(Last reviewed: Oct 17, 2012)	criteria provided, multiple submitters, no conflicts	VCV000048187	2	26702193	2	26479325	48187	57351	rs111033383	NC_000002.12:26479324:C:T
NM_000441.2(SLC26A4):c.1336C>T (p.Gln446Ter)	SLC26A4	Q446*	Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043504	7	107334920	7	107694475	43504	52674	rs397516416	NC_000007.14:107694474:C:T
NM_000260.4(MYO7A):c.4821T>A (p.Tyr1607Ter)	MYO7A	Y1607*, Y1558*, Y1569*	not provided|Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043261	11	76910832	11	77199787	43261	52431	rs397516315	NC_000011.10:77199786:T:A
NM_004086.3(COCH):c.1625G>T (p.Cys542Phe)	COCH|LOC100506071	C542F, C607F	Deafness, autosomal dominant 9|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006614	14	31358969	14	30889763	6614	21653	rs121908932	NC_000014.9:30889762:G:T
NM_001146079.2(CLDN14):c.254T>A (p.Val85Asp)	CLDN14|CLDN14-AS1	V85D	Deafness, autosomal recessive 29|Hearing impairment|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000004851	21	37833740	21	36461442	4851	19890	rs74315437	NC_000021.9:36461441:A:T
NM_206933.4(USH2A):c.3661C>T (p.Gln1221Ter)	USH2A|USH2A-AS1	Q1221*	not provided|Deafness|Deafness, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000560919	1	216373119	1	216199777	560919	551994	rs767797828	NC_000001.11:216199776:G:A
NM_000260.4(MYO7A):c.1344-2A>G	MYO7A		Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043143	11	76873164	11	77162118	43143	52313	rs111033415	NC_000011.10:77162117:A:G
NM_032861.4(SERAC1):c.916C>T (p.Arg306Ter)	SERAC1	R306*	not provided|3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Jul 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000869397	6	158549239	6	158128207	869397	857617	rs780664696	NC_000006.12:158128206:G:A
NM_001199107.2(TBC1D24):c.1153C>T (p.Gln385Ter)	TBC1D24	Q379*, Q385*	Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000852959	16	2549368	16	2499367	852959	843668	rs2065771024	NC_000016.10:2499366:C:T
NM_001692.4(ATP6V1B1):c.1386C>G (p.Tyr462Ter)	ATP6V1B1	Y462*	not provided|Renal tubular acidosis with progressive nerve deafness	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801719	2	71192095	2	70964965	801719	790289	rs1572924733	NC_000002.12:70964964:C:G
NM_001692.4(ATP6V1B1):c.1248+1G>C	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555327	2	71191673	2	70964543	555327	542147	rs1553420702	NC_000002.12:70964542:G:C
NM_006088.6(TUBB4B):c.1172G>A (p.Arg391His)	TUBB4B	R391H	not provided|Leber congenital amaurosis with early-onset deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000492938	9	140137842	9	137243390	492938	485877	rs1554786803	NC_000009.12:137243389:G:A
NM_000441.2(SLC26A4):c.2074T>C (p.Phe692Leu)	SLC26A4	F692L	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446462	7	107344815	7	107704370	446462	439909	rs1399914687	NC_000007.14:107704369:T:C
NM_032861.4(SERAC1):c.1403+1G>C	SERAC1		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic(Last reviewed: Nov 17, 2021)	no assertion criteria provided	VCV000430610	6	158538758	6	158117726	430610	423258	rs1131690799	NC_000006.12:158117725:C:G
NM_000260.4(MYO7A):c.285+1G>C	MYO7A		Deafness, autosomal recessive 2|Usher syndrome type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419493	11	76858997	11	77147951	419493	408476	rs782661097	NC_000011.10:77147950:G:C
NM_001199107.2(TBC1D24):c.878G>C (p.Arg293Pro)	TBC1D24	R293P	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000100678	16	2547027	16	2497026	100678	106550	rs199700840	NC_000016.10:2497025:G:C
NM_015340.4(LARS2):c.1886C>T (p.Thr629Met)	LARS2	T629M	Nonsyndromic hearing loss and deafness|Perrault syndrome 4	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, single submitter	VCV000055872	3	45557610	3	45516118	55872	70523	rs398123036	NC_000003.12:45516117:C:T
NM_001130823.3(DNMT1):c.1709C>T (p.Ala570Val)	DNMT1	A570V, A554V, A449V	not provided|Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	Pathogenic(Last reviewed: Jan 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000050920	19	10265385	19	10154709	50920	65579	rs397509392	NC_000019.10:10154708:G:A
NC_012920.1:m.7505T>C	MT-TS1		Deafness, nonsyndromic sensorineural, mitochondrial	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000040885	MT	7505	MT	7505	40885	49378	rs724159989	NC_012920.1:7504:T:C
NM_001614.5(ACTG1):c.791C>T (p.Pro264Leu)	ACTG1	P264L	Deafness, autosomal dominant 20|not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000018318	17	79478225	17	81511199	18318	33357	rs104894546	NC_000017.11:81511198:G:A
NM_004004.6(GJB2):c.132G>C (p.Trp44Cys)	GJB2	W44C	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000017019	13	20763589	13	20189450	17019	32058	rs104894407	NC_000013.11:20189449:C:G
NM_000260.4(MYO7A):c.1373A>T (p.Asn458Ile)	MYO7A	N458I, N447I	not provided|Deafness, autosomal dominant 11	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000011863	11	76873195	11	77162149	11863	26902	rs121965084	NC_000011.10:77162148:A:T
NM_000260.4(MYO7A):c.1797G>A (p.Met599Ile)	MYO7A	M599I, M588I	Deafness, autosomal recessive 2|Usher syndrome type 1B	Pathogenic(Last reviewed: Jun 15, 2001)	no assertion criteria provided	VCV000011856	11	76877208	11	77166162	11856	26895	rs121965082	NC_000011.10:77166161:G:A
NM_000328.3(RPGR):c.469+1G>T	RPGR		Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness|not provided	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000009912	X	38178081	X	38318828	9912	24951	rs62638646	NC_000023.11:38318827:C:A
NM_012188.5(FOXI1):c.800G>A (p.Arg267Gln)	FOXI1	R267Q	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000008450	5	169535278	5	170108274	8450	23489	rs121909341	NC_000005.10:170108273:G:A
NM_005422.4(TECTA):c.5609A>G (p.Tyr1870Cys)	TBCEL-TECTA|TECTA	Y1870C, Y2184C	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000007014	11	121038785	11	121168076	7014	22053	rs121909058	NC_000011.10:121168075:A:G
NM_004086.3(COCH):c.326T>A (p.Ile109Asn)	LOC100506071|COCH	I109N, I174N	Deafness, autosomal dominant 9|not provided	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, single submitter	VCV000006612	14	31348103	14	30878897	6612	21651	rs121908930	NC_000014.9:30878896:T:A
NM_194248.3(OTOF):c.4960+1G>C	OTOF		Auditory neuropathy, autosomal recessive, 1|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006140	2	26687736	2	26464868	6140	21179	rs80356602	NC_000002.12:26464867:C:G
NM_001110219.3(GJB6):c.14C>T (p.Thr5Met)	GJB6	T5M	Deafness, autosomal dominant 3b	Pathogenic(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000005543	13	20797606	13	20223467	5543	20582	rs104894414	NC_000013.11:20223466:G:A
NM_000441.2(SLC26A4):c.1540C>A (p.Gln514Lys)	SLC26A4	Q514K	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000004841	7	107336480	7	107696035	4841	19880	rs121908366	NC_000007.14:107696034:C:A
NM_057176.3(BSND):c.10G>T (p.Glu4Ter)	BSND	E4*	Hearing impairment|Sensorineural deafness with mild renal dysfunction	Pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, single submitter	VCV000004389	1	55464869	1	54999196	4389	19428	rs121908145	NC_000001.11:54999195:G:T
NM_001145809.2(MYH14):c.359C>T (p.Ser120Leu)	MYH14	S120L	Deafness, autosomal dominant 4|not provided	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002200	19	50713981	19	50210724	2200	17239	rs119103281	NC_000019.10:50210723:C:T
NM_001039141.3(TRIOBP):c.1039C>T (p.Arg347Ter)	TRIOBP	R347*	Deafness, autosomal recessive 28|not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000001490	22	38119602	22	37723595	1490	16529	rs118204026	NC_000022.11:37723594:C:T
NM_001378609.3(OTOGL):c.1078C>T (p.Arg360Ter)	OTOGL	R351*, R360*	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000667382	12	80645498	12	80251718	667382	654726	rs368844341	NC_000012.12:80251717:C:T
NM_022124.6(CDH23):c.1036C>T (p.Pro346Ser)	CDH23	P346S	Deafness, autosomal recessive 12	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000402250	10	73377052	10	71617295	402250	389233	rs1060499791	NC_000010.11:71617294:C:T
NM_001378609.3(OTOGL):c.5014C>T (p.Arg1672Ter)	OTOGL	R1663*, R1627*, R1672*	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Aug 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228384	12	80733008	12	80339228	228384	230401	rs759174628	NC_000012.12:80339227:C:T
NM_206933.4(USH2A):c.6398G>A (p.Trp2133Ter)	USH2A	W2133*	Retinitis pigmentosa 39|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000166484	1	216173832	1	216000490	166484	172768	rs727503725	NC_000001.11:216000489:C:T
NM_153700.2(STRC):c.3670C>T (p.Arg1224Ter)	STRC	R1224*	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Dec 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000165315	15	43900289	15	43608091	165315	176115	rs727503444	NC_000015.10:43608090:G:A
NM_002473.6(MYH9):c.4546G>T (p.Val1516Leu)	MYH9	V1516L	Rare genetic deafness	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000164432	22	36685142	22	36289096	164432	176262	rs727503284	NC_000022.11:36289095:C:A
NM_206933.4(USH2A):c.1143+1G>A	USH2A		Rare genetic deafness|Cone-rod dystrophy	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048376	1	216498646	1	216325304	48376	57538	rs397517974	NC_000001.11:216325303:C:T
NM_000260.4(MYO7A):c.4006C>T (p.Gln1336Ter)	MYO7A	Q1336*, Q1325*	not provided|Usher syndrome type 1B|Deafness, autosomal recessive 2|Deafness, autosomal dominant 11|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000561263	11	76903177	11	77192132	561263	552405	rs750647872	NC_000011.10:77192131:C:T
NM_004004.6(GJB2):c.533T>C (p.Val178Ala)	GJB2	V178A	not provided|Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550961	13	20763188	13	20189049	550961	546777	rs568612627	NC_000013.11:20189048:A:G
NM_000260.4(MYO7A):c.470+1G>A	MYO7A		Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome type 1	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177712	11	76867138	11	77156092	177712	178183	rs797044510	NC_000011.10:77156091:G:A
NM_022124.6(CDH23):c.6049+1G>A	CDH23		Deafness, autosomal recessive|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045999	10	73550171	10	71790414	45999	55164	rs111033247	NC_000010.11:71790413:G:A
NM_001384474.1(LOXHD1):c.5002C>T (p.Arg1668Ter)	LOXHD1	R1668*, R461*, R557*	Deafness, autosomal recessive 77|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554146	18	44102147	18	46522184	554146	549036	rs961865375	NC_000018.10:46522183:G:A
NM_001384474.1(LOXHD1):c.4099G>T (p.Glu1367Ter)	LOXHD1	E1367*, E160*, E256*	not provided|Rare genetic deafness|Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000163910	18	44114411	18	46534448	163910	176564	rs373937326	NC_000018.10:46534447:C:A
NM_004004.6(GJB2):c.506G>A (p.Cys169Tyr)	GJB2	C169Y	Knuckle pads, deafness AND leukonychia syndrome|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Mutilating keratoderma|Deafness, autosomal recessive 1A|Hystrix-like ichthyosis with deafness|Deafness, autosomal dominant 3a|Deafness, X-linked 2|not provided|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Aug 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265481	13	20763215	13	20189076	265481	260039	rs774518779	NC_000013.11:20189075:C:T
NM_004004.6(GJB2):c.379C>T (p.Arg127Cys)	GJB2	R127C	Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal dominant 3a|Deafness, X-linked 2|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000163514	13	20763342	13	20189203	163514	175763	rs727503066	NC_000013.11:20189202:G:A
NM_194248.3(OTOF):c.2122C>T (p.Arg708Ter)	OTOF	R708*	Deafness, autosomal recessive|Deafness, autosomal recessive 9|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021831	2	26702224	2	26479356	21831	34683	rs80356590	NC_000002.12:26479355:G:A
NM_000260.3(MYO7A):c.1969C>T	MYO7A	R657W, R646W	Deafness, autosomal dominant 11|Usher syndrome type 1|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal recessive 2|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242392	11	76885835	11	77174789	242392	237614	rs878853236	NC_000011.10:77174788:C:T
NM_005219.5(DIAPH1):c.3637C>T (p.Arg1213Ter)	DIAPH1	R1213*, R1204*	Rare genetic deafness|not provided|Deafness, autosomal dominant 1	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000228577	5	140903734	5	141524167	228577	229284	rs876657776	NC_000005.10:141524166:G:A
NM_194248.3(OTOF):c.2239G>T (p.Glu747Ter)	OTOF	E747*, E57*	not provided|Deafness, autosomal recessive 9|Rare genetic deafness	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000065787	2	26700593	2	26477725	65787	76695	rs397515591	NC_000002.12:26477724:C:A
NM_000260.4(MYO7A):c.5101C>T (p.Arg1701Ter)	MYO7A	R1701*, R1663*, R1652*	Deafness, autosomal recessive 2|Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043270	11	76913402	11	77202357	43270	52440	rs111033182	NC_000011.10:77202356:C:T
NM_001038603.3(MARVELD2):c.1498C>T (p.Arg500Ter)	MARVELD2	R500*, R488*	not provided|Deafness, autosomal recessive 49|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001198	5	68728915	5	69433088	1198	16237	rs118203957	NC_000005.10:69433087:C:T
NM_001110219.3(GJB6):c.263C>T (p.Ala88Val)	GJB6	A88V	Hidrotic ectodermal dysplasia syndrome|Deafness, autosomal recessive 1b|Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A|Hidrotic ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000005545	13	20797357	13	20223218	5545	20584	rs28937872	NC_000013.11:20223217:G:A
NM_005422.2(TECTA):c.[5458C>T;5471G>A]	TBCEL-TECTA|TECTA	G1824D, G2138D, L1820F, L2134F	Deafness, autosomal dominant 12	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000007013	11|11	121037374	11|11	121166665	7013	38440|22052	rs267607107|rs281865415	NC_000011.10:121166664:G:A|NC_000011.10:121166651:C:T
NM_138691.3(TMC1):c.1714G>A (p.Asp572Asn)	TMC1	D572N	none provided|Deafness, autosomal dominant 36|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004102	9	75431077	9	72816161	4102	19141	rs121908072	NC_000009.12:72816160:G:A
NM_000260.4(MYO7A):c.689C>T (p.Ala230Val)	MYO7A	A230V, A219V	not specified|Bilateral sensorineural hearing impairment|Deafness, autosomal dominant 11|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000178993	11	76868004	11	77156958	178993	178258	rs797044512	NC_000011.10:77156957:C:T
NM_000441.2(SLC26A4):c.304G>A (p.Gly102Arg)	SLC26A4	G102R	not specified|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV001301849	7	107303880	7	107663435	1301849	1292132		NC_000007.14:107663434:G:A
NM_000260.4(MYO7A):c.733C>T (p.Gln245Ter)	MYO7A	Q234*, Q245*	not provided|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV001073929	11	76868048	11	77157002	1073929	1062509		NC_000011.10:77157001:C:T
NM_017433.5(MYO3A):c.2090T>G (p.Leu697Trp)	MYO3A	L697W	Nonsyndromic hearing loss and deafness|not provided|nonsyndromic sensorineural hearing loss	Pathogenic(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000617675	10	26414513	10	26125584	617675	609078	rs1564573788	NC_000010.11:26125583:T:G
NM_004100.5(EYA4):c.1759C>T (p.Arg587Ter)	TARID|EYA4	R587*, R593*, R564*, R539*	Deafness, autosomal dominant 10|not provided	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000523780	6	133846312	6	133525174	523780	514523	rs1554275988	NC_000006.12:133525173:C:T
NM_001199107.2(TBC1D24):c.483C>A (p.Cys161Ter)	TBC1D24	C161*	Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000489172	16	2546632	16	2496631	489172	482095	rs745800110	NC_000016.10:2496630:C:A
NM_000441.2(SLC26A4):c.2007C>A (p.Asp669Glu)	SLC26A4	D669E	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446461	7	107342475	7	107702030	446461	439908	rs749013429	NC_000007.14:107702029:C:A
NM_000441.2(SLC26A4):c.82A>G (p.Ser28Gly)	SLC26A4|SLC26A4-AS1	S28G	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446459	7	107302168	7	107661723	446459	439899	rs1554352234	NC_000007.14:107661722:A:G
NM_001256317.3(TMPRSS3):c.346G>A (p.Val116Met)	TMPRSS3	V116M	not provided|Deafness, autosomal recessive 8	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000432009	21	43808612	21	42388503	432009	426362	rs200090033	NC_000021.9:42388502:C:T
NM_000441.2(SLC26A4):c.296C>G (p.Thr99Arg)	SLC26A4	T99R	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic, Affects(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000417623	7	107303872	7	107663427	417623	404601	rs141142414	NC_000007.14:107663426:C:G
NM_002764.4(PRPS1):c.830A>C (p.Gln277Pro)	PRPS1	Q277P, Q73P	Arts syndrome|Deafness, X-linked 1	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223100	X	106890961	X	107647731	223100	224827	rs869025593	NC_000023.11:107647730:A:C
NM_004004.6(GJB2):c.465T>A (p.Tyr155Ter)	GJB2	Y155*	not provided|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195205	13	20763256	13	20189117	195205	192366	rs772264564	NC_000013.11:20189116:A:T
NM_001199107.2(TBC1D24):c.208G>T (p.Asp70Tyr)	TBC1D24	D70Y	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000100677	16	2546357	16	2496356	100677	106549	rs587777147	NC_000016.10:2496355:G:T
NM_194248.3(OTOF):c.2887C>T (p.Arg963Ter)	OTOF	R963*, R216*, R273*	not provided|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000021840	2	26698886	2	26476018	21840	34692	rs80356595	NC_000002.12:26476017:G:A
NM_005247.4(FGF3):c.310C>T (p.Arg104Ter)	FGF3	R104*	Deafness with labyrinthine aplasia microtia and microdontia (LAMM)	Pathogenic	criteria provided, single submitter	VCV000013838	11	69631102	11	69816334	13838	28877	rs121917704	NC_000011.10:69816333:G:A
m.7510T>C	MT-TS1		Deafness, nonsyndromic sensorineural, mitochondrial	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000009565	MT	7510	MT	7510	9565	24604	rs199474820	NC_012920.1:7509:T:C
NM_194248.3(OTOF):c.3032T>C (p.Leu1011Pro)	OTOF	L1011P, L264P, L321P	Deafness, autosomal recessive 9|Auditory neuropathy, autosomal recessive, 1	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006142	2	26698321	2	26475453	6142	21181	rs80356596	NC_000002.12:26475452:A:G
NM_001042702.5(PJVK):c.547C>T (p.Arg183Trp)	PJVK	R183W, R186W, R218W, R24W	not provided|Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000001297	2	179320876	2	178456149	1297	16336	rs111706634	NC_000002.12:178456148:C:T
NM_001354604.2(MITF):c.956-1G>A	MITF		Waardenburg syndrome type 2A|Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness	Pathogenic	criteria provided, single submitter	VCV000375217	3	70005605	3	69956454	375217	361918	rs1057519327	NC_000003.12:69956453:G:A
NM_130837.3(OPA1):c.1459A>G (p.Ile487Val)	OPA1	I432V, I487V, I450V, I309V, I469V, I308V, I396V, I414V, I433V, I451V	Mitochondrial disease|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000030460	3	193361398	3	193643609	30460	39417	rs387906899	NC_000003.12:193643608:A:G
NM_016239.4(MYO15A):c.3385C>T (p.Arg1129Ter)	MYO15A	R1129*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Feb 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000505802	17	18025499	17	18122185	505802	497270	rs748868741	NC_000017.11:18122184:C:T
NM_153700.2(STRC):c.4837G>T (p.Glu1613Ter)	STRC	E1613*	Deafness, autosomal recessive 16|not provided	Pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000499237	15	43893077	15	43600879	499237	490661	rs769443188	NC_000015.10:43600878:C:A
NM_181458.4(PAX3):c.668G>A (p.Arg223Gln)	PAX3	R222Q, R223Q	not provided|Waardenburg syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228387	2	223096921	2	222232202	228387	228932	rs876657717	NC_000002.12:222232201:C:T
NM_000260.4(MYO7A):c.77C>A (p.Ala26Glu)	MYO7A	A26E, A15E	Rare genetic deafness	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000177731	11	76853813	11	77142767	177731	178186	rs369125667	NC_000011.10:77142766:C:A
NM_032119.4(ADGRV1):c.7006C>T (p.Arg2336Ter)	ADGRV1	R2336*	Rare genetic deafness|Usher syndrome, type 2C	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000143160	5	89988476	5	90692659	143160	152878	rs527236133	NC_000005.10:90692658:C:T
NM_206933.4(USH2A):c.12067-1G>C	USH2A		Rare genetic deafness|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000048389	1	215853719	1	215680377	48389	57551	rs397517977	NC_000001.11:215680376:C:G
NM_022124.6(CDH23):c.7776G>A (p.Trp2592Ter)	CDH23	W2592*, W352*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000046039	10	73563081	10	71803324	46039	55204	rs397517353	NC_000010.11:71803323:G:A
NM_022124.6(CDH23):c.3706C>T (p.Arg1236Ter)	C10orf105|CDH23	R1236*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, multiple submitters, no conflicts	VCV000045929	10	73490352	10	71730595	45929	55094	rs397517327	NC_000010.11:71730594:C:T
NM_000260.4(MYO7A):c.1963C>T (p.Gln655Ter)	MYO7A	Q655*, Q644*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043167	11	76885829	11	77174783	43167	52337	rs397516291	NC_000011.10:77174782:C:T
NM_000503.6(EYA1):c.922C>T (p.Arg308Ter)	EYA1	R308*, R186*, R302*, R337*, R331*, R332*	Branchiootorenal Syndrome 1|Rare genetic deafness	Pathogenic(Last reviewed: Sep 17, 2011)	criteria provided, single submitter	VCV000007929	8	72184037	8	71271802	7929	22968	rs121909195	NC_000008.11:71271801:G:A
NM_000260.4(MYO7A):c.6028G>A (p.Asp2010Asn)	MYO7A	D2010N, D1961N, D1972N	Usher syndrome type 1|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551533	11	76919825	11	77208780	551533	547079	rs755934966	NC_000011.10:77208779:G:A
NM_000260.4(MYO7A):c.3892G>A (p.Gly1298Arg)	MYO7A	G1298R, G1287R	Deafness, autosomal recessive 2|Usher syndrome type 1|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000164693	11	76901883	11	77190838	164693	175223	rs727503329	NC_000011.10:77190837:G:A
NM_004700.4(KCNQ4):c.853G>A (p.Gly285Ser)	KCNQ4	G285S	Nonsyndromic hearing loss and deafness|Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness	Pathogenic(Last reviewed: Sep 11, 2018)	reviewed by expert panel	VCV000006241	1	41285565	1	40819893	6241	21280	rs28937588	NC_000001.11:40819892:G:A
NM_022124.6(CDH23):c.4309C>T (p.Arg1437Ter)	CDH23	R1437*	not provided|Usher syndrome type 1D|Pituitary adenoma 5, multiple types|Deafness, autosomal recessive 12|Rare genetic deafness	Pathogenic(Last reviewed: Jan 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000045943	10	73498354	10	71738597	45943	55108	rs397517329	NC_000010.11:71738596:C:T
NM_000260.4(MYO7A):c.2323C>T (p.Gln775Ter)	MYO7A	Q775*, Q764*	Rare genetic deafness|Usher syndrome type 1|Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371700	11	76890131	11	77179085	371700	358080	rs201892914	NC_000011.10:77179084:C:T
NM_004004.6(GJB2):c.246C>G (p.Ile82Met)	GJB2	I82M	not provided|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188756	13	20763475	13	20189336	188756	186859	rs781534323	NC_000013.11:20189335:G:C
NM_147196.3(TMIE):c.250C>T (p.Arg84Trp)	TMIE	R84W, R31W	Sensorineural hearing loss disorder|not provided|Deafness, autosomal recessive 6|Hearing impairment|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003391	3	46750654	3	46709164	3391	18430	rs28942097	NC_000003.12:46709163:C:T
NM_005422.4(TECTA):c.4085G>A (p.Trp1362Ter)	TBCEL-TECTA|TECTA	W1362*, W1681*	Nonsyndromic hearing loss and deafness|Deafness, autosomal dominant 12|Rare genetic deafness|not provided|Deafness, autosomal recessive 21	Pathogenic(Last reviewed: Jan 21, 2020)	reviewed by expert panel	VCV000498538	11	121016805	11	121146096	498538	489962	rs199638531	NC_000011.10:121146095:G:A
NM_000441.2(SLC26A4):c.1262A>T (p.Gln421Leu)	SLC26A4	Q421L	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	criteria provided, single submitter	VCV000691513	7	107330681	7	107690236	691513	679199	rs201660407	NC_000007.14:107690235:A:T
NM_001199107.2(TBC1D24):c.116C>T (p.Ala39Val)	TBC1D24	A39V	Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1|not provided	Pathogenic(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000474302	16	2546265	16	2496264	474302	466552	rs773916549	NC_000016.10:2496263:C:T
NM_000441.2(SLC26A4):c.226C>T (p.Pro76Ser)	SLC26A4	P76S	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446451	7	107303802	7	107663357	446451	439900	rs1554352676	NC_000007.14:107663356:C:T
NM_001199107.2(TBC1D24):c.121C>T (p.Gln41Ter)	TBC1D24	Q41*	Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000391687	16	2546270	16	2496269	391687	377427	rs1057524191	NC_000016.10:2496268:C:T
NM_000441.2(SLC26A4):c.1544+1G>A	SLC26A4		Rare genetic deafness|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228395	7	107336485	7	107696040	228395	229537	rs876657722	NC_000007.14:107696039:G:A
NM_032229.3(SLITRK6):c.1240C>T (p.Gln414Ter)	SLITRK6	Q414*	Deafness and myopia	Pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, single submitter	VCV000088860	13	86369404	13	85795269	88860	94429	rs587777069	NC_000013.11:85795268:G:A
NM_014208.3(DSPP):c.52G>T (p.Val18Phe)	DSPP	V18F	Deafness, autosomal dominant nonsyndromic sensorineural 39, with dentinogenesis imperfecta 1|Dentinogenesis imperfecta type 3|Dentinogenesis imperfecta type 2	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000016856	4	88533257	4	87612105	16856	31895	rs121912987	NC_000004.12:87612104:G:T
NM_013296.5(GPSM2):c.379C>T (p.Arg127Ter)	GPSM2	R127*	Chudley-McCullough syndrome|Deafness, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000001823	1	109440214	1	108897592	1823	16862	rs267606854	NC_000001.11:108897591:C:T
NM_000260.4(MYO7A):c.6439-1G>A	MYO7A		Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000802710	11	76924904	11	77213859	802710	791181	rs1591514873	NC_000011.10:77213858:G:A
NM_032119.4(ADGRV1):c.8620C>T (p.Gln2874Ter)	ADGRV1	Q2874*	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666993	5	90002101	5	90706284	666993	654402	rs758834029	NC_000005.10:90706283:C:T
NM_022124.6(CDH23):c.1037C>T (p.Pro346Leu)	CDH23	P346L	not provided|Deafness, autosomal recessive 12	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000402251	10	73377053	10	71617296	402251	389234	rs778251205	NC_000010.11:71617295:C:T
NM_004999.4(MYO6):c.458C>G (p.Ser153Ter)	MYO6	S153*	Rare genetic deafness	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000228376	6	76542625	6	75832908	228376	229510	rs876657710	NC_000006.12:75832907:C:G
NM_206933.4(USH2A):c.11440G>T (p.Gly3814Ter)	USH2A	G3814*	Rare genetic deafness|Retinitis pigmentosa	Pathogenic(Last reviewed: Nov 12, 2014)	criteria provided, single submitter	VCV000180084	1	215916627	1	215743285	180084	172889	rs727505337	NC_000001.11:215743284:C:A
NM_000372.5(TYR):c.1199G>T (p.Trp400Leu)	TYR	W400L	Tyrosinase-negative oculocutaneous albinism|Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000099541	11	89017955	11	89284787	99541	105430	rs62645916	NC_000011.10:89284786:G:T
NM_000260.4(MYO7A):c.4117C>T (p.Arg1373Ter)	MYO7A	R1373*, R1362*	not provided|Deafness, autosomal dominant 11|Usher syndrome type 1|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551138	11	76903288	11	77192243	551138	546696	rs766641715	NC_000011.10:77192242:C:T
NM_001384474.1(LOXHD1):c.3061+1G>A	LOXHD1		Deafness, autosomal recessive 77|Hearing impairment|Deafness, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000523622	18	44140045	18	46560082	523622	514275	rs537227442	NC_000018.10:46560081:C:T
NM_000260.4(MYO7A):c.5899C>T (p.Arg1967Ter)	MYO7A	R1967*, R1929*, R1918*	Retinal dystrophy|MYO7A-Related Disorders|Deafness, autosomal recessive 2|Rare genetic deafness|not provided|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000178495	11	76919517	11	77208472	178495	175522	rs376764423	NC_000011.10:77208471:C:T
NM_000441.2(SLC26A4):c.1437+2T>G	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided|Rare genetic deafness|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043508	7	107335163	7	107694718	43508	52678	rs397516418	NC_000007.14:107694717:T:G
NM_000260.4(MYO7A):c.6070C>T (p.Arg2024Ter)	MYO7A	R2024*, R1975*, R1986*	not provided|Usher syndrome type 1|Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043318	11	76922215	11	77211170	43318	52488	rs111033198	NC_000011.10:77211169:C:T
NM_144612.6(LOXHD1):c.4714C>T	LOXHD1	R1572*, R461*, R365*	Rare genetic deafness|not provided|Deafness, autosomal recessive 77	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030990	18	44104697	18	46524734	30990	39947	rs75949023	NC_000018.10:46524733:G:A
NM_000260.4(MYO7A):c.5660C>T (p.Pro1887Leu)	MYO7A	P1887L, P1849L, P1838L	not provided|Usher syndrome type 1|Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043295	11	76917165	11	77206120	43295	52465	rs199606180	NC_000011.10:77206119:C:T
NM_000260.4(MYO7A):c.1900C>T (p.Arg634Ter)	MYO7A	R634*, R623*	Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1|not provided|Usher syndrome type 1|Rare genetic deafness|Usher syndrome type 1B	Pathogenic(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043164	11	76883896	11	77172850	43164	52334	rs111033180	NC_000011.10:77172849:C:T
NM_000260.4(MYO7A):c.1556G>A (p.Gly519Asp)	MYO7A	G519D, G508D	Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome type 1|not provided|Deafness, autosomal dominant 11|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043151	11	76873900	11	77162854	43151	52321	rs111033206	NC_000011.10:77162853:G:A
NM_001292063.2(OTOG):c.2464C>T (p.Gln822Ter)	OTOG	Q834*, Q822*	Deafness, autosomal recessive 18b|not provided|Rare genetic deafness|Seizures|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000417941	11	17596437	11	17574890	417941	404799	rs554847663	NC_000011.10:17574889:C:T
NM_001384140.1(PCDH15):c.3316C>T (p.Arg1106Ter)	PCDH15	R1106*, R1084*, R1118*, R1069*, R1035*, R1111*, R1113*	Rare genetic deafness|Usher syndrome type 1F|Usher syndrome type 1D|Deafness, autosomal recessive 23|Usher syndrome type 1F|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000046464	10	55698632	10	53938872	46464	55629	rs202033121	NC_000010.11:53938871:G:A
NM_000260.4(MYO7A):c.52C>T (p.Gln18Ter)	MYO7A	Q18*, Q7*	not provided|Rare genetic deafness|Usher syndrome type 1|Deafness, autosomal recessive 2|Deafness, autosomal dominant 11	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504505	11	76853788	11	77142742	504505	497811	rs1555051455	NC_000011.10:77142741:C:T
NM_004004.6(GJB2):c.238C>T (p.Gln80Ter)	GJB2	Q80*	Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Nonsyndromic Deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371685	13	20763483	13	20189344	371685	358132	rs199883710	NC_000013.11:20189343:G:A
NM_000441.2(SLC26A4):c.1522A>G (p.Thr508Ala)	SLC26A4	T508A	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000179732	7	107336462	7	107696017	179732	174027	rs727505088	NC_000007.14:107696016:A:G
NM_000260.4(MYO7A):c.722G>A (p.Arg241His)	MYO7A	R241H, R230H	Rare genetic deafness|Inborn genetic diseases|Deafness, autosomal recessive	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000043340	11	76868037	11	77156991	43340	52510	rs111033284	NC_000011.10:77156990:G:A
NM_000260.4(MYO7A):c.5618G>A (p.Arg1873Gln)	MYO7A	R1873Q, R1824Q, R1835Q	not provided|Deafness, autosomal recessive 2|Rare genetic deafness|Usher syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	reviewed by expert panel	VCV000043292	11	76916644	11	77205599	43292	52462	rs397516322	NC_000011.10:77205598:G:A
NM_000260.4(MYO7A):c.1996C>T (p.Arg666Ter)	MYO7A	R666*, R655*	Rare genetic deafness|Usher syndrome type 1|Deafness, autosomal recessive 2|not provided|Usher syndrome type 1B	Pathogenic(Last reviewed: Jun 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011860	11	76885862	11	77174816	11860	26899	rs121965085	NC_000011.10:77174815:C:T
NM_000260.4(MYO7A):c.494C>T (p.Thr165Met)	MYO7A	T165M, T154M	not provided|Deafness, autosomal recessive 2|Rare genetic deafness	Pathogenic(Last reviewed: Nov 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043264	11	76867729	11	77156683	43264	52434	rs111033174	NC_000011.10:77156682:C:T
NM_004004.6(GJB2):c.59T>C (p.Ile20Thr)	GJB2	I20T	nonsyndromic sensorineural hearing loss|Deafness, autosomal dominant 3a|Hearing loss|Nonsyndromic hearing loss and deafness|not provided|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371766	13	20763662	13	20189523	371766	358134	rs1057517519	NC_000013.11:20189522:A:G
NM_194248.3(OTOF):c.4718T>C (p.Ile1573Thr)	OTOF	I1573T, I806T, I883T	Bilateral sensorineural hearing impairment|Rare genetic deafness|Deafness, autosomal recessive 9|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048240	2	26688621	2	26465753	48240	57404	rs111033405	NC_000002.12:26465752:A:G
NM_004086.3(COCH):c.151C>T (p.Pro51Ser)	COCH|LOC100506071	P51S, P116S	Deafness, autosomal dominant 9|not provided|Hearing impairment|Rare genetic deafness|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	VCV000006611	14	31346846	14	30877640	6611	21650	rs28938175	NC_000014.9:30877639:C:T
NM_194248.3(OTOF):c.3049G>T (p.Glu1017Ter)	OTOF	E1017*, E270*, E327*	Deafness, autosomal recessive 9|Bilateral sensorineural hearing impairment	Pathogenic	criteria provided, multiple submitters, no conflicts	VCV001185578	2	26698304	2	26475436	1185578	1175551		NC_000002.12:26475435:C:A
NM_024063.3(SPATA5L1):c.527G>T (p.Gly176Val)	SPATA5L1	G176V	DEAFNESS, AUTOSOMAL RECESSIVE 119|NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY|SPATA5L1-associated disorder|See cases	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000976779	15	45695154	15	45402956	976779	964864	rs145451123	NC_000015.10:45402955:G:T
NM_000441.2(SLC26A4):c.601-1G>A	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446452	7	107315389	7	107674944	446452	439901	rs1554355011	NC_000007.14:107674943:G:A
NM_002764.4(PRPS1):c.343A>G (p.Met115Val)	PRPS1		Deafness, X-linked 1|Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140572	X	106884168	X	107640938	140572	150246	rs587781262	NC_000023.11:107640937:A:G
NM_000441.2(SLC26A4):c.765+2T>C	SLC26A4		Rare genetic deafness|not specified|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043567	7	107315556	7	107675111	43567	52736	rs397516432	NC_000007.14:107675110:T:C
NM_000441.2(SLC26A4):c.1204G>A (p.Val402Met)	SLC26A4	V402M	SLC26A4-Related Disorders|Pendred syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Feb 19, 2020)	reviewed by expert panel	VCV000043495	7	107330623	7	107690178	43495	52665	rs397516414	NC_000007.14:107690177:G:A
m.7445A>C	MT-TS1|MT-CO1		Deafness, nonsyndromic sensorineural, mitochondrial	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000009568	MT	7445	MT	7445	9568	24607	rs199474818	NC_012920.1:7444:A:C
NM_002241.5(KCNJ10):c.500C>T (p.Ala167Val)	KCNJ10	A167V	EAST syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|EAST syndrome|Pendred syndrome	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, single submitter	VCV000007466	1	160011823	1	160042033	7466	22505	rs137853070	NC_000001.11:160042032:G:A
NM_001256317.3(TMPRSS3):c.753G>C (p.Trp251Cys)	TMPRSS3	W251C, W124C	not provided|Hearing impairment|Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004944	21	43803171	21	42383062	4944	19983	rs137852999	NC_000021.9:42383061:C:G
NM_001174089.2(SLC4A11):c.2480T>C (p.Leu827Pro)	SLC4A11	L843P, L827P, L789P, L870P	Corneal dystrophy-perceptive deafness syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001316	20	3208983	20	3228337	1316	16355	rs121909394	NC_000020.11:3228336:A:G
NM_001384474.1(LOXHD1):c.2008C>T (p.Arg670Ter)	LOXHD1	R670*	Deafness, autosomal recessive 77|not provided	Pathogenic(Last reviewed: Jun 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000395	18	44152088	18	46572125	395	15434	rs121918370	NC_000018.10:46572124:G:A
NM_022124.6(CDH23):c.8064+1G>T	CDH23|LOC111982869		not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000517297	10	73565755	10	71805998	517297	497169	rs1474524543	NC_000010.11:71805997:G:T
NM_153700.2(STRC):c.4057C>T	STRC	Q1353*	Deafness, autosomal recessive 16|not provided	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000242391	15	43896918	15	43604720	242391	237617	rs774312182	NC_000015.10:43604719:G:A
NM_001384140.1(PCDH15):c.3358C>T (p.Arg1120Ter)	PCDH15	R1120*, R1083*, R1125*, R1127*, R1049*, R1132*, R1098*	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000228389	10	55698590	10	53938830	228389	229815	rs773404494	NC_000010.11:53938829:G:A
NM_153700.2(STRC):c.4402C>T (p.Arg1468Ter)	STRC	R1468*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179758	15	43895583	15	43603385	179758	176111	rs377480477	NC_000015.10:43603384:G:A
NM_000372.5(TYR):c.346C>T (p.Arg116Ter)	TYR	R116*	Tyrosinase-negative oculocutaneous albinism|not provided|Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000099565	11	88911467	11	89178299	99565	105454	rs61753256	NC_000011.10:89178298:C:T
NM_206933.4(USH2A):c.820C>T (p.Arg274Ter)	USH2A	R274*	Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000048595	1	216500961	1	216327619	48595	57757	rs397518036	NC_000001.11:216327618:G:A
NM_206933.4(USH2A):c.7244C>G (p.Ser2415Ter)	USH2A	S2415*	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048579	1	216108014	1	215934672	48579	57741	rs397518029	NC_000001.11:215934671:G:C
NM_206933.4(USH2A):c.11954G>A (p.Trp3985Ter)	USH2A	W3985*	Rare genetic deafness|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048388	1	215901484	1	215728142	48388	57550	rs397517976	NC_000001.11:215728141:C:T
NM_022124.6(CDH23):c.7362+5G>A	CDH23		Usher syndrome type 1D|Rare genetic deafness	Pathogenic(Last reviewed: Sep 25, 2013)	criteria provided, single submitter	VCV000004918	10	73559391	10	71799634	4918	19957	rs727502931	NC_000010.11:71799633:G:A
NM_016366.3(CABP2):c.637+1G>T	CABP2		Deafness, autosomal recessive 93|Deafness, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000597198	11	67287263	11	67519792	597198	588259	rs149712664	NC_000011.10:67519791:C:A
NM_000441.2(SLC26A4):c.1337A>G (p.Gln446Arg)	SLC26A4	Q446R	Deafness, autosomal recessive|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000550505	7	107334921	7	107694476	550505	544412	rs768471577	NC_000007.14:107694475:A:G
NM_004004.6(GJB2):c.456C>A (p.Tyr152Ter)	GJB2	Y152*	not provided|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000044753	13	20763265	13	20189126	44753	53920	rs111033420	NC_000013.11:20189125:G:T
NM_194248.3(OTOF):c.2485C>T (p.Gln829Ter)	OTOF	Q829*, Q139*, Q82*	not provided|Deafness, autosomal recessive 9|Rare genetic deafness	Pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006137	2	26700078	2	26477210	6137	21176	rs80356593	NC_000002.12:26477209:G:A
NM_000260.4(MYO7A):c.5617C>T (p.Arg1873Trp)	MYO7A	R1873W, R1824W, R1835W	not provided|Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043291	11	76916643	11	77205598	43291	52461	rs397516321	NC_000011.10:77205597:C:T
NM_000260.4(MYO7A):c.2904G>T (p.Glu968Asp)	MYO7A	E968D, E957D	not provided|Rare genetic deafness|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043196	11	76892635	11	77181589	43196	52366	rs111033233	NC_000011.10:77181588:G:T
NM_004004.6(GJB2):c.224G>A (p.Arg75Gln)	GJB2	R75Q	not provided|Deafness, autosomal recessive|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Hereditary palmoplantar keratoderma|Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017027	13	20763497	13	20189358	17027	32066	rs28931593	NC_000013.11:20189357:C:T
NM_004004.6(GJB2):c.134G>A (p.Gly45Glu)	GJB2	G45E	Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017033	13	20763587	13	20189448	17033	32072	rs72561723	NC_000013.11:20189447:C:T
NM_000260.4(MYO7A):c.73G>A (p.Gly25Arg)	MYO7A	G25R, G14R	Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000177722	11	76853809	11	77142763	177722	178185	rs782252317	NC_000011.10:77142762:G:A
NM_000260.4(MYO7A):c.999T>G (p.Tyr333Ter)	MYO7A	Y333*, Y322*	Usher syndrome type 1B|not provided|Rare genetic deafness|Retinal dystrophy|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043345	11	76869472	11	77158426	43345	52515	rs111033285	NC_000011.10:77158425:T:G
NM_001110219.3(GJB6):c.31G>A (p.Gly11Arg)	GJB6	G11R	Hidrotic ectodermal dysplasia syndrome|Deafness, autosomal recessive 1b|Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A|not provided|Hidrotic ectodermal dysplasia syndrome|Deafness, X-linked 2|Hidrotic ectodermal dysplasia syndrome|Deafness, autosomal recessive 1b|Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005544	13	20797589	13	20223450	5544	20583	rs104894415	NC_000013.11:20223449:C:T
NM_144612.6(LOXHD1):c.4480C>T	LOXHD1	R1494*, R383*, R287*	Nonsyndromic hearing loss and deafness|not provided|Deafness, autosomal recessive 77|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000178396	18	44109190	18	46529227	178396	176561	rs201587138	NC_000018.10:46529226:G:A
NM_000260.4(MYO7A):c.93C>A (p.Cys31Ter)	MYO7A	C31*, C20*	Deafness, autosomal recessive|Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|Usher syndrome type 1B|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011859	11	76853829	11	77142783	11859	26898	rs35689081	NC_000011.10:77142782:C:A
NM_000260.4(MYO7A):c.640G>A (p.Gly214Arg)	MYO7A	G214R, G203R	Usher syndrome type 1|not provided|Deafness, autosomal recessive 2|Rare genetic deafness|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043327	11	76867955	11	77156909	43327	52497	rs111033283	NC_000011.10:77156908:G:A
NM_004004.6(GJB2):c.239A>C (p.Gln80Pro)	GJB2	Q80P	Deafness, autosomal recessive 1A|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000177735	13	20763482	13	20189343	177735	175905	rs727504302	NC_000013.11:20189342:T:G
NM_016239.4(MYO15A):c.4351G>A (p.Asp1451Asn)	MYO15A	D1451N	not provided|Deafness, autosomal recessive 3|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000869471	17	18036569	17	18133255	869471	857687	rs767270134	NC_000017.11:18133254:G:A
NM_000441.2(SLC26A4):c.1415G>A (p.Trp472Ter)	SLC26A4	W472*	not provided|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553228	7	107335139	7	107694694	553228	544045	rs1554359693	NC_000007.14:107694693:G:A
NM_000260.4(MYO7A):c.47T>A (p.Leu16Ter)	MYO7A	L16*, L5*	not provided|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549974	11	76853783	11	77142737	549974	546385	rs1052030	NC_000011.10:77142736:T:A
NM_000441.2(SLC26A4):c.2048T>C (p.Phe683Ser)	SLC26A4	F683S	Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000402277	7	107344789	7	107704344	402277	389229	rs1060499808	NC_000007.14:107704343:T:C
NM_194248.3(OTOF):c.4747C>T (p.Arg1583Cys)	OTOF	R1583C, R816C, R893C	Deafness, autosomal recessive 9|Bilateral sensorineural hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000402270	2	26688592	2	26465724	402270	389219	rs781688103	NC_000002.12:26465723:G:A
NM_000260.4(MYO7A):c.6196C>T (p.Gln2066Ter)	MYO7A	Q2066*, Q2017*, Q2028*	Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000402265	11	76922341	11	77211296	402265	389242	rs1060499801	NC_000011.10:77211295:C:T
NM_194248.3(OTOF):c.4483C>T (p.Arg1495Ter)	OTOF	R1495*, R728*, R805*	not specified|Hearing impairment|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065804	2	26689599	2	26466731	65804	76712	rs147321712	NC_000002.12:26466730:G:A
NM_194248.3(OTOF):c.2891C>A (p.Ala964Glu)	OTOF	A964E, A217E, A274E	Bilateral sensorineural hearing impairment|Deafness, autosomal recessive 9	Pathogenic	criteria provided, single submitter	VCV000065793	2	26698882	2	26476014	65793	76701	rs201329629	NC_000002.12:26476013:G:T
NM_000441.2(SLC26A4):c.1105A>G (p.Lys369Glu)	SLC26A4	K369E	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic, Affects(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000004822	7	107329601	7	107689156	4822	19861	rs121908361	NC_000007.14:107689155:A:G
NM_153676.4(USH1C):c.672C>A (p.Cys224Ter)	USH1C	C224*	not provided|Deafness, autosomal recessive 18|Usher syndrome, type 1C	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556381	11	17547896	11	17526349	556381	545971	rs1223763703	NC_000011.10:17526348:G:T
NM_000260.4(MYO7A):c.5095C>T (p.Gln1699Ter)	MYO7A	Q1699*, Q1650*, Q1661*	not provided|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000451703	11	76913396	11	77202351	451703	444891	rs530520654	NC_000011.10:77202350:C:T
NM_000260.4(MYO7A):c.2283-1G>T	MYO7A		Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome type 1|Deafness, autosomal dominant 11|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000043178	11	76890090	11	77179044	43178	52348	rs397516295	NC_000011.10:77179043:G:T
NM_001038603.3(MARVELD2):c.1331+2T>C	MARVELD2		Deafness, autosomal recessive 49|not provided|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000871776	5	68728504	5	69432677	871776	859444	rs772048719	NC_000005.10:69432676:T:C
NM_001384140.1(PCDH15):c.274C>T (p.Gln92Ter)	PCDH15	Q92*, Q97*, Q70*	Usher syndrome type 1F|Deafness, autosomal recessive 23|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000555038	10	56138586	10	54378826	555038	545915	rs143842048	NC_000010.11:54378825:G:A
NM_006005.3(WFS1):c.2389G>A (p.Asp797Asn)	WFS1	D797N	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000517360	4	6303911	4	6302184	517360	496379	rs1553879004	NC_000004.12:6302183:G:A
NM_000260.4(MYO7A):c.2863G>A (p.Gly955Ser)	MYO7A	G955S, G944S	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000177733	11	76892594	11	77181548	177733	178188	rs781988557	NC_000011.10:77181547:G:A
NM_032119.4(ADGRV1):c.2398C>T (p.Arg800Ter)	ADGRV1	R800*	Febrile seizures, familial, 4|Usher syndrome, type 2C|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000046306	5	89938703	5	90642886	46306	55471	rs373780305	NC_000005.10:90642885:C:T
NM_080680.3(COL11A2):c.4135C>T (p.Arg1379Ter)	COL11A2	R1272*, R1293*, R1379*	not provided|Deafness, autosomal dominant 13|Otospondylomegaepiphyseal dysplasia, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017127	6	33135082	6	33167305	17127	32166	rs121912950	NC_000006.12:33167304:G:A
NM_000260.4(MYO7A):c.3508G>A (p.Glu1170Lys)	MYO7A	E1170K, E1159K	not provided|Retinal dystrophy|Deafness, autosomal recessive 2|Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043208	11	76900393	11	77189348	43208	52378	rs111033214	NC_000011.10:77189347:G:A
NM_004004.6(GJB2):c.44A>C (p.Lys15Thr)	GJB2	K15T	Rare genetic deafness|Deafness, autosomal recessive 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044752	13	20763677	13	20189538	44752	53919	rs111033217	NC_000013.11:20189537:T:G
NM_000260.4(MYO7A):c.6439-2A>G	MYO7A		not provided|Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome type 1B|MYO7A-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043329	11	76924903	11	77213858	43329	52499	rs397516330	NC_000011.10:77213857:A:G
NM_000260.4(MYO7A):c.5392C>T (p.Gln1798Ter)	MYO7A	Q1798*, Q1749*, Q1760*	Rare genetic deafness|Deafness, autosomal recessive 2|Usher syndrome type 1B|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043282	11	76915186	11	77204141	43282	52452	rs397516317	NC_000011.10:77204140:C:T
NM_000260.4(MYO7A):c.2005C>T (p.Arg669Ter)	MYO7A	R669*, R658*	not provided|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome type 1B|Rare genetic deafness|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043169	11	76885871	11	77174825	43169	52339	rs111033201	NC_000011.10:77174824:C:T
NM_004004.6(GJB2):c.223C>T (p.Arg75Trp)	GJB2	R75W	none provided|Deafness, autosomal recessive|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Hereditary palmoplantar keratoderma|Nonsyndromic hearing loss and deafness|Rare genetic deafness	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017011	13	20763498	13	20189359	17011	32050	rs104894402	NC_000013.11:20189358:G:A
NM_005548.3(KARS1):c.599C>T (p.Pro200Leu)	KARS1	P200L, P228L, P44L	Deafness, autosomal recessive 89|not provided|Deafness, congenital, and adult-onset progressive leukoencephalopathy|LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH DEAFNESS|KARS-related disorders|KARS1-related disorder|Optic neuropathy|Abnormal pyramidal sign|Congenital sensorineural hearing impairment|Progressive cerebellar ataxia|Abnormal cerebral white matter morphology|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000224983	16	75669880	16	75635982	224983	226957	rs201650281	NC_000016.10:75635981:G:A
NM_004004.6(GJB2):c.1A>G (p.Met1Val)	GJB2	M1V	none provided|not provided|Deafness, autosomal recessive 1A|Rare genetic deafness|Mutilating keratoderma|Deafness, autosomal recessive 1A|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2	Pathogenic(Last reviewed: Sep 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044729	13	20763720	13	20189581	44729	53896	rs111033293	NC_000013.11:20189580:T:C
NC_012920.1:m.7445A>G	MT-TS1|MT-CO1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Deafness, nonsyndromic sensorineural, mitochondrial|Palmoplantar keratoderma-deafness syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009563	MT	7445	MT	7445	9563	24602	rs199474818	NC_012920.1:7444:A:G
NM_000260.4(MYO7A):c.5648G>A (p.Arg1883Gln)	MYO7A	R1883Q, R1845Q, R1834Q	not provided|Deafness, autosomal recessive 2|Usher syndrome type 1B|Rare genetic deafness|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043294	11	76917153	11	77206108	43294	52464	rs111033215	NC_000011.10:77206107:G:A
NM_000260.4(MYO7A):c.2187+1G>A	MYO7A		Usher syndrome type 1|Deafness, autosomal recessive 2|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000043175	11	76886511	11	77175465	43175	52345	rs111033290	NC_000011.10:77175464:G:A
NM_000260.4(MYO7A):c.5573T>C (p.Leu1858Pro)	MYO7A	L1858P, L1809P, L1820P	not provided|Deafness, autosomal recessive 2|Rare genetic deafness|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome type 1B|MYO7A-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043288	11	76916599	11	77205554	43288	52458	rs368657015	NC_000011.10:77205553:T:C
NM_000260.4(MYO7A):c.6051+1G>A	MYO7A		Usher syndrome type 1|Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558500	11	76919849	11	77208804	558500	546721	rs1403288739	NC_000011.10:77208803:G:A
NM_000260.4(MYO7A):c.5168+2T>C	MYO7A		not provided|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558006	11	76913471	11	77202426	558006	546826	rs1192104600	NC_000011.10:77202425:T:C
NM_000260.4(MYO7A):c.3924+1G>C	MYO7A		not provided|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000558000	11	76901916	11	77190871	558000	547038	rs1226046110	NC_000011.10:77190870:G:C
NM_001692.4(ATP6V1B1):c.943C>T (p.Arg315Ter)	ATP6V1B1	R315*	Renal tubular acidosis with progressive nerve deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554499	2	71190325	2	70963195	554499	542319	rs145536062	NC_000002.12:70963194:C:T
NM_000260.4(MYO7A):c.285+2T>G	MYO7A		Deafness, autosomal recessive 2|Usher syndrome type 1|not provided|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554125	11	76858998	11	77147952	554125	546614	rs782292032	NC_000011.10:77147951:T:G
NM_000441.2(SLC26A4):c.2228T>A (p.Leu743Ter)	SLC26A4	L743*	Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371476	7	107350637	7	107710192	371476	357553	rs1057517303	NC_000007.14:107710191:T:A
NM_000260.4(MYO7A):c.5968C>T (p.Gln1990Ter)	MYO7A	Q1990*, Q1952*, Q1941*	Usher syndrome type 1|Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000197497	11	76919765	11	77208720	197497	194658	rs773844428	NC_000011.10:77208719:C:T
NM_194248.3(OTOF):c.3400C>T (p.Arg1134Ter)	OTOF	R1134*, R387*, R444*	Bilateral sensorineural hearing impairment|Deafness, autosomal recessive 9	Pathogenic	criteria provided, multiple submitters, no conflicts	VCV000065798	2	26696867	2	26473999	65798	76706	rs199848801	NC_000002.12:26473998:G:A
NM_001174089.2(SLC4A11):c.1765C>T (p.Arg589Ter)	SLC4A11	R605*, R589*, R551*, R632*	not provided|Congenital hereditary endothelial dystrophy of the cornea|Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000001307	20	3210076	20	3229430	1307	16346	rs121909390	NC_000020.11:3229429:G:A
NM_006996.3(SLC19A2):c.515G>A (p.Gly172Asp)	SLC19A2	G172D	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005957	1	169446685	1	169477447	5957	20996	rs28937595	NC_000001.11:169477446:C:T
NM_032119.4(ADGRV1):c.9877C>T (p.Arg3293Ter)	ADGRV1	R3293*	Rare genetic deafness|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000517415	5	90020777	5	90724960	517415	496836	rs769215629	NC_000005.10:90724959:C:T
NM_206933.4(USH2A):c.2809+2T>A	USH2A		not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504388	1	216419925	1	216246583	504388	495068	rs1553320397	NC_000001.11:216246582:A:T
NM_206933.4(USH2A):c.5788C>T (p.Arg1930Ter)	USH2A|USH2A-AS2	R1930*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048543	1	216246300	1	216072958	48543	57705	rs397518021	NC_000001.11:216072957:G:A
NM_206933.4(USH2A):c.12294+1G>C	USH2A		not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048394	1	215853490	1	215680148	48394	57556	rs111033526	NC_000001.11:215680147:C:G
NM_001256317.3(TMPRSS3):c.1273G>A (p.Ala425Thr)	TMPRSS3	A426T, A299T, A425T	not provided|Deafness, autosomal recessive 8|Nonsyndromic hearing loss and deafness|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000046102	21	43795896	21	42375787	46102	55267	rs56264519	NC_000021.9:42375786:C:T
NM_004004.6(GJB2):c.250G>A (p.Val84Met)	GJB2	V84M	Progressive sensorineural hearing impairment|not provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic(Last reviewed: May 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017036	13	20763471	13	20189332	17036	32075	rs104894409	NC_000013.11:20189331:C:T
NM_004004.6(GJB2):c.283G>A (p.Val95Met)	GJB2	V95M	Nonsyndromic hearing loss and deafness|not provided|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Hystrix-like ichthyosis with deafness|Palmoplantar keratoderma-deafness syndrome|Deafness, X-linked 2|Deafness, autosomal recessive 1A|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Mutilating keratoderma|Hearing impairment|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044735	13	20763438	13	20189299	44735	53902	rs111033299	NC_000013.11:20189298:C:T
NM_004004.6(GJB2):c.231G>A (p.Trp77Ter)	GJB2	W77*	Deafness, autosomal recessive|Rare genetic deafness|Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|not provided|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b	Pathogenic(Last reviewed: Sep 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017001	13	20763490	13	20189351	17001	32040	rs80338944	NC_000013.11:20189350:C:T
NM_004004.6(GJB2):c.550C>T (p.Arg184Trp)	GJB2	R184W	Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Hearing loss|not provided	Pathogenic(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000560669	13	20763171	13	20189032	560669	551725	rs998045226	NC_000013.11:20189031:G:A
NM_000441.2(SLC26A4):c.2089+1G>A	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided|Rare genetic deafness|Pendred syndrome	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000165263	7	107344831	7	107704386	165263	174032	rs727503430	NC_000007.14:107704385:G:A
NM_000260.4(MYO7A):c.635G>A (p.Arg212His)	MYO7A	R212H, R201H	Retinal dystrophy|Rare genetic deafness|Usher syndrome type 1|Deafness, autosomal recessive 2|Usher syndrome type 1B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011850	11	76867950	11	77156904	11850	26889	rs28934610	NC_000011.10:77156903:G:A
NM_004004.6(GJB2):c.229T>C (p.Trp77Arg)	GJB2	W77R	Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Nonsyndromic hearing loss and deafness|Deafness, autosomal dominant 3a|Hearing impairment|not provided|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017003	13	20763492	13	20189353	17003	32042	rs104894397	NC_000013.11:20189352:A:G
NM_004004.6(GJB2):c.131G>A (p.Trp44Ter)	GJB2	W44*	Inborn genetic diseases|not provided|Deafness, autosomal recessive 1A|none provided|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Deafness, autosomal recessive 1A|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188830	13	20763590	13	20189451	188830	186861	rs104894413	NC_000013.11:20189450:C:T
NM_004004.6(GJB2):c.617A>G (p.Asn206Ser)	GJB2	N206S	Hearing impairment|none provided|Deafness, autosomal recessive 1A|Rare genetic deafness|Mutilating keratoderma|Deafness, autosomal recessive 1A|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|not provided|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044763	13	20763104	13	20188965	44763	53930	rs111033294	NC_000013.11:20188964:T:C
NM_000441.2(SLC26A4):c.2171A>G (p.Asp724Gly)	SLC26A4	D724G	Rare genetic deafness|Pendred syndrome|SLC26A4-Related Disorders|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228396	7	107350580	7	107710135	228396	229545	rs757820624	NC_000007.14:107710134:A:G
NM_001256317.3(TMPRSS3):c.916G>A (p.Ala306Thr)	TMPRSS3	A306T, A179T	not provided|Rare genetic deafness|Hearing impairment|Deafness, autosomal recessive 8	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000046131	21	43802210	21	42382101	46131	55296	rs181949335	NC_000021.9:42382100:C:T
NM_022124.6(CDH23):c.6050-9G>A	CDH23		Rare genetic deafness|Deafness, autosomal recessive|Usher syndrome type 1|not provided|Usher syndrome type 1D|Deafness, autosomal recessive 12|Pituitary adenoma 5, multiple types	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000046001	10	73550880	10	71791123	46001	55166	rs367928692	NC_000010.11:71791122:G:A
NM_000260.4(MYO7A):c.5434G>A (p.Glu1812Lys)	MYO7A	E1812K, E1763K, E1774K	Deafness, autosomal recessive|MYO7A-Related Disorders|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000632175	11	76915228	11	77204183	632175	620422	rs377267777	NC_000011.10:77204182:G:A
NM_001256317.3(TMPRSS3):c.316C>T (p.Arg106Cys)	TMPRSS3	R106C	not provided|Hearing impairment|Deafness, autosomal recessive 8	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000381714	21	43809044	21	42388935	381714	378449	rs139805921	NC_000021.9:42388934:G:A
NM_000260.4(MYO7A):c.1555-8C>G	MYO7A		Usher syndrome type 1|Deafness, autosomal recessive 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372430	11	76873891	11	77162845	372430	359920	rs1057517774	NC_000011.10:77162844:C:G
NM_004004.6(GJB2):c.385G>T (p.Glu129Ter)	GJB2	E129*	Deafness, autosomal recessive 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225223	13	20763336	13	20189197	225223	227136	rs397516875	NC_000013.11:20189196:C:A
NM_000441.2(SLC26A4):c.918+1G>T	SLC26A4		Rare genetic deafness|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043571	7	107323800	7	107683355	43571	52740	rs111033245	NC_000007.14:107683354:G:T
NM_000441.2(SLC26A4):c.68C>A (p.Ser23Ter)	SLC26A4|SLC26A4-AS1	S23*	Rare genetic deafness|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043563	7	107302154	7	107661709	43563	52732	rs397516430	NC_000007.14:107661708:C:A
NM_000441.2(SLC26A4):c.1115C>T (p.Ala372Val)	SLC26A4	A372V	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000004823	7	107329611	7	107689166	4823	19862	rs121908364	NC_000007.14:107689165:C:T
NM_006005.3(WFS1):c.2146G>A (p.Ala716Thr)	WFS1	A716T	not provided|Rare genetic deafness|Autosomal dominant nonsyndromic hearing loss 6	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004520	4	6303668	4	6301941	4520	19559	rs28937893	NC_000004.12:6301940:G:A
NM_001384474.1(LOXHD1):c.442A>T (p.Lys148Ter)	LOXHD1	K148*	not provided|Deafness, autosomal recessive 77	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000291140	18	44219648	18	46639685	291140	275377	rs886044666	NC_000018.10:46639684:T:A
NM_206933.4(USH2A):c.9304C>T (p.Gln3102Ter)	USH2A	Q3102*	Retinitis pigmentosa 39|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jun 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048621	1	216011400	1	215838058	48621	57783	rs397518046	NC_000001.11:215838057:G:A
NM_206933.4(USH2A):c.6224G>A (p.Trp2075Ter)	USH2A	W2075*	Retinal dystrophy|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jul 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048554	1	216219874	1	216046532	48554	57716	rs111033386	NC_000001.11:216046531:C:T
NM_004004.6(GJB2):c.230G>A (p.Trp77Ter)	GJB2	W77*	Rare genetic deafness|Deafness, autosomal recessive 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189176	13	20763491	13	20189352	189176	186860	rs104894395	NC_000013.11:20189351:C:T
NM_004004.6(GJB2):c.148G>A (p.Asp50Asn)	GJB2	D50N	Hearing loss|Hystrix-like ichthyosis with deafness|Sensorineural hearing loss disorder|not provided|Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017020	13	20763573	13	20189434	17020	32059	rs28931594	NC_000013.11:20189433:C:T
NM_001256317.3(TMPRSS3):c.413C>A (p.Ala138Glu)	TMPRSS3	A138E, A11E	Hearing impairment|Rare genetic deafness|Deafness, autosomal recessive 8|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000046119	21	43808545	21	42388436	46119	55284	rs147231991	NC_000021.9:42388435:G:T
NM_004004.6(GJB2):c.139G>T (p.Glu47Ter)	GJB2	E47*	Hearing loss|Rare genetic deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A|not provided|Hearing impairment|none provided	Pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017005	13	20763582	13	20189443	17005	32044	rs104894398	NC_000013.11:20189442:C:A
NM_000260.4(MYO7A):c.700C>T (p.Gln234Ter)	MYO7A	Q234*, Q223*	Usher syndrome type 1B|Deafness, autosomal recessive 2|Usher syndrome type 1|not provided|Rare genetic deafness|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011848	11	76868015	11	77156969	11848	26887	rs41298133	NC_000011.10:77156968:C:T
NM_000441.2(SLC26A4):c.716T>A (p.Val239Asp)	SLC26A4	V239D	not provided|Pendred syndrome|Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000043566	7	107315505	7	107675060	43566	52735	rs111033256	NC_000007.14:107675059:T:A
NM_004004.6(GJB2):c.71G>A (p.Trp24Ter)	GJB2	W24*	Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Hearing loss|Rare genetic deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Deafness, autosomal recessive|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|not provided|Hearing impairment|none provided	Pathogenic(Last reviewed: Sep 17, 2018)	reviewed by expert panel	VCV000017002	13	20763650	13	20189511	17002	32041	rs104894396	NC_000013.11:20189510:C:T
NM_000260.4(MYO7A):c.5856G>A (p.Lys1952=)	MYO7A		not provided|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556557	11	76918447	11	77207402	556557	546845	rs1453053718	NC_000011.10:77207401:G:A
NM_001079866.2(BCS1L):c.548G>A (p.Arg183His)	BCS1L	R183H, R63H, R16H	Leigh syndrome|Pili torti-deafness syndrome	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000006170	2	219526569	2	218661846	6170	21209	rs121908577	NC_000002.12:218661845:G:A
NM_153676.4(USH1C):c.1039C>T (p.Gln347Ter)	USH1C	Q347*, Q328*	Deafness, autosomal recessive 18|not provided|Usher syndrome, type 1C	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000500413	11	17542939	11	17521392	500413	491837	rs762551629	NC_000011.10:17521391:G:A
NM_004004.6(GJB2):c.365A>T (p.Lys122Ile)	GJB2	K122I	Hearing impairment|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Hearing loss|not specified|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044742	13	20763356	13	20189217	44742	53909	rs111033295	NC_000013.11:20189216:T:A
NM_206933.4(USH2A):c.12868C>T (p.Gln4290Ter)	USH2A	Q4290*	Retinal dystrophy|not provided|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048408	1	215848385	1	215675043	48408	57570	rs397517983	NC_000001.11:215675042:G:A
NM_173477.5(USH1G):c.1373A>T (p.Asp458Val)	USH1G	D458V, D355V	not provided|Usher syndrome, type 1G|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048127	17	72915558	17	74919463	48127	57291	rs397517925	NC_000017.11:74919462:T:A
NM_001384140.1(PCDH15):c.1998-2A>G	PCDH15		Usher syndrome type 1F|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000046449	10	55839186	10	54079426	46449	55614	rs397517452	NC_000010.11:54079425:T:C
NM_004004.6(GJB2):c.35G>T (p.Gly12Val)	GJB2	G12V	Nonsyndromic hearing loss and deafness|none provided|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Hearing impairment|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021387	13	20763686	13	20189547	21387	34239	rs1801002	NC_000013.11:20189546:C:A
NM_004004.6(GJB2):c.19C>T (p.Gln7Ter)	GJB2	Q7*	not provided|Deafness, autosomal recessive 1A|Rare genetic deafness|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044728	13	20763702	13	20189563	44728	53895	rs111033451	NC_000013.11:20189562:G:A
NM_000441.2(SLC26A4):c.-3-2A>G	SLC26A4|SLC26A4-AS1		Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided|Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043486	7	107302082	7	107661637	43486	52656	rs397516411	NC_000007.14:107661636:A:G
NM_022124.6(CDH23):c.719C>T (p.Pro240Leu)	CDH23	P240L	Usher syndrome type 1D|Deafness, autosomal recessive 12|Nonsyndromic hearing loss and deafness|not provided	Pathogenic(Last reviewed: Jul 22, 2019)	reviewed by expert panel	VCV000004928	10	73330641	10	71570884	4928	19967	rs121908354	NC_000010.11:71570883:C:T
NM_006005.3(WFS1):c.2590G>A (p.Glu864Lys)	WFS1	E864K	Nonsyndromic hearing loss and deafness|not provided|Rare genetic deafness|Wolfram syndrome 1|DFNA6/14/38 Nonsyndromic Low-Frequency Sensorineural Hearing Loss|Wolfram-like syndrome, autosomal dominant|Autosomal dominant nonsyndromic hearing loss 6	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004526	4	6304112	4	6302385	4526	19565	rs74315205	NC_000004.12:6302384:G:A
NM_004004.6(GJB2):c.95G>A (p.Arg32His)	GJB2	R32H	nonsyndromic sensorineural hearing loss|Rare genetic deafness|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|not provided	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044766	13	20763626	13	20189487	44766	53933	rs111033190	NC_000013.11:20189486:C:T
NM_004004.6(GJB2):c.101T>C (p.Met34Thr)	GJB2	M34T	Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Inborn genetic diseases|Hearing loss|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Palmoplantar keratoderma-deafness syndrome|Knuckle pads, deafness AND leukonychia syndrome|Hystrix-like ichthyosis with deafness|Nonsyndromic Deafness|none provided|Nonsyndromic hearing loss and deafness|Deafness, autosomal dominant 3a|Hearing impairment|not provided|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic(Last reviewed: Jun 24, 2019)	reviewed by expert panel	VCV000017000	13	20763620	13	20189481	17000	32039	rs35887622	NC_000013.11:20189480:A:G
NM_013296.5(GPSM2):c.1492C>T (p.Arg498Ter)	GPSM2	R498*	GPSM2-Related Disorders|not provided|Rare genetic deafness|Chudley-McCullough syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504591	1	109465090	1	108922468	504591	496561	rs370907055	NC_000001.11:108922467:C:T
NM_001692.4(ATP6V1B1):c.1037C>G (p.Pro346Arg)	ATP6V1B1	P346R	not provided|Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Nov 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280139	2	71190419	2	70963289	280139	264108	rs781838938	NC_000002.12:70963288:C:G
NM_032861.4(SERAC1):c.442C>T (p.Arg148Ter)	SERAC1	R148*	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000035556	6	158567859	6	158146827	35556	44229	rs387907236	NC_000006.12:158146826:G:A
m.7511T>C	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Deafness, nonsyndromic sensorineural, mitochondrial	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009566	MT	7511	MT	7511	9566	24605	rs199474821	NC_012920.1:7510:T:C
NM_000441.2(SLC26A4):c.754T>C (p.Ser252Pro)	SLC26A4	S252P	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001065210	7	107315543	7	107675098	1065210	1053520		NC_000007.14:107675097:T:C
NM_000441.2(SLC26A4):c.439A>G (p.Met147Val)	SLC26A4	M147V	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV000691508	7	107314632	7	107674187	691508	679194	rs760413427	NC_000007.14:107674186:A:G
NM_022124.6(CDH23):c.3880C>T (p.Gln1294Ter)	C10orf105|CDH23	Q1294*	Usher syndrome type 1D|Deafness, autosomal recessive|not provided	Pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV000004921	10	73491908	10	71732151	4921	19960	rs121908350	NC_000010.11:71732150:C:T
NM_001844.5(COL2A1):c.258C>A (p.Cys86Ter)	COL2A1	C86*	Avascular necrosis of femoral head, primary, 1|Achondrogenesis type II|Namaqualand hip dysplasia|Epiphyseal dysplasia, multiple, with myopia and conductive deafness|Spondyloperipheral dysplasia-short ulna syndrome|Stickler syndrome type 1|Platyspondylic dysplasia, Torrance type|Spondyloepiphyseal dysplasia congenita|Kniest dysplasia|Czech dysplasia, metatarsal type|Stickler syndrome, type I, nonsyndromic ocular|Legg-Calve-Perthes disease|Spondylometaphyseal dysplasia|Spondyloepiphyseal dysplasia, stanescu type|not provided	Pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000195148	12	48393736	12	47999953	195148	192309	rs794727261	NC_000012.12:47999952:G:T
NM_206933.4(USH2A):c.14911C>T (p.Arg4971Ter)	USH2A	R4971*	Retinitis pigmentosa 39|Usher syndrome, type 2A|Cone-rod dystrophy|Rare genetic deafness	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048449	1	215813957	1	215640615	48449	57611	rs397517994	NC_000001.11:215640614:G:A
NM_032119.4(ADGRV1):c.14973-2A>G	ADGRV1		Rare genetic deafness|Usher syndrome type 2|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000046275	5	90106048	5	90810231	46275	55440	rs371981035	NC_000005.10:90810230:A:G
NM_000503.6(EYA1):c.1319G>A (p.Arg440Gln)	EYA1	R440Q, R318Q, R433Q, R434Q, R469Q	Branchiootorenal Syndrome 1|Rare genetic deafness	Pathogenic(Last reviewed: Jun 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007935	8	72128968	8	71216733	7935	22974	rs121909196	NC_000008.11:71216732:C:T
NM_000441.2(SLC26A4):c.1001G>T (p.Gly334Val)	SLC26A4	G334V	not provided|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189039	7	107323982	7	107683537	189039	186733	rs146281367	NC_000007.14:107683536:G:T
NM_004004.6(GJB2):c.596C>T (p.Ser199Phe)	GJB2	S199F	not provided|Rare genetic deafness|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189183	13	20763125	13	20188986	189183	186854	rs771748289	NC_000013.11:20188985:G:A
NM_004004.6(GJB2):c.370C>T (p.Gln124Ter)	GJB2	Q124*	not provided|Deafness, autosomal recessive 1A|Rare genetic deafness|Hearing loss	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000044744	13	20763351	13	20189212	44744	53911	rs397516874	NC_000013.11:20189211:G:A
NM_000260.4(MYO7A):c.5581C>T (p.Arg1861Ter)	MYO7A	R1861*, R1812*, R1823*	not provided|Usher syndrome type 1|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557045	11	76916607	11	77205562	557045	546716	rs878864531	NC_000011.10:77205561:C:T
NM_000441.2(SLC26A4):c.2215C>T (p.Gln739Ter)	SLC26A4	Q739*	not provided|Rare genetic deafness|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000165265	7	107350624	7	107710179	165265	174033	rs727503431	NC_000007.14:107710178:C:T
NM_001243133.2(NLRP3):c.1055C>T (p.Ala352Val)	NLRP3	A352V, A354V	Cryopyrin associated periodic syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004373	1	247587806	1	247424504	4373	19412	rs121908149	NC_000001.11:247424503:C:T
NM_000260.4(MYO7A):c.6487G>A (p.Gly2163Ser)	MYO7A	G2163S, G2123S, G2114S	not provided|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000402267	11	76924953	11	77213908	402267	389244	rs747656448	NC_000011.10:77213907:G:A
NM_000441.2(SLC26A4):c.2T>C (p.Met1Thr)	SLC26A4|SLC26A4-AS1	M1T	Pendred syndrome|not provided|Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043553	7	107302088	7	107661643	43553	52722	rs111033302	NC_000007.14:107661642:T:C
NM_206933.4(USH2A):c.14180G>A (p.Trp4727Ter)	USH2A	W4727*	Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048429	1	215824097	1	215650755	48429	57591	rs397517989	NC_000001.11:215650754:C:T
NM_001844.5(COL2A1):c.1957C>T (p.Arg653Ter)	COL2A1	R584*, R653*	Avascular necrosis of femoral head, primary, 1|Spondyloepiphyseal dysplasia, stanescu type|Stickler syndrome, type I, nonsyndromic ocular|Spondyloepiphyseal dysplasia congenita|Namaqualand hip dysplasia|Spondylometaphyseal dysplasia|Platyspondylic dysplasia, Torrance type|Spondyloperipheral dysplasia-short ulna syndrome|Stickler syndrome type 1|Kniest dysplasia|Czech dysplasia, metatarsal type|Legg-Calve-Perthes disease|Epiphyseal dysplasia, multiple, with myopia and conductive deafness|Achondrogenesis type II|not provided|Stickler syndrome type 1|Rhegmatogenous retinal detachment, autosomal dominant	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017395	12	48377504	12	47983721	17395	32434	rs121912893	NC_000012.12:47983720:G:A
NM_004004.6(GJB2):c.250G>C (p.Val84Leu)	GJB2	V84L	Rare genetic deafness|Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A|Hearing impairment|not provided	Pathogenic(Last reviewed: May 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017032	13	20763471	13	20189332	17032	32071	rs104894409	NC_000013.11:20189331:C:G
NM_206933.4(USH2A):c.10712C>T (p.Thr3571Met)	USH2A	T3571M	Rare genetic deafness|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinitis pigmentosa 39|Usher syndrome, type 2A|Nonsyndromic hearing loss and deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048355	1	215955412	1	215782070	48355	57517	rs202175091	NC_000001.11:215782069:G:A
NM_000441.2(SLC26A4):c.1105A>T (p.Lys369Ter)	SLC26A4	K369*	not provided|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553253	7	107329601	7	107689156	553253	544379	rs121908361	NC_000007.14:107689155:A:T
NM_004004.6(GJB2):c.95G>T (p.Arg32Leu)	GJB2	R32L	Hearing loss|Deafness, autosomal recessive 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000499513	13	20763626	13	20189487	499513	490937	rs111033190	NC_000013.11:20189486:C:A
NM_000441.2(SLC26A4):c.1579A>C (p.Thr527Pro)	SLC26A4	T527P	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000446454	7	107338521	7	107698076	446454	439903	rs1554360358	NC_000007.14:107698075:A:C
NM_001692.4(ATP6V1B1):c.242T>C (p.Leu81Pro)	ATP6V1B1	L81P	Renal tubular acidosis with progressive nerve deafness|Nephrocalcinosis|Nephrolithiasis|not provided	Pathogenic(Last reviewed: Nov 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012228	2	71185243	2	70958113	12228	27267	rs121964880	NC_000002.12:70958112:T:C
NM_022124.6(CDH23):c.4021G>A (p.Asp1341Asn)	C10orf105|CDH23	D1341N	Deafness, autosomal recessive 12|Usher syndrome type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004923	10	73492049	10	71732292	4923	19962	rs121908351	NC_000010.11:71732291:G:A
NM_000441.2(SLC26A4):c.85G>T (p.Glu29Ter)	SLC26A4|SLC26A4-AS1	E29*	Rare genetic deafness|not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043569	7	107302171	7	107661726	43569	52738	rs111033205	NC_000007.14:107661725:G:T
NM_004004.6(GJB2):c.428G>A (p.Arg143Gln)	GJB2	R143Q	Deafness, autosomal dominant 3a|not provided|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017017	13	20763293	13	20189154	17017	32056	rs104894401	NC_000013.11:20189153:C:T
NM_016239.4(MYO15A):c.10045C>T (p.Gln3349Ter)	MYO15A	Q3349*	Inborn genetic diseases|Rare genetic deafness	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000930033	17	18071000	17	18167686	930033	918423	rs1345580310	NC_000017.11:18167685:C:T
NM_001384140.1(PCDH15):c.1927C>T (p.Arg643Ter)	PCDH15	R643*, R621*, R650*, R655*, R606*, R648*	not provided|Rare genetic deafness|Usher syndrome type 1F|Usher syndrome type 1D	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000177724	10	55849814	10	54090054	177724	175133	rs727504301	NC_000010.11:54090053:G:A
NM_000260.4(MYO7A):c.721C>T (p.Arg241Cys)	MYO7A	R241C, R230C	Deafness, autosomal recessive 2|Usher syndrome|not provided|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000438180	11	76868036	11	77156990	438180	431762	rs782166819	NC_000011.10:77156989:C:T
NM_001199107.2(TBC1D24):c.724C>T (p.Arg242Cys)	TBC1D24	R242C	not provided|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|Early infantile epileptic encephalopathy 16|DOORS syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000091395	16	2546873	16	2496872	91395	96871	rs398122965	NC_000016.10:2496871:C:T
NM_000441.2(SLC26A4):c.2167C>G (p.His723Asp)	SLC26A4	H723D	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000949741	7	107350576	7	107710131	949741	924579	rs1417146153	NC_000007.14:107710130:C:G
NM_004004.6(GJB2):c.169C>T (p.Gln57Ter)	GJB2	Q57*	Deafness, autosomal recessive 1A|not provided|Rare genetic deafness|Hearing loss	Pathogenic(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000044725	13	20763552	13	20189413	44725	53892	rs111033297	NC_000013.11:20189412:G:A
NM_000441.2(SLC26A4):c.1151A>G (p.Glu384Gly)	SLC26A4	E384G	not provided|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Rare genetic deafness|SLC26A4-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004820	7	107330570	7	107690125	4820	19859	rs111033244	NC_000007.14:107690124:A:G
m.8363G>A	MT-TK		Cardiomyopathy and Deafness|MERRF syndrome|Leigh syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009581	MT	8363	MT	8363	9581	24620	rs118192100	NC_012920.1:8362:G:A
NM_206933.4(USH2A):c.11241C>A (p.Tyr3747Ter)	USH2A	Y3747*	not provided|Usher syndrome, type 2A|Usher syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Sep 17, 2018)	reviewed by expert panel	VCV000506273	1	215932085	1	215758743	506273	496182	rs777465132	NC_000001.11:215758742:G:T
NM_206933.4(USH2A):c.5858-1G>A	USH2A		not provided|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048545	1	216243635	1	216070293	48545	57707	rs397518023	NC_000001.11:216070292:C:T
NM_206933.4(USH2A):c.14287G>A (p.Gly4763Arg)	USH2A	G4763R	Usher syndrome, type 2A|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048433	1	215823990	1	215650648	48433	57595	rs397517990	NC_000001.11:215650647:C:T
NM_016239.3(MYO15A):c.8183G>A	MYO15A	R2728H	Rare genetic deafness|Hearing impairment|Deafness, autosomal recessive 3|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228276	17	18058028	17	18154714	228276	230744	rs184435771	NC_000017.11:18154713:G:A
NM_000441.2(SLC26A4):c.1341+1G>C	SLC26A4		not provided|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370343	7	107334926	7	107694481	370343	357545	rs376653349	NC_000007.14:107694480:G:C
NM_130837.3(OPA1):c.1800C>G (p.Ser600Arg)	OPA1	S545R, S600R, S421R, S564R, S582R, S422R, S527R, S546R, S509R, S563R	not provided|Mitochondrial disease|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Jan 25, 2021)	criteria provided, single submitter	VCV000030461	3	193364899	3	193647110	30461	39418	rs398124298	NC_000003.12:193647109:C:G
NM_001844.5(COL2A1):c.2710C>T (p.Arg904Cys)	COL2A1	R835C, R904C	Epiphyseal dysplasia, multiple, with myopia and conductive deafness|Myopia|not provided|none provided	Pathogenic(Last reviewed: Nov 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017379	12	48373317	12	47979534	17379	32418	rs121912882	NC_000012.12:47979533:G:A
NM_000304.4(PMP22):c.199G>C (p.Ala67Pro)	PMP22	A67P	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease and deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008436	17	15142908	17	15239591	8436	23475	rs104894623	NC_000017.11:15239590:C:G
NM_001243133.2(NLRP3):c.778C>T (p.Arg260Ter)	NLRP3	R260W, R262W, R260*, R262*	not provided|Cryopyrin associated periodic syndrome|none provided|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1	Pathogenic(Last reviewed: Nov 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004374	1	247587529	1	247424227	4374	19413	rs121908150	NC_000001.11:247424226:C:T
NM_022124.6(CDH23):c.3016G>A (p.Glu1006Lys)	CDH23	E1006K	not provided|Usher syndrome type 1|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000618010	10	73466716	10	71706959	618010	609763	rs745571683	NC_000010.11:71706958:G:A
NM_153676.4(USH1C):c.496+1G>T	USH1C		not provided|Usher syndrome, type 1C|Deafness, autosomal recessive 18	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551814	11	17548769	11	17527222	551814	546258	rs138138689	NC_000011.10:17527221:C:A
NM_015340.4(LARS2):c.1565C>A (p.Thr522Asn)	LARS2|LARS2-AS1	T522N	not provided|Hydrops, lactic acidosis, and sideroblastic anemia|Rare genetic deafness|Perrault syndrome 4|Perrault syndrome	Pathogenic(Last reviewed: Nov 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000055871	3	45537808	3	45496316	55871	70522	rs199589947	NC_000003.12:45496315:C:A
NM_138691.2(TMC1):c.1165C>T	TMC1	R389*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000047856	9	75404174	9	72789258	47856	57020	rs151001642	NC_000009.12:72789257:C:T
NM_000245.4(MET):c.3689A>G (p.Tyr1230Cys)	MET	Y1248C, Y1230C, Y800C	Carcinoma|Kidney Carcinoma|Renal cell carcinoma, papillary, 1|Deafness, autosomal recessive 97|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000013885	7	116423414	7	116783360	13885	28924	rs121913246	NC_000007.14:116783359:A:G
NM_000372.5(TYR):c.164G>A (p.Cys55Tyr)	TYR	C55Y	Oculocutaneous albinism type 1B|Tyrosinase-negative oculocutaneous albinism|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|not provided|Oculocutaneous albinism|Tyrosinase-negative oculocutaneous albinism	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003790	11	88911285	11	89178117	3790	18829	rs28940879	NC_000011.10:89178116:G:A
NM_000441.2(SLC26A4):c.626G>T (p.Gly209Val)	SLC26A4	G209V	Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|SLC26A4-Related Disorders|not provided	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004821	7	107315415	7	107674970	4821	19860	rs111033303	NC_000007.14:107674969:G:T
NM_153676.4(USH1C):c.216G>A (p.Val72=)	USH1C		Deafness, autosomal recessive 18|Usher syndrome, type 1C|Usher syndrome|Usher syndrome type 1|Usher syndrome, type 1C|Usher syndrome type 1|Deafness, autosomal recessive 18|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005143	11	17552978	11	17531431	5143	20182	rs151045328	NC_000011.10:17531430:C:T
NM_000441.2(SLC26A4):c.1667A>G (p.Tyr556Cys)	SLC26A4	Y556C	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not specified	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000446456	7	107340580	7	107700135	446456	439905	rs763006761	NC_000007.14:107700134:A:G
NM_000441.2(SLC26A4):c.1586T>G (p.Ile529Ser)	SLC26A4	I529S	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189160	7	107338528	7	107698083	189160	186737	rs786204739	NC_000007.14:107698082:T:G
NM_000441.2(SLC26A4):c.1615-2A>G	SLC26A4		not provided|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV001033029	7	107340526	7	107700081	1033029	1020324	rs758823761	NC_000007.14:107700080:A:G
NM_000260.4(MYO7A):c.1190C>A (p.Ala397Asp)	MYO7A	A397D, A386D	Usher syndrome type 1|not provided|Usher syndrome type 1|Deafness, autosomal recessive 2|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553245	11	76871318	11	77160272	553245	546746	rs1555067667	NC_000011.10:77160271:C:A
NM_000441.2(SLC26A4):c.1614+1G>C	SLC26A4		Rare genetic deafness|not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000179170	7	107338557	7	107698112	179170	174164	rs111033312	NC_000007.14:107698111:G:C
NM_206933.4(USH2A):c.8559-2A>G	USH2A		Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinitis pigmentosa|Usher syndrome|Rare genetic deafness|Retinal dystrophy|not provided|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Oct 9, 2018)	reviewed by expert panel	VCV000048604	1	216051224	1	215877882	48604	57766	rs397518039	NC_000001.11:215877881:T:C
NM_206933.4(USH2A):c.14453C>T (p.Pro4818Leu)	USH2A	P4818L	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000504509	1	215821999	1	215648657	504509	496179	rs143344549	NC_000001.11:215648656:G:A
NM_206933.4(USH2A):c.13130C>A (p.Ser4377Ter)	USH2A	S4377*	Usher syndrome, type 2A|not provided|Retinitis pigmentosa 39|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048412	1	215848123	1	215674781	48412	57574	rs111033385	NC_000001.11:215674780:G:T
NM_206933.4(USH2A):c.12295-2A>G	USH2A		Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048392	1	215848960	1	215675618	48392	57554	rs151148854	NC_000001.11:215675617:T:C
NM_174878.3(CLRN1):c.368C>A (p.Ala123Asp)	CLRN1	A123D, A47D, C180*	Usher Syndrome, Type III|not provided|Usher syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048146	3	150659434	3	150941647	48146	57310	rs374963432	NC_000003.12:150941646:G:T
NM_005982.4(SIX1):c.386A>G (p.Tyr129Cys)	SIX1	Y129C	Branchiootorenal Syndrome 1|not provided|Branchiootorenal Syndrome 1|Deafness, autosomal dominant 23|Branchiootic syndrome 3|Branchiootic syndrome 3|Deafness, autosomal dominant 23	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008308	14	61115522	14	60648804	8308	23347	rs104894478	NC_000014.9:60648803:T:C
NM_000214.3(JAG1):c.551G>A (p.Arg184His)	JAG1	R184H	Deafness, congenital heart defects, and posterior embryotoxon|Tetralogy of Fallot|Alagille syndrome 1|not provided|Alagille syndrome 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007620	20	10639259	20	10658611	7620	22659	rs121918351	NC_000020.11:10658610:C:T
NM_004004.6(GJB2):c.551G>A (p.Arg184Gln)	GJB2	R184Q	Hearing impairment|not specified|Deafness, autosomal dominant 3a|Hearing loss|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029662	13	20763170	13	20189031	29662	38617	rs80338950	NC_000013.11:20189030:C:T
NM_004700.4(KCNQ4):c.827G>C (p.Trp276Ser)	KCNQ4	W276S	Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000006242	1	41285137	1	40819465	6242	21281	rs80358277	NC_000001.11:40819464:G:C
NM_000260.4(MYO7A):c.5824G>T (p.Gly1942Ter)	MYO7A	G1942*, G1893*, G1904*	Rare genetic deafness|Usher syndrome type 1|MYO7A-Related Disorders|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043300	11	76918415	11	77207370	43300	52470	rs111033192	NC_000011.10:77207369:G:T
NM_206933.4(USH2A):c.5581G>A (p.Gly1861Ser)	USH2A|USH2A-AS2	G1861S	Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Rare genetic deafness|Usher syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	reviewed by expert panel	VCV000048535	1	216246634	1	216073292	48535	57697	rs375668376	NC_000001.11:216073291:C:T
NM_000372.5(TYR):c.1A>G (p.Met1Val)	TYR	M1V	Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1B|Albinism, ocular, with sensorineural deafness|Tyrosinase-negative oculocutaneous albinism|Skin/hair/eye pigmentation, variation in, 3|not provided|Hypopigmentation of the skin|Iris transillumination defect|Horizontal nystagmus|Hypopigmentation of hair|Choroidal neovascularization|Albinism|Foveal hypoplasia|Slow decrease in visual acuity|Elevated hepatic transaminase|Abnormality of metabolism/homeostasis|Tyrosinase-negative oculocutaneous albinism|Myopia|Albinism|Nystagmus	Pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003807	11	88911122	11	89177954	3807	18846	rs28940881	NC_000011.10:89177953:A:G
NM_000441.2(SLC26A4):c.1334T>G (p.Leu445Trp)	SLC26A4	L445W	Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided|Pendred syndrome	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004829	7	107334918	7	107694473	4829	19868	rs111033307	NC_000007.14:107694472:T:G
NM_000260.4(MYO7A):c.133-2A>G	MYO7A		Deafness, autosomal recessive 2|MYO7A-Related Disorders|not provided|Usher syndrome type 1|Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555778	11	76858842	11	77147796	555778	546607	rs782064437	NC_000011.10:77147795:A:G
NM_001692.4(ATP6V1B1):c.232G>A (p.Gly78Arg)	ATP6V1B1	G78R	Inborn genetic diseases|not provided|Renal tubular acidosis with progressive nerve deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012229	2	71185233	2	70958103	12229	27268	rs121964881	NC_000002.12:70958102:G:A
NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro)	NLRP3	L353P, L355P	not provided|Cryopyrin associated periodic syndrome|Familial amyloid nephropathy with urticaria AND deafness|Chronic infantile neurological, cutaneous and articular syndrome|Hearing loss, autosomal dominant 34, with or without inflammation|Familial cold autoinflammatory syndrome 1|Keratitis fugax hereditaria|not specified|Familial cold autoinflammatory syndrome 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004379	1	247587809	1	247424507	4379	19418	rs28937896	NC_000001.11:247424506:T:C
NM_000441.2(SLC26A4):c.164+2T>C	SLC26A4		Rare genetic deafness|Pendred syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043518	7	107302252	7	107661807	43518	52687	rs397516420	NC_000007.14:107661806:T:C
NM_000441.2(SLC26A4):c.1541A>G (p.Gln514Arg)	SLC26A4	Q514R	Rare genetic deafness|Pendred syndrome|not specified|not provided	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043511	7	107336481	7	107696036	43511	52680	rs111033316	NC_000007.14:107696035:A:G
NM_000441.2(SLC26A4):c.1264-1G>C	SLC26A4		Rare genetic deafness|not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043500	7	107334847	7	107694402	43500	52670	rs111033311	NC_000007.14:107694401:G:C
NM_022124.6(CDH23):c.2289+1G>A	CDH23		Usher syndrome type 1|Usher syndrome type 1D|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504507	10	73454017	10	71694260	504507	496950	rs769433759	NC_000010.11:71694259:G:A
NM_206933.4(USH2A):c.10759C>T (p.Gln3587Ter)	USH2A	Q3587*	Rare genetic deafness|not provided|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048357	1	215953365	1	215780023	48357	57519	rs111033418	NC_000001.11:215780022:G:A
NM_001844.5(COL2A1):c.2965C>T (p.Arg989Cys)	COL2A1	R920C, R989C	Avascular necrosis of femoral head, primary, 1|Spondyloepiphyseal dysplasia, stanescu type|Stickler syndrome, type I, nonsyndromic ocular|Spondyloepiphyseal dysplasia congenita|Namaqualand hip dysplasia|Spondylometaphyseal dysplasia|Platyspondylic dysplasia, Torrance type|Spondyloperipheral dysplasia-short ulna syndrome|Stickler syndrome type 1|Kniest dysplasia|Czech dysplasia, metatarsal type|Legg-Calve-Perthes disease|Epiphyseal dysplasia, multiple, with myopia and conductive deafness|Achondrogenesis type II|not provided|Spondyloperipheral dysplasia-short ulna syndrome|Spondyloepiphyseal dysplasia congenita	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000017366	12	48372112	12	47978329	17366	32405	rs121912874	NC_000012.12:47978328:G:A
NM_001384140.1(PCDH15):c.733C>T (p.Arg245Ter)	PCDH15	R245*, R208*, R223*, R250*	Usher syndrome type 1F|Usher syndrome type 1D|Usher syndrome, type 1G|Deafness, autosomal recessive 23|Usher syndrome type 1D|Usher syndrome type 1F|Usher syndrome type 1|Deafness, autosomal recessive 23|not provided|Rare genetic deafness	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004933	10	56077174	10	54317414	4933	19972	rs111033260	NC_000010.11:54317413:G:A
NM_001692.4(ATP6V1B1):c.340C>T (p.Arg114Ter)	ATP6V1B1	R114*	not provided|Renal tubular acidosis with progressive nerve deafness|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521461	2	71185529	2	70958399	521461	511434	rs782138777	NC_000002.12:70958398:C:T
NM_153676.4(USH1C):c.91C>T (p.Arg31Ter)	USH1C	R31*	Usher syndrome, type 1C|Deafness, autosomal recessive 18|Usher syndrome, type 1C|Usher syndrome type 1|Deafness, autosomal recessive 18|not provided	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005146	11	17554815	11	17533268	5146	20185	rs121908370	NC_000011.10:17533267:G:A
NM_001243133.2(NLRP3):c.907G>A (p.Asp303Asn)	NLRP3	D303N, D305N	Cryopyrin associated periodic syndrome|Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004377	1	247587658	1	247424356	4377	19416	rs121908153	NC_000001.11:247424355:G:A
NM_004004.6(GJB2):c.94C>T (p.Arg32Cys)	GJB2	R32C	Rare genetic deafness|not specified|Deafness, autosomal recessive 1A|not provided	Pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188758	13	20763627	13	20189488	188758	186863	rs371024165	NC_000013.11:20189487:G:A
NM_004004.6(GJB2):c.298C>T (p.His100Tyr)	GJB2	H100Y	none provided|Hearing loss|nonsyndromic sensorineural hearing loss|Hearing impairment|not provided|Deafness, autosomal recessive 1A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000158607	13	20763423	13	20189284	158607	169011	rs143343083	NC_000013.11:20189283:G:A
NM_000441.2(SLC26A4):c.707T>C (p.Leu236Pro)	SLC26A4	L236P	Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided|Hearing impairment|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|SLC26A4-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004817	7	107315496	7	107675051	4817	19856	rs80338848	NC_000007.14:107675050:T:C
NM_004004.5(GJB2):c.[134G>A;408C>A]	GJB2	G45E, Y136*	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000267367	13|13	20763587	13|13	20189448	267367	32072|186856	rs72561723|rs786204690	NC_000013.11:20189447:C:T|NC_000013.11:20189173:G:T
NM_000441.2(SLC26A4):c.412G>T (p.Val138Phe)	SLC26A4	V138F	not provided|Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Pendred syndrome|Hearing impairment|SLC26A4-Related Disorders	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	VCV000004835	7	107312690	7	107672245	4835	19874	rs111033199	NC_000007.14:107672244:G:T
NM_000441.2(SLC26A4):c.1238A>G (p.Gln413Arg)	SLC26A4	Q413R	Deafness, autosomal recessive|not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370080	7	107330657	7	107690212	370080	357541	rs142498437	NC_000007.14:107690211:A:G
NM_001243133.2(NLRP3):c.1043C>T (p.Thr348Met)	NLRP3	T350M, T348M	not provided|Familial amyloid nephropathy with urticaria AND deafness|Cryopyrin associated periodic syndrome|Familial cold autoinflammatory syndrome 1	Pathogenic(Last reviewed: Jun 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000097909	1	247587794	1	247424492	97909	103801	rs151344629	NC_000001.11:247424491:C:T
NM_206933.4(USH2A):c.10450C>T (p.Arg3484Ter)	USH2A	R3484*	Rare genetic deafness|Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048348	1	215956215	1	215782873	48348	57510	rs111033379	NC_000001.11:215782872:G:A
NM_000372.5(TYR):c.823G>T (p.Val275Phe)	TYR	V275F	Oculocutaneous albinism|Oculocutaneous albinism type 1B|Tyrosinase-negative oculocutaneous albinism|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|not provided|Oculocutaneous albinism type 1B|Skin/hair/eye pigmentation, variation in, 3|Tyrosinase-negative oculocutaneous albinism	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003773	11	88924373	11	89191205	3773	18812	rs104894314	NC_000011.10:89191204:G:T
NM_000441.2(SLC26A4):c.1001+1G>A	SLC26A4		Rare genetic deafness|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|SLC26A4-Related Disorders|not provided	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004819	7	107323983	7	107683538	4819	19858	rs80338849	NC_000007.14:107683537:G:A
NM_206933.4(USH2A):c.1841-2A>G	USH2A		Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|USH2A-Related Disorders|not provided|Nonsyndromic hearing loss and deafness|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Nov 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048476	1	216462754	1	216289412	48476	57638	rs397518003	NC_000001.11:216289411:T:C
NM_004004.6(GJB2):c.132G>A (p.Trp44Ter)	GJB2	W44*	Deafness, autosomal recessive 1A|not provided|Hearing impairment	Pathogenic(Last reviewed: Dec 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000158605	13	20763589	13	20189450	158605	169013	rs104894407	NC_000013.11:20189449:C:T
m.14709T>C	MT-TE		Myopathy, mitochondrial, with diabetes mellitus|Diabetes-deafness syndrome maternally transmitted|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial disease|Mitochondrial myopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009617	MT	14709	MT	14709	9617	24656	rs121434453	NC_012920.1:14708:T:C
NM_206933.4(USH2A):c.1055C>T (p.Thr352Ile)	USH2A	T352I	Retinitis pigmentosa 39|Usher syndrome|Rare genetic deafness|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000438002	1	216498735	1	216325393	438002	431606	rs780308389	NC_000001.11:216325392:G:A
NM_206933.4(USH2A):c.8740C>T (p.Arg2914Ter)	USH2A	R2914*	Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228417	1	216040454	1	215867112	228417	228320	rs766590491	NC_000001.11:215867111:G:A
NM_206933.4(USH2A):c.9799T>C (p.Cys3267Arg)	USH2A	C3267R	Retinal dystrophy|not provided|Retinitis pigmentosa|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048634	1	215972408	1	215799066	48634	57796	rs111033263	NC_000001.11:215799065:A:G
NM_206933.4(USH2A):c.9371+1G>C	USH2A		Retinitis pigmentosa 39|Rare genetic deafness|not provided|Usher syndrome, type 2A	Pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048624	1	216011332	1	215837990	48624	57786	rs41308425	NC_000001.11:215837989:C:G
NM_000441.2(SLC26A4):c.1588T>C (p.Tyr530His)	SLC26A4	Y530H	Rare genetic deafness|not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004836	7	107338530	7	107698085	4836	19875	rs111033254	NC_000007.14:107698084:T:C
NM_032119.4(ADGRV1):c.6901C>T (p.Gln2301Ter)	ADGRV1	Q2301*	Usher syndrome|Usher syndrome, type 2C|Febrile seizures, familial, 4|Usher syndrome, type 2C|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006798	5	89986808	5	90690991	6798	21837	rs121909762	NC_000005.10:90690990:C:T
NM_206933.4(USH2A):c.9459C>A (p.Cys3153Ter)	USH2A	C3153*	Usher syndrome, type 2A|Retinal dystrophy|not provided|Rare genetic deafness|Usher syndrome|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Oct 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048628	1	215990450	1	215817108	48628	57790	rs73090721	NC_000001.11:215817107:G:T
NM_174878.3(CLRN1):c.189C>A (p.Tyr63Ter)	CLRN1	Y63*	Usher syndrome, type 3A|Retinitis pigmentosa|not provided|Usher Syndrome, Type III|Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004397	3	150690307	3	150972520	4397	19436	rs111033267	NC_000003.12:150972519:G:T
NM_130837.3(OPA1):c.1499G>A (p.Arg500His)	OPA1	R500H, R409H, R322H, R463H, R427H, R321H, R446H, R464H, R482H	Mitochondrial disease|not provided|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005091	3	193361785	3	193643996	5091	20130	rs80356529	NC_000003.12:193643995:G:A
NM_000441.2(SLC26A4):c.84C>A (p.Ser28Arg)	SLC26A4-AS1|SLC26A4	S28R	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188998	7	107302170	7	107661725	188998	186723	rs539699299	NC_000007.14:107661724:C:A
NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly)	BCS1L	S78G	Mitochondrial complex III deficiency, nuclear type 1|not provided|Leigh syndrome|Mitochondrial complex III deficiency, nuclear type 1|GRACILE syndrome|Pili torti-deafness syndrome|GRACILE syndrome	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006167	2	219525942	2	218661219	6167	21206	rs28937590	NC_000002.12:218661218:A:G
NM_206933.4(USH2A):c.9570+1G>A	USH2A		not provided|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000228418	1	215990338	1	215816996	228418	228312	rs760225886	NC_000001.11:215816995:C:T
NM_206933.4(USH2A):c.14803C>T (p.Arg4935Ter)	USH2A	R4935*	Retinitis pigmentosa 39|Retinal dystrophy|Rare genetic deafness|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000177760	1	215814065	1	215640723	177760	172511	rs146733615	NC_000001.11:215640722:G:A
NM_174878.3(CLRN1):c.528T>G (p.Tyr176Ter)	CLRN1	Y176*, Y100*, Y189*	Rare genetic deafness|not provided|Usher Syndrome, Type III|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004392	3	150645894	3	150928107	4392	19431	rs121908140	NC_000003.12:150928106:A:C
NM_206933.4(USH2A):c.4645C>T (p.Arg1549Ter)	USH2A	R1549*	Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Rare genetic deafness	Pathogenic(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504513	1	216270538	1	216097196	504513	496156	rs199679165	NC_000001.11:216097195:G:A
NM_206933.4(USH2A):c.2209C>T (p.Arg737Ter)	USH2A	R737*	Rare genetic deafness|Usher syndrome type 2|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002361	1	216420527	1	216247185	2361	17400	rs111033334	NC_000001.11:216247184:G:A
NM_000441.1(SLC26A4):c.[1468A>C;1489G>A]	SLC26A4	G497S, I490L	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000004816	7|7	107336429	7|7	107695984	4816	19855|38434	rs111033308|rs200511789	NC_000007.14:107695983:G:A|NC_000007.14:107695962:A:C
NM_000260.4(MYO7A):c.3719G>A (p.Arg1240Gln)	MYO7A	R1240Q, R1229Q	Usher syndrome type 1|Inborn genetic diseases|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome type 1|Deafness, autosomal recessive 2|Usher syndrome type 1B|Usher syndrome|MYO7A-Related Disorders|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043218	11	76901153	11	77190108	43218	52388	rs111033178	NC_000011.10:77190107:G:A
NM_004004.6(GJB2):c.250G>T (p.Val84Leu)	GJB2	V84L	Deafness, autosomal recessive 1A|not specified|not provided	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000167134	13	20763471	13	20189332	167134	177744	rs104894409	NC_000013.11:20189331:C:A
NM_001101.5(ACTB):c.547C>T (p.Arg183Trp)	ACTB	R183W	Inborn genetic diseases|ACTB-related BAFopathy|not provided|Developmental malformations-deafness-dystonia syndrome|Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000018275	7	5568167	7	5528536	18275	33314	rs104894003	NC_000007.14:5528535:G:A
NM_206933.4(USH2A):c.2610C>A (p.Cys870Ter)	LOC122152296|USH2A	C870*	Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome|Rare genetic deafness|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557167	1	216420126	1	216246784	557167	541060	rs767078782	NC_000001.11:216246783:G:T
NM_206933.4(USH2A):c.13010C>T (p.Thr4337Met)	USH2A	T4337M	Rare genetic deafness|Retinal dystrophy|not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000143172	1	215848243	1	215674901	143172	152890	rs527236137	NC_000001.11:215674900:G:A
NM_130837.3(OPA1):c.1034G>A (p.Arg345Gln)	OPA1	R345Q, R291Q, R166Q, R167Q, R272Q, R309Q, R327Q, R254Q, R308Q	Autosomal dominant optic atrophy classic form|not provided|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005084	3	193355069	3	193637280	5084	20123	rs121908375	NC_000003.12:193637279:G:A
NM_206933.4(USH2A):c.1606T>C (p.Cys536Arg)	USH2A	C536R	Usher syndrome, type 2A|Retinal dystrophy|Retinitis pigmentosa 39|Rare genetic deafness|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048471	1	216495263	1	216321921	48471	57633	rs111033273	NC_000001.11:216321920:A:G
NM_000372.5(TYR):c.140G>A (p.Gly47Asp)	TYR	G47D	Oculocutaneous albinism type 1B|Tyrosinase-negative oculocutaneous albinism|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|Inborn genetic diseases|not provided|Oculocutaneous albinism type 1B|Tyrosinase-negative oculocutaneous albinism	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003794	11	88911261	11	89178093	3794	18833	rs61753180	NC_000011.10:89178092:G:A
NM_001079866.2(BCS1L):c.166C>T (p.Arg56Ter)	BCS1L	R56*	Mitochondrial complex III deficiency, nuclear type 1|BCS1L-Related Disorders|Leigh syndrome|Mitochondrial complex III deficiency, nuclear type 1|GRACILE syndrome|Pili torti-deafness syndrome|GRACILE syndrome|not provided	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006169	2	219525876	2	218661153	6169	21208	rs121908576	NC_000002.12:218661152:C:T
NM_206933.4(USH2A):c.8981G>A (p.Trp2994Ter)	USH2A	W2994*	Usher syndrome, type 2A|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinitis pigmentosa 39|Rare genetic deafness|Retinitis pigmentosa|Usher syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048611	1	216019240	1	215845898	48611	57773	rs397518041	NC_000001.11:215845897:C:T
NM_206933.4(USH2A):c.1000C>T (p.Arg334Trp)	USH2A	R334W	Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome, type 2A|not provided|Usher syndrome type 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228411	1	216498790	1	216325448	228411	228349	rs397517963	NC_000001.11:216325447:G:A
NM_000260.4(MYO7A):c.3503G>A (p.Arg1168Gln)	MYO7A	R1168Q, R1157Q	not specified|Deafness, autosomal recessive 2|Usher syndrome type 1|Usher syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Sep 16, 2019)	reviewed by expert panel	VCV000179479	11	76895760	11	77184715	179479	178280	rs797044516	NC_000011.10:77184714:G:A
NM_000372.5(TYR):c.832C>T (p.Arg278Ter)	TYR	R278*	not provided|Oculocutaneous albinism|Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|Nonsyndromic Oculocutaneous Albinism|Tyrosinase-negative oculocutaneous albinism	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000099583	11	88924382	11	89191214	99583	105472	rs62645904	NC_000011.10:89191213:C:T
NM_206933.4(USH2A):c.10561T>C (p.Trp3521Arg)	USH2A	W3521R	Rare genetic deafness|Usher syndrome|not provided|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048352	1	215956104	1	215782762	48352	57514	rs111033264	NC_000001.11:215782761:A:G
NM_153676.4(USH1C):c.496+1G>A	USH1C		not provided|Inborn genetic diseases|Usher syndrome, type 1C|Deafness, autosomal recessive 18	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371732	11	17548769	11	17527222	371732	357961	rs138138689	NC_000011.10:17527221:C:T
NM_206933.4(USH2A):c.12067-2A>G	USH2A		Usher syndrome type 2|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|Retinal dystrophy|not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048390	1	215853720	1	215680378	48390	57552	rs397517978	NC_000001.11:215680377:T:C
NM_000372.5(TYR):c.1147G>A (p.Asp383Asn)	TYR	D383N	not provided|Tyrosinase-negative oculocutaneous albinism|Nonsyndromic Oculocutaneous Albinism|Inborn genetic diseases|Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003775	11	88961101	11	89227933	3775	18814	rs121908011	NC_000011.10:89227932:G:A
NM_206933.4(USH2A):c.1036A>C (p.Asn346His)	USH2A	N346H	Rare genetic deafness|Usher syndrome|not provided|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 14, 2018)	reviewed by expert panel	VCV000048347	1	216498754	1	216325412	48347	57509	rs369522997	NC_000001.11:216325411:T:G
NM_174878.3(CLRN1):c.144T>G (p.Asn48Lys)	CLRN1|CLRN1-AS1	N48K	not provided|Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa|Usher syndrome, type 3A|Usher Syndrome, Type III|not specified	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004395	3	150690352	3	150972565	4395	19434	rs111033258	NC_000003.12:150972564:A:C
NM_000372.5(TYR):c.1118C>A (p.Thr373Lys)	TYR	T373K	Oculocutaneous albinism type 1B|Tyrosinase-negative oculocutaneous albinism|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|not provided|Oculocutaneous albinism|Skin/hair/eye pigmentation, variation in, 3|Tyrosinase-negative oculocutaneous albinism	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003774	11	88961072	11	89227904	3774	18813	rs61754388	NC_000011.10:89227903:C:A
NM_206933.4(USH2A):c.949C>A (p.Arg317=)	USH2A		Rare genetic deafness|Retinal dystrophy|Usher syndrome type 2|Pigmentary retinopathy|Abnormal macular morphology|Rod-cone dystrophy|Retinal pigment epithelial atrophy|Blindness|Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002358	1	216498841	1	216325499	2358	17397	rs111033272	NC_000001.11:216325498:G:T
NM_206933.4(USH2A):c.9424G>T (p.Gly3142Ter)	USH2A	G3142*	Inborn genetic diseases|not provided|Usher syndrome type 2|Usher syndrome|Rare genetic deafness|Retinitis pigmentosa|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048626	1	215990485	1	215817143	48626	57788	rs397518048	NC_000001.11:215817142:C:A
NM_206933.4(USH2A):c.5776+1G>A	USH2A-AS2|USH2A		Usher syndrome, type 2A|Usher syndrome|not provided|Autosomal recessive retinitis pigmentosa|Retinal dystrophy|Usher syndrome type 2|Retinitis pigmentosa 39|Retinitis pigmentosa|Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000228414	1	216246438	1	216073096	228414	228337	rs876657731	NC_000001.11:216073095:C:T
NM_000372.5(TYR):c.1037-7T>A	TYR		Oculocutaneous albinism|Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|Nonsyndromic Oculocutaneous Albinism|not provided|Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Nystagmus|Albinism|Myopia	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000099527	11	88960984	11	89227816	99527	105416	rs61754381	NC_000011.10:89227815:T:A
NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe)	USH2A	C419F	USH2A-Related Disorders|Retinal dystrophy|Usher syndrome|not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002359	1	216497582	1	216324240	2359	17398	rs121912600	NC_000001.11:216324239:C:A
NM_006005.3(WFS1):c.2051C>T (p.Ala684Val)	WFS1	A684V	Inborn genetic diseases|not provided|Autosomal dominant nonsyndromic hearing loss 6|Wolfram-like syndrome, autosomal dominant|Wolfram syndrome 1|Rare genetic deafness|Wolfram syndrome 1	Pathogenic(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030556	4	6303573	4	6301846	30556	39513	rs387906930	NC_000004.12:6301845:C:T
NM_000307.5(POU3F4):c.478C>T (p.Gln160Ter)	POU3F4	Q160*	Autosomal recessive sensorineural hearing loss	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562096	X	82763810	X	83508802	562096	553274	rs1569280235	NC_000023.11:83508801:C:T
NM_000219.6(KCNE1):c.51G>A (p.Trp17Ter)	KCNE1	W17*	Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000547164	21	35821882	21	34449584	547164	537652	rs1244688796	NC_000021.9:34449583:C:T
NM_000219.6(KCNE1):c.50G>A (p.Trp17Ter)	KCNE1	W17*	Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000547163	21	35821883	21	34449585	547163	537653	rs779124360	NC_000021.9:34449584:C:T
NM_000219.6(KCNE1):c.138C>A (p.Tyr46Ter)	KCNE1	Y46*	Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000547162	21	35821795	21	34449497	547162	537651	rs758346045	NC_000021.9:34449496:G:T
NM_006941.4(SOX10):c.127C>T (p.Arg43Ter)	POLR2F|SOX10	R43*	Waardenburg syndrome type 4C|Waardenburg syndrome type 2E	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547774	22	38379665	22	37983658	547774	538273	rs1555939523	NC_000022.11:37983657:G:A
NM_006941.4(SOX10):c.232C>T (p.Gln78Ter)	POLR2F|SOX10	Q78*	not provided|Waardenburg syndrome type 2E	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523884	22	38379560	22	37983553	523884	514782	rs1555939491	NC_000022.11:37983552:G:A
NM_022124.6(CDH23):c.7872+1G>A	CDH23		Childhood onset hearing loss	Pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, single submitter	VCV001027559	10	73563178	10	71803421	1027559	1015327	rs746152246	NC_000010.11:71803420:G:A
NM_001199799.2(ILDR1):c.9G>A (p.Trp3Ter)	ILDR1	W3*	Childhood onset hearing loss	Pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, single submitter	VCV001027551	3	121740916	3	122022069	1027551	1015319	rs2071865513	NC_000003.12:122022068:C:T
NM_001199799.2(ILDR1):c.775C>T (p.Arg259Ter)	ILDR1	R170*, R259*	Childhood onset hearing loss	Pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, single submitter	VCV001027550	3	121713032	3	121994185	1027550	1015318	rs920852517	NC_000003.12:121994184:G:A
NM_174878.3(CLRN1):c.254-2A>G	CLRN1		Usher Syndrome, Type III	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000932234	3	150659550	3	150941763	932234	906128	rs1713861377	NC_000003.12:150941762:T:C
NM_022124.6(CDH23):c.271C>T (p.Gln91Ter)	CDH23-AS1|CDH23	Q91*	Childhood onset hearing loss	Pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, single submitter	VCV001027560	10	73269964	10	71510207	1027560	1015324	rs1853882557	NC_000010.11:71510206:C:T
NM_206933.4(USH2A):c.4396+2T>G	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000932237	1	216363563	1	216190221	932237	906127	rs2034687381	NC_000001.11:216190220:A:C
NM_032119.4(ADGRV1):c.1626A>T (p.Thr542=)	ADGRV1		Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000932232	5	89925143	5	90629326	932232	906124	rs1765197280	NC_000005.10:90629325:A:T
NM_206933.4(USH2A):c.3841A>T (p.Arg1281Ter)	USH2A|USH2A-AS1	R1281*	Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000932236	1	216371897	1	216198555	932236	906122	rs2034908088	NC_000001.11:216198554:T:A
NM_001384140.1(PCDH15):c.92-528C>T	LOC105378311|PCDH15		Usher syndrome type 1D	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000932235	10	56288165	10	54528405	932235	906129	rs190773725	NC_000010.11:54528404:G:A
NM_001354604.2(MITF):c.1096C>T (p.Arg366Ter)	MITF	R197*, R253*, R259*, R308*, R343*, R344*, R359*, R360*, R365*, R366*	Waardenburg syndrome type 2A|not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000995922	3	70008488	3	69959337	995922	983626	rs2066482593	NC_000003.12:69959336:C:T
NM_181458.4(PAX3):c.210C>A (p.Cys70Ter)	PAX3	C70*	Waardenburg syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547732	2	223161808	2	222297089	547732	537731	rs1356246522	NC_000002.12:222297088:G:T
NM_181458.4(PAX3):c.811C>T (p.Arg271Cys)	PAX3	R271C, R270C	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547748	2	223086088	2	222221369	547748	537715	rs1380858784	NC_000002.12:222221368:G:A
NM_001354604.2(MITF):c.1230G>A (p.Thr410=)	MITF		not provided|Waardenburg syndrome type 2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381604	3	70014048	3	69964897	381604	367718	rs1057521096	NC_000003.12:69964896:G:A
NM_181458.4(PAX3):c.784C>T (p.Arg262Ter)	PAX3	R262*, R261*	not provided|Waardenburg syndrome type 1	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280007	2	223096805	2	222232086	280007	264092	rs886041319	NC_000002.12:222232085:G:A
NM_001354604.2(MITF):c.1031+1G>A	MITF		Waardenburg syndrome type 2A|not provided|Waardenburg syndrome type 1	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000545015	3	70005682	3	69956531	545015	535279	rs1559749017	NC_000003.12:69956530:G:A
NM_181458.4(PAX3):c.812G>A (p.Arg271His)	PAX3	R271H, R270H	not provided|Waardenburg syndrome type 1	Pathogenic(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279964	2	223086087	2	222221368	279964	264095	rs774528745	NC_000002.12:222221367:C:T
NM_002834.5(PTPN11):c.1471C>G (p.Pro491Ala)	PTPN11	P491A, P495A, P490A	not provided|Noonan syndrome|Noonan syndrome 1	Pathogenic(Last reviewed: Dec 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000181503	12	112926851	12	112489047	181503	179456	rs397507539	NC_000012.12:112489046:C:G
NM_006941.4(SOX10):c.523C>T (p.Pro175Ser)	POLR2F|SOX10	P175S	Inborn genetic diseases|Waardenburg syndrome type 2E	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521356	22	38374048	22	37978041	521356	512523	rs1555938395	NC_000022.11:37978040:G:A
NM_001354604.2(MITF):c.961C>T (p.Arg321Ter)	MITF	R214*, R315*, R152*, R298*, R263*, R314*, R320*, R208*, R299*, R321*	Waardenburg syndrome type 2A|Poliosis|Prelingual sensorineural hearing impairment|Heterochromia iridis|Hearing impairment|not provided	Pathogenic(Last reviewed: Nov 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014276	3	70005611	3	69956460	14276	29315	rs104893746	NC_000003.12:69956459:C:T
NM_206933.4(USH2A):c.11864G>A (p.Trp3955Ter)	USH2A	W3955*	Retinitis pigmentosa 39|Retinal dystrophy|Usher syndrome, type 2A|Rod-cone dystrophy|Rare genetic deafness|Usher syndrome|Usher syndrome type 2|Retinitis pigmentosa|Hearing impairment|Congenital sensorineural hearing impairment|not provided	Pathogenic(Last reviewed: Jun 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002357	1	215901574	1	215728232	2357	17396	rs111033364	NC_000001.11:215728231:C:T
NM_206933.4(USH2A):c.2168-2A>G	USH2A		Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556562	1	216420570	1	216247228	556562	540964	rs993185407	NC_000001.11:216247227:T:C
NM_181458.4(PAX3):c.667C>T (p.Arg223Ter)	PAX3	R223*, R222*	not provided|Waardenburg syndrome type 3|Waardenburg syndrome type 1	Pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503680	2	223096922	2	222232203	503680	495125	rs772241382	NC_000002.12:222232202:G:A
NM_001384140.1(PCDH15):c.1737C>G (p.Tyr579Ter)	PCDH15	Y579*, Y542*, Y557*, Y584*, Y586*, Y591*	Retinal dystrophy|not provided|Childhood onset hearing loss|Usher syndrome type 1F	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371411	10	55912907	10	54153147	371411	357865	rs1057517251	NC_000010.11:54153146:G:C
NM_002834.5(PTPN11):c.1529A>G (p.Gln510Arg)	PTPN11	Q510R, Q514R, Q509R	none provided|not provided|LEOPARD syndrome 1|Noonan syndrome 1|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013345	12	112926909	12	112489105	13345	28384	rs121918470	NC_000012.12:112489104:A:G
NM_000218.3(KCNQ1):c.1780C>T (p.Arg594Ter)	KCNQ1	R467*, R594*	not provided|Congenital long QT syndrome|Long QT syndrome|Long QT syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000200858	11	2799253	11	2778023	200858	197504	rs794728537	NC_000011.10:2778022:C:T
NM_002834.5(PTPN11):c.1471C>T (p.Pro491Ser)	PTPN11	P491S, P495S, P490S	not provided|Noonan syndrome|not specified|Rasopathy|Noonan syndrome 1	Pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040550	12	112926851	12	112489047	40550	49020	rs397507539	NC_000012.12:112489046:C:T
NM_002834.5(PTPN11):c.179G>C (p.Gly60Ala)	PTPN11	G60A, G59A	not provided|Noonan syndrome|Rasopathy|Noonan syndrome 1	Pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040493	12	112888163	12	112450359	40493	48963	rs397507509	NC_000012.12:112450358:G:C
NC_012920.1:m.3243A>G	MT-TL1		Muscle stiffness, painful|Age-related macular degeneration 2|Cyclical vomiting syndrome|Mitochondrial complex IV deficiency|Leigh syndrome|Cerebral palsy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Diabetes-deafness syndrome maternally transmitted|MERRF/MELAS overlap syndrome|3-Methylglutaconic aciduria type 1|not provided|Stroke|Glucose intolerance|Short stature|Sensorineural hearing loss disorder|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|Mitochondrial disease	Pathogenic(Last reviewed: Nov 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G
NM_002834.5(PTPN11):c.1472C>T (p.Pro491Leu)	PTPN11	P491L, P495L, P490L	not specified|not provided|Noonan syndrome|Noonan syndrome 1|Rasopathy|LEOPARD syndrome 1	Pathogenic(Last reviewed: Feb 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040552	12	112926852	12	112489048	40552	49022	rs397507540	NC_000012.12:112489047:C:T
NM_002834.5(PTPN11):c.836A>G (p.Tyr279Cys)	PTPN11	Y279C, Y278C	Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not specified|not provided|Noonan syndrome 1|Cardiovascular phenotype|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|Noonan syndrome with multiple lentigines|Noonan syndrome|LEOPARD syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013328	12	112910827	12	112473023	13328	28367	rs121918456	NC_000012.12:112473022:A:G
NM_002834.5(PTPN11):c.1510A>G (p.Met504Val)	PTPN11	M504V, M508V, M503V	Rasopathy|none provided|Inborn genetic diseases|Noonan syndrome|Metachondromatosis|Juvenile myelomonocytic leukemia|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040562	12	112926890	12	112489086	40562	49032	rs397507547	NC_000012.12:112489085:A:G
NM_002834.5(PTPN11):c.417G>C (p.Glu139Asp)	PTPN11	E139D, E138D	Rasopathy|Juvenile myelomonocytic leukemia|Noonan syndrome|Inborn genetic diseases|Hypertrophic cardiomyopathy|Metachondromatosis|Juvenile myelomonocytic leukemia|Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome 3|Cardiovascular phenotype|Noonan syndrome|not specified|PTPN11 Related Disorders|Pectus excavatum|Ptosis|Microcephaly|Brachycephaly|Global developmental delay|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040513	12	112891083	12	112453279	40513	48983	rs397507520	NC_000012.12:112453278:G:C
NM_002834.5(PTPN11):c.188A>G (p.Tyr63Cys)	PTPN11	Y63C, Y62C	Lymphoma|B lymphoblastic leukemia lymphoma, no ICD-O subtype|Rasopathy|Noonan syndrome|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|Noonan syndrome 3|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013333	12	112888172	12	112450368	13333	28372	rs121918459	NC_000012.12:112450367:A:G
NM_016156.6(MTMR2):c.1164G>A (p.Trp388Ter)	MTMR2	W388*, W316*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549685	11	95580893	11	95847729	549685	540457	rs1555060024	NC_000011.10:95847728:C:T
NM_001199107.2(TBC1D24):c.58C>T (p.Gln20Ter)	TBC1D24	Q20*	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000419782	16	2546207	16	2496206	419782	409576	rs201257588	NC_000016.10:2496205:C:T
NM_013296.5(GPSM2):c.832C>T (p.Arg278Ter)	GPSM2	R278*	Chudley-McCullough syndrome	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001299315	1	109444446	1	108901824	1299315	1289174		NC_000001.11:108901823:C:T
NM_001854.4(COL11A1):c.494A>T (p.His165Leu)	COL11A1	H165L	Hearing loss, autosomal dominant 37	Pathogenic(Last reviewed: May 24, 2021)	no assertion criteria provided	VCV001119973	1	103540331	1	103074775	1119973	1108750		NC_000001.11:103074774:T:A
NM_001378457.1(DMXL2):c.918G>T (p.Gln306His)	DMXL2	Q306H	Hearing loss, autosomal dominant 71	Pathogenic(Last reviewed: May 4, 2021)	no assertion criteria provided	VCV001065611	15	51837792	15	51545595	1065611	1053960		NC_000015.10:51545594:C:A
NM_001079827.2(CLRN2):c.494C>A (p.Thr165Lys)	CLRN2	T165K	Hearing loss, autosomal recessive 117	Pathogenic(Last reviewed: Aug 10, 2021)	no assertion criteria provided	VCV000996040	4	17528500	4	17526877	996040	983750	rs1711990645	NC_000004.12:17526876:C:A
NM_001037582.3(SCD5):c.626G>C (p.Trp209Ser)	SCD5	W209S	Hearing loss, autosomal dominant 79	Pathogenic(Last reviewed: Nov 9, 2020)	no assertion criteria provided	VCV000984674	4	83557920	4	82636767	984674	972756	rs192654796	NC_000004.12:82636766:C:G
NM_001046.3(SLC12A2):c.2938G>A (p.Glu980Lys)	SLC12A2	E980K	Hearing loss, autosomal dominant 78	Pathogenic(Last reviewed: Nov 9, 2020)	no assertion criteria provided	VCV000984668	5	127512805	5	128177113	984668	972750	rs1763563407	NC_000005.10:128177112:G:A
NM_001304438.2(TMEM132E):c.2474C>T (p.Pro825Leu)	TMEM132E	P825L	Hearing loss, autosomal recessive 99	Pathogenic(Last reviewed: Sep 2, 2020)	no assertion criteria provided	VCV000977485	17	32964500	17	34637481	977485	965614	rs370232097	NC_000017.11:34637480:C:T
NM_001304438.2(TMEM132E):c.382G>T (p.Ala128Ser)	TMEM132E	A128S	Hearing loss, autosomal recessive 99	Pathogenic(Last reviewed: Sep 4, 2020)	no assertion criteria provided	VCV000977484	17	32953460	17	34626441	977484	965613	rs766225189	NC_000017.11:34626440:G:T
NM_004996.4(ABCC1):c.1769A>G (p.Asn590Ser)	ABCC1	N590S	Hearing loss, autosomal dominant 77	Pathogenic(Last reviewed: Jun 19, 2020)	no assertion criteria provided	VCV000929256	16	16162104	16	16068247	929256	917577	rs199797323	NC_000016.10:16068246:A:G
NM_001375524.1(TRRAP):c.511C>T (p.Arg171Cys)	TRRAP	R171C	Hearing loss, autosomal dominant 75	Pathogenic(Last reviewed: Feb 18, 2020)	no assertion criteria provided	VCV000812648	7	98495367	7	98897744	812648	800899	rs200157211	NC_000007.14:98897743:C:T
NM_001854.4(COL11A1):c.652-2A>C	COL11A1		Hearing loss, autosomal dominant 37	Pathogenic(Last reviewed: May 24, 2021)	no assertion criteria provided	VCV000666252	1	103496802	1	103031246	666252	653816	rs747787770	NC_000001.11:103031245:T:G
NM_001039213.4(CEACAM16):c.37G>T (p.Ala13Ser)	CEACAM16	A13S	Hearing loss, autosomal recessive 113	Pathogenic(Last reviewed: Aug 3, 2021)	no assertion criteria provided	VCV000626323	19	45204763	19	44701493	626323	614655	rs1198256157	NC_000019.10:44701492:G:T
NM_001039213.4(CEACAM16):c.662-1G>C	CEACAM16		Hearing loss, autosomal recessive 113	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000626322	19	45208859	19	44705589	626322	614654	rs1568528171	NC_000019.10:44705588:G:C
NM_001195263.2(PDZD7):c.1576C>T (p.Gln526Ter)	PDZD7	Q526*	Hearing loss, autosomal recessive 57	Pathogenic(Last reviewed: Jun 1, 2018)	no assertion criteria provided	VCV000545402	10	102775566	10	101015809	545402	535666	rs1554834186	NC_000010.11:101015808:G:A
NM_005012.4(ROR1):c.2207G>C (p.Arg736Thr)	ROR1	R736T	Hearing loss, autosomal recessive 108	Pathogenic(Last reviewed: Sep 13, 2017)	no assertion criteria provided	VCV000437889	1	64643931	1	64178248	437889	431510	rs1553163562	NC_000001.11:64178247:G:C
NM_012478.4(WBP2):c.487A>C (p.Met163Leu)	WBP2	M163L	Hearing loss, autosomal recessive 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437833	17	73843922	17	75847841	437833	431408	rs1555604710	NC_000017.11:75847840:T:G
NM_012478.4(WBP2):c.671C>T (p.Ala224Val)	WBP2	A224V, A179V	Hearing loss, autosomal recessive 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437832	17	73843050	17	75846969	437832	431407	rs1555604549	NC_000017.11:75846968:G:A
NM_012478.4(WBP2):c.478G>A (p.Ala160Thr)	WBP2	A160T	Hearing loss, autosomal recessive 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437831	17	73843931	17	75847850	437831	431406	rs202022024	NC_000017.11:75847849:C:T
NM_001378457.1(DMXL2):c.7250G>A (p.Arg2417His)	DMXL2	R2417H, R2416H, R1780H, R1743H, R2336H	Hearing loss, autosomal dominant 71	Pathogenic(Last reviewed: May 5, 2021)	no assertion criteria provided	VCV000431430	15	51763562	15	51471365	431430	424951	rs754786373	NC_000015.10:51471364:C:T
NM_025257.3(SLC44A4):c.466A>G (p.Met156Val)	SLC44A4	M156V, M80V	Hearing loss, autosomal dominant 72	Pathogenic(Last reviewed: Sep 19, 2018)	no assertion criteria provided	VCV000431429	6	31842500	6	31874723	431429	424950	rs1135402753	NC_000006.12:31874722:T:C
NM_145331.3(MAP3K7):c.721T>A (p.Trp241Arg)	MAP3K7	W241R	Cardiospondylocarpofacial syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264705	6	91263192	6	90553473	264705	259297	rs886039237	NC_000006.12:90553472:A:T
NM_001199107.2(TBC1D24):c.313T>C (p.Cys105Arg)	TBC1D24	C105R	DOORS syndrome	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000183153	16	2546462	16	2496461	183153	181289	rs797044547	NC_000016.10:2496460:T:C
NM_018344.6(SLC29A3):c.1228C>T (p.Gln410Ter)	SLC29A3	Q410*, Q332*	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000130338	10	73122165	10	71362408	130338	135785	rs587780462	NC_000010.11:71362407:C:T
NM_001256447.2(BCAP31):c.97C>T (p.Gln33Ter)	BCAP31	Q33*, Q100*	Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068446	X	152986423	X	153720968	68446	79337	rs397515620	NC_000023.11:153720967:G:A
NM_001256447.2(BCAP31):c.194-2A>G	BCAP31		Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068444	X	152981146	X	153715691	68444	79335	rs879255569	NC_000023.11:153715690:T:C
NM_018344.6(SLC29A3):c.607T>C (p.Ser203Pro)	SLC29A3	S203P, S125P	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039871	10	73111542	10	71351785	39871	48470	rs397514626	NC_000010.11:71351784:T:C
NM_002473.6(MYH9):c.3494G>T (p.Arg1165Leu)	MYH9	R1165L	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Feb 16, 2021)	no assertion criteria provided	VCV000038965	22	36691114	22	36295068	38965	47568	rs80338830	NC_000022.11:36295067:C:A
NM_002241.5(KCNJ10):c.225T>G (p.Phe75Leu)	KCNJ10	F75L	EAST syndrome	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030252	1	160012098	1	160042308	30252	39208	rs757159382	NC_000001.11:160042307:A:C
NM_207034.3(EDN3):c.476G>T (p.Cys159Phe)	EDN3	C159F	Waardenburg syndrome type 4B	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000016644	20	57896182	20	59321127	16644	31683	rs74315384	NC_000020.11:59321126:G:T
NM_000618.5(IGF1):c.274G>A (p.Val92Met)	IGF1	V76M, V92M	Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000014789	12	102813415	12	102419637	14789	29828	rs121912430	NC_000012.12:102419636:C:T
IGF1, MUTATION IN POLYADENYLATION SIGNAL, T-A	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000014788					14788	29827		
NM_057176.3(BSND):c.23G>T (p.Arg8Leu)	BSND	R8L	Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004386	1	55464882	1	54999209	4386	19425	rs74315288	NC_000001.11:54999208:G:T
NM_020436.5(SALL4):c.523A>T (p.Lys175Ter)	SALL4	K175*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Mar 26, 2020)	no assertion criteria provided	VCV000003325	20	50408499	20	51791960	3325	18364	rs74315426	NC_000020.11:51791959:T:A
NM_001007527.2(LMBRD2):c.1448G>A (p.Arg483His)	LMBRD2	R483H	DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES	Pathogenic(Last reviewed: Jan 12, 2022)	no assertion criteria provided	VCV001334128	5	36115211	5	36115109	1334128	1324935		NC_000005.10:36115108:C:T
NM_031407.7(HUWE1):c.646-1G>A	HUWE1		Intellectual disability, X-linked syndromic, Turner type	Pathogenic(Last reviewed: Apr 19, 2021)	criteria provided, single submitter	VCV001334036	X	53658567	X	53631615	1334036	1324806		NC_000023.11:53631614:C:T
NM_006158.5(NEFL):c.18C>G (p.Tyr6Ter)	NEFL	Y6*	Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV001333320	8	24814012	8	24956498	1333320	1324095		NC_000008.11:24956497:G:C
NM_018671.5(UNC45A):c.1313T>A (p.Val438Asp)	UNC45A	V423D, V293D, V438D	OSTEOOTOHEPATOENTERIC SYNDROME	Pathogenic(Last reviewed: Jun 15, 2021)	no assertion criteria provided	VCV001164082	15	91489957	15	90946727	1164082	1153082		NC_000015.10:90946726:T:A
NM_001376.5(DYNC1H1):c.1739A>C (p.Glu580Ala)	DYNC1H1	E580A	Charcot-Marie-Tooth disease, axonal, type 2O	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001075692	14	102452301	14	101985964	1075692	1063045		NC_000014.9:101985963:A:C
NM_001046.3(SLC12A2):c.2962C>T (p.Pro988Ser)	SLC12A2	P988S	Sensorineural hearing loss disorder	Pathogenic	criteria provided, single submitter	VCV000972899	5	127512829	5	128177137	972899	961221	rs1581138965	NC_000005.10:128177136:C:T
NM_001376.5(DYNC1H1):c.1678G>A (p.Val560Met)	DYNC1H1	V560M	Charcot-Marie-Tooth disease, axonal, type 2O	Pathogenic(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000844512	14	102452240	14	101985903	844512	841021	rs2047931446	NC_000014.9:101985902:G:A
NM_001080472.4(FITM2):c.652C>T (p.Gln218Ter)	FITM2	Q218*	Siddiqi syndrome	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692231	20	42935402	20	44306762	692231	680035	rs773801337	NC_000020.11:44306761:G:A
NM_001080472.4(FITM2):c.4G>T (p.Glu2Ter)	FITM2	E2*	Siddiqi syndrome	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692229	20	42939785	20	44311145	692229	680033	rs1004658892	NC_000020.11:44311144:C:A
NM_182916.3(TRNT1):c.443C>T (p.Ala148Val)	TRNT1	A148V	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000691999	3	3182294	3	3140610	691999	679744	rs761516140	NC_000003.12:3140609:C:T
NM_031407.7(HUWE1):c.12188G>A (p.Arg4063Gln)	HUWE1	R4063Q	Intellectual disability, X-linked syndromic, Turner type	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000627417	X	53563578	X	53536617	627417	615772	rs1569399945	NC_000023.11:53536616:C:T
NM_006941.4(SOX10):c.487C>T (p.Gln163Ter)	POLR2F|SOX10	Q163*	Waardenburg syndrome type 2E	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000599071	22	38374084	22	37978077	599071	590340	rs1569169289	NC_000022.11:37978076:G:A
NM_033109.5(PNPT1):c.208T>C (p.Ser70Pro)	PNPT1	S70P	Combined oxidative phosphorylation deficiency 13	Pathogenic(Last reviewed: Jan 23, 2019)	no assertion criteria provided	VCV000587376	2	55914794	2	55687659	587376	578333	rs1559114055	NC_000002.12:55687658:A:G
NM_006158.5(NEFL):c.487G>T (p.Glu163Ter)	NEFL	E163*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000369981	8	24813543	8	24956029	369981	354198	rs876661155	NC_000008.11:24956028:C:A
NM_006701.5(TXNL4A):c.153+3A>G	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000253187	18	77748237	18	79988237	253187	247601	rs879255559	NC_000018.10:79988236:T:C
NM_005221.6(DLX5):c.115G>T (p.Glu39Ter)	DLX5	E39*	Split-hand/foot malformation 1	Pathogenic(Last reviewed: Sep 5, 2014)	no assertion criteria provided	VCV000156469	7	96653821	7	97024509	156469	166235	rs587777842	NC_000007.14:97024508:C:A
NM_000618.5(IGF1):c.292C>T (p.Arg98Trp)	IGF1	R98W, R82W	Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic	no assertion criteria provided	VCV000127243	12	102813397	12	102419619	127243	132700	rs587779350	NC_000012.12:102419618:G:A
NM_006947.4(SRP72):c.620G>A (p.Arg207His)	SRP72	R207H	Bone marrow failure syndrome 1	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031660	4	57342846	4	56476680	31660	40335	rs387907189	NC_000004.12:56476679:G:A
NM_001005373.4(LRSAM1):c.1914G>A (p.Glu638=)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 26, 2010)	no assertion criteria provided	VCV000030859	9	130263290	9	127501011	30859	39816	rs387907032	NC_000009.12:127501010:G:A
NM_014918.5(CHSY1):c.205C>T (p.Gln69Ter)	CHSY1	Q69*	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030712	15	101791457	15	101251252	30712	39669	rs387906984	NC_000015.10:101251251:G:A
NM_005221.6(DLX5):c.533A>C (p.Gln178Pro)	DLX5	Q178P	Split-hand/foot malformation 1 with sensorineural hearing loss	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030021	7	96651504	7	97022192	30021	38976	rs387906737	NC_000007.14:97022191:T:G
NM_006158.5(NEFL):c.628G>T (p.Glu210Ter)	NEFL	E210*	Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000029803	8	24813402	8	24955888	29803	38758	rs199422214	NC_000008.11:24955887:C:A
NM_080680.3(COL11A2):c.2492C>A (p.Ser831Ter)	COL11A2	S724*, S745*, S831*	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000017126	6	33141825	6	33174048	17126	32165	rs121912949	NC_000006.12:33174047:G:T
NM_080680.3(COL11A2):c.1981G>A (p.Gly661Arg)	COL11A2	G554R, G575R, G661R	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jun 13, 1997)	no assertion criteria provided	VCV000017121	6	33144993	6	33177216	17121	32160	rs121912945	NC_000006.12:33177215:C:T
NM_000443.4(ABCB4):c.1207T>C (p.Tyr403His)	ABCB4	Y403H	Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: Jan 6, 1998)	no assertion criteria provided	VCV000013695	7	87073002	7	87443686	13695	28734	rs121918443	NC_000007.14:87443685:A:G
m.4269A>G	MT-TI		Cardiomyopathy, fatal	Pathogenic(Last reviewed: Jul 15, 1992)	no assertion criteria provided	VCV000009602	MT	4269	MT	4269	9602	24641	rs121434466	NC_012920.1:4268:A:G
m.5532G>A	MT-TW		Neurogastrointestinal syndrome, mitochondrial	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000009557	MT	5532	MT	5532	9557	24596	rs199474674	NC_012920.1:5531:G:A
m.5549G>A	MT-TW		Mitochondrial encephalopathy	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000009554	MT	5549	MT	5549	9554	24593	rs199474671	NC_012920.1:5548:G:A
NM_178138.6(LHX3):c.133A>T (p.Lys45Ter)	LHX3	K50*, K45*, K34*	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Jul 15, 2008)	no assertion criteria provided	VCV000009029	9	139092546	9	136200700	9029	24068	rs137854506	NC_000009.12:136200699:T:A
NM_178138.6(LHX3):c.672G>A (p.Trp224Ter)	LHX3	W224*, W213*, W229*	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009027	9	139090601	9	136198755	9027	24066	rs137854505	NC_000009.12:136198754:C:T
NM_178138.6(LHX3):c.629C>T (p.Ala210Val)	LHX3	A210V, A199V, A215V	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009024	9	139090644	9	136198798	9024	24063	rs137854503	NC_000009.12:136198797:G:A
NM_000376.3(VDR):c.1036G>A (p.Val346Met)	VDR	V346M, V396M	Vitamin D-dependent rickets type II with alopecia	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007759	12	48238777	12	47844994	7759	22798	rs267607169	NC_000012.12:47844993:C:T
NM_005450.6(NOG):c.615G>C (p.Trp205Cys)	NOG	W205C	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006707	17	54672199	17	56594838	6707	21746	rs104894615	NC_000017.11:56594837:G:C
NM_005450.6(NOG):c.614G>A (p.Trp205Ter)	NOG	W205*	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000006706	17	54672198	17	56594837	6706	21745	rs1567745119	NC_000017.11:56594836:G:A
NM_005450.6(NOG):c.386T>A (p.Leu129Ter)	NOG	L129*	Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006700	17	54671970	17	56594609	6700	21739	rs104894613	NC_000017.11:56594608:T:A
NM_016156.6(MTMR2):c.1444C>T (p.Gln482Ter)	MTMR2	Q482*, Q410*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006234	11	95574816	11	95841652	6234	21273	rs121434404	NC_000011.10:95841651:G:A
NM_003730.6(RNASET2):c.262-2A>G	RNASET2		Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000414	6	167356579	6	166943091	414	15453		NC_000006.12:166943090:T:C
NM_003730.6(RNASET2):c.550T>C (p.Cys184Arg)	RNASET2	C184R	Leukoencephalopathy, cystic, without megalencephaly	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000000412	6	167344549	6	166931061	412	15451	rs121918137	NC_000006.12:166931060:A:G
NM_033409.4(SLC52A3):c.986A>G (p.Tyr329Cys)	SLC52A3	Y329C	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Apr 6, 2021)	no assertion criteria provided	VCV001315574	20	744229	20	763585	1315574	1305834		NC_000020.11:763584:T:C
NM_033409.4(SLC52A3):c.710C>T (p.Ala237Val)	SLC52A3	A237V	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Apr 6, 2021)	no assertion criteria provided	VCV001315573	20	744505	20	763861	1315573	1305833		NC_000020.11:763860:G:A
NM_002968.3(SALL1):c.1873G>T (p.Glu625Ter)	SALL1	E528*, E625*	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jul 23, 2017)	criteria provided, single submitter	VCV000973255	16	51174260	16	51140349	973255	961625	rs1197587893	NC_000016.10:51140348:C:A
NM_004700.4(KCNQ4):c.140T>C (p.Leu47Pro)	KCNQ4	L47P	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000585006	1	41249905	1	40784233	585006	576062	rs1271250198	NC_000001.11:40784232:T:C
NM_001195263.2(PDZD7):c.1648C>T (p.Gln550Ter)	PDZD7	Q550*	Hearing loss, autosomal recessive 57	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000545404	10	102775494	10	101015737	545404	535668	rs1554834161	NC_000010.11:101015736:G:A
NM_000218.3(KCNQ1):c.115G>T (p.Glu39Ter)	KCNQ1	E39*	Jervell and Lange-Nielsen syndrome 1	Pathogenic(Last reviewed: Jan 5, 2017)	no assertion criteria provided	VCV000375455	11	2466443	11	2445213	375455	362222	rs1554958045	NC_000011.10:2445212:G:T
NM_145331.3(MAP3K7):c.328G>T (p.Gly110Cys)	MAP3K7	G110C	Cardiospondylocarpofacial syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	no assertion criteria provided	VCV000264703	6	91271356	6	90561637	264703	259295	rs886039235	NC_000006.12:90561636:C:A
NM_033409.4(SLC52A3):c.1296C>A (p.Cys432Ter)	SLC52A3	C432*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210027	20	741784	20	761140	210027	206611	rs758570021	NC_000020.11:761139:G:T
NM_033409.4(SLC52A3):c.989G>T (p.Gly330Val)	SLC52A3	G330V	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210023	20	744226	20	763582	210023	206615	rs797045196	NC_000020.11:763581:C:A
NM_033409.4(SLC52A3):c.955C>T (p.Pro319Ser)	SLC52A3	P319S	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210022	20	744260	20	763616	210022	206616	rs797045195	NC_000020.11:763615:G:A
NM_033409.4(SLC52A3):c.659C>A (p.Pro220His)	SLC52A3	P220H	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210019	20	744556	20	763912	210019	206620	rs797045194	NC_000020.11:763911:G:T
NM_033409.4(SLC52A3):c.224T>C (p.Ile75Thr)	SLC52A3	I75T	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210016	20	746195	20	765551	210016	206625	rs797045193	NC_000020.11:765550:A:G
NM_033409.4(SLC52A3):c.211G>A (p.Glu71Lys)	SLC52A3	E71K	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210015	20	746208	20	765564	210015	206626	rs267606683	NC_000020.11:765563:C:T
NM_033409.4(SLC52A3):c.173T>A (p.Val58Asp)	SLC52A3	V58D	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210014	20	746246	20	765602	210014	206627	rs797045192	NC_000020.11:765601:A:T
NM_033409.4(SLC52A3):c.160G>A (p.Gly54Arg)	SLC52A3	G54R	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210013	20	746259	20	765615	210013	206628	rs797045191	NC_000020.11:765614:C:T
NM_001304438.2(TMEM132E):c.1529G>A (p.Arg510Gln)	TMEM132E	R510Q	Hearing loss, autosomal recessive 99	Pathogenic(Last reviewed: Sep 2, 2020)	no assertion criteria provided	VCV000143842	17	32959769	17	34632750	143842	153574	rs139895222	NC_000017.11:34632749:G:A
NM_006941.4(SOX10):c.2T>G (p.Met1Arg)	POLR2F|SOX10	M1R	Waardenburg syndrome type 2E, without neurologic involvement	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000065483	22	38379790	22	37983783	65483	76394	rs397515457	NC_000022.11:37983782:A:C
NM_018344.6(SLC29A3):c.1157G>A (p.Arg386Gln)	SLC29A3	R386Q, R308Q	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039870	10	73122094	10	71362337	39870	48469	rs397515429	NC_000010.11:71362336:G:A
NM_022787.4(NMNAT1):c.25G>A (p.Val9Met)	NMNAT1	V9M	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037140	1	10032156	1	9972098	37140	45801	rs387907294	NC_000001.11:9972097:G:A
NM_013296.5(GPSM2):c.1684C>T (p.Gln562Ter)	GPSM2	Q562*	Chudley-McCullough syndrome	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000030781	1	109466705	1	108924083	30781	39738	rs387907010	NC_000001.11:108924082:C:T
NM_033380.3(COL4A5):c.4631G>C (p.Trp1544Ser)	COL4A5	W1538S, W1544S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000024751	X	107936080	X	108692850	24751	36092	rs104886293	NC_000023.11:108692849:G:C
NM_001354604.2(MITF):c.951C>G (p.Asn317Lys)	MITF	N210K, N311K, N295K, N310K, N316K, N259K, N294K, N204K, N148K, N317K	Tietz syndrome	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000014275	3	70001033	3	69951882	14275	29314	rs104893745	NC_000003.12:69951881:C:G
NM_004070.4(CLCNKA):c.778C>T (p.Gln260Ter)	CLCNKA|LOC106501712	Q260*, Q217*	Bartter syndrome, type 4b	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000007590	1	16353927	1	16027432	7590	22629	rs121909138	NC_000001.11:16027431:C:T
NM_004070.4(CLCNKA):c.240G>C (p.Trp80Cys)	CLCNKA|LOC106501712	C80W, W80C	Bartter syndrome, type 4b	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000007589	1	16351268	1	16024773	7589	22628	rs121909137	NC_000001.11:16024772:G:C
NM_002241.5(KCNJ10):c.491C>T (p.Thr164Ile)	KCNJ10	T164I	EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007465	1	160011832	1	160042042	7465	22504	rs137853069	NC_000001.11:160042041:G:A
NM_002241.5(KCNJ10):c.418T>C (p.Cys140Arg)	KCNJ10	C140R	EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007464	1	160011905	1	160042115	7464	22503	rs137853068	NC_000001.11:160042114:A:G
NM_002968.3(SALL1):c.1256T>A (p.Leu419Ter)	SALL1	L419*, L322*	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: May 15, 2007)	no assertion criteria provided	VCV000007435	16	51174877	16	51140966	7435	22474	rs137853084	NC_000016.10:51140965:A:T
NM_002968.3(SALL1):c.1115C>G (p.Ser372Ter)	SALL1	S372*, S275*	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007429	16	51175018	16	51141107	7429	22468	rs104894535	NC_000016.10:51141106:G:C
NM_005450.6(NOG):c.649T>G (p.Trp217Gly)	NOG	W217G	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006693	17	54672233	17	56594872	6693	21732	rs104894603	NC_000017.11:56594871:T:G
NM_054027.6(ANKH):c.1001T>G (p.Leu334Arg)	ANKH	L334R	Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000005202	5	14741946	5	14741837	5202	20241	rs267606657	NC_000005.10:14741836:A:C
NM_057176.3(BSND):c.28G>A (p.Gly10Ser)	BSND	G10S	Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004385	1	55464887	1	54999214	4385	19424	rs74315287	NC_000001.11:54999213:G:A
NM_020436.5(SALL4):c.1954C>T (p.Gln652Ter)	SALL4	Q652*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000003318	20	50407068	20	51790529	3318	18357	rs74315424	NC_000020.11:51790528:G:A
NM_152564.5(VPS13B):c.2905C>T (p.Gln969Ter)	VPS13B	Q969*	Cohen syndrome	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV001333322	8	100396516	8	99384288	1333322	1324097		NC_000008.11:99384287:C:T
NM_174916.3(UBR1):c.4524T>A (p.Tyr1508Ter)	UBR1	Y1508*	Johanson-Blizzard syndrome	Pathogenic(Last reviewed: May 21, 2019)	no assertion criteria provided	VCV001323737					1323737	1314018		
NM_033380.3(COL4A5):c.866G>A (p.Gly289Asp)	COL4A5	G289D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 13, 2020)	no assertion criteria provided	VCV001322136					1322136	1312452		
NM_033380.3(COL4A5):c.2087G>A (p.Gly696Asp)	COL4A5	G696D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 24, 2021)	no assertion criteria provided	VCV001322135					1322135	1312451		
NM_001101.5(ACTB):c.454G>A (p.Val152Met)	ACTB	V152M	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319338	7	5568260	7	5528629	1319338	1309591		NC_000007.14:5528628:C:T
NM_000404.4(GLB1):c.451G>T (p.Asp151Tyr)	GLB1	D151Y, D121Y, D199Y	Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Oct 14, 2021)	no assertion criteria provided	VCV001300015	3	33109728	3	33068236	1300015	1290180		NC_000003.12:33068235:C:A
NM_006005.3(WFS1):c.1961C>G (p.Ser654Ter)	WFS1	S654*	Wolfram syndrome 1	Pathogenic	criteria provided, single submitter	VCV001264332	4	6303483	4	6301756	1264332	1254233		NC_000004.12:6301755:C:G
NM_018671.5(UNC45A):c.2626C>T (p.Gln876Ter)	RCCD1-AS1|UNC45A	Q861*, Q731*, Q876*	OSTEOOTOHEPATOENTERIC SYNDROME	Pathogenic(Last reviewed: Jun 15, 2021)	no assertion criteria provided	VCV001164085	15	91496737	15	90953507	1164085	1153086		NC_000015.10:90953506:C:T
NM_001005373.4(LRSAM1):c.988C>T (p.Gln330Ter)	LRSAM1	Q330*, Q67*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Sep 4, 2020)	criteria provided, single submitter	VCV001073788	9	130242202	9	127479923	1073788	1061543		NC_000009.12:127479922:C:T
NM_000443.4(ABCB4):c.2692G>A (p.Glu898Lys)	ABCB4	E898K	Progressive familial intrahepatic cholestasis 3	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000982084	7	87043024	7	87413708	982084	970221	rs1808782267	NC_000007.14:87413707:C:T
NM_001540.5(HSPB1):c.153G>A (p.Trp51Ter)	HSPB1	W51*	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000917325	7	75932182	7	76302865	917325	905200	rs769118115	NC_000007.14:76302864:G:A
NM_024577.4(SH3TC2):c.2095C>T (p.Gln699Ter)	SH3TC2	Q699*	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000916841	5	148407200	5	149027637	916841	905152	rs1754094644	NC_000005.10:149027636:G:A
NM_033380.3(COL4A5):c.2510-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 25, 2019)	no assertion criteria provided	VCV000829947	X	107863488	X	108620258	829947	818355	rs770451831	NC_000023.11:108620257:G:T
NM_033380.3(COL4A5):c.1904G>T (p.Gly635Val)	COL4A5	G635V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807574	X	107842056	X	108598826	807574	798788	rs281874683	NC_000023.11:108598825:G:T
NM_033380.3(COL4A5):c.1673G>A (p.Gly558Asp)	COL4A5	G558D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000807571	X	107840692	X	108597462	807571	798785	rs1603290148	NC_000023.11:108597461:G:A
NM_033380.3(COL4A5):c.1402C>T (p.Gln468Ter)	COL4A5	Q468*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000807569	X	107834853	X	108591623	807569	798783	rs1603287820	NC_000023.11:108591622:C:T
NM_033380.3(COL4A5):c.973G>C (p.Gly325Arg)	COL4A5	G325R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807568	X	107826150	X	108582920	807568	798782	rs104886088	NC_000023.11:108582919:G:C
NM_033380.3(COL4A5):c.4470T>G (p.Tyr1490Ter)	COL4A5	Y1484*, Y1490*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000807397	X	107930866	X	108687636	807397	798799	rs1603323355	NC_000023.11:108687635:T:G
NM_033380.3(COL4A5):c.3772G>A (p.Gly1258Ser)	COL4A5	G1258S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000807396	X	107911716	X	108668486	807396	798798	rs1603311030	NC_000023.11:108668485:G:A
NM_033380.3(COL4A5):c.4441C>T (p.Gln1481Ter)	COL4A5	Q1475*, Q1481*	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000805941	X	107930837	X	108687607	805941	794269	rs1603323278	NC_000023.11:108687606:C:T
NM_000404.4(GLB1):c.1697C>A (p.Pro566His)	GLB1	P435H, P536H, P614H, P566H	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000645125	3	33055585	3	33014093	645125	631173	rs1575410340	NC_000003.12:33014092:G:T
NM_000530.8(MPZ):c.159G>A (p.Trp53Ter)	MPZ	W53*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000640717	1	161277123	1	161307333	640717	627028	rs1571820100	NC_000001.11:161307332:C:T
NM_000530.8(MPZ):c.204C>A (p.Tyr68Ter)	MPZ	Y68*	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637508	1	161277078	1	161307288	637508	625066	rs1571819906	NC_000001.11:161307287:G:T
NM_018972.4(GDAP1):c.1A>T (p.Met1Leu)	GDAP1	M1L	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637503	8	75262697	8	74350462	637503	625156	rs1474390668	NC_000008.11:74350461:A:T
NM_002047.4(GARS1):c.1031+1G>A	GARS1		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637502	7	30651862	7	30612246	637502	625744	rs1554338272	NC_000007.14:30612245:G:A
NM_014874.4(MFN2):c.1392+1G>A	MFN2		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637063	1	12064671	1	12004614	637063	625726	rs1569861708	NC_000001.11:12004613:G:A
NM_033380.3(COL4A5):c.3319G>T (p.Gly1107Ter)	COL4A5	G1107*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 11, 2019)	no assertion criteria provided	VCV000635552	X	107898633	X	108655403	635552	623361	rs104886225	NC_000023.11:108655402:G:T
NM_033380.3(COL4A5):c.3482G>A (p.Gly1161Glu)	COL4A5	G1161E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 27, 2018)	no assertion criteria provided	VCV000635536	X	107909753	X	108666523	635536	623364	rs1603310380	NC_000023.11:108666522:G:A
NM_033380.3(COL4A5):c.3481G>C (p.Gly1161Arg)	COL4A5	G1161R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 21, 2018)	no assertion criteria provided	VCV000635512	X	107909752	X	108666522	635512	623363	rs104886235	NC_000023.11:108666521:G:C
NM_033380.3(COL4A5):c.3475C>T (p.Gln1159Ter)	COL4A5	Q1159*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 9, 2018)	no assertion criteria provided	VCV000635495	X	107909746	X	108666516	635495	623362	rs1603310370	NC_000023.11:108666515:C:T
NM_033380.3(COL4A5):c.3604+2T>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000599120	X	107910415	X	108667185	599120	590353	rs1569505613	NC_000023.11:108667184:T:A
NM_033380.3(COL4A5):c.834+2T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 17, 2018)	no assertion criteria provided	VCV000599107	X	107823818	X	108580588	599107	590343	rs1569490932	NC_000023.11:108580587:T:G
NM_033380.3(COL4A5):c.1843G>A (p.Gly615Arg)	COL4A5	G615R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 9, 2018)	no assertion criteria provided	VCV000599064	X	107841995	X	108598765	599064	590347	rs1569494304	NC_000023.11:108598764:G:A
NM_033380.3(COL4A5):c.3247-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 19, 2017)	no assertion criteria provided	VCV000599056	X	107898560	X	108655330	599056	590351	rs1569504056	NC_000023.11:108655329:G:A
NM_152564.5(VPS13B):c.9416G>A (p.Trp3139Ter)	VPS13B	W3139*, W3164*	Cohen syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000568179	8	100844682	8	99832454	568179	565309	rs1563497844	NC_000008.11:99832453:G:A
NM_004525.3(LRP2):c.2639+1G>A	LRP2		Donnai-Barrow syndrome	Pathogenic(Last reviewed: Apr 12, 2018)	no assertion criteria provided	VCV000559644	2	170113633	2	169257123	559644	550350	rs746752313	NC_000002.12:169257122:C:T
NM_001005373.4(LRSAM1):c.636C>G (p.Tyr212Ter)	LRSAM1	Y212*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000540003	9	130236096	9	127473817	540003	524474	rs1345228128	NC_000009.12:127473816:C:G
NM_033380.3(COL4A5):c.3314T>A (p.Leu1105Ter)	COL4A5	L1105*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522457	X	107898628	X	108655398	522457	513161	rs1556439394	NC_000023.11:108655397:T:A
NM_001101.5(ACTB):c.1117A>T (p.Lys373Ter)	ACTB	K373*	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Mar 8, 2018)	no assertion criteria provided	VCV000495295	7	5567390	7	5527759	495295	486792	rs1554329068	NC_000007.14:5527758:T:A
NM_016589.4(TIMMDC1):c.597-1340A>G	TIMMDC1		Mitochondrial complex 1 deficiency, nuclear type 31	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV000429020	3	119234712	3	119515865	429020	420976	rs781525096	NC_000003.12:119515864:A:G
NM_152564.5(VPS13B):c.8915G>A (p.Trp2972Ter)	VPS13B	W2972*, W2997*	Cohen syndrome	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000212584	8	100832271	8	99820043	212584	207590	rs797046098	NC_000008.11:99820042:G:A
NM_174916.3(UBR1):c.4107T>A (p.Cys1369Ter)	UBR1	C1369*	Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	VCV000208624	15	43276138	15	42983940	208624	205177	rs797045112	NC_000015.10:42983939:A:T
NM_152564.5(VPS13B):c.11044+2T>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000132795	8	100871710	8	99859482	132795	136544	rs587777382	NC_000008.11:99859481:T:C
NM_001101.5(ACTB):c.586C>A (p.Arg196Ser)	ACTB	R196S	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000127170	7	5568128	7	5528497	127170	132668	rs281875333	NC_000007.14:5528496:G:T
NM_001101.5(ACTB):c.446C>T (p.Thr149Ile)	ACTB	T149I	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000127169	7	5568268	7	5528637	127169	132667	rs587779775	NC_000007.14:5528636:G:A
NM_001101.5(ACTB):c.356T>C (p.Met119Thr)	ACTB	M119T	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000127167	7	5568799	7	5529168	127167	132665	rs587779773	NC_000007.14:5529167:A:G
NM_018972.4(GDAP1):c.821C>T (p.Pro274Leu)	GDAP1	P274L, P216L, P165L, P206L	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Aug 9, 2011)	no assertion criteria provided	VCV000050559	8	75276346	8	74364111	50559	59597	rs397515443	NC_000008.11:74364110:C:T
NM_018972.4(GDAP1):c.467C>G (p.Ala156Gly)	GDAP1	A156G, A47G, A88G	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Aug 9, 2011)	no assertion criteria provided	VCV000050557	8	75272528	8	74360293	50557	59595	rs397515441	NC_000008.11:74360292:C:G
NM_014918.5(CHSY1):c.1616C>G (p.Pro539Arg)	CHSY1	P539R	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030714	15	101718386	15	101178181	30714	39671	rs387906985	NC_000015.10:101178180:G:C
NM_014918.5(CHSY1):c.321-3C>G	CHSY1		Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030713	15	101775785	15	101235580	30713	39670	rs1567106459	NC_000015.10:101235579:G:C
NM_006005.3(WFS1):c.2119G>T (p.Val707Phe)	WFS1	V707F	Wolfram syndrome 1	Pathogenic(Last reviewed: Dec 15, 2008)	no assertion criteria provided	VCV000030552	4	6303641	4	6301914	30552	39509	rs71524377	NC_000004.12:6301913:G:T
NM_005450.6(NOG):c.696C>G (p.Cys232Trp)	NOG	C232W	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000030290	17	54672280	17	56594919	30290	39246	rs387906844	NC_000017.11:56594918:C:G
NM_002764.4(PRPS1):c.424G>C (p.Val142Leu)	PRPS1	V142L	Arts syndrome	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000029989	X	106885614	X	107642384	29989	38944	rs398122855	NC_000023.11:107642383:G:C
NM_006208.3(ENPP1):c.795+1G>A	ENPP1		Arterial calcification, generalized, of infancy, 1	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000029844	6	132179888	6	131858748	29844	38799	rs753851892	NC_000006.12:131858747:G:A
NM_033380.3(COL4A5):c.3721G>T (p.Gly1241Cys)	COL4A5	G1241C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000024676	X	107911665	X	108668435	24676	36017	rs104886255	NC_000023.11:108668434:G:T
NM_033380.3(COL4A5):c.2165G>A (p.Gly722Glu)	COL4A5	G722E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000024494	X	107846212	X	108602982	24494	35835	rs104886163	NC_000023.11:108602981:G:A
NM_033380.3(COL4A5):c.1423G>A (p.Gly475Ser)	COL4A5	G475S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000024409	X	107834874	X	108591644	24409	35750	rs281874667	NC_000023.11:108591643:G:A
NM_033380.3(COL4A5):c.611G>A (p.Gly204Asp)	COL4A5	G204D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000024300	X	107821183	X	108577953	24300	35641	rs104886063	NC_000023.11:108577952:G:A
NM_000088.4(COL1A1):c.4391T>C (p.Leu1464Pro)	COL1A1		Osteogenesis imperfecta type III	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000017332	17	48262867	17	50185506	17332	32371	rs72656353	NC_000017.11:50185505:A:G
NM_080680.3(COL11A2):c.3991C>T (p.Arg1331Ter)	COL11A2	R1224*, R1245*, R1331*	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000017128	6	33135599	6	33167822	17128	32167	rs121912951	NC_000006.12:33167821:G:A
NM_001122659.3(EDNRB):c.757C>T (p.Arg253Ter)	EDNRB-AS1|EDNRB	R253*, R343*	Waardenburg syndrome type 4A	Pathogenic(Last reviewed: Nov 5, 1999)	no assertion criteria provided	VCV000016639	13	78477335	13	77903200	16639	31678	rs104894390	NC_000013.11:77903199:G:A
NM_001122659.3(EDNRB):c.548C>G (p.Ala183Gly)	EDNRB-AS1|EDNRB	A183G, A273G	Waardenburg syndrome type 4A	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000016634	13	78477678	13	77903543	16634	31673	rs104894388	NC_000013.11:77903542:G:C
NM_005522.5(HOXA1):c.76C>T (p.Arg26Ter)	HOXA1	R26*	Human HOXA1 syndromes	Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000014900	7	27135456	7	27095837	14900	29939	rs104894018	NC_000007.14:27095836:G:A
NM_000530.8(MPZ):c.178G>C (p.Asp60His)	MPZ	D60H	Charcot-Marie-Tooth disease type 2I	Pathogenic(Last reviewed: Jul 13, 2004)	no assertion criteria provided	VCV000014193	1	161277104	1	161307314	14193	29232	rs121913604	NC_000001.11:161307313:C:G
NM_002764.4(PRPS1):c.579C>G (p.His193Gln)	PRPS1	H193Q	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009933	X	106888455	X	107645225	9933	24972	rs137852545	NC_000023.11:107645224:C:G
NM_002764.4(PRPS1):c.569C>T (p.Ala190Val)	PRPS1	A190V	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009932	X	106888445	X	107645215	9932	24971	rs137852544	NC_000023.11:107645214:C:T
NM_002764.4(PRPS1):c.385C>A (p.Leu129Ile)	PRPS1	L129I	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009931	X	106884210	X	107640980	9931	24970	rs137852543	NC_000023.11:107640979:C:A
m.7587T>C	MT-CO2	M1T	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000009658	MT	7587	MT	7587	9658	24697	rs199474825	NC_012920.1:7586:T:C
m.8313G>A	MT-TK		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000009583	MT	8313	MT	8313	9583	24622	rs118192101	NC_012920.1:8312:G:A
NM_178138.6(LHX3):c.332A>G (p.Tyr111Cys)	LHX3	Y116C, Y111C, Y100C	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: Jul 15, 2008)	no assertion criteria provided	VCV000009021	9	139091646	9	136199800	9021	24060	rs104894117	NC_000009.12:136199799:T:C
NM_006941.4(SOX10):c.521A>C (p.Gln174Pro)	POLR2F|SOX10	Q174P	Waardenburg syndrome type 2E, with neurologic involvement	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000007410	22	38374050	22	37978043	7410	22449	rs267607081	NC_000022.11:37978042:T:G
NM_006941.4(SOX10):c.698-2A>C	POLR2F|SOX10		Waardenburg syndrome type 2E, with neurologic involvement	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000007409	22	38370207	22	37974200	7409	22448	rs397515370	NC_000022.11:37974199:T:G
NM_006941.4(SOX10):c.748C>T (p.Gln250Ter)	POLR2F|SOX10	Q250*	Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000007403	22	38370155	22	37974148	7403	22442	rs74315521	NC_000022.11:37974147:G:A
MTMR2, IVS13, G-A, +1	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006232					6232	21271		
NM_021999.5(ITM2B):c.799T>A (p.Ter267Arg)	ITM2B		ABri amyloidosis	Pathogenic(Last reviewed: Jun 24, 1999)	no assertion criteria provided	VCV000005979	13	48835358	13	48261222	5979	21018	rs104894417	NC_000013.11:48261221:T:A
NM_054027.6(ANKH):c.1015T>C (p.Cys339Arg)	ANKH	C339R	Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000005200	5	14716941	5	14716832	5200	20239	rs267606656	NC_000005.10:14716831:A:G
NM_174916.3(UBR1):c.2839+5G>A	UBR1		Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000004681	15	43314895	15	43022697	4681	19720	rs1596106023	NC_000015.10:43022696:C:T
NM_174916.3(UBR1):c.1537C>T (p.Gln513Ter)	UBR1	Q513*	Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000004680	15	43340592	15	43048394	4680	19719	rs119477055	NC_000015.10:43048393:G:A
NG_012182.1:g.78523T>C	UBR1		Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000004679					4679	19718		
NM_174916.3(UBR1):c.407A>G (p.His136Arg)	UBR1	H136R	Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000004678	15	43374846	15	43082648	4678	19717	rs119477054	NC_000015.10:43082647:T:C
NM_006005.3(WFS1):c.2455C>T (p.Gln819Ter)	WFS1	Q819*	Wolfram syndrome 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000004517	4	6303977	4	6302250	4517	19556	rs104893881	NC_000004.12:6302249:C:T
NM_006005.3(WFS1):c.676C>T (p.Gln226Ter)	WFS1	Q226*	Wolfram syndrome 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000004516	4	6293688	4	6291961	4516	19555	rs104893880	NC_000004.12:6291960:C:T
NM_006005.3(WFS1):c.1944G>A (p.Trp648Ter)	WFS1	W648*	Wolfram syndrome 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000004511	4	6303466	4	6301739	4511	19550	rs104893879	NC_000004.12:6301738:G:A
NM_006005.3(WFS1):c.2084G>T (p.Gly695Val)	WFS1	G695V	Wolfram syndrome 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000004510	4	6303606	4	6301879	4510	19549	rs28937891	NC_000004.12:6301878:G:T
NM_018972.4(GDAP1):c.678A>T (p.Arg226Ser)	GDAP1	R226S, R117S, R168S, R158S	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000004204	8	75275272	8	74363037	4204	19243	rs267606842	NC_000008.11:74363036:A:T
NM_018972.4(GDAP1):c.719G>A (p.Cys240Tyr)	GDAP1	C240Y, C131Y, C182Y, C172Y	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000004203	8	75276244	8	74364009	4203	19242	rs121908115	NC_000008.11:74364008:G:A
NM_018972.4(GDAP1):c.652C>G (p.Gln218Glu)	GDAP1	Q218E, Q160E, Q109E, Q150E	Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000004201	8	75275246	8	74363011	4201	19240	rs121908113	NC_000008.11:74363010:C:G
NM_152564.5(VPS13B):c.6503T>G (p.Leu2168Arg)	VPS13B	L2193R, L2168R	Cohen syndrome	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002819	8	100729447	8	99717219	2819	17858	rs120074149	NC_000008.11:99717218:T:G
NM_001370298.3(FGD4):c.2167G>T (p.Gly723Ter)	FGD4	G586*, G671*, G242*, G338*, G402*, G493*, G723*	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001014	12	32778708	12	32625774	1014	16053	rs118203973	NC_000012.12:32625773:G:T
NM_000404.4(GLB1):c.247T>C (p.Tyr83His)	GLB1	Y83H, Y131H, Y53H	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000000937	3	33110461	3	33068969	937	15976	rs72555364	NC_000003.12:33068968:A:G
NM_000404.4(GLB1):c.1527G>T (p.Trp509Cys)	GLB1	W509C, W378C, W557C, W479C	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	VCV000000933	3	33055755	3	33014263	933	15972	rs72555363	NC_000003.12:33014262:C:A
NM_000441.2(SLC26A4):c.703C>T (p.Gln235Ter)	SLC26A4	Q235*	Pendred syndrome	Pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, single submitter	VCV001065045	7	107315492	7	107675047	1065045	1053275		NC_000007.14:107675046:C:T
NM_001046.3(SLC12A2):c.2962C>A (p.Pro988Thr)	SLC12A2	P988T	Hearing loss, autosomal dominant 78|Hearing loss	Pathogenic, association(Last reviewed: Nov 9, 2020)	no assertion criteria provided	VCV000804309	5	127512829	5	128177137	804309	792664	rs1581138965	NC_000005.10:128177136:C:A
NM_001046.3(SLC12A2):c.2930-2A>G	SLC12A2		Hearing loss, autosomal dominant 78|Hearing loss	Pathogenic, association(Last reviewed: Nov 9, 2020)	no assertion criteria provided	VCV000804308	5	127512795	5	128177103	804308	792665	rs1581138932	NC_000005.10:128177102:A:G
NM_001046.3(SLC12A2):c.2941G>T (p.Asp981Tyr)	SLC12A2	D981Y	Hearing loss, autosomal dominant 78|Hearing loss	Pathogenic, association(Last reviewed: Nov 9, 2020)	no assertion criteria provided	VCV000804307	5	127512808	5	128177116	804307	792663	rs1581138944	NC_000005.10:128177115:G:T
NM_004208.4(AIFM1):c.422C>T (p.Thr141Ile)	AIFM1|RAB33A	T141I, T137I	Cowchock syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000732674	X	129281779	X	130147804	732674	745482	rs1603227409	NC_000023.11:130147803:G:A
NM_004208.4(AIFM1):c.784G>A (p.Gly262Ser)	RAB33A|AIFM1	G262S, G258S	Cowchock syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000732670	X	129273844	X	130139869	732670	745480	rs1603224817	NC_000023.11:130139868:C:T
NM_018344.6(SLC29A3):c.479G>A (p.Trp160Ter)	SLC29A3	W160*, W82*	not provided|Histiocytosis-lymphadenopathy plus syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000573984	10	73111414	10	71351657	573984	566470	rs776960135	NC_000010.11:71351656:G:A
NM_017697.4(ESRP1):c.775C>G (p.Leu259Val)	ESRP1	L259V	Hearing loss, autosomal recessive 109	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000545506	8	95677174	8	94664946	545506	536011	rs1554577402	NC_000008.11:94664945:C:G
NM_001142966.3(GREB1L):c.4368G>T (p.Gln1456His)	GREB1L	Q1456H	Hearing loss, autosomal dominant 80|Inner ear malformation	Pathogenic(Last reviewed: Apr 14, 2021)	no assertion criteria provided	VCV000446527	18	19085910	18	21505949	446527	440045	rs1555661490	NC_000018.10:21505948:G:T
NM_001142966.3(GREB1L):c.982C>T (p.Arg328Ter)	GREB1L	R328*	Hearing loss, autosomal dominant 80|Inner ear malformation	Pathogenic(Last reviewed: Apr 14, 2021)	no assertion criteria provided	VCV000446526	18	19020262	18	21440301	446526	440044	rs1555648043	NC_000018.10:21440300:C:T
NM_002764.4(PRPS1):c.46T>C (p.Ser16Pro)	PRPS1	S16P	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000223101	X	106871904	X	107628674	223101	224828	rs869025594	NC_000023.11:107628673:T:C
NM_033409.4(SLC52A3):c.49T>C (p.Trp17Arg)	SLC52A3	W17R	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210011	20	746370	20	765726	210011	206630	rs797045190	NC_000020.11:765725:A:G
NM_004700.4(KCNQ4):c.2039C>T (p.Ser680Phe)	KCNQ4	S680F, S626F	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208373	1	41304146	1	40838474	208373	204602	rs772135867	NC_000001.11:40838473:C:T
NM_004700.4(KCNQ4):c.872C>T (p.Pro291Leu)	KCNQ4	P291L	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208370	1	41285584	1	40819912	208370	204599	rs797044970	NC_000001.11:40819911:C:T
NM_004700.4(KCNQ4):c.871C>T (p.Pro291Ser)	KCNQ4	P291S	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208369	1	41285583	1	40819911	208369	204598	rs797044969	NC_000001.11:40819910:C:T
NM_004700.4(KCNQ4):c.823T>C (p.Trp275Arg)	KCNQ4	W275R	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208368	1	41285133	1	40819461	208368	204597	rs797044968	NC_000001.11:40819460:T:C
NM_004700.4(KCNQ4):c.808T>C (p.Tyr270His)	KCNQ4	Y270H	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208367	1	41285118	1	40819446	208367	204596	rs797044967	NC_000001.11:40819445:T:C
NM_004700.4(KCNQ4):c.689T>A (p.Val230Glu)	KCNQ4	V230E	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208365	1	41284333	1	40818661	208365	204594	rs797044965	NC_000001.11:40818660:T:A
NM_152564.5(VPS13B):c.9331-1G>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000189197	8	100844596	8	99832368	189197	187088	rs386834119	NC_000008.11:99832367:G:C
NM_002764.4(PRPS1):c.362C>G (p.Ala121Gly)	PRPS1	A121G	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000100767	X	106884187	X	107640957	100767	106633	rs587777150	NC_000023.11:107640956:C:G
NM_001199107.2(TBC1D24):c.468C>A (p.Cys156Ter)	TBC1D24	C156*	Early infantile epileptic encephalopathy 16	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000056847	16	2546617	16	2496616	56847	71465	rs397514714	NC_000016.10:2496615:C:A
NM_025000.4(DCAF17):c.387G>A (p.Trp129Ter)	DCAF17	W129*	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031580	2	172305256	2	171448746	31580	40264	rs1559264135	NC_000002.12:171448745:G:A
NM_004700.4(KCNQ4):c.785A>T (p.Asp262Val)	KCNQ4	D262V	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000021427	1	41285095	1	40819423	21427	34279	rs80358275	NC_000001.11:40819422:A:T
NM_002473.6(MYH9):c.3464C>T (p.Thr1155Ile)	MYH9	T1155I	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000014077	22	36691572	22	36295526	14077	29116	rs121913656	NC_000022.11:36295525:G:A
NM_002241.5(KCNJ10):c.229G>C (p.Gly77Arg)	KCNJ10	G77R	EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007468	1	160012094	1	160042304	7468	22507	rs137853072	NC_000001.11:160042303:C:G
NM_002968.3(SALL1):c.1115C>A (p.Ser372Ter)	SALL1	S372*, S275*	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007427	16	51175018	16	51141107	7427	22466	rs104894535	NC_000016.10:51141106:G:T
NM_000441.2(SLC26A4):c.1002-4C>G	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000004833	7	107329494	7	107689049	4833	19872		NC_000007.14:107689048:C:G
NM_000441.2(SLC26A4):c.415+7A>G	SLC26A4		Pendred syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000004828	7	107312700	7	107672255	4828	19867	rs765884316	NC_000007.14:107672254:A:G
NM_000441.2(SLC26A4):c.2000T>G (p.Phe667Cys)	SLC26A4	F667C	Pendred syndrome	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000004812	7	107342468	7	107702023	4812	19851	rs121908360	NC_000007.14:107702022:T:G
NM_020436.5(SALL4):c.2713C>T (p.Arg905Ter)	SALL4	R905*, R468*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000003328	20	50405429	20	51788890	3328	18367	rs74315428	NC_000020.11:51788889:G:A
NM_020436.5(SALL4):c.1849C>T (p.Arg617Ter)	SALL4	R617*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000003326	20	50407173	20	51790634	3326	18365	rs74315427	NC_000020.11:51790633:G:A
NM_138477.4(CDAN1):c.1796A>G (p.Asn599Ser)	CDAN1	N599S	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003178	15	43023473	15	42731275	3178	18217	rs120074166	NC_000015.10:42731274:T:C
NM_018344.6(SLC29A3):c.347T>G (p.Met116Arg)	SLC29A3	M116R, M38R	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Sep 3, 2010)	no assertion criteria provided	VCV000000568	10	73104012	10	71344255	568	15607	rs267607057	NC_000010.11:71344254:T:G
NM_033409.4(SLC52A3):c.82C>A (p.Pro28Thr)	SLC52A3	P28T	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000145	20	746337	20	765693	145	15184	rs267606688	NC_000020.11:765692:G:T
NM_033409.4(SLC52A3):c.211G>T (p.Glu71Ter)	SLC52A3	E71*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000140	20	746208	20	765564	140	15179	rs267606683	NC_000020.11:765563:C:A
NM_001199107.2(TBC1D24):c.751T>C (p.Phe251Leu)	TBC1D24	F251L	Myoclonic epilepsy, familial infantile	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000000050	16	2546900	16	2496899	50	15089	rs267607104	NC_000016.10:2496898:T:C
NM_033380.3(COL4A5):c.3181C>T (p.Gln1061Ter)	COL4A5	Q1061*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV001333704	X	107869514	X	108626284	1333704	35941	rs104886213	NC_000023.11:108626283:C:T
NM_001605.3(AARS1):c.1009G>A (p.Glu337Lys)	AARS1	E337K	not provided|Charcot-Marie-Tooth disease, type 2N	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2022)	no assertion criteria provided	VCV001323797	16	70302236	16	70268333	1323797	1314078		NC_000016.10:70268332:C:T
NM_033380.3(COL4A5):c.2974C>T (p.Gln992Ter)	COL4A5	Q992*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001300189	X	107867522	X	108624292	1300189	1290474		NC_000023.11:108624291:C:T
NM_006005.3(WFS1):c.387G>A (p.Trp129Ter)	WFS1	W129*	Wolfram syndrome 1	Pathogenic	criteria provided, single submitter	VCV001264331	4	6290785	4	6289058	1264331	1254232		NC_000004.12:6289057:G:A
NM_000404.4(GLB1):c.75+2T>G	GLB1|TMPPE		Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: May 12, 2021)	no assertion criteria provided	VCV001077168	3	33138501	3	33097009	1077168	1065829		NC_000003.12:33097008:A:C
NM_033380.3(COL4A5):c.4787G>A (p.Trp1596Ter)	COL4A5	W1590*, W1596*	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077056	X	107938117	X	108694887	1077056	1065709		NC_000023.11:108694886:G:A
NM_033380.3(COL4A5):c.322-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077055	X	107811988	X	108568758	1077055	1065692		NC_000023.11:108568757:G:T
NM_033380.3(COL4A5):c.3670G>T (p.Glu1224Ter)	COL4A5	E1224*	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077053	X	107911614	X	108668384	1077053	1065705		NC_000023.11:108668383:G:T
NM_033380.3(COL4A5):c.4528G>C (p.Gly1510Arg)	COL4A5	G1504R, G1510R	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077051	X	107930924	X	108687694	1077051	1065708		NC_000023.11:108687693:G:C
NM_033380.3(COL4A5):c.1480G>T (p.Gly494Cys)	COL4A5	G494C	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077050	X	107838795	X	108595565	1077050	1065699		NC_000023.11:108595564:G:T
NM_033380.3(COL4A5):c.1033-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077047	X	107829843	X	108586613	1077047	1065698		NC_000023.11:108586612:A:G
NM_033380.3(COL4A5):c.2146G>A (p.Gly716Ser)	COL4A5	G716S	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077046	X	107845219	X	108601989	1077046	1065702		NC_000023.11:108601988:G:A
NM_033380.3(COL4A5):c.1871G>T (p.Gly624Val)	COL4A5	G624V	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077043	X	107842023	X	108598793	1077043	1065700		NC_000023.11:108598792:G:T
NM_033380.3(COL4A5):c.439-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077037	X	107815040	X	108571810	1077037	1065693		NC_000023.11:108571809:G:A
NM_001005373.4(LRSAM1):c.1144C>T (p.Arg382Ter)	LRSAM1	R119*, R382*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001076638	9	130245284	9	127483005	1076638	1061544		NC_000009.12:127483004:C:T
NM_000404.4(GLB1):c.1699C>T (p.Gln567Ter)	GLB1	Q436*, Q537*, Q567*, Q615*	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001075413	3	33055583	3	33014091	1075413	1059728		NC_000003.12:33014090:G:A
NM_001130823.3(DNMT1):c.4490-1G>C	DNMT1		Hereditary sensory neuropathy type IE	Pathogenic(Last reviewed: Aug 28, 2020)	criteria provided, single submitter	VCV001072609	19	10246964	19	10136288	1072609	1064583		NC_000019.10:10136287:C:G
NM_000530.8(MPZ):c.171G>A (p.Trp57Ter)	MPZ	W57*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV001070662	1	161277111	1	161307321	1070662	1058461		NC_000001.11:161307320:C:T
NM_000404.4(GLB1):c.1324C>T (p.Arg442Ter)	GLB1	R311*, R412*, R442*, R490*	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001069817	3	33059963	3	33018471	1069817	1059730		NC_000003.12:33018470:G:A
NM_152564.5(VPS13B):c.3446-23T>G	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, single submitter	VCV001048631	8	100479619	8	99467391	1048631	1036720		NC_000008.11:99467390:T:G
NM_003680.4(YARS1):c.806T>C (p.Phe269Ser)	YARS1	F269S	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2|Corpus callosum, agenesis of|Severe hearing impairment|Retinal degeneration|Primary amenorrhea|Hepatic steatosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2021)	no assertion criteria provided	VCV000996695	1	33252555	1	32786954	996695	984288	rs1653248260	NC_000001.11:32786953:A:G
NM_000530.8(MPZ):c.20C>G (p.Ser7Ter)	MPZ	S7*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000940939	1	161279676	1	161309886	940939	930123	rs1558155838	NC_000001.11:161309885:G:C
NM_145261.4(DNAJC19):c.63C>G (p.Tyr21Ter)	DNAJC19	Y21*	3-methylglutaconic aciduria type V	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000937620	3	180705877	3	180988089	937620	931852	rs145786060	NC_000003.12:180988088:G:C
NM_000260.4(MYO7A):c.5785C>T (p.Gln1929Ter)	MYO7A	Q1880*, Q1891*, Q1929*	not provided	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000864590	11	76918376	11	77207331	864590	839081	rs1957512851	NC_000011.10:77207330:C:T
NM_006158.5(NEFL):c.32C>A (p.Ser11Ter)	NEFL	S11*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000852797	8	24813998	8	24956484	852797	834566	rs766951637	NC_000008.11:24956483:G:T
NM_152564.5(VPS13B):c.6046+1G>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812107	8	100673720	8	99661492	812107	800371	rs750003804	NC_000008.11:99661491:G:C
NM_033380.3(COL4A5):c.2314G>A (p.Gly772Ser)	COL4A5	G772S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000807578	X	107850041	X	108606811	807578	798792	rs1603293570	NC_000023.11:108606810:G:A
NM_000404.4(GLB1):c.553-1G>C	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000639100	3	33099762	3	33058270	639100	651170	rs1575459735	NC_000003.12:33058269:C:G
NM_152564.5(VPS13B):c.11746-1G>A	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552760	8	100887645	8	99875417	552760	544586	rs372327659	NC_000008.11:99875416:G:A
NM_006158.5(NEFL):c.1117C>T (p.Gln373Ter)	NEFL	Q373*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000533513	8	24811747	8	24954233	533513	523411	rs757417962	NC_000008.11:24954232:G:A
NM_000304.4(PMP22):c.83G>A (p.Trp28Ter)	PMP22	W28*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000531680	17	15162506	17	15259189	531680	531103	rs1555568475	NC_000017.11:15259188:C:T
NM_001854.4(COL11A1):c.3816+5G>A	COL11A1		not provided|Marshall syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000391809	1	103381182	1	102915626	391809	364319	rs1057524237	NC_000001.11:102915625:C:T
NM_024678.6(NARS2):c.727C>T (p.Arg243Ter)	NARS2	R16*, R243*	not provided|Hearing loss, autosomal recessive 94	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379735	11	78204204	11	78493158	379735	372454	rs952741388	NC_000011.10:78493157:G:A
NM_000091.5(COL4A3):c.3955G>A (p.Gly1319Arg)	COL4A3|MFF-DT	G1319R	Alport syndrome, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000373896	2	228167826	2	227303110	373896	360796	rs765661521	NC_000002.12:227303109:G:A
NM_152564.5(VPS13B):c.9685C>T (p.Arg3229Ter)	VPS13B	R3229*, R3254*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370254	8	100847495	8	99835267	370254	357735	rs941969577	NC_000008.11:99835266:C:T
NM_001005373.4(LRSAM1):c.2081G>A (p.Cys694Tyr)	LRSAM1	C694Y, C667Y, C431Y, C661Y	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 8, 2016)	no assertion criteria provided	VCV000268046	9	130265087	9	127502808	268046	263456	rs886041051	NC_000009.12:127502807:G:A
NM_001983.4(ERCC1):c.676A>T (p.Lys226Ter)	ERCC1	K226*	Cockayne syndrome	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000264678	19	45918145	19	45414887	264678	259255	rs886039224	NC_000019.10:45414886:T:A
NM_001005373.4(LRSAM1):c.2068T>C (p.Cys690Arg)	LRSAM1	C690R, C663R, C427R, C657R	not provided|Charcot-Marie-Tooth disease type 2P	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000242907	9	130265074	9	127502795	242907	244017	rs879253755	NC_000009.12:127502794:T:C
NM_001005373.4(LRSAM1):c.1279C>T (p.Arg427Ter)	LRSAM1	R427*, R164*	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000241836	9	130249974	9	127487695	241836	240444	rs138226428	NC_000009.12:127487694:C:T
NM_000260.4(MYO7A):c.1952T>C (p.Leu651Pro)	MYO7A	L651P, L640P	Usher syndrome type 1	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226432	11	76885818	11	77174772	226432	228234	rs876657416	NC_000011.10:77174771:T:C
NM_006005.3(WFS1):c.873C>G (p.Tyr291Ter)	WFS1	Y291*	Wolfram syndrome	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000212616	4	6302395	4	6300668	212616	207139	rs777580652	NC_000004.12:6300667:C:G
NM_006005.3(WFS1):c.2369C>A (p.Ser790Ter)	WFS1	S790*	Wolfram syndrome	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000212614	4	6303891	4	6302164	212614	207144	rs369107336	NC_000004.12:6302163:C:A
NM_152564.5(VPS13B):c.8870T>A (p.Leu2957Ter)	VPS13B	L2957*, L2982*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, multiple submitters, no conflicts	VCV000167832	8	100832226	8	99819998	167832	177388	rs727504219	NC_000008.11:99819997:T:A
NM_005360.5(MAF):c.176C>T (p.Pro59Leu)	MAF	P59L	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162516	16	79633624	16	79599727	162516	172187	rs727502770	NC_000016.10:79599726:G:A
NC_000018.9:g.77748356G>A	TXNL4A	Q13*	Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162205	18	77748356	18	79988356	162205	171913	rs727502794	NC_000018.10:79988355:G:A
NM_001101.5(ACTB):c.34A>C (p.Asn12His)	ACTB	N12H	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000127166	7	5569255	7	5529624	127166	132664	rs281875331	NC_000007.14:5529623:T:G
NM_005221.6(DLX5):c.558G>T (p.Gln186His)	DLX5	Q186H	not provided|Split-hand/foot malformation 1	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000091861	7	96650360	7	97021048	91861	97338	rs398122527	NC_000007.14:97021047:C:A
NM_174916.3(UBR1):c.1440-1G>A	UBR1		Johanson-Blizzard syndrome	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000031918	15	43340690	15	43048492	31918	40574	rs1596118528	NC_000015.10:43048491:C:T
NM_025000.4(DCAF17):c.341C>A (p.Ser114Ter)	DCAF17	S114*	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031582	2	172305210	2	171448700	31582	40266	rs760978794	NC_000002.12:171448699:C:A
NM_007055.4(POLR3A):c.2690T>A (p.Ile897Asn)	POLR3A	I897N	Hypomyelinating leukodystrophy 7	Pathogenic(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000031148	10	79753052	10	77993294	31148	40105	rs267608681	NC_000010.11:77993293:A:T
NM_033380.3(COL4A5):c.584G>A (p.Gly195Asp)	COL4A5	G195D	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV000024292	X	107819177	X	108575947	24292	35633	rs104886061	NC_000023.11:108575946:G:A
NM_000092.5(COL4A4):c.4923C>A (p.Cys1641Ter)	COL4A4	C1641*	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000017408	2	227872191	2	227007475	17408	32447	rs121912862	NC_000002.12:227007474:G:T
NM_006158.5(NEFL):c.418G>T (p.Glu140Ter)	NEFL	E140*	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000014034	8	24813612	8	24956098	14034	29073	rs121913663	NC_000008.11:24956097:C:A
NM_006158.5(NEFL):c.281T>C (p.Leu94Pro)	NEFL	L94P	not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000014033	8	24813749	8	24956235	14033	29072	rs62636505	NC_000008.11:24956234:A:G
NM_000266.4(NDP):c.302C>T (p.Ser101Phe)	NDP|NDP-AS1	S101F	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000010699	X	43809145	X	43949899	10699	25738	rs104894883	NC_000023.11:43949898:G:A
NM_000266.4(NDP):c.218C>A (p.Ser73Ter)	NDP|NDP-AS1	S73*	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000010698	X	43809229	X	43949983	10698	25737	rs104894882	NC_000023.11:43949982:G:T
NM_033380.3(COL4A5):c.161G>A (p.Gly54Asp)	COL4A5	G54D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000010465	X	107802313	X	108559083	10465	25504	rs104886043	NC_000023.11:108559082:G:A
NM_033380.3(COL4A5):c.974G>A (p.Gly325Glu)	COL4A5	G325E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000010463	X	107826151	X	108582921	10463	25502	rs104886091	NC_000023.11:108582920:G:A
NM_033380.3(COL4A5):c.1561G>T (p.Gly521Cys)	COL4A5	G521C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 25, 1992)	no assertion criteria provided	VCV000010462	X	107840272	X	108597042	10462	25501	rs104886121	NC_000023.11:108597041:G:T
NM_033380.3(COL4A5):c.3428G>A (p.Gly1143Asp)	COL4A5	G1143D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000010458	X	107908791	X	108665561	10458	25497	rs104886229	NC_000023.11:108665560:G:A
NM_002764.4(PRPS1):c.398A>C (p.Gln133Pro)	PRPS1	Q133P	Arts syndrome	Pathogenic(Last reviewed: Nov 18, 2010)	no assertion criteria provided	VCV000009937	X	106884223	X	107640993	9937	24976	rs80338675	NC_000023.11:107640992:A:C
NM_001453.3(FOXC1):c.245G>C (p.Ser82Thr)	FOXC1	S82T	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008458	6	1610925	6	1610690	8458	23497	rs104893953	NC_000006.12:1610689:G:C
NM_014317.5(PDSS1):c.924T>G (p.Asp308Glu)	PDSS1	D308E, D138E	Coenzyme Q10 deficiency, primary, 2	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003237	10	27024406	10	26735477	3237	18276	rs119463988	NC_000010.11:26735476:T:G
NM_000404.4(GLB1):c.818G>T (p.Trp273Leu)	GLB1	W273L, W243L, W142L, W321L	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000000931	3	33093471	3	33051979	931	15970	rs72555362	NC_000003.12:33051978:C:A
NM_001109809.5(ZFP57):c.829C>A (p.His277Asn)	ZFP57	H277N, H205N	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000720	6	29641059	6	29673282	720	15759	rs78378398	NC_000006.12:29673281:G:T
NM_001109809.5(ZFP57):c.743G>A (p.Arg248His)	ZFP57	R248H, R176H	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000719	6	29641145	6	29673368	719	15758	rs77625743	NC_000006.12:29673367:C:T
NM_001109809.5(ZFP57):c.1372C>G (p.His458Asp)	ZFP57	H458D, H386D	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000718	6	29640516	6	29672739	718	15757	rs79020217	NC_000006.12:29672738:G:C
NM_001046.3(SLC12A2):c.2935G>A (p.Glu979Lys)	SLC12A2	E979K	Hearing loss, autosomal dominant 78|Hearing loss	Pathogenic, association(Last reviewed: Nov 9, 2020)	no assertion criteria provided	VCV000804310	5	127512802	5	128177110	804310	792662	rs1581138934	NC_000005.10:128177109:G:A
NM_004086.3(COCH):c.292C>T (p.Arg98Ter)	COCH|LOC100506071	R98*, R163*	Prelingual sensorineural hearing impairment|Hearing loss, autosomal recessive 110	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000431458	14	31348069	14	30878863	431458	424972	rs756790858	NC_000014.9:30878862:C:T
NM_033409.4(SLC52A3):c.1198-2A>C	SLC52A3		Brown-Vialetto-Van Laere syndrome 1|Progressive bulbar palsy of childhood	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210025	20	741884	20	761240	210025	206613	rs754753126	NC_000020.11:761239:T:G
NM_002764.4(PRPS1):c.925G>T (p.Val309Phe)	PRPS1	V105F	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140573	X	106893230	X	107650000	140573	150247	rs587781263	NC_000023.11:107649999:G:T
NM_002473.6(MYH9):c.4270G>T (p.Asp1424Tyr)	MYH9	D1424Y	MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000038966	22	36688106	22	36292060	38966	47569	rs80338831	NC_000022.11:36292059:C:A
NM_013296.5(GPSM2):c.1661C>A (p.Ser554Ter)	GPSM2	S554*	not provided|Chudley-McCullough syndrome	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000035493	1	109466682	1	108924060	35493	44166	rs145191476	NC_000001.11:108924059:C:A
NM_000092.5(COL4A4):c.3601G>A (p.Gly1201Ser)	COL4A4	G1201S	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000017404	2	227896969	2	227032253	17404	32443	rs121912858	NC_000002.12:227032252:C:T
NM_004004.6(GJB2):c.196G>C (p.Asp66His)	GJB2	D66H	Hearing loss|Mutilating keratoderma	Pathogenic(Last reviewed: May 11, 2015)	no assertion criteria provided	VCV000017012	13	20763525	13	20189386	17012	32051	rs104894403	NC_000013.11:20189385:C:G
NM_002473.6(MYH9):c.4270G>C (p.Asp1424His)	MYH9	D1424H	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Feb 16, 2021)	no assertion criteria provided	VCV000014076	22	36688106	22	36292060	14076	29115	rs80338831	NC_000022.11:36292059:C:G
NM_002764.4(PRPS1):c.129A>C (p.Glu43Asp)	PRPS1	E43D	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Aug 26, 2008)	no assertion criteria provided	VCV000009934	X	106882531	X	107639301	9934	24973	rs80338731	NC_000023.11:107639300:A:C
NM_057176.3(BSND):c.1A>T (p.Met1Leu)	BSND	M1L	Bartter disease type 4a|not provided	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004380	1	55464860	1	54999187	4380	19419	rs74315284	NC_000001.11:54999186:A:T
NM_033409.4(SLC52A3):c.670T>C (p.Phe224Leu)	SLC52A3	F224L	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000142	20	744545	20	763901	142	15181	rs267606685	NC_000020.11:763900:A:G
NM_001199107.2(TBC1D24):c.439G>C (p.Asp147His)	TBC1D24	D147H	Myoclonic epilepsy, familial infantile	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000000048	16	2546588	16	2496587	48	15087	rs267607103	NC_000016.10:2496586:G:C
NM_020436.5(SALL4):c.1801C>T (p.Arg601Ter)	SALL4	R601*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000854661	20	50407221	20	51790682	854661	848481	rs2078031226	NC_000020.11:51790681:G:A
NM_004208.4(AIFM1):c.1478A>T (p.Glu493Val)	AIFM1|RAB33A	E493V, E154V, E489V	Cowchock syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039601	X	129265745	X	130131770	39601	48200	rs281864468	NC_000023.11:130131769:T:A
NM_000414.4(HSD17B4):c.650A>G (p.Tyr217Cys)	HSD17B4	Y217C, Y77C, Y193C, Y199C, Y242C	Perrault syndrome 1	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000030228	5	118824914	5	119489219	30228	39184	rs387906825	NC_000005.10:119489218:A:G
NM_020436.5(SALL4):c.2663A>G (p.His888Arg)	SALL4	H888R, H451R	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000003329	20	50405479	20	51788940	3329	18368	rs74315429	NC_000020.11:51788939:T:C
NM_018344.6(SLC29A3):c.1346C>G (p.Thr449Arg)	SLC29A3	T449R, T371R	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000000569	10	73122283	10	71362526	569	15608	rs267607058	NC_000010.11:71362525:C:G
NM_000404.4(GLB1):c.1010T>C (p.Leu337Pro)	GLB1	L206P, L307P, L337P, L385P	Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	VCV001251981	3	33087670	3	33046178	1251981	1241930	rs752177002	NC_000003.12:33046177:A:G
NM_006158.5(NEFL):c.1099C>T (p.Arg367Ter)	NEFL	R367*	Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001074146	8	24811765	8	24954251	1074146	1061293		NC_000008.11:24954250:G:A
NM_000404.4(GLB1):c.1258A>C (p.Thr420Pro)	GLB1	T289P, T390P, T420P, T468P	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001070505	3	33060029	3	33018537	1070505	1059731		NC_000003.12:33018536:T:G
NM_001854.4(COL11A1):c.3816+1G>C	COL11A1		not provided|Marshall syndrome	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000976188	1	103381186	1	102915630	976188	964641	rs398122828	NC_000001.11:102915629:C:G
NM_000092.5(COL4A4):c.3205G>C (p.Gly1069Arg)	COL4A4	G1069R	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974517	2	227914793	2	227050077	974517	962677	rs1973758214	NC_000002.12:227050076:C:G
NM_000092.5(COL4A4):c.1324G>T (p.Gly442Cys)	COL4A4	G442C	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974512	2	227958886	2	227094170	974512	962681	rs2060086619	NC_000002.12:227094169:C:A
NM_033380.3(COL4A5):c.465+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974468	X	107815068	X	108571838	974468	962844	rs2066070056	NC_000023.11:108571837:G:A
NM_033380.3(COL4A5):c.1768A>T (p.Lys590Ter)	COL4A5	K590*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974423	X	107840787	X	108597557	974423	962809	rs368137679	NC_000023.11:108597556:A:T
NM_033380.3(COL4A5):c.141+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974387	X	107783036	X	108539806	974387	962842	rs2065509989	NC_000023.11:108539805:G:A
NM_000092.5(COL4A4):c.558+1G>A	COL4A4		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974382	2	227979343	2	227114627	974382	962829	rs2061393783	NC_000002.12:227114626:C:T
NM_000404.4(GLB1):c.734-2A>G	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000946866	3	33095043	3	33053551	946866	940748	rs1699088102	NC_000003.12:33053550:T:C
NM_006005.3(WFS1):c.1620G>A (p.Trp540Ter)	WFS1	W540*	Wolfram syndrome 1	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV000929945	4	6303142	4	6301415	929945	918249	rs1038816435	NC_000004.12:6301414:G:A
NM_001101.5(ACTB):c.616C>T (p.Arg206Trp)	ACTB	R206W	not provided|Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000860924	7	5568098	7	5528467	860924	833728	rs1057518071	NC_000007.14:5528466:G:A
NM_022124.6(CDH23):c.7872G>A (p.Glu2624=)	CDH23		Usher syndrome type 1	Pathogenic	criteria provided, single submitter	VCV000813418	10	73563177	10	71803420	813418	801689	rs1292050472	NC_000010.11:71803419:G:A
NM_000260.4(MYO7A):c.4852+1G>A	MYO7A		Usher syndrome type 1	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000813195	11	76910864	11	77199819	813195	801432	rs1956938352	NC_000011.10:77199818:G:A
NM_033380.3(COL4A5):c.1807G>A (p.Gly603Ser)	COL4A5	G603S	Alport syndrome 1, X-linked recessive|Alport syndrome	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000807573	X	107841959	X	108598729	807573	798787	rs1603290681	NC_000023.11:108598728:G:A
NM_000304.4(PMP22):c.179-2A>G	PMP22		Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000637829	17	15142930	17	15239613	637829	625765	rs1597608225	NC_000017.11:15239612:T:C
NM_000530.8(MPZ):c.681A>T (p.Arg227Ser)	MPZ	R227S	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000637330	1	161275732	1	161305942	637330	624997	rs1571817146	NC_000001.11:161305941:T:A
NM_000166.6(GJB1):c.381C>G (p.Ile127Met)	GJB1	I127M	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000637216	X	70443938	X	71224088	637216	625589	rs1602349264	NC_000023.11:71224087:C:G
NM_000166.6(GJB1):c.260C>T (p.Pro87Leu)	GJB1	P87L	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000637139	X	70443817	X	71223967	637139	625557	rs1602349021	NC_000023.11:71223966:C:T
NM_000166.6(GJB1):c.633C>A (p.Tyr211Ter)	GJB1	Y211*	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000620115	X	70444190	X	71224340	620115	611955	rs1569215443	NC_000023.11:71224339:C:A
NM_000304.4(PMP22):c.307C>T (p.Gln103Ter)	PMP22	Q103*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000618333	17	15142800	17	15239483	618333	610055	rs1567704621	NC_000017.11:15239482:G:A
NM_033380.3(COL4A5):c.2918-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV000587182	X	107867465	X	108624235	587182	578199	rs104886372	NC_000023.11:108624234:G:A
NM_024577.4(SH3TC2):c.3596G>A (p.Trp1199Ter)	SH3TC2	W1199*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000579413	5	148386523	5	149006960	579413	560193	rs761972717	NC_000005.10:149006959:C:T
NM_000399.5(EGR2):c.1066G>A (p.Glu356Lys)	EGR2	E356K, E306K	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000577101	10	64573332	10	62813572	577101	563802	rs751448371	NC_000010.11:62813571:C:T
NM_025000.4(DCAF17):c.85C>T (p.Gln29Ter)	DCAF17|METTL8	Q29*	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000571994	2	172291172	2	171434662	571994	557694	rs868533593	NC_000002.12:171434661:C:T
NM_152564.5(VPS13B):c.2932C>T (p.Gln978Ter)	VPS13B	Q978*	Cohen syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566147	8	100396543	8	99384315	566147	563189	rs1563700205	NC_000008.11:99384314:C:T
NM_152564.5(VPS13B):c.11758C>T (p.Arg3920Ter)	VPS13B	R3920*, R3945*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550808	8	100887658	8	99875430	550808	545072	rs933746831	NC_000008.11:99875429:C:T
NM_033380.3(COL4A5):c.2686G>A (p.Gly896Ser)	COL4A5	G896S	Alport syndrome|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2018)	no assertion criteria provided	VCV000522413	X	107865041	X	108621811	522413	513159	rs1556420349	NC_000023.11:108621810:G:A
NM_017780.4(CHD7):c.2858G>A (p.Trp953Ter)	CHD7	W953*	CHARGE association	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488479	8	61734605	8	60822046	488479	481347	rs1554597465	NC_000008.11:60822045:G:A
NM_033380.3(COL4A5):c.584G>T (p.Gly195Val)	COL4A5	G195V	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000451889	X	107819177	X	108575947	451889	446463	rs104886061	NC_000023.11:108575946:G:T
NM_001005373.4(LRSAM1):c.2080T>C (p.Cys694Arg)	LRSAM1	C694R, C667R, C431R, C661R	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000408267	9	130265086	9	127502807	408267	396678	rs759312530	NC_000009.12:127502806:T:C
NM_000304.4(PMP22):c.448G>C (p.Gly150Arg)	PMP22	G150R	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000384327	17	15134269	17	15230952	384327	375772	rs104894624	NC_000017.11:15230951:C:G
NM_182476.3(COQ6):c.1341G>A (p.Trp447Ter)	COQ6|ENTPD5	W422*, W447*	Coenzyme Q10 deficiency, primary, 6	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375344	14	74428570	14	73961867	375344	362108	rs1057519351	NC_000014.9:73961866:G:A
NM_182476.3(COQ6):c.763G>A (p.Gly255Arg)	COQ6|ENTPD5	G230R, G255R	Coenzyme Q10 deficiency, primary, 6	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375342	14	74425907	14	73959204	375342	362106	rs1057519350	NC_000014.9:73959203:G:A
NM_152564.5(VPS13B):c.5515C>T (p.Gln1839Ter)	VPS13B	Q1839*, Q1864*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370619	8	100654333	8	99642105	370619	357705	rs1057516633	NC_000008.11:99642104:C:T
NM_017780.4(CHD7):c.3526C>T (p.Gln1176Ter)	CHD7	Q1176*	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267425	8	61742884	8	60830325	267425	262650	rs886040986	NC_000008.11:60830324:C:T
NM_014874.4(MFN2):c.1198C>T (p.Arg400Ter)	MFN2	R400*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000245768	1	12064086	1	12004029	245768	244198	rs879253939	NC_000001.11:12004028:C:T
NM_000166.6(GJB1):c.282C>A (p.His94Gln)	GJB1	H94Q	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	VCV000245724	X	70443839	X	71223989	245724	245183	rs756000896	NC_000023.11:71223988:C:A
NM_000166.6(GJB1):c.556G>T (p.Glu186Ter)	GJB1	E186*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000234612	X	70444113	X	71224263	234612	232162	rs116840821	NC_000023.11:71224262:G:T
NM_001384140.1(PCDH15):c.158-1G>A	PCDH15		Usher syndrome type 1	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226439	10	56138703	10	54378943	226439	228230	rs876657418	NC_000010.11:54378942:C:T
NM_000260.4(MYO7A):c.2311G>T (p.Ala771Ser)	MYO7A	A771S, A760S	Usher syndrome type 1	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000226433	11	76890119	11	77179073	226433	228235	rs782384464	NC_000011.10:77179072:G:T
NM_016653.3(MAP3K20):c.1103T>G (p.Phe368Cys)	MAP3K20|MAP3K20-AS1	F368C	Split-foot malformation with mesoaxial polydactyly|Split-hand/foot malformation 1	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000218144	2	174097087	2	173232359	218144	214792	rs863225437	NC_000002.12:173232358:T:G
NM_005360.5(MAF):c.176C>A (p.Pro59His)	MAF	P59H	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162515	16	79633624	16	79599727	162515	172188	rs727502770	NC_000016.10:79599726:G:T
NM_005360.5(MAF):c.172A>G (p.Thr58Ala)	MAF	T58A	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162513	16	79633628	16	79599731	162513	172190	rs727502767	NC_000016.10:79599730:T:C
NM_005360.5(MAF):c.161C>T (p.Ser54Leu)	MAF	S54L	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162512	16	79633639	16	79599742	162512	172191	rs727502766	NC_000016.10:79599741:G:A
NC_000018.9:g.77733765C>A	TXNL4A	E117*, E46*, E109*, E78*	Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162204	18	77733765	18	79973765	162204	171912	rs727502793	NC_000018.10:79973764:C:A
NM_001101.5(ACTB):c.611C>G (p.Ala204Gly)	ACTB	A204G	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000127171	7	5568103	7	5528472	127171	132669	rs587779776	NC_000007.14:5528471:G:C
NM_006158.5(NEFL):c.23C>A (p.Pro8Gln)	NEFL	P8Q	Charcot-Marie-Tooth disease|not provided	Pathogenic	criteria provided, single submitter	VCV000066687	8	24814007	8	24956493	66687	77584	rs61491953	NC_000008.11:24956492:G:T
NM_152564.5(VPS13B):c.8622-9A>G	VPS13B		not provided|Cohen syndrome	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000056697	8	100831631	8	99819403	56697	71336	rs386834116	NC_000008.11:99819402:A:G
NM_025000.4(DCAF17):c.906G>A (p.Trp302Ter)	DCAF17	W302*	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031581	2	172325465	2	171468955	31581	40265	rs761229686	NC_000002.12:171468954:G:A
NM_001605.3(AARS1):c.211A>T (p.Asn71Tyr)	AARS1	N71Y	not provided|Charcot-Marie-Tooth disease, type 2N	Pathogenic(Last reviewed: Nov 3, 2021)	no assertion criteria provided	VCV000030155	16	70310991	16	70277088	30155	39111	rs387906792	NC_000016.10:70277087:T:A
NM_033380.3(COL4A5):c.1912G>A (p.Gly638Ser)	COL4A5	G638S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000024461	X	107842064	X	108598834	24461	35802	rs104886147	NC_000023.11:108598833:G:A
NM_000092.5(COL4A4):c.3713C>A (p.Ser1238Ter)	COL4A4	S1238*	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000017405	2	227896765	2	227032049	17405	32444	rs121912859	NC_000002.12:227032048:G:T
NM_003106.4(SOX2):c.529C>T (p.Gln177Ter)	SOX2|SOX2-OT	Q177*	Anophthalmia/microphthalmia-esophageal atresia syndrome	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000012814	3	181430677	3	181712889	12814	27853	rs104893799	NC_000003.12:181712888:C:T
NM_002764.4(PRPS1):c.547G>C (p.Asp183His)	PRPS1	D183H	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000009929	X	106888423	X	107645193	9929	24968	rs137852541	NC_000023.11:107645192:G:C
m.4332G>A	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000009616	MT	4332	MT	4332	9616	24655	rs199476141	NC_012920.1:4331:G:A
NM_004525.3(LRP2):c.1093C>T (p.Arg365Ter)	LRP2	R365*	Donnai-Barrow syndrome	Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009457	2	170139461	2	169282951	9457	24496	rs80338744	NC_000002.12:169282950:G:A
NM_004525.3(LRP2):c.1341+2T>G	LRP2		Donnai-Barrow syndrome	Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009456	2	170136858	2	169280348	9456	24495	rs80338745	NC_000002.12:169280347:A:C
NM_004525.3(LRP2):c.10195C>T (p.Arg3399Ter)	LRP2	R3399*	Donnai-Barrow syndrome	Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009455	2	170034511	2	169178001	9455	24494	rs80338752	NC_000002.12:169178000:G:A
NM_004525.3(LRP2):c.8452+1G>A	LRP2		Donnai-Barrow syndrome	Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009454	2	170058137	2	169201627	9454	24493	rs80338748	NC_000002.12:169201626:C:T
NM_004525.3(LRP2):c.2640-1G>A	LRP2		Donnai-Barrow syndrome	Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009452	2	170112747	2	169256237	9452	24491	rs587776717	NC_000002.12:169256236:C:T
NM_006941.4(SOX10):c.939C>G (p.Tyr313Ter)	POLR2F|SOX10	Y313*	Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000007398	22	38369964	22	37973957	7398	22437	rs74315516	NC_000022.11:37973956:G:C
NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	RPS19	G127E	Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Jul 15, 2007)	no assertion criteria provided	VCV000006320	19	42373792	19	41869722	6320	21359	rs786200936	NC_000019.10:41869721:G:A
NM_054027.6(ANKH):c.1172T>C (p.Leu391Pro)	ANKH|LOC100130744|OTULIN	L391P	Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000005201	5	14713746	5	14713637	5201	20240	rs267606658	NC_000005.10:14713636:A:G
NM_021830.5(TWNK):c.952G>A (p.Ala318Thr)	TWNK	A318T	Infantile onset spinocerebellar ataxia	Pathogenic(Last reviewed: Jul 22, 2010)	no assertion criteria provided	VCV000004630	10	102748919	10	100989162	4630	19669	rs80356542	NC_000010.11:100989161:G:A
NM_006005.3(WFS1):c.460+1G>A	WFS1		not provided|Wolfram syndrome 1	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000004515	4	6290859	4	6289132	4515	19554	rs1191510461	NC_000004.12:6289131:G:A
NM_025136.4(OPA3):c.277G>A (p.Gly93Ser)	OPA3	G93S	Optic atrophy 3	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	VCV000004240	19	46057035	19	45553777	4240	19279	rs80356524	NC_000019.10:45553776:C:T
NM_001370298.3(FGD4):c.1081C>T (p.Arg361Ter)	FGD4	R224*, R309*, R40*, R131*, R361*	Charcot-Marie-Tooth disease, type 4H|not provided	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000001011	12	32751500	12	32598566	1011	16050	rs118203972	NC_000012.12:32598565:C:T
NM_001109809.2(ZFP57):c.783C>A (p.Cys261Ter)	ZFP57	C261*, C189*	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000715	6	29641105	6	29673328	715	15754	rs61730328	NC_000006.12:29673327:G:T
NM_025000.4(DCAF17):c.1091+6T>G	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000533	2	172330491	2	171473981	533	15572	rs1559289651	NC_000002.12:171473980:T:G
NM_025000.4(DCAF17):c.1422+5G>T	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000532	2	172336708	2	171480198	532	15571	rs1314048356	NC_000002.12:171480197:G:T
NM_033409.4(SLC52A3):c.550G>T (p.Glu184Ter)	SLC52A3	E184*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001070902	20	745869	20	765225	1070902	1064879		NC_000020.11:765224:C:A
NM_013296.5(GPSM2):c.1062+1G>T	GPSM2		not specified|not provided|Chudley-McCullough syndrome	Pathogenic(Last reviewed: Sep 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000035494	1	109445857	1	108903235	35494	44167	rs777695770	NC_000001.11:108903234:G:T
NM_004700.4(KCNQ4):c.886G>A (p.Gly296Ser)	KCNQ4	G296S	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000006249	1	41285598	1	40819926	6249	21288	rs80358279	NC_000001.11:40819925:G:A
NM_006005.3(WFS1):c.1901A>C (p.Lys634Thr)	WFS1	K634T	Autosomal dominant nonsyndromic hearing loss 6	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000004524	4	6303423	4	6301696	4524	19563	rs104893882	NC_000004.12:6301695:A:C
NM_145331.3(MAP3K7):c.737-7A>G	MAP3K7		Cardiospondylocarpofacial syndrome|not provided	Pathogenic(Last reviewed: Jun 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000974910	6	91261905	6	90552186	974910	963206	rs1776199533	NC_000006.12:90552185:T:C
NM_018344.6(SLC29A3):c.139G>T (p.Glu47Ter)	SLC29A3	E47*	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000862781	10	73082650	10	71322893	862781	837184	rs377762611	NC_000010.11:71322892:G:T
NM_000441.2(SLC26A4):c.2319+1G>A	SLC26A4		Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371164	7	107353068	7	107712623	371164	357554	rs542079779	NC_000007.14:107712622:G:A
NM_004700.4(KCNQ4):c.859G>C (p.Gly287Arg)	KCNQ4	G287R	not provided|Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000156337	1	41285571	1	40819899	156337	166117	rs137853969	NC_000001.11:40819898:G:C
NM_017780.4(CHD7):c.6322G>A (p.Gly2108Arg)	CHD7	G2108R	CHARGE association	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002032	8	61765606	8	60853047	2032	17071	rs121434343	NC_000008.11:60853046:G:A
NM_017780.4(CHD7):c.3770T>G (p.Leu1257Arg)	CHD7	L1257R	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002023	8	61743128	8	60830569	2023	17062	rs121434339	NC_000008.11:60830568:T:G
NM_000530.6(MPZ):c.[241C>T;337G>T]	MPZ	H81Y, V113F	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	VCV000208147	1|1	161276705	1|1	161306915	208147	49438|49442	rs281865123|rs281865126	NC_000001.11:161306914:G:A|NC_000001.11:161306818:C:A
NM_033380.2(COL4A5):c.[866G>T;4282C>T]	COL4A5	G289V, R1422C, R1428C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000010464	X|X	107823943	X|X	108580713	10464	35671|38451	rs104886450|rs144282156	NC_000023.11:108580712:G:T|NC_000023.11:108686095:C:T
NM_017780.4(CHD7):c.1603C>T (p.Gln535Ter)	CHD7	Q535*	CHARGE association	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, single submitter	VCV001320236	8	61655594	8	60743035	1320236	1310481		NC_000008.11:60743034:C:T
NM_017780.4(CHD7):c.2097-1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319729	8	61707544	8	60794985	1319729	1309979		NC_000008.11:60794984:G:A
NM_000404.4(GLB1):c.1580G>A (p.Trp527Ter)	GLB1	W396*, W497*, W527*, W575*	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001076248	3	33055702	3	33014210	1076248	1059729		NC_000003.12:33014209:C:T
NM_152564.5(VPS13B):c.2425C>T (p.Gln809Ter)	VPS13B	Q809*	Cohen syndrome	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001075879	8	100205195	8	99192967	1075879	1061459		NC_000008.11:99192966:C:T
NM_152564.5(VPS13B):c.3664C>T (p.Gln1222Ter)	VPS13B	Q1222*	Cohen syndrome	Pathogenic(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001075593	8	100479860	8	99467632	1075593	1061466		NC_000008.11:99467631:C:T
NM_152564.5(VPS13B):c.1757T>A (p.Leu586Ter)	VPS13B	L586*	Cohen syndrome	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001075352	8	100155307	8	99143079	1075352	1061457		NC_000008.11:99143078:T:A
NM_152564.5(VPS13B):c.3025C>T (p.Gln1009Ter)	VPS13B	Q1009*	Cohen syndrome	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001073817	8	100403875	8	99391647	1073817	1061462		NC_000008.11:99391646:C:T
NM_152564.5(VPS13B):c.8437C>T (p.Gln2813Ter)	VPS13B	Q2813*, Q2838*	Cohen syndrome	Pathogenic(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001073463	8	100830754	8	99818526	1073463	1061476		NC_000008.11:99818525:C:T
NM_000304.4(PMP22):c.236C>T (p.Ser79Phe)	PMP22	S79F	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001072721	17	15142871	17	15239554	1072721	1063846		NC_000017.11:15239553:G:A
NM_152564.5(VPS13B):c.9333T>G (p.Tyr3111Ter)	VPS13B	Y3111*, Y3136*	Cohen syndrome	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001072023	8	100844599	8	99832371	1072023	1061480		NC_000008.11:99832370:T:G
NM_152564.5(VPS13B):c.2560C>T (p.Gln854Ter)	VPS13B	Q854*	Cohen syndrome	Pathogenic(Last reviewed: Jul 3, 2020)	criteria provided, single submitter	VCV001071592	8	100286470	8	99274242	1071592	1061460		NC_000008.11:99274241:C:T
NM_152564.5(VPS13B):c.8341G>T (p.Glu2781Ter)	VPS13B	E2781*, E2806*	Cohen syndrome	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV001071088	8	100830011	8	99817783	1071088	1061474		NC_000008.11:99817782:G:T
NM_152564.5(VPS13B):c.6315C>A (p.Cys2105Ter)	VPS13B	C2130*, C2105*	Cohen syndrome	Pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001070680	8	100712021	8	99699793	1070680	1061470		NC_000008.11:99699792:C:A
NM_152564.5(VPS13B):c.6395T>A (p.Leu2132Ter)	VPS13B	L2132*, L2157*	Cohen syndrome	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001069136	8	100712101	8	99699873	1069136	1061471		NC_000008.11:99699872:T:A
NM_000288.4(PEX7):c.112C>T (p.Gln38Ter)	PEX7	Q38*	Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001068851	6	137143915	6	136822777	1068851	1060619		NC_000006.12:136822776:C:T
NM_152564.5(VPS13B):c.8230C>T (p.Gln2744Ter)	VPS13B	Q2744*, Q2769*	Cohen syndrome	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001068584	8	100829900	8	99817672	1068584	1061473		NC_000008.11:99817671:C:T
NM_152564.5(VPS13B):c.855C>A (p.Tyr285Ter)	VPS13B	Y285*	Cohen syndrome	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000961849	8	100128020	8	99115792	961849	946238	rs1256482530	NC_000008.11:99115791:C:A
NM_152564.5(VPS13B):c.10087A>T (p.Lys3363Ter)	VPS13B	K3388*, K3363*	Cohen syndrome	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000958788	8	100865704	8	99853476	958788	946271	rs1816395005	NC_000008.11:99853475:A:T
NM_152564.5(VPS13B):c.1246C>T (p.Gln416Ter)	VPS13B	Q416*	Cohen syndrome	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000957546	8	100146899	8	99134671	957546	946240	rs1809977682	NC_000008.11:99134670:C:T
NM_152564.5(VPS13B):c.7576C>T (p.Gln2526Ter)	VPS13B	Q2526*, Q2551*	Cohen syndrome	Pathogenic(Last reviewed: May 26, 2019)	criteria provided, single submitter	VCV000951118	8	100791056	8	99778828	951118	925295	rs1811869155	NC_000008.11:99778827:C:T
NM_152564.5(VPS13B):c.547G>T (p.Glu183Ter)	VPS13B	E183*	Cohen syndrome	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000943737	8	100115315	8	99103087	943737	934453	rs1227284058	NC_000008.11:99103086:G:T
NM_152564.5(VPS13B):c.4569T>A (p.Tyr1523Ter)	VPS13B	Y1523*, Y1548*	Cohen syndrome	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000943639	8	100523676	8	99511448	943639	934465	rs1361356353	NC_000008.11:99511447:T:A
NM_001692.4(ATP6V1B1):c.469C>T (p.Arg157Cys)	ATP6V1B1	R157C	not provided	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000850234	2	71187092	2	70959962	850234	826921	rs782500780	NC_000002.12:70959961:C:T
NM_000304.4(PMP22):c.351C>A (p.Tyr117Ter)	PMP22	Y117*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000846662	17	15134366	17	15231049	846662	844719	rs1906290133	NC_000017.11:15231048:G:T
NM_152564.5(VPS13B):c.11131C>T (p.Gln3711Ter)	VPS13B	Q3711*, Q3736*	Cohen syndrome	Pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000844524	8	100874090	8	99861862	844524	835270	rs1451352816	NC_000008.11:99861861:C:T
NM_031407.7(HUWE1):c.9209G>A (p.Arg3070His)	HUWE1	R3070H	not provided|Intellectual disability, X-linked syndromic, Turner type	Pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000841299	X	53578038	X	53551077	841299	850200	rs2061745581	NC_000023.11:53551076:C:T
NM_033380.3(COL4A5):c.1933C>T (p.Gln645Ter)	COL4A5	Q645*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000829955	X	107842085	X	108598855	829955	818353	rs1603290796	NC_000023.11:108598854:C:T
NM_022124.6(CDH23):c.4105-2A>T	C10orf105|CDH23		Usher syndrome type 1	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000813029	10	73493995	10	71734238	813029	801422	rs1416386069	NC_000010.11:71734237:A:T
NM_000091.5(COL4A3):c.1831G>A (p.Gly611Arg)	COL4A3|MFF-DT	G611R	Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000807567	2	228137737	2	227273021	807567	798504	rs1574753929	NC_000002.12:227273020:G:A
NM_152564.5(VPS13B):c.2014-2A>G	VPS13B		not provided|Cohen syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800514	8	100168775	8	99156547	800514	789124	rs1588095580	NC_000008.11:99156546:A:G
NM_152564.5(VPS13B):c.8827C>T (p.Arg2943Ter)	VPS13B	R2943*, R2968*	Cohen syndrome	Pathogenic(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000663053	8	100832183	8	99819955	663053	637540	rs755996065	NC_000008.11:99819954:C:T
NM_017780.4(CHD7):c.889C>T (p.Gln297Ter)	CHD7	Q297*	CHARGE association	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000661514	8	61654880	8	60742321	661514	637309	rs1586249808	NC_000008.11:60742320:C:T
NM_017780.4(CHD7):c.7824T>G (p.Tyr2608Ter)	CHD7	Y2608*	CHARGE association	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000655421	8	61773678	8	60861119	655421	637349	rs1586460329	NC_000008.11:60861118:T:G
NM_017780.4(CHD7):c.7781G>A (p.Trp2594Ter)	CHD7	W2594*	CHARGE association	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000651792	8	61773635	8	60861076	651792	637348	rs748126701	NC_000008.11:60861075:G:A
NM_000166.6(GJB1):c.281A>G (p.His94Arg)	GJB1	H94R	Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000637565	X	70443838	X	71223988	637565	625569	rs1602349095	NC_000023.11:71223987:A:G
NM_000166.6(GJB1):c.195T>G (p.Tyr65Ter)	GJB1	Y65*	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000637562	X	70443752	X	71223902	637562	625526	rs1602348907	NC_000023.11:71223901:T:G
NM_000530.8(MPZ):c.197G>A (p.Trp66Ter)	MPZ	W66*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000637507	1	161277085	1	161307295	637507	625070	rs1571819946	NC_000001.11:161307294:C:T
NM_014874.4(MFN2):c.776G>T (p.Arg259Leu)	MFN2	R259L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000637279	1	12059112	1	11999055	637279	624925	rs755065651	NC_000001.11:11999054:G:T
NM_000166.6(GJB1):c.238C>T (p.Gln80Ter)	GJB1	Q80*	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000637135	X	70443795	X	71223945	637135	625542	rs1602348981	NC_000023.11:71223944:C:T
NM_000530.8(MPZ):c.303G>A (p.Trp101Ter)	MPZ	W101*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586153	1	161276643	1	161306853	586153	576434	rs1558154149	NC_000001.11:161306852:C:T
NM_000530.8(MPZ):c.411C>T (p.Gly137=)	MPZ		Charcot-Marie-Tooth disease, type I|Dejerine-Sottas disease	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000577671	1	161276535	1	161306745	577671	557010	rs1558153994	NC_000001.11:161306744:G:A
NM_017780.4(CHD7):c.3379G>T (p.Glu1127Ter)	CHD7	E1127*	CHARGE association	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000573842	8	61741222	8	60828663	573842	565194	rs1563636399	NC_000008.11:60828662:G:T
NM_017780.4(CHD7):c.3412C>T (p.Gln1138Ter)	CHD7	Q1138*	CHARGE association	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000548946	8	61741255	8	60828696	548946	539430	rs1554599035	NC_000008.11:60828695:C:T
NM_017780.4(CHD7):c.5210+3A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547193	8	61757971	8	60845412	547193	537833	rs1554602588	NC_000008.11:60845411:A:G
NM_000530.8(MPZ):c.298C>T (p.Gln100Ter)	MPZ	Q100*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000531678	1	161276648	1	161306858	531678	515242	rs1553259683	NC_000001.11:161306857:G:A
NM_017780.4(CHD7):c.7132G>T (p.Glu2378Ter)	CHD7	E2378*	CHARGE association	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000529132	8	61768729	8	60856170	529132	524267	rs878975068	NC_000008.11:60856169:G:T
NM_000166.6(GJB1):c.515C>T (p.Pro172Leu)	GJB1	P172L	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000477599	X	70444072	X	71224222	477599	471000	rs1555937218	NC_000023.11:71224221:C:T
NM_000530.8(MPZ):c.256C>T (p.Gln86Ter)	MPZ	Q86*	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000462792	1	161276690	1	161306900	462792	447368	rs1553259703	NC_000001.11:161306899:G:A
NM_017780.4(CHD7):c.6473C>A (p.Ser2158Ter)	CHD7	S2158*	CHARGE association	Pathogenic(Last reviewed: Apr 23, 2017)	criteria provided, single submitter	VCV000459559	8	61765757	8	60853198	459559	458569	rs376056567	NC_000008.11:60853197:C:A
NM_017780.4(CHD7):c.5238C>G (p.Tyr1746Ter)	CHD7	Y1746*	CHARGE association	Pathogenic(Last reviewed: Mar 25, 2017)	criteria provided, single submitter	VCV000459551	8	61761101	8	60848542	459551	458496	rs1554603151	NC_000008.11:60848541:C:G
NM_017780.4(CHD7):c.3490C>T (p.Gln1164Ter)	CHD7	Q1164*	CHARGE association	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000459546	8	61741333	8	60828774	459546	458489	rs1554599065	NC_000008.11:60828773:C:T
NM_017780.4(CHD7):c.1735C>T (p.Gln579Ter)	CHD7	Q579*	CHARGE association	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000459542	8	61693628	8	60781069	459542	458486	rs780953224	NC_000008.11:60781068:C:T
NM_017780.4(CHD7):c.7312C>T (p.Gln2438Ter)	CHD7	Q2438*	CHARGE association	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000411190	8	61769151	8	60856592	411190	396674	rs1060503188	NC_000008.11:60856591:C:T
NM_017780.4(CHD7):c.3093G>C (p.Trp1031Cys)	CHD7	W1031C	CHARGE association	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000411188	8	61735197	8	60822638	411188	396259	rs1060503187	NC_000008.11:60822637:G:C
NM_017780.4(CHD7):c.3202-3T>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000411184	8	61736396	8	60823837	411184	396262	rs1060503183	NC_000008.11:60823836:T:G
NM_017780.4(CHD7):c.2097-1G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000411182	8	61707544	8	60794985	411182	396666	rs1060503182	NC_000008.11:60794984:G:C
NM_017780.4(CHD7):c.5211-1G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: May 22, 2016)	criteria provided, single submitter	VCV000411179	8	61761073	8	60848514	411179	396667	rs1060503180	NC_000008.11:60848513:G:C
NM_000166.6(GJB1):c.101T>C (p.Met34Thr)	GJB1	M34T	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000406224	X	70443658	X	71223808	406224	404290	rs1060500998	NC_000023.11:71223807:T:C
NM_152564.5(VPS13B):c.10735A>T (p.Lys3579Ter)	VPS13B	K3579*, K3604*	Cohen syndrome|not provided	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379881	8	100866352	8	99854124	379881	369643	rs1057520769	NC_000008.11:99854123:A:T
NM_152564.5(VPS13B):c.9331-1G>A	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370547	8	100844596	8	99832368	370547	357732	rs386834119	NC_000008.11:99832367:G:A
NM_017780.4(CHD7):c.2215G>T (p.Glu739Ter)	CHD7	E739*	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267419	8	61707663	8	60795104	267419	262644	rs886040981	NC_000008.11:60795103:G:T
NM_017780.4(CHD7):c.3768C>G (p.Tyr1256Ter)	CHD7	Y1256*	CHARGE association	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000241192	8	61743126	8	60830567	241192	240395	rs878855032	NC_000008.11:60830566:C:G
NM_017780.4(CHD7):c.5023C>T (p.Gln1675Ter)	CHD7	Q1675*	CHARGE association	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000210719	8	61757595	8	60845036	210719	207558	rs797045467	NC_000008.11:60845035:C:T
NM_033380.3(COL4A5):c.4016-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	VCV000209142	X	107924114	X	108680884	209142	205798	rs797045035	NC_000023.11:108680883:G:A
NM_006158.5(NEFL):c.1261C>T (p.Arg421Ter)	NEFL	R421*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E	Pathogenic	criteria provided, single submitter	VCV000192322	8	24811218	8	24953704	192322	190114	rs191346286	NC_000008.11:24953703:G:A
NM_000166.6(GJB1):c.116C>T (p.Ala39Val)	GJB1	A39V	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	VCV000188136	X	70443673	X	71223823	188136	186290	rs786204095	NC_000023.11:71223822:C:T
NM_001130823.3(DNMT1):c.1531T>C (p.Tyr511His)	DNMT1	Y495H, Y511H, Y390H	Hereditary sensory neuropathy type IE|not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000162188	19	10265694	19	10155018	162188	171896	rs199473692	NC_000019.10:10155017:A:G
NM_017780.4(CHD7):c.8055G>A (p.Trp2685Ter)	CHD7	W2685*, W636*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158322	8	61775190	8	60862631	158322	168638	rs587783459	NC_000008.11:60862630:G:A
NM_017780.4(CHD7):c.5666-2A>C	CHD7		CHARGE association	Pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	VCV000158304	8	61764576	8	60852017	158304	168620	rs587783448	NC_000008.11:60852016:A:C
NM_017780.4(CHD7):c.5551G>T (p.Glu1851Ter)	CHD7	E1851*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158303	8	61763607	8	60851048	158303	168619	rs587783447	NC_000008.11:60851047:G:T
NM_017780.4(CHD7):c.2815G>T (p.Glu939Ter)	CHD7	E939*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158285	8	61734466	8	60821907	158285	168602	rs587783434	NC_000008.11:60821906:G:T
NM_017780.4(CHD7):c.2643T>G (p.Tyr881Ter)	CHD7	Y881*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158284	8	61732595	8	60820036	158284	168601	rs587783433	NC_000008.11:60820035:T:G
NM_017780.4(CHD7):c.2613+1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158283	8	61729061	8	60816502	158283	168599	rs587783432	NC_000008.11:60816501:G:A
NM_017780.4(CHD7):c.1246G>T (p.Gly416Ter)	CHD7	G416*	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158278	8	61655237	8	60742678	158278	168593	rs587783428	NC_000008.11:60742677:G:T
NM_001101.5(ACTB):c.193C>T (p.Leu65Phe)	ACTB	L65F	Baraitser-Winter syndrome 1|Intellectual disability	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000127161	7	5568962	7	5529331	127161	132659	rs281875332	NC_000007.14:5529330:G:A
NM_001101.5(ACTB):c.349G>A (p.Glu117Lys)	ACTB	E117K	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000066051	7	5568806	7	5529175	66051	76956	rs397515470	NC_000007.14:5529174:C:T
NM_182476.3(COQ6):c.1058C>A (p.Ala353Asp)	COQ6|ENTPD5	A353D, A328D	Coenzyme Q10 deficiency, primary, 6	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000031595	14	74428042	14	73961339	31595	40280	rs397514479	NC_000014.9:73961338:C:A
NM_001101.5(ACTB):c.34A>G (p.Asn12Asp)	ACTB	N12D	Baraitser-Winter syndrome 1|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029602	7	5569255	7	5529624	29602	38556	rs281875331	NC_000007.14:5529623:T:C
NM_001101.5(ACTB):c.193C>G (p.Leu65Val)	ACTB	L65V	Baraitser-Winter syndrome 1|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029601	7	5568962	7	5529331	29601	38555	rs281875332	NC_000007.14:5529330:G:C
NM_001614.5(ACTG1):c.608C>A (p.Thr203Lys)	ACTG1	T203K	not provided|Baraitser-Winter Syndrome 2	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029588	17	79478408	17	81511382	29588	38542	rs281875327	NC_000017.11:81511381:G:T
NM_033380.3(COL4A5):c.4217-1G>A	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024714	X	107929260	X	108686030	24714	36055	rs587776402	NC_000023.11:108686029:G:A
NM_033380.3(COL4A5):c.2917+1G>C	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024574	X	107866056	X	108622826	24574	35915	rs104886371	NC_000023.11:108622825:G:C
NM_033380.3(COL4A5):c.687+1G>A	COL4A5		Alport syndrome|Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV000024312	X	107821350	X	108578120	24312	35653	rs104886440	NC_000023.11:108578119:G:A
NM_000122.2(ERCC3):c.296T>C (p.Phe99Ser)	ERCC3	F99S, F35S	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016583	2	128050361	2	127292785	16583	31622	rs121913045	NC_000002.12:127292784:A:G
ERCC3, IVS14AS, C-A, -6	ERCC3		Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016582					16582	31621		
NM_031407.7(HUWE1):c.12559C>T (p.Arg4187Cys)	HUWE1	R4187C	not provided|Intellectual disability, X-linked syndromic, Turner type	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000010678	X	53562435	X	53535474	10678	25717	rs121918527	NC_000023.11:53535473:G:A
NM_000288.4(PEX7):c.40A>C (p.Thr14Pro)	PEX7	T14P	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000007790	6	137143843	6	136822705	7790	22829	rs61753233	NC_000006.12:136822704:A:C
NM_001540.5(HSPB1):c.544C>T (p.Pro182Ser)	HSPB1	P182S	Charcot-Marie-Tooth disease axonal type 2F|Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000007483	7	75933416	7	76304099	7483	22522	rs104894020	NC_000007.14:76304098:C:T
NM_016156.6(MTMR2):c.826G>T (p.Glu276Ter)	MTMR2	E276*, E204*	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000006233	11	95583005	11	95849841	6233	21272	rs121434403	NC_000011.10:95849840:C:A
NM_016156.6(MTMR2):c.1276C>T (p.Gln426Ter)	MTMR2	Q426*, Q354*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000006231	11	95578227	11	95845063	6231	21270	rs121434402	NC_000011.10:95845062:G:A
NM_021102.4(SPINT2):c.488A>G (p.Tyr163Cys)	SPINT2	Y163C, Y106C	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000005205	19	38780855	19	38290215	5205	20244	rs121908403	NC_000019.10:38290214:A:G
NM_054027.6(ANKH):c.1142-4A>G	LOC100130744|OTULIN|ANKH		Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000005193	5	14713780	5	14713671	5193	20232	rs1579998709	NC_000005.10:14713670:T:C
NM_012431.3(SEMA3E):c.2108C>T (p.Ser703Leu)	SEMA3E	S703L, S643L	CHARGE association	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002505	7	82997122	7	83367806	2505	17544	rs121918341	NC_000007.14:83367805:G:A
NM_017780.4(CHD7):c.3811G>T (p.Glu1271Ter)	CHD7	E1271*	CHARGE association	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000002028	8	61748664	8	60836105	2028	17067	rs121434342	NC_000008.11:60836104:G:T
NM_017780.4(CHD7):c.6955C>A (p.Arg2319Ser)	CHD7	R2319S	CHARGE association	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000002027	8	61768552	8	60855993	2027	17066	rs121434341	NC_000008.11:60855992:C:A
NM_017780.4(CHD7):c.5418C>G (p.Tyr1806Ter)	CHD7	Y1806*	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002024	8	61763065	8	60850506	2024	17063	rs121434340	NC_000008.11:60850505:C:G
NM_005797.4(MPZL2):c.220C>T (p.Gln74Ter)	MPZL2	Q74*	Hearing loss, autosomal recessive 111	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000585269	11	118133651	11	118262936	585269	576319	rs146689036	NC_000011.10:118262935:G:A
NM_001199107.2(TBC1D24):c.999G>T (p.Leu333Phe)	TBC1D24	L333F, L327F	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000183155	16	2548254	16	2498253	183155	181291	rs797044548	NC_000016.10:2498252:G:T
NM_001199107.2(TBC1D24):c.119G>T (p.Arg40Leu)	TBC1D24	R40L	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000183152	16	2546268	16	2496267	183152	181288	rs760474458	NC_000016.10:2496266:G:T
NM_001199107.2(TBC1D24):c.1206+5G>A	TBC1D24		DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000091399	16	2549426	16	2499425	91399	96875	rs398122968	NC_000016.10:2499424:G:A
NM_001199107.2(TBC1D24):c.58C>G (p.Gln20Glu)	TBC1D24	Q20E	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000091397	16	2546207	16	2496206	91397	96873	rs201257588	NC_000016.10:2496205:C:G
NM_002473.6(MYH9):c.279C>G (p.Asn93Lys)	MYH9	N93K	MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000014075	22	36745003	22	36348958	14075	29114	rs121913655	NC_000022.11:36348957:G:C
NM_004700.4(KCNQ4):c.821T>A (p.Leu274His)	KCNQ4	L274H	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000006247	1	41285131	1	40819459	6247	21286	rs80358276	NC_000001.11:40819458:T:A
NM_004700.4(KCNQ4):c.853G>T (p.Gly285Cys)	KCNQ4	G285C	Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	VCV000006244	1	41285565	1	40819893	6244	21283	rs28937588	NC_000001.11:40819892:G:T
NM_000092.5(COL4A4):c.735+2T>C	COL4A4		Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000974385	2	227973295	2	227108579	974385	962827	rs2060993180	NC_000002.12:227108578:A:G
NM_001854.4(COL11A1):c.4547G>T (p.Gly1516Val)	COL11A1	G1516V, G1528V, G1400V, G1477V	not provided|Marshall syndrome|Marshall syndrome|Stickler syndrome type 2|Hearing loss, autosomal dominant 37	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000498797	1	103354286	1	102888730	498797	490221	rs1553193910	NC_000001.11:102888729:C:A
NM_018344.6(SLC29A3):c.300+1G>A	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000130339	10	73082812	10	71323055	130339	135786	rs587780463	NC_000010.11:71323054:G:A
NM_181457.3(PAX3):c.242G>C (p.Gly81Ala)	PAX3	G81A	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000004210	2	223161776	2	222297057	4210	19249	rs587776586	NC_000002.12:222297056:C:G
NM_018344.6(SLC29A3):c.1279G>A (p.Gly427Ser)	SLC29A3	G427S, G349S	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000000563	10	73122216	10	71362459	563	15602	rs121912583	NC_000010.11:71362458:G:A
NM_005236.3(ERCC4):c.22C>T (p.Arg8Ter)	ERCC4	R8*	Cockayne syndrome|Xeroderma pigmentosum, group F|Fanconi anemia, complementation group Q	Pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001075759	16	14014044	16	13920187	1075759	1063505		NC_000016.10:13920186:C:T
NM_017780.4(CHD7):c.3522+1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Mar 3, 2021)	criteria provided, single submitter	VCV000998080	8	61741366	8	60828807	998080	985808	rs1804369859	NC_000008.11:60828806:G:A
NM_152564.5(VPS13B):c.3984G>A (p.Trp1328Ter)	VPS13B	W1328*	Cohen syndrome	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000963996	8	100514028	8	99501800	963996	946255	rs1156390688	NC_000008.11:99501799:G:A
NM_153676.4(USH1C):c.628A>T (p.Lys210Ter)	USH1C	K210*	not provided	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000936958	11	17547940	11	17526393	936958	935448	rs755601799	NC_000011.10:17526392:T:A
NM_000530.8(MPZ):c.235-1G>T	MPZ		not provided|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000935883	1	161276712	1	161306922	935883	939778	rs1571819375	NC_000001.11:161306921:C:A
NM_000404.4(GLB1):c.149A>G (p.Tyr50Cys)	GLB1	Y50C, Y98C, Y20C	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000917831	3	33114132	3	33072640	917831	906152	rs1207569870	NC_000003.12:33072639:T:C
NM_000441.2(SLC26A4):c.1171A>C (p.Ser391Arg)	SLC26A4	S391R	not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000862716	7	107330590	7	107690145	862716	832778	rs1791526034	NC_000007.14:107690144:A:C
NM_000404.4(GLB1):c.931G>A (p.Gly311Arg)	GLB1	G180R, G311R, G281R, G359R	GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jul 19, 2020)	criteria provided, single submitter	VCV000854615	3	33093274	3	33051782	854615	827904	rs368568171	NC_000003.12:33051781:C:T
NM_033380.3(COL4A5):c.3197G>A (p.Gly1066Asp)	COL4A5	G1066D	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000807395	X	107869530	X	108626300	807395	798797	rs104886221	NC_000023.11:108626299:G:A
NM_000530.8(MPZ):c.68-1G>A	MPZ		Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000655415	1	161277215	1	161307425	655415	650671	rs1057518021	NC_000001.11:161307424:C:T
NM_000530.8(MPZ):c.316C>T (p.Arg106Cys)	MPZ	R106C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV000637797	1	161276630	1	161306840	637797	625050	rs1571819084	NC_000001.11:161306839:G:A
NM_022489.4(INF2):c.395T>C (p.Leu132Pro)	INF2	L132P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV000637706	14	105169445	14	104703108	637706	625305	rs387907038	NC_000014.9:104703107:T:C
NM_022489.4(INF2):c.170T>C (p.Leu57Pro)	INF2	L57P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000637700	14	105167872	14	104701535	637700	625294	rs1595163736	NC_000014.9:104701534:T:C
NM_016156.6(MTMR2):c.1593+1G>A	MTMR2		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000637472	11	95571257	11	95838093	637472	625719	rs1590970875	NC_000011.10:95838092:C:T
NM_000304.4(PMP22):c.79-2A>G	PMP22		not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000637371	17	15162512	17	15259195	637371	625768	rs1597633171	NC_000017.11:15259194:T:C
NM_005340.7(HINT1):c.368G>A (p.Trp123Ter)	HINT1	W123*	Charcot-Marie-Tooth disease|Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637254	5	130495153	5	131159460	637254	625108	rs1580682390	NC_000005.10:131159459:C:T
NM_017780.4(CHD7):c.7803C>A (p.Tyr2601Ter)	CHD7	Y2601*	CHARGE association|not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000620425	8	61773657	8	60861098	620425	611705	rs1563669432	NC_000008.11:60861097:C:A
NM_000082.4(ERCC8):c.769G>A (p.Gly257Arg)	ERCC8	G257R, G104R, G199R	Cockayne syndrome type A|Cockayne syndrome	Pathogenic(Last reviewed: Nov 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000590788	5	60194177	5	60898350	590788	581726	rs770499406	NC_000005.10:60898349:C:T
NM_014874.4(MFN2):c.638T>C (p.Ile213Thr)	MFN2	I213T	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000575481	1	12058865	1	11998808	575481	556615	rs1557524703	NC_000001.11:11998807:T:C
NM_000530.8(MPZ):c.302G>A (p.Trp101Ter)	MPZ	W101*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jul 13, 2019)	criteria provided, single submitter	VCV000570159	1	161276644	1	161306854	570159	556664	rs1017715903	NC_000001.11:161306853:C:T
NM_033380.3(COL4A5):c.3685G>A (p.Gly1229Ser)	COL4A5	G1229S	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000562403	X	107911629	X	108668399	562403	553587	rs1569505771	NC_000023.11:108668398:G:A
NM_000404.4(GLB1):c.1144-2A>G	GLB1		Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557226	3	33063149	3	33021657	557226	542937	rs1553607014	NC_000003.12:33021656:T:C
NM_017780.4(CHD7):c.1312C>T (p.Gln438Ter)	CHD7	Q438*	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000529121	8	61655303	8	60742744	529121	524254	rs1554581657	NC_000008.11:60742743:C:T
NM_015340.4(LARS2):c.1987C>T (p.Arg663Trp)	LARS2	R663W	Perrault syndrome 4	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431124	3	45557711	3	45516219	431124	424646	rs774649299	NC_000003.12:45516218:C:T
NM_001101.5(ACTB):c.629G>A (p.Arg210His)	ACTB	R210H	Baraitser-Winter syndrome 1|ACTB-related BAFopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000418804	7	5568085	7	5528454	418804	407161	rs1064793444	NC_000007.14:5528453:C:T
NM_017780.4(CHD7):c.7285G>T (p.Glu2429Ter)	CHD7	E2429*	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411189	8	61769124	8	60856565	411189	396545	rs773047607	NC_000008.11:60856564:G:T
NM_017780.4(CHD7):c.496C>T (p.Gln166Ter)	CHD7	Q166*	CHARGE association	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000267414	8	61654487	8	60741928	267414	262639	rs886040978	NC_000008.11:60741927:C:T
NM_000530.8(MPZ):c.584+2T>G	MPZ		Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000246029	1	161276117	1	161306327	246029	244251	rs879254054	NC_000001.11:161306326:A:C
NM_006158.5(NEFL):c.1179G>C (p.Leu393Phe)	NEFL	L393F	not provided|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245748	8	24811300	8	24953786	245748	244521	rs879253927	NC_000008.11:24953785:C:G
NM_000260.4(MYO7A):c.1976C>A (p.Ser659Ter)	MYO7A	S659*, S648*	Retinal dystrophy|Usher syndrome type 1	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000236487	11	76885842	11	77174796	236487	238053	rs878853378	NC_000011.10:77174795:C:A
NM_000530.8(MPZ):c.314C>T (p.Pro105Leu)	MPZ	P105L	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188325	1	161276632	1	161306842	188325	185951	rs786204215	NC_000001.11:161306841:G:A
NM_152564.5(VPS13B):c.1225G>T (p.Glu409Ter)	VPS13B	E409*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056646	8	100146878	8	99134650	56646	71285	rs386834071	NC_000008.11:99134649:G:T
NM_152564.5(VPS13B):c.10871G>A (p.Trp3624Ter)	VPS13B	W3649*, W3624*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056631	8	100871535	8	99859307	56631	71270	rs386834057	NC_000008.11:99859306:G:A
NM_033380.3(COL4A5):c.3196G>A (p.Gly1066Ser)	COL4A5	G1066S	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000024603	X	107869529	X	108626299	24603	35944	rs104886219	NC_000023.11:108626298:G:A
NM_001983.4(ERCC1):c.693C>G (p.Phe231Leu)	ERCC1	F231L	Cockayne syndrome|Cerebrooculofacioskeletal syndrome 4	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000016778	19	45918128	19	45414870	16778	31817	rs121913028	NC_000019.10:45414869:G:C
NM_006158.5(NEFL):c.995A>C (p.Gln332Pro)	NEFL	Q332P	not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000014028	8	24813035	8	24955521	14028	29067	rs59443585	NC_000008.11:24955520:T:G
NM_000489.6(ATRX):c.6392G>A (p.Arg2131Gln)	ATRX	R2093Q, R2131Q	X-linked intellectual disability-hypotonic face syndrome|Alpha thalassemia-X-linked intellectual disability syndrome|Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000011731	X	76814252	X	77558781	11731	26770	rs122445101	NC_000023.11:77558780:C:T
NM_006941.4(SOX10):c.1129C>T (p.Gln377Ter)	POLR2F|SOX10	Q377*	Waardenburg syndrome type 4C|not provided|Waardenburg syndrome type 2E, with neurologic involvement	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000007402	22	38369774	22	37973767	7402	22441	rs74315520	NC_000022.11:37973766:G:A
NM_021830.5(TWNK):c.1370C>T (p.Thr457Ile)	TWNK	T457I, T3I	Infantile onset spinocerebellar ataxia|Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Jul 22, 2010)	no assertion criteria provided	VCV000004626	10	102749527	10	100989770	4626	19665	rs80356544	NC_000010.11:100989769:C:T
FGD4, 893T-G	FGD4		Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001012					1012	16051		
NM_018344.6(SLC29A3):c.1088G>A (p.Arg363Gln)	SLC29A3	R363Q, R285Q	Histiocytosis-lymphadenopathy plus syndrome	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000030948	10	73122025	10	71362268	30948	39905	rs387907066	NC_000010.11:71362267:G:A
NM_002241.5(KCNJ10):c.194G>C (p.Arg65Pro)	KCNJ10	R65P	Microcephaly|Cerebellar ataxia|Renal tubular dysfunction|Spastic diplegia|Bilateral sensorineural hearing impairment|EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007462	1	160012129	1	160042339	7462	22501	rs137853066	NC_000001.11:160042338:C:G
NM_001126108.2(SLC12A3):c.3025C>T (p.Arg1009Ter)	SLC12A3	R1009*, R1017*, R1018*	Bartter syndrome|Familial hypokalemia-hypomagnesemia|not provided	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000835523	16	56947276	16	56913364	835523	844031	rs781209989	NC_000016.10:56913363:C:T
NM_001126108.2(SLC12A3):c.1314C>G (p.Tyr438Ter)	SLC12A3	Y437*, Y438*	Bartter syndrome|Familial hypokalemia-hypomagnesemia|not provided	Pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000834760	16	56913118	16	56879206	834760	844025	rs776210036	NC_000016.10:56879205:C:G
NM_000530.6(MPZ):c.[266T>A;274G>A;486C>G]	MPZ	V92M, I162M, I89N	Charcot-Marie-Tooth disease type 2I	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000014182	1|1|1	161276672	1|1|1	161306882	14182	38404|38403|29221	rs267607245|rs267607246|rs267607244	NC_000001.11:161306881:C:T|NC_000001.11:161306426:G:C|NC_000001.11:161306889:A:T
NM_015046.5(SETX):c.[3880C>T;822G>H]	SETX	R1294C, M274I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: May 23, 2006)	no assertion criteria provided	VCV000441281	9|9	135203105	9|9	132327718	441281	38425|17333	rs267607044|rs997473183	NC_000009.12:132327717:G:A|NC_000009.12:132334623:C:D
NM_002241.5(KCNJ10):c.595C>T (p.Arg199Ter)	KCNJ10	R199*	EAST syndrome	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV000007463	1	160011728	1	160041938	7463	22502	rs137853067	NC_000001.11:160041937:G:A
NM_000441.2(SLC26A4):c.3G>C (p.Met1Ile)	SLC26A4|SLC26A4-AS1	M1I	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188721	7	107302089	7	107661644	188721	186722	rs786204426	NC_000007.14:107661643:G:C
NM_001122659.3(EDNRB):c.601C>T (p.Arg201Ter)	EDNRB-AS1|EDNRB	R201*, R291*	Waardenburg syndrome type 4A|ABCD syndrome|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000016640	13	78477491	13	77903356	16640	31679	rs104894391	NC_000013.11:77903355:G:A
NM_002968.3(SALL1):c.967C>T (p.Gln323Ter)	SALL1	Q323*, Q226*	Townes syndrome|Townes-Brocks syndrome 1|Townes-Brocks-branchiootorenal-like syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007434	16	51175166	16	51141255	7434	22473	rs104894538	NC_000016.10:51141254:G:A
NM_017780.4(CHD7):c.4906G>T (p.Glu1636Ter)	CHD7	E1636*	CHARGE association	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001075493	8	61757478	8	60844919	1075493	1061386		NC_000008.11:60844918:G:T
NM_017780.4(CHD7):c.4360C>T (p.Gln1454Ter)	CHD7	Q1454*	CHARGE association	Pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001070565	8	61750641	8	60838082	1070565	1061384		NC_000008.11:60838081:C:T
NM_017780.4(CHD7):c.7684C>T (p.Gln2562Ter)	CHD7	Q2562*	CHARGE association	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001069987	8	61773538	8	60860979	1069987	1061390		NC_000008.11:60860978:C:T
NM_025000.4(DCAF17):c.1091+2T>C	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001069883	2	172330487	2	171473977	1069883	1059100		NC_000002.12:171473976:T:C
NM_017780.4(CHD7):c.7160C>G (p.Ser2387Ter)	CHD7	S2387*	CHARGE association	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001069783	8	61768757	8	60856198	1069783	1061389		NC_000008.11:60856197:C:G
NM_017780.4(CHD7):c.667G>T (p.Gly223Ter)	CHD7	G223*	CHARGE association	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000971388	8	61654658	8	60742099	971388	955470	rs1809060881	NC_000008.11:60742098:G:T
NM_017780.4(CHD7):c.7681G>T (p.Gly2561Ter)	CHD7	G2561*	CHARGE association	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000968757	8	61773535	8	60860976	968757	955482	rs774255090	NC_000008.11:60860975:G:T
NM_152564.5(VPS13B):c.6657+2T>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000957837	8	100729603	8	99717375	957837	959904	rs1832966881	NC_000008.11:99717374:T:C
NM_017780.4(CHD7):c.5357G>A (p.Trp1786Ter)	CHD7	W1786*	CHARGE association	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000951305	8	61761666	8	60849107	951305	925250	rs1805338299	NC_000008.11:60849106:G:A
NM_001540.5(HSPB1):c.544C>G (p.Pro182Ala)	HSPB1	P182A	Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000946496	7	75933416	7	76304099	946496	924907	rs104894020	NC_000007.14:76304098:C:G
NM_017780.4(CHD7):c.3641A>C (p.Gln1214Pro)	CHD7	Q1214P	CHARGE association	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000941341	8	61742999	8	60830440	941341	934381	rs1804454889	NC_000008.11:60830439:A:C
NM_017780.4(CHD7):c.4738G>T (p.Glu1580Ter)	CHD7	E1580*	CHARGE association	Pathogenic(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000839015	8	61754499	8	60841940	839015	834952	rs1804993220	NC_000008.11:60841939:G:T
NM_017780.4(CHD7):c.5110C>T (p.Gln1704Ter)	CHD7	Q1704*	CHARGE association	Pathogenic(Last reviewed: Jan 19, 2019)	criteria provided, single submitter	VCV000838744	8	61757868	8	60845309	838744	834956	rs1805157634	NC_000008.11:60845308:C:T
NM_017780.4(CHD7):c.2729C>G (p.Ser910Ter)	CHD7	S910*	CHARGE association	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000836642	8	61734380	8	60821821	836642	834939	rs1804054410	NC_000008.11:60821820:C:G
NM_017780.4(CHD7):c.2836-1G>A	CHD7		CHARGE association	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000665863	8	61734582	8	60822023	665863	651906	rs1586389929	NC_000008.11:60822022:G:A
NM_017780.4(CHD7):c.2257C>T (p.Gln753Ter)	CHD7	Q753*	not specified|CHARGE association	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660551	8	61712965	8	60800406	660551	637319	rs1586350727	NC_000008.11:60800405:C:T
NM_017780.4(CHD7):c.1300C>T (p.Gln434Ter)	CHD7	Q434*	CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000653661	8	61655291	8	60742732	653661	637313	rs1586251038	NC_000008.11:60742731:C:T
NM_014874.4(MFN2):c.922G>T (p.Glu308Ter)	MFN2	E308*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000637744	1	12061563	1	12001506	637744	624932	rs1553143852	NC_000001.11:12001505:G:T
NM_014874.4(MFN2):c.275T>C (p.Leu92Pro)	MFN2	L92P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000637730	1	12052711	1	11992654	637730	624892	rs1569816285	NC_000001.11:11992653:T:C
NM_022489.4(INF2):c.341G>A (p.Gly114Asp)	INF2	G114D	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV000637704	14	105168043	14	104701706	637704	625304	rs1595164091	NC_000014.9:104701705:G:A
NM_000166.6(GJB1):c.47A>T (p.His16Leu)	GJB1	H16L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637615	X	70443604	X	71223754	637615	625463	rs1602348610	NC_000023.11:71223753:A:T
NM_000166.6(GJB1):c.68T>C (p.Val23Ala)	GJB1	V23A	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000637585	X	70443625	X	71223775	637585	625474	rs1602348650	NC_000023.11:71223774:T:C
NM_002529.4(NTRK1):c.2303C>T (p.Pro768Leu)	NTRK1	P768L, P732L, P762L	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000637485	1	156851346	1	156881554	637485	624990	rs756981419	NC_000001.11:156881553:C:T
NM_002529.4(NTRK1):c.429-1G>C	NTRK1		Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000637475	1	156837895	1	156868103	637475	625729	rs748672380	NC_000001.11:156868102:G:C
NM_000304.4(PMP22):c.256C>T (p.Gln86Ter)	PMP22	Q86*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000637389	17	15142851	17	15239534	637389	625386	rs11545341	NC_000017.11:15239533:G:A
NM_014874.4(MFN2):c.2213C>T (p.Ala738Val)	MFN2	A738V	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, single submitter	VCV000637283	1	12071561	1	12011504	637283	624963	rs1569889919	NC_000001.11:12011503:C:T
NM_000166.6(GJB1):c.518G>T (p.Cys173Phe)	GJB1	C173F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637236	X	70444075	X	71224225	637236	625645	rs1602349535	NC_000023.11:71224224:G:T
NM_000166.6(GJB1):c.89T>C (p.Ile30Thr)	GJB1	I30T	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000637215	X	70443646	X	71223796	637215	625484	rs104894817	NC_000023.11:71223795:T:C
NM_000091.5(COL4A3):c.1594G>T (p.Gly532Cys)	COL4A3|MFF-DT	G532C	Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000635483	2	228135504	2	227270788	635483	623264	rs779575469	NC_000002.12:227270787:G:T
NM_017780.4(CHD7):c.511C>T (p.Gln171Ter)	CHD7	Q171*	not provided|CHARGE association	Pathogenic(Last reviewed: Aug 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620120	8	61654502	8	60741943	620120	611702	rs1563560018	NC_000008.11:60741942:C:T
NM_003742.4(ABCB11):c.1763C>T (p.Ala588Val)	ABCB11	A588V	not provided|Progressive familial intrahepatic cholestasis	Pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000594531	2	169826601	2	168970091	594531	585594	rs917981474	NC_000002.12:168970090:G:A
NM_152564.5(VPS13B):c.7247+2T>C	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000583375	8	100779200	8	99766972	583375	562561	rs1563908020	NC_000008.11:99766971:T:C
NM_000091.5(COL4A3):c.1006G>T (p.Gly336Cys)	MFF-DT|COL4A3	G336C	not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000562453	2	228122337	2	227257621	562453	553637	rs1559873550	NC_000002.12:227257620:G:T
NM_000092.5(COL4A4):c.1405G>T (p.Gly469Ter)	COL4A4	G469*	Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553870	2	227954638	2	227089922	553870	541867	rs926605269	NC_000002.12:227089921:C:A
NM_000530.8(MPZ):c.397C>A (p.Pro133Thr)	MPZ	P133T	Roussy-Lvy syndrome|Charcot-Marie-Tooth disease dominant intermediate d|Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Congenital hypomyelinating neuropathy 1, autosomal recessive|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000462797	1	161276549	1	161306759	462797	447245	rs1553259648	NC_000001.11:161306758:G:T
NM_017780.4(CHD7):c.604C>T (p.Gln202Ter)	CHD7	Q202*	CHARGE association	Pathogenic(Last reviewed: Sep 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000459557	8	61654595	8	60742036	459557	458971	rs1554581277	NC_000008.11:60742035:C:T
NM_152564.5(VPS13B):c.5955G>A (p.Trp1985Ter)	VPS13B	W1985*, W2010*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000451620	8	100673628	8	99661400	451620	444317	rs1554892040	NC_000008.11:99661399:G:A
NM_000092.5(COL4A4):c.1396G>A (p.Gly466Arg)	COL4A4	G466R	not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000447180	2	227954647	2	227089931	447180	440665	rs201859109	NC_000002.12:227089930:C:T
NM_000091.5(COL4A3):c.520G>A (p.Gly174Arg)	COL4A3|MFF-DT	G174R	not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000447175	2	228113210	2	227248494	447175	440674	rs1014839148	NC_000002.12:227248493:G:A
NM_000166.6(GJB1):c.566T>G (p.Val189Gly)	GJB1	V189G	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420023	X	70444123	X	71224273	420023	411472	rs1064794244	NC_000023.11:71224272:T:G
NM_031407.7(HUWE1):c.12928G>C (p.Gly4310Arg)	HUWE1	G4310R	not provided|Intellectual disability, X-linked syndromic, Turner type	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000375725	X	53561062	X	53534101	375725	362599	rs1556909287	NC_000023.11:53534100:C:G
NM_000489.6(ATRX):c.6532C>T (p.Arg2178Trp)	ATRX	R2178W, R2140W	not provided|X-linked intellectual disability-hypotonic face syndrome	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372309	X	76813089	X	77557618	372309	360661	rs1057517707	NC_000023.11:77557617:G:A
NM_000288.4(PEX7):c.277C>T (p.Gln93Ter)	PEX7	Q93*	Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370682	6	137147545	6	136826407	370682	357425	rs763514968	NC_000006.12:136826406:C:T
NM_152564.5(VPS13B):c.1915C>T (p.Arg639Ter)	VPS13B	R639*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265334	8	100160140	8	99147912	265334	259908	rs764776104	NC_000008.11:99147911:C:T
NM_003680.4(YARS1):c.586G>C (p.Glu196Gln)	YARS1	E196Q	Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000243071	1	33263369	1	32797768	243071	244151	rs121908834	NC_000001.11:32797767:C:G
NM_017780.4(CHD7):c.2836-2A>T	CHD7		not provided|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000241191	8	61734581	8	60822022	241191	240394	rs878855031	NC_000008.11:60822021:A:T
NM_000166.6(GJB1):c.208C>G (p.Pro70Ala)	GJB1	P70A	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237122	X	70443765	X	71223915	237122	243822	rs878853697	NC_000023.11:71223914:C:G
NM_001005373.4(LRSAM1):c.1913-1G>A	LRSAM1		Charcot-Marie-Tooth disease type 2P|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000204301	9	130263288	9	127501009	204301	200697	rs756880678	NC_000009.12:127501008:G:A
NM_017780.4(CHD7):c.6995G>A (p.Trp2332Ter)	CHD7	W2332*	not provided|CHARGE association	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000196870	8	61768592	8	60856033	196870	194031	rs794727569	NC_000008.11:60856032:G:A
NM_001101.5(ACTB):c.359C>T (p.Thr120Ile)	ACTB	T120I	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000127168	7	5568796	7	5529165	127168	132666	rs587779774	NC_000007.14:5529164:G:A
NM_006158.5(NEFL):c.23C>T (p.Pro8Leu)	NEFL	P8L	not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000066689	8	24814007	8	24956493	66689	77586	rs61491953	NC_000008.11:24956492:G:A
NM_152564.5(VPS13B):c.4336C>T (p.Arg1446Ter)	VPS13B	R1471*, R1446*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056664	8	100523443	8	99511215	56664	71303	rs386834086	NC_000008.11:99511214:C:T
NM_001136472.2(LITAF):c.332C>G (p.Ala111Gly)	LITAF	A111G	Charcot-Marie-Tooth disease, type 1C|Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000041229	16	11647434	16	11553578	41229	49653	rs281865134	NC_000016.10:11553577:G:C
NM_033380.3(COL4A5):c.665T>G (p.Phe222Cys)	COL4A5	F222C	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000038751	X	107821327	X	108578097	38751	47356	rs281874761	NC_000023.11:108578096:T:G
NM_001614.5(ACTG1):c.359C>T (p.Thr120Ile)	ACTG1	T120I	not provided|Baraitser-Winter Syndrome 2	Pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV000029586	17	79478933	17	81511907	29586	38540	rs281875325	NC_000017.11:81511906:G:A
NM_024577.4(SH3TC2):c.1178-1G>A	SH3TC2		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000021688	5	148408118	5	149028555	21688	34540	rs80338922	NC_000005.10:149028554:C:T
NM_024105.4(ALG12):c.437G>A (p.Arg146Gln)	ALG12	R146Q	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003435	22	50304114	22	49910466	3435	18474	rs121907932	NC_000022.11:49910465:C:T
NM_001034850.3(RETREG1):c.433C>T (p.Gln145Ter)	RETREG1	Q145*	Hereditary sensory and autonomic neuropathy type IIB|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000000330	5	16565897	5	16565788	330	15369	rs137852737	NC_000005.10:16565787:G:A
NM_033409.4(SLC52A3):c.639C>G (p.Tyr213Ter)	SLC52A3	Y213*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV000210018	20	744576	20	763932	210018	206621	rs778363575	NC_000020.11:763931:G:C
NM_001199107.2(TBC1D24):c.118C>T (p.Arg40Cys)	TBC1D24	R40C	not provided|DOORS syndrome	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000091396	16	2546267	16	2496266	91396	96872	rs398122966	NC_000016.10:2496265:C:T
NM_004004.6(GJB2):c.195C>G (p.Tyr65Ter)	GJB2	Y65*	not provided|GJB2-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000631698	13	20763526	13	20189387	631698	620468	rs763572195	NC_000013.11:20189386:G:C
NM_017780.4(CHD7):c.2957+2T>C	CHD7		CHARGE association	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001072857	8	61734706	8	60822147	1072857	1061381		NC_000008.11:60822146:T:C
NM_000404.4(GLB1):c.994G>A (p.Asp332Asn)	GLB1	D201N, D302N, D332N, D380N	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV001071414	3	33087686	3	33046194	1071414	1059732		NC_000003.12:33046193:C:T
NM_000260.4(MYO7A):c.6184G>T (p.Glu2062Ter)	MYO7A	E2013*, E2024*, E2062*	Usher syndrome type 1|not provided	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000983990	11	76922329	11	77211284	983990	972158	rs530700420	NC_000011.10:77211283:G:T
NM_017780.4(CHD7):c.5211-2A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000945371	8	61761072	8	60848513	945371	940909	rs1805310365	NC_000008.11:60848512:A:G
NM_005236.3(ERCC4):c.793-2A>G	ERCC4		Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000942911	16	14024565	16	13930708	942911	940343	rs2032155264	NC_000016.10:13930707:A:G
NM_017780.4(CHD7):c.689C>A (p.Ser230Ter)	CHD7	S230*	CHARGE association	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000935346	8	61654680	8	60742121	935346	934374	rs1809062715	NC_000008.11:60742120:C:A
NM_017780.4(CHD7):c.8077-2A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000862228	8	61777573	8	60865014	862228	851698	rs1806173195	NC_000008.11:60865013:A:G
NM_000288.4(PEX7):c.592C>T (p.Gln198Ter)	PEX7	Q198*	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813366	6	137187830	6	136866692	813366	801613	rs764924345	NC_000006.12:136866691:C:T
NM_017780.4(CHD7):c.8077-1G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000656743	8	61777574	8	60865015	656743	651995	rs1586466948	NC_000008.11:60865014:G:C
NM_017780.4(CHD7):c.6937-2A>G	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000651945	8	61768532	8	60855973	651945	651795	rs1586451506	NC_000008.11:60855972:A:G
NM_000530.8(MPZ):c.392A>G (p.Asn131Ser)	MPZ	N131S	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000637784	1	161276554	1	161306764	637784	625034	rs1571818819	NC_000001.11:161306763:T:C
NM_000530.8(MPZ):c.435T>A (p.Tyr145Ter)	MPZ	Y145*	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637781	1	161276511	1	161306721	637781	625018	rs1571818632	NC_000001.11:161306720:A:T
NM_014874.4(MFN2):c.692C>T (p.Ser231Phe)	MFN2	S231F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000637741	1	12058919	1	11998862	637741	624917	rs1569842714	NC_000001.11:11998861:C:T
NM_181882.3(PRX):c.1864C>T (p.Gln622Ter)	PRX	Q622*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000637509	19	40902395	19	40396488	637509	625424	rs1210729449	NC_000019.10:40396487:G:A
NM_000304.4(PMP22):c.320G>T (p.Gly107Val)	PMP22	G107V	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000637376	17	15134397	17	15231080	637376	625377	rs1597597900	NC_000017.11:15231079:C:A
NM_000166.6(GJB1):c.119C>T (p.Ala40Val)	GJB1	A40V	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000637200	X	70443676	X	71223826	637200	625499	rs1602348786	NC_000023.11:71223825:C:T
NM_014874.4(MFN2):c.2037C>G (p.Tyr679Ter)	MFN2	Y679*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000637064	1	12067274	1	12007217	637064	624958	rs1569871830	NC_000001.11:12007216:C:G
NM_025136.4(OPA3):c.52C>T (p.Gln18Ter)	OPA3	Q18*	3-Methylglutaconic aciduria type 3|Optic atrophy 3|not provided|3-Methylglutaconic aciduria type 3	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620409	19	46087971	19	45584713	620409	611904	rs1568413644	NC_000019.10:45584712:G:A
NM_022124.6(CDH23):c.8803C>T (p.Arg2935Ter)	CDH23	R2935*, R695*	Retinal dystrophy|Usher syndrome type 1|not provided	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620124	10	73569657	10	71809900	620124	611734	rs1190307769	NC_000010.11:71809899:C:T
NM_017780.4(CHD7):c.2572C>T (p.Arg858Ter)	CHD7	R858*	not provided|CHARGE association	Pathogenic(Last reviewed: Feb 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000620086	8	61729019	8	60816460	620086	611703	rs1563625351	NC_000008.11:60816459:C:T
NM_017780.4(CHD7):c.538C>T (p.Gln180Ter)	CHD7	Q180*	not provided|CHARGE association	Pathogenic(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000618017	8	61654529	8	60741970	618017	609700	rs1563560149	NC_000008.11:60741969:C:T
NM_022489.4(INF2):c.550G>A (p.Glu184Lys)	INF2	E184K	Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease, dominant intermediate E|Charcot-Marie-Tooth disease|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000599128	14	105169674	14	104703337	599128	590307	rs1566778676	NC_000014.9:104703336:G:A
NM_017780.4(CHD7):c.4015C>T (p.Arg1339Ter)	CHD7	R1339*	not provided|CHARGE association	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000592245	8	61749401	8	60836842	592245	583283	rs1563644066	NC_000008.11:60836841:C:T
NM_000091.5(COL4A3):c.3109C>T (p.Arg1037Ter)	COL4A3|MFF-DT	R1037*	Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554110	2	228155501	2	227290785	554110	542038	rs766900945	NC_000002.12:227290784:C:T
NM_000530.8(MPZ):c.152C>T (p.Ser51Phe)	MPZ	S51F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000531693	1	161277130	1	161307340	531693	515335	rs1553259790	NC_000001.11:161307339:G:A
NM_152564.5(VPS13B):c.7048C>T (p.Gln2350Ter)	VPS13B	Q2350*, Q2375*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504191	8	100733273	8	99721045	504191	495617	rs767858119	NC_000008.11:99721044:C:T
NM_017780.4(CHD7):c.2440C>T (p.Gln814Ter)	CHD7	Q814*	CHARGE association	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000488369	8	61714150	8	60801591	488369	481214	rs1554593049	NC_000008.11:60801590:C:T
NM_033380.3(COL4A5):c.3410G>A (p.Gly1137Asp)	COL4A5	G1137D	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000430135	X	107908773	X	108665543	430135	422402	rs1131691795	NC_000023.11:108665542:G:A
NM_017780.4(CHD7):c.7879C>T (p.Arg2627Ter)	CHD7	R2627*, R578*	not provided|CHARGE association	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000418655	8	61774803	8	60862244	418655	407437	rs1064793346	NC_000008.11:60862243:C:T
NM_000530.8(MPZ):c.403A>C (p.Ile135Leu)	MPZ	I135L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243089	1	161276543	1	161306753	243089	244171	rs879253858	NC_000001.11:161306752:T:G
NM_006736.6(DNAJB2):c.352+1G>A	DNAJB2		Spinal muscular atrophy, distal, autosomal recessive, 5|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000217886	2	220146784	2	219282062	217886	214533	rs756614404	NC_000002.12:219282061:G:A
NM_005360.5(MAF):c.173C>T (p.Thr58Ile)	MAF	T58I	Ayme-gripp syndrome|not provided	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000162514	16	79633627	16	79599730	162514	172189	rs727502769	NC_000016.10:79599729:G:A
NM_000404.4(GLB1):c.171C>G (p.Tyr57Ter)	GLB1	Y57*, Y105*, Y27*	GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092900	3	33114110	3	33072618	92900	98807	rs398123350	NC_000003.12:33072617:G:C
NM_006383.4(CIB2):c.192G>C (p.Glu64Asp)	CIB2	E64D, E21D	Usher syndrome, type 1J|Usher syndrome type 1	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000039688	15	78403513	15	78111171	39688	48287	rs145415848	NC_000015.10:78111170:C:G
NM_015915.5(ATL1):c.1065C>A (p.Asn355Lys)	ATL1	N355K	Charcot-Marie-Tooth disease|Distal lower limb muscle weakness|Distal sensory impairment|Osteomyelitis leading to amputation due to slow healing fractures|Penetrating foot ulcers|Hereditary sensory neuropathy type 1D	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000030579	14	51089912	14	50623194	30579	39536	rs1555365597	NC_000014.9:50623193:C:A
NM_001614.5(ACTG1):c.404C>T (p.Ala135Val)	ACTG1	A135V	Baraitser-Winter Syndrome 2|not provided	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000029587	17	79478612	17	81511586	29587	38541	rs11549190	NC_000017.11:81511585:G:A
NM_001614.5(ACTG1):c.464C>T (p.Ser155Phe)	ACTG1	S155F	not provided|Baraitser-Winter Syndrome 2	Pathogenic(Last reviewed: Sep 25, 2013)	criteria provided, single submitter	VCV000029585	17	79478552	17	81511526	29585	38539	rs281875326	NC_000017.11:81511525:G:A
NM_033380.3(COL4A5):c.4931G>A (p.Cys1644Tyr)	COL4A5	C1638Y, C1644Y	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024780	X	107938606	X	108695376	24780	36121	rs104886302	NC_000023.11:108695375:G:A
NM_033380.3(COL4A5):c.3659G>A (p.Gly1220Asp)	COL4A5	G1220D	Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024666	X	107911603	X	108668373	24666	36007	rs104886251	NC_000023.11:108668372:G:A
NM_000399.5(EGR2):c.1234G>A (p.Glu412Lys)	EGR2	E412K, E362K	Dejerine-sottas neuropathy, autosomal dominant|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 27, 2019)	criteria provided, single submitter	VCV000016753	10	64573164	10	62813404	16753	31792	rs121434563	NC_000010.11:62813403:C:T
C108S	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000010454					10454	25493		
m.15967G>A	MT-TP		MERFF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009572	MT	15967	MT	15967	9572	24611	rs199474701	NC_012920.1:15966:G:A
NM_000304.4(PMP22):c.206T>A (p.Met69Lys)	PMP22	M69K	Charcot-Marie-Tooth disease, type I|not provided|Dejerine-Sottas syndrome, autosomal dominant	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008432	17	15142901	17	15239584	8432	23471	rs104894620	NC_000017.11:15239583:A:T
NM_054027.6(ANKH):c.1165G>A (p.Gly389Arg)	ANKH|LOC100130744|OTULIN	G389R	Chondrocalcinosis 2|Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000005192	5	14713753	5	14713644	5192	20231	rs28939080	NC_000005.10:14713643:C:T
NM_014874.4(MFN2):c.617C>T (p.Thr206Ile)	MFN2	T206I	Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000002279	1	12058844	1	11998787	2279	17318	rs119103266	NC_000001.11:11998786:C:T
NM_014874.4(MFN2):c.751C>G (p.Pro251Ala)	MFN2	P251A	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic	criteria provided, single submitter	VCV000002272	1	12059087	1	11999030	2272	17311	rs28940295	NC_000001.11:11999029:C:G
NM_017780.4(CHD7):c.4795C>T (p.Gln1599Ter)	CHD7	Q1599*	CHARGE association|not provided	Pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	VCV000002038	8	61754556	8	60841997	2038	17077	rs267606724	NC_000008.11:60841996:C:T
NM_017780.4(CHD7):c.2501C>T (p.Ser834Phe)	CHD7	S834F	CHARGE association|Hypogonadotropic hypogonadism 5 without anosmia	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000002033	8	61728948	8	60816389	2033	17072	rs121434344	NC_000008.11:60816388:C:T
NM_001370298.3(FGD4):c.1234C>T (p.Arg412Ter)	FGD4	R275*, R360*, R182*, R27*, R91*, R412*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000001016	12	32754344	12	32601410	1016	16055	rs118203974	NC_000012.12:32601409:C:T
NM_152524.5:c.1453_1454delGA,NM_012130.3:c.254T>A	CLDN14|CLDN14-AS1|SGO2	V85D, E485fs	Perrault syndrome	Pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000375673	21|2	37833740	21|2	36461442	375673	19890|362513	rs74315437|rs1057519602	NC_000021.9:36461441:A:T|NC_000002.12:200571795:AGAGA:AGA
NM_000530.8(MPZ):c.224A>T (p.Asp75Val)	MPZ	D75V	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease type 2J	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000014184	1	161277058	1	161307268	14184	29223	rs121913597	NC_000001.11:161307267:T:A
NM_004700.4(KCNQ4):c.842T>C (p.Leu281Ser)	KCNQ4	L281S	not provided|Autosomal dominant nonsyndromic hearing loss 2A	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006246	1	41285554	1	40819882	6246	21285	rs80358278	NC_000001.11:40819881:T:C
NM_000441.2(SLC26A4):c.416-1G>A	SLC26A4		Pendred syndrome|not provided	Pathogenic(Last reviewed: May 19, 2021)	criteria provided, single submitter	VCV000371079	7	107314608	7	107674163	371079	357530	rs1057516988	NC_000007.14:107674162:G:A
NM_000441.2(SLC26A4):c.170C>A (p.Ser57Ter)	SLC26A4	S57*	not provided	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001075541	7	107303746	7	107663301	1075541	1060943		NC_000007.14:107663300:C:A
NM_017780.4(CHD7):c.3378+5G>C	CHD7		CHARGE association	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001072858	8	61736580	8	60824021	1072858	1061382		NC_000008.11:60824020:G:C
NM_033380.3(COL4A5):c.4962G>A (p.Trp1654Ter)	COL4A5	W1648*, W1654*	Alport syndrome 1, X-linked recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000860456	X	107938637	X	108695407	860456	849556	rs2068718016	NC_000023.11:108695406:G:A
NM_004637.6(RAB7A):c.471G>T (p.Lys157Asn)	RAB7A	K157N	Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000846631	3	128526457	3	128807614	846631	827519	rs121909081	NC_000003.12:128807613:G:T
NM_000091.5(COL4A3):c.28C>T (p.Gln10Ter)	COL4A3	Q10*	not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000807562	2	228029470	2	227164754	807562	798499	rs1453590085	NC_000002.12:227164753:C:T
NM_000404.4(GLB1):c.716C>T (p.Thr239Met)	GLB1	T239M, T287M, T209M	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000807421	3	33099598	3	33058106	807421	798530	rs746766232	NC_000003.12:33058105:G:A
NM_000304.4(PMP22):c.420G>A (p.Trp140Ter)	PMP22	W140*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000648604	17	15134297	17	15230980	648604	645317	rs1597597527	NC_000017.11:15230979:C:T
NM_181882.3(PRX):c.2689C>T (p.Arg897Ter)	PRX	R897*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000646421	19	40901570	19	40395663	646421	648104	rs756689732	NC_000019.10:40395662:G:A
NM_000288.4(PEX7):c.130+1G>A	PEX7		Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000639671	6	137143934	6	136822796	639671	651523	rs267608253	NC_000006.12:136822795:G:A
NM_000530.8(MPZ):c.194C>A (p.Thr65Asn)	MPZ	T65N	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jun 11, 2020)	criteria provided, single submitter	VCV000637928	1	161277088	1	161307298	637928	625072	rs1571819964	NC_000001.11:161307297:G:T
NM_000166.6(GJB1):c.238C>A (p.Gln80Lys)	GJB1	Q80K	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 1, 2020)	criteria provided, single submitter	VCV000637563	X	70443795	X	71223945	637563	625541	rs1602348981	NC_000023.11:71223944:C:A
NM_000399.5(EGR2):c.1141C>T (p.Arg381Cys)	EGR2	R381C, R331C	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000637524	10	64573257	10	62813497	637524	625202	rs1589080524	NC_000010.11:62813496:G:A
NM_014874.4(MFN2):c.1081C>T (p.His361Tyr)	MFN2	H361Y	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000637315	1	12062081	1	12002024	637315	624937	rs1569854012	NC_000001.11:12002023:C:T
NM_005340.7(HINT1):c.316C>T (p.Gln106Ter)	HINT1	Q106*	not provided|Charcot-Marie-Tooth disease|Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637252	5	130495205	5	131159512	637252	625110	rs1028404937	NC_000005.10:131159511:G:A
NM_022489.4(INF2):c.640C>T (p.Arg214Cys)	INF2	R214C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate E|Focal segmental glomerulosclerosis 5|Focal segmental glomerulosclerosis 5	Pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000635443	14	105169764	14	104703427	635443	623317	rs912928648	NC_000014.9:104703426:C:T
NM_000443.4(ABCB4):c.3136C>T (p.Arg1046Ter)	ABCB4	R1046*, R999*	Cholestasis, intrahepatic, of pregnancy 3|Low phospholipid associated cholelithiasis|Progressive familial intrahepatic cholestasis 3|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000587488	7	87037496	7	87408180	587488	578462	rs759202962	NC_000007.14:87408179:G:A
NM_000166.6(GJB1):c.100A>G (p.Met34Val)	GJB1	M34V	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000565409	X	70443657	X	71223807	565409	573989	rs1569215061	NC_000023.11:71223806:A:G
NM_000404.4(GLB1):c.1479+1G>A	GLB1		Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557669	3	33058200	3	33016708	557669	543181	rs1022476871	NC_000003.12:33016707:C:T
NM_000091.5(COL4A3):c.1A>C (p.Met1Leu)	COL4A3	M1L	not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555012	2	228029443	2	227164727	555012	541992	rs1396602090	NC_000002.12:227164726:A:C
NM_000091.5(COL4A3):c.4486C>T (p.Arg1496Ter)	COL4A3|MFF-DT	R1496*	Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554855	2	228173638	2	227308922	554855	542058	rs769863513	NC_000002.12:227308921:C:T
NM_152564.5(VPS13B):c.8995-2A>G	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554219	8	100833520	8	99821292	554219	545032	rs1554569259	NC_000008.11:99821291:A:G
NM_017780.4(CHD7):c.6199C>T (p.Gln2067Ter)	CHD7	Q2067*	not provided|CHARGE association	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488803	8	61765483	8	60852924	488803	481823	rs766862122	NC_000008.11:60852923:C:T
NM_152564.5(VPS13B):c.8446-1G>T	VPS13B		Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000459251	8	100830940	8	99818712	459251	458111	rs1554566596	NC_000008.11:99818711:G:T
NM_152564.5(VPS13B):c.11496-2A>G	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449747	8	100883674	8	99871446	449747	444321	rs1554588353	NC_000008.11:99871445:A:G
NM_152564.5(VPS13B):c.9330+1G>C	VPS13B		Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449600	8	100836207	8	99823979	449600	444319	rs756013171	NC_000008.11:99823978:G:C
NM_000092.5(COL4A4):c.1118G>A (p.Gly373Glu)	COL4A4	G373E	Alport syndrome, autosomal recessive|Benign familial hematuria|not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000447179	2	227963496	2	227098780	447179	440666	rs755649235	NC_000002.12:227098779:C:T
NM_000091.5(COL4A3):c.1372G>C (p.Gly458Arg)	COL4A3|MFF-DT	G458R	not provided|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive|Benign familial hematuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447166	2	228131189	2	227266473	447166	440679	rs757341933	NC_000002.12:227266472:G:C
NM_017780.4(CHD7):c.1170T>G (p.Tyr390Ter)	CHD7	Y390*	not provided|CHARGE association	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379836	8	61655161	8	60742602	379836	371928	rs554737227	NC_000008.11:60742601:T:G
NM_001376.5(DYNC1H1):c.2327C>T (p.Pro776Leu)	DYNC1H1	P776L	not provided|Charcot-Marie-Tooth disease, axonal, type 2O|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Pathogenic(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372934	14	102452889	14	101986552	372934	360017	rs1057518083	NC_000014.9:101986551:C:T
NM_152564.5(VPS13B):c.2158C>T (p.Gln720Ter)	VPS13B	Q720*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000369684	8	100168921	8	99156693	369684	353898	rs777593389	NC_000008.11:99156692:C:T
NM_017780.4(CHD7):c.5029C>T (p.Arg1677Ter)	CHD7	R1677*	not provided|CHARGE association	Pathogenic(Last reviewed: Mar 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279762	8	61757601	8	60845042	279762	264397	rs777652245	NC_000008.11:60845041:C:T
NM_017780.4(CHD7):c.3379-2A>C	CHD7		CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000220434	8	61741220	8	60828661	220434	221761	rs864622523	NC_000008.11:60828660:A:C
NM_000530.8(MPZ):c.182A>G (p.Asp61Gly)	MPZ	D61G	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188168	1	161277100	1	161307310	188168	185952	rs786204119	NC_000001.11:161307309:T:C
NM_006158.5(NEFL):c.1319C>T (p.Pro440Leu)	NEFL	P440L	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000155738	8	24811160	8	24953646	155738	165492	rs587777882	NC_000008.11:24953645:G:A
NM_152564.5(VPS13B):c.1563G>A (p.Lys521=)	VPS13B		not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068084	8	100147961	8	99135733	68084	78975	rs180177355	NC_000008.11:99135732:G:A
NM_152564.5(VPS13B):c.8044C>T (p.Arg2682Ter)	VPS13B	R2707*, R2682*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056691	8	100821705	8	99809477	56691	71330	rs386834110	NC_000008.11:99809476:C:T
NM_152564.5(VPS13B):c.7429+1G>A	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056687	8	100789185	8	99776957	56687	71326	rs386834106	NC_000008.11:99776956:G:A
NM_001370298.3(FGD4):c.1304T>G (p.Met435Arg)	FGD4	M298R, M383R, M50R, M205R, M114R, M435R	Charcot-Marie-Tooth disease, type 4H|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000038445	12	32755151	12	32602217	38445	47004	rs63749871	NC_000012.12:32602216:T:G
m.586G>A	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial encephalopathy	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000030005	MT	586	MT	586	30005	38960	rs387906734	NC_012920.1:585:G:A
NM_033380.3(COL4A5):c.1A>G (p.Met1Val)	COL4A5	M1V	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024214	X	107683356	X	108440126	24214	35555	rs104886050	NC_000023.11:108440125:A:G
NM_000530.8(MPZ):c.286A>G (p.Lys96Glu)	MPZ	K96E	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000014166	1	161276660	1	161306870	14166	29205	rs121913583	NC_000001.11:161306869:T:C
NM_000371.4(TTR):c.148G>C (p.Val50Leu)	TTR	V50L	Charcot-Marie-Tooth disease|Amyloidogenic transthyretin amyloidosis	Pathogenic	criteria provided, single submitter	VCV000013440	18	29172937	18	31592974	13440	28479	rs28933979	NC_000018.10:31592973:G:C
NM_000166.6(GJB1):c.164C>T (p.Thr55Ile)	GJB1	T55I	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000010446	X	70443721	X	71223871	10446	25485	rs104894824	NC_000023.11:71223870:C:T
NM_021830.5(TWNK):c.1523A>G (p.Tyr508Cys)	TWNK	Y508C, Y54C	Infantile onset spinocerebellar ataxia|not provided	Pathogenic(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004627	10	102750231	10	100990474	4627	19666	rs80356540	NC_000010.11:100990473:A:G
NM_006005.3(WFS1):c.1511C>T (p.Pro504Leu)	WFS1	P504L	not provided|Wolfram syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004512	4	6303033	4	6301306	4512	19551	rs28937892	NC_000004.12:6301305:C:T
NM_002473.6(MYH9):c.5521G>A (p.Glu1841Lys)	MYH9	E1841K	MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|not provided	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014073	22	36680520	22	36284474	14073	29112	rs80338834	NC_000022.11:36284473:C:T
NM_057176.3(BSND):c.3G>A (p.Met1Ile)	BSND	M1I	Bartter syndrome|not provided|Bartter disease type 4a	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004384	1	55464862	1	54999189	4384	19423	rs74315286	NC_000001.11:54999188:G:A
NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser)	MPZ	Y145S	not provided|Dejerine-Sottas disease|Roussy-Lvy syndrome|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, demyelinating, type 1b|Congenital hypomyelinating neuropathy 1, autosomal recessive|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Nov 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014191	1	161276512	1	161306722	14191	29230	rs121913603	NC_000001.11:161306721:T:G
NM_002241.5(KCNJ10):c.889C>T (p.Arg297Cys)	KCNJ10	R297C	not provided|EAST syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007467	1	160011434	1	160041644	7467	22506	rs137853071	NC_000001.11:160041643:G:A
NM_000441.2(SLC26A4):c.1595G>T (p.Ser532Ile)	SLC26A4	S532I	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370114	7	107338537	7	107698092	370114	357549	rs1057516243	NC_000007.14:107698091:G:T
NM_020436.5(SALL4):c.2593C>T (p.Arg865Ter)	SALL4	R865*, R428*	Duane-radial ray syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003322	20	50405549	20	51789010	3322	18361	rs74315425	NC_000020.11:51789009:G:A
NM_017780.4(CHD7):c.2442+5G>C	CHD7		Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Pathogenic	criteria provided, single submitter	VCV000002034	8	61714157	8	60801598	2034	17073	rs387906271	NC_000008.11:60801597:G:C
NM_000399.5(EGR2):c.1142G>T (p.Arg381Leu)	EGR2	R331L, R381L	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV001075624	10	64573256	10	62813496	1075624	1061937		NC_000010.11:62813495:C:A
NM_000091.5(COL4A3):c.1615G>T (p.Glu539Ter)	MFF-DT|COL4A3	E539*	Alport syndrome, autosomal recessive|not provided	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000984358	2	228135525	2	227270809	984358	971768	rs2071189852	NC_000002.12:227270808:G:T
NM_000260.4(MYO7A):c.2914C>T (p.Arg972Ter)	MYO7A	R972*, R961*	Usher syndrome type 1|not provided	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000855092	11	76893006	11	77181960	855092	839057	rs782281371	NC_000011.10:77181959:C:T
NM_017780.4(CHD7):c.4353+1G>T	CHD7		CHARGE association	Pathogenic(Last reviewed: May 12, 2019)	criteria provided, single submitter	VCV000854953	8	61750395	8	60837836	854953	852142	rs1804804514	NC_000008.11:60837835:G:T
NM_000260.4(MYO7A):c.2837T>G (p.Met946Arg)	MYO7A	M935R, M946R	not provided|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000813430	11	76892568	11	77181522	813430	801714	rs1296612982	NC_000011.10:77181521:T:G
NM_014874.4(MFN2):c.475-1G>C	MFN2		Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000637718	1	12057353	1	11997296	637718	625724	rs1569834500	NC_000001.11:11997295:G:C
NM_000166.6(GJB1):c.191G>A (p.Cys64Tyr)	GJB1	C64Y	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000637608	X	70443748	X	71223898	637608	625522	rs1602348897	NC_000023.11:71223897:G:A
NM_002529.4(NTRK1):c.1960C>T (p.Arg654Cys)	NTRK1	R618C, R648C, R654C	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV000637430	1	156849068	1	156879276	637430	624987	rs764992664	NC_000001.11:156879275:C:T
NM_004637.6(RAB7A):c.482A>T (p.Asn161Ile)	RAB7A	N161I	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV000637404	3	128526468	3	128807625	637404	625104	rs121909080	NC_000003.12:128807624:A:T
NM_014874.4(MFN2):c.2251C>T (p.Gln751Ter)	MFN2	Q751*	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000572169	1	12071599	1	12011542	572169	556909	rs1557539119	NC_000001.11:12011541:C:T
NM_018972.4(GDAP1):c.112C>T (p.Gln38Ter)	GDAP1	Q38*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4A	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000569560	8	75262808	8	74350573	569560	565215	rs761035569	NC_000008.11:74350572:C:T
NM_000404.4(GLB1):c.733+1G>A	GLB1		not provided|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553125	3	33099580	3	33058088	553125	542941	rs1041204916	NC_000003.12:33058087:C:T
NM_000404.4(GLB1):c.1321G>A (p.Asp441Asn)	GLB1	D441N, D310N, D489N, D411N	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 3	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551496	3	33059966	3	33018474	551496	542934	rs780724173	NC_000003.12:33018473:C:T
NM_000092.5(COL4A4):c.2878G>A (p.Gly960Arg)	COL4A4	G960R	not provided|Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550472	2	227917111	2	227052395	550472	542043	rs769783985	NC_000002.12:227052394:C:T
NM_017780.4(CHD7):c.5607+1G>A	CHD7		CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547194	8	61763664	8	60851105	547194	537834	rs1554603672	NC_000008.11:60851104:G:A
NM_000166.6(GJB1):c.8G>A (p.Trp3Ter)	GJB1	W3*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000543927	X	70443565	X	71223715	543927	534951	rs1555936989	NC_000023.11:71223714:G:A
NM_018972.4(GDAP1):c.571C>T (p.Arg191Ter)	GDAP1	R191*, R123*, R133*, R82*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV000535790	8	75274205	8	74361970	535790	524304	rs1554547986	NC_000008.11:74361969:C:T
NM_017780.4(CHD7):c.8023G>T (p.Glu2675Ter)	CHD7	E2675*, E626*	CHARGE association|not provided	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504190	8	61775158	8	60862599	504190	495395	rs748504264	NC_000008.11:60862598:G:T
NM_017780.4(CHD7):c.3106C>T (p.Arg1036Ter)	CHD7	R1036*	not provided|CHARGE association	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488373	8	61735210	8	60822651	488373	481216	rs1554597716	NC_000008.11:60822650:C:T
NM_000166.6(GJB1):c.478T>C (p.Tyr160His)	GJB1	Y160H	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447432	X	70444035	X	71224185	447432	442447	rs1555937197	NC_000023.11:71224184:T:C
NM_000166.6(GJB1):c.266T>C (p.Leu89Pro)	GJB1	L89P	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447428	X	70443823	X	71223973	447428	442443	rs1555937122	NC_000023.11:71223972:T:C
NM_001540.5(HSPB1):c.416C>T (p.Thr139Met)	HSPB1	T139M	not provided|Charcot-Marie-Tooth disease axonal type 2F|none provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000421350	7	75933170	7	76303853	421350	407260	rs1064795077	NC_000007.14:76303852:C:T
NM_031407.7(HUWE1):c.329G>A (p.Arg110Gln)	HUWE1	R110Q	not provided|Intellectual disability, X-linked syndromic, Turner type	Pathogenic(Last reviewed: Dec 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000375709	X	53674333	X	53647390	375709	362615	rs1557036768	NC_000023.11:53647389:C:T
NM_001365088.1(SLC12A6):c.1118+1G>A	SLC12A6		Charcot-Marie-Tooth disease|not provided|Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370139	15	34546548	15	34254347	370139	358288	rs762730861	NC_000015.10:34254346:C:T
NM_031407.7(HUWE1):c.9208C>T (p.Arg3070Cys)	HUWE1	R3070C	not provided|Intellectual disability|Intellectual disability, X-linked syndromic, Turner type	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280723	X	53578039	X	53551078	280723	265043	rs886041876	NC_000023.11:53551077:G:A
NM_024577.4(SH3TC2):c.3154C>T (p.Arg1052Ter)	SH3TC2	R1052*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220408	5	148392197	5	149012634	220408	221609	rs370115218	NC_000005.10:149012633:G:A
NM_000399.5(EGR2):c.1226G>A (p.Arg409Gln)	EGR2	R409Q, R359Q	Charcot-Marie-Tooth disease, type I|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219844	10	64573172	10	62813412	219844	221982	rs864622273	NC_000010.11:62813411:C:T
NM_001540.5(HSPB1):c.523C>T (p.Gln175Ter)	HSPB1	Q175*	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217231	7	75933395	7	76304078	217231	213814	rs863225023	NC_000007.14:76304077:C:T
NM_206933.4(USH2A):c.9827C>G (p.Ser3276Ter)	USH2A	S3276*	not provided|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217027	1	215972380	1	215799038	217027	213519	rs863224941	NC_000001.11:215799037:G:C
NM_000166.6(GJB1):c.83T>A (p.Ile28Asn)	GJB1	I28N	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000215983	X	70443640	X	71223790	215983	213498	rs768834663	NC_000023.11:71223789:T:A
NM_017780.4(CHD7):c.4318C>T (p.Gln1440Ter)	CHD7	Q1440*	CHARGE association	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158294	8	61750359	8	60837800	158294	168609	rs587783440	NC_000008.11:60837799:C:T
NM_152564.5(VPS13B):c.3598C>T (p.Arg1200Ter)	VPS13B	R1200*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000095846	8	100479794	8	99467566	95846	101743	rs140353201	NC_000008.11:99467565:C:T
NM_017780.4(CHD7):c.2839C>T (p.Arg947Ter)	CHD7	R947*	not provided|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Pathogenic(Last reviewed: Feb 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000095781	8	61734586	8	60822027	95781	101678	rs200220845	NC_000008.11:60822026:C:T
NM_000404.4(GLB1):c.397-1G>A	GLB1		not provided|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000092906	3	33109783	3	33068291	92906	98813	rs398123353	NC_000003.12:33068290:C:T
NM_152564.5(VPS13B):c.1504C>T (p.Arg502Ter)	VPS13B	R502*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068083	8	100147902	8	99135674	68083	78974	rs180177354	NC_000008.11:99135673:C:T
NM_152564.5(VPS13B):c.1219C>T (p.Gln407Ter)	VPS13B	Q407*	not provided|Muscular hypotonia|Global developmental delay|Unsteady gait|Microcephaly|Intellectual disability|Generalized joint laxity|Carious teeth|Attention deficit hyperactivity disorder|Cohen syndrome	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000056645	8	100146872	8	99134644	56645	71284	rs386834070	NC_000008.11:99134643:C:T
NM_001376.5(DYNC1H1):c.10031G>A (p.Arg3344Gln)	DYNC1H1	R3344Q	Mental retardation, autosomal dominant 13|Charcot-Marie-Tooth disease, axonal, type 2O|Lissencephaly|Intellectual disability	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000055855	14	102498756	14	102032419	55855	70509	rs397509412	NC_000014.9:102032418:G:A
NM_002834.5(PTPN11):c.1402A>C (p.Thr468Pro)	PTPN11	T468P, T472P, T467P	Rasopathy|not provided|Noonan syndrome with multiple lentigines	Pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040547	12	112926269	12	112488465	40547	49017	rs397507537	NC_000012.12:112488464:A:C
NM_033380.3(COL4A5):c.4709G>C (p.Cys1570Ser)	COL4A5	C1564S, C1570S	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jan 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024761	X	107938039	X	108694809	24761	36102	rs104886287	NC_000023.11:108694808:G:C
NM_033380.3(COL4A5):c.884G>A (p.Gly295Asp)	COL4A5	G295D	Alport syndrome|not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000024336	X	107823961	X	108580731	24336	35677	rs104886079	NC_000023.11:108580730:G:A
NM_024577.4(SH3TC2):c.1969G>A (p.Glu657Lys)	SH3TC2	E657K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000021689	5	148407326	5	149027763	21689	34541	rs80338925	NC_000005.10:149027762:C:T
NM_000530.8(MPZ):c.103G>T (p.Asp35Tyr)	MPZ	D35Y	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease dominant intermediate d	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014183	1	161277179	1	161307389	14183	29222	rs121913596	NC_000001.11:161307388:C:A
NM_000530.8(MPZ):c.499G>C (p.Gly167Arg)	MPZ	G167R	Dejerine-Sottas disease|Roussy-Lvy syndrome|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, demyelinating, type 1b|Congenital hypomyelinating neuropathy 1, autosomal recessive|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Dejerine-Sottas syndrome, autosomal dominant|Dejerine-Sottas disease	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	VCV000014170	1	161276204	1	161306414	14170	29209	rs121913586	NC_000001.11:161306413:C:G
NM_025136.4(OPA3):c.313C>G (p.Gln105Glu)	OPA3	Q105E	3-Methylglutaconic aciduria type 3|Optic atrophy 3|not provided|Optic atrophy 3	Pathogenic(Last reviewed: Dec 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004241	19	46056999	19	45553741	4241	19280	rs80356525	NC_000019.10:45553740:G:C
NM_030962.4(SBF2):c.1459C>T (p.Arg487Ter)	SBF2	R487*, R444*	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000002912	11	9990029	11	9968482	2912	17951	rs120074139	NC_000011.10:9968481:G:A
NM_000404.2(GLB1):c.367G>A	GLB1	G123R, G171R, G93R	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000928	3	33110341	3	33068849	928	15967	rs28934274	NC_000003.12:33068848:C:T
NM_000414.4(HSD17B4):c.1516C>T (p.Arg506Cys)	HSD17B4	R506C, R366C, R488C, R531C, R482C	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495866	5	118860923	5	119525228	495866	487165	rs766199971	NC_000005.10:119525227:C:T
NM_000441.2(SLC26A4):c.142G>T (p.Glu48Ter)	SLC26A4|SLC26A4-AS1	E48*	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371369	7	107302228	7	107661783	371369	357527	rs201636911	NC_000007.14:107661782:G:T
NM_000530.6(MPZ):c.[341T>C;346A>C;382G>A]	MPZ	D128N, N116H, I114T	Dejerine-sottas syndrome, sporadic	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014180	1|1|1	161276564	1|1|1	161306774	14180	38402|38401|29219	rs267607243|rs267607242|rs267607241	NC_000001.11:161306773:C:T|NC_000001.11:161306809:T:G|NC_000001.11:161306814:A:G
NM_017780.4(CHD7):c.6775+1G>T	CHD7		not provided|CHARGE association	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000971285	8	61766060	8	60853501	971285	960655	rs1805573066	NC_000008.11:60853500:G:T
NM_000091.5(COL4A3):c.351C>A (p.Tyr117Ter)	COL4A3|MFF-DT	Y117*	Alport syndrome, autosomal recessive|not provided	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000807563	2	228110696	2	227245980	807563	798500	rs750308686	NC_000002.12:227245979:C:A
NM_152564.5(VPS13B):c.6865+1G>T	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Nov 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000644958	8	100732781	8	99720553	644958	651927	rs202046738	NC_000008.11:99720552:G:T
NM_024577.4(SH3TC2):c.1378C>T (p.Gln460Ter)	SH3TC2	Q460*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637510	5	148407917	5	149028354	637510	625125	rs1580901350	NC_000005.10:149028353:G:A
NM_018972.4(GDAP1):c.311-1G>A	GDAP1		not provided|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000637452	8	75272371	8	74360136	637452	625748	rs1370011538	NC_000008.11:74360135:G:A
NM_000530.8(MPZ):c.296T>C (p.Ile99Thr)	MPZ	I99T	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000637349	1	161276650	1	161306860	637349	625053	rs1571819182	NC_000001.11:161306859:A:G
NM_002180.3(IGHMBP2):c.2362C>T (p.Arg788Ter)	IGHMBP2	R788*	Autosomal dominant distal hereditary motor neuropathy|Charcot-Marie-Tooth disease|not provided|Spinal muscular atrophy, distal, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV000637262	11	68704310	11	68936842	637262	625255	rs199839840	NC_000011.10:68936841:C:T
NM_000091.5(COL4A3):c.3643C>T (p.Arg1215Ter)	MFF-DT|COL4A3	R1215*	Alport syndrome, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000620143	2	228162467	2	227297751	620143	611565	rs368434069	NC_000002.12:227297750:C:T
NM_014874.4(MFN2):c.313A>G (p.Thr105Ala)	MFN2	T105A	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, single submitter	VCV000543234	1	12056214	1	11996157	543234	515078	rs1553142428	NC_000001.11:11996156:A:G
NM_003742.4(ABCB11):c.2494C>T (p.Arg832Cys)	ABCB11	R832C	Progressive familial intrahepatic cholestasis 3|Progressive familial intrahepatic cholestasis 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000501603	2	169801231	2	168944721	501603	493027	rs772294884	NC_000002.12:168944720:G:A
NM_078480.3(PUF60):c.389G>A (p.Arg130His)	PUF60	R130H, R101H, R129H, R87H, R150H, R70H, R112H, R113H, R167H, R84H	CHARGE association|Verheij syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000488376	8	144900664	8	143818494	488376	481211	rs1554643584	NC_000008.11:143818493:C:T
NM_000166.6(GJB1):c.77C>G (p.Ser26Trp)	GJB1	S26W	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000477604	X	70443634	X	71223784	477604	472198	rs587777876	NC_000023.11:71223783:C:G
NM_000530.8(MPZ):c.103G>A (p.Asp35Asn)	MPZ	D35N	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000462790	1	161277179	1	161307389	462790	447442	rs121913596	NC_000001.11:161307388:C:T
NM_000092.5(COL4A4):c.1045C>T (p.Arg349Ter)	COL4A4	R349*	Nephrotic syndrome|not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447178	2	227964390	2	227099674	447178	440667	rs534522842	NC_000002.12:227099673:G:A
NM_000404.4(GLB1):c.902C>T (p.Ala301Val)	GLB1	A301V, A170V, A349V, A271V	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000381567	3	33093387	3	33051895	381567	368399	rs750531880	NC_000003.12:33051894:G:A
NM_017780.4(CHD7):c.2959C>T (p.Arg987Ter)	CHD7	R987*	not provided|CHARGE association	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000267421	8	61735063	8	60822504	267421	262646	rs886040983	NC_000008.11:60822503:C:T
NM_000166.6(GJB1):c.231G>A (p.Trp77Ter)	GJB1	W77*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000246095	X	70443788	X	71223938	246095	245181	rs879254096	NC_000023.11:71223937:G:A
NM_000304.4(PMP22):c.327C>A (p.Cys109Ter)	PMP22	C109*	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217237	17	15134390	17	15231073	217237	213836	rs863225028	NC_000017.11:15231072:G:T
NM_000530.8(MPZ):c.487G>A (p.Gly163Arg)	MPZ	G163R	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000208148	1	161276216	1	161306426	208148	204408	rs281865128	NC_000001.11:161306425:C:T
NM_014874.4(MFN2):c.746C>T (p.Ser249Phe)	MFN2	S249F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000202171	1	12059082	1	11999025	202171	198602	rs794729198	NC_000001.11:11999024:C:T
NM_017780.4(CHD7):c.6850C>T (p.Arg2284Ter)	CHD7	R2284*	CHARGE association	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158313	8	61766996	8	60854437	158313	168629	rs587783454	NC_000008.11:60854436:C:T
NM_152564.5(VPS13B):c.7528C>T (p.Arg2510Ter)	VPS13B	R2535*, R2510*	Cohen syndrome	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056688	8	100791008	8	99778780	56688	71327	rs386834107	NC_000008.11:99778779:C:T
NM_001101.5(ACTB):c.587G>A (p.Arg196His)	ACTB	R196H	Baraitser-Winter syndrome 1|not provided	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029599	7	5568127	7	5528496	29599	38553	rs281875334	NC_000007.14:5528495:C:T
NM_000530.8(MPZ):c.270C>A (p.Asp90Glu)	MPZ	D90E	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014167	1	161276676	1	161306886	14167	29206	rs121913584	NC_000001.11:161306885:G:T
NM_002047.4(GARS1):c.548T>C (p.Leu183Pro)	GARS1	L129P, L183P	not provided|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000009205	7	30640795	7	30601179	9205	24244	rs137852644	NC_000007.14:30601178:T:C
NM_000085.5(CLCNKB):c.610G>A (p.Ala204Thr)	CLCNKB|LOC106501713	A204T	not provided|Bartter syndrome, type 4b|Bartter syndrome type 3|Bartter syndrome type 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007592	1	16375032	1	16048537	7592	22631	rs121909132	NC_000001.11:16048536:G:A
NM_003680.4(YARS1):c.586G>A (p.Glu196Lys)	YARS1	E196K	Charcot-Marie-Tooth disease, dominant intermediate C|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000006189	1	33263369	1	32797768	6189	21228	rs121908834	NC_000001.11:32797767:C:T
NM_181882.3(PRX):c.586C>T (p.Arg196Ter)	PRX	R196*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000004791	19	40903673	19	40397766	4791	19830	rs104894706	NC_000019.10:40397765:G:A
NM_000404.4(GLB1):c.202C>T (p.Arg68Trp)	GLB1	R68W, R116W, R38W	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000944	3	33114079	3	33072587	944	15983	rs72555370	NC_000003.12:33072586:G:A
NM_001034850.3(RETREG1):c.926C>G (p.Ser309Ter)	RETREG1	S309*, S168*	not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type IIB	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000328	5	16477845	5	16477736	328	15367	rs137852739	NC_000005.10:16477735:G:C
NM_000441.2(SLC26A4):c.1920G>A (p.Trp640Ter)	SLC26A4	W640*	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189017	7	107342388	7	107701943	189017	186739	rs368119540	NC_000007.14:107701942:G:A
NM_018344.6(SLC29A3):c.1087C>T (p.Arg363Trp)	SLC29A3	R363W, R285W	not provided|Histiocytosis-lymphadenopathy plus syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030949	10	73122024	10	71362267	30949	39906	rs387907067	NC_000010.11:71362266:C:T
NM_002968.3(SALL1):c.826C>T (p.Arg276Ter)	SALL1	R276*, R179*	Townes syndrome|Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Apr 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007428	16	51175307	16	51141396	7428	22467	rs104894537	NC_000016.10:51141395:G:A
NM_002473.6(MYH9):c.4270G>A (p.Asp1424Asn)	MYH9	D1424N	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|Thrombocytopenia|MYH9-related disorder	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014082	22	36688106	22	36292060	14082	29121	rs80338831	NC_000022.11:36292059:C:T
NM_000441.2(SLC26A4):c.165-1G>A	SLC26A4		Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000828068	7	107303740	7	107663295	828068	816404	rs759792660	NC_000007.14:107663294:G:A
NM_000414.4(HSD17B4):c.1704T>A (p.Tyr568Ter)	HSD17B4	Y428*, Y544*, Y593*, Y550*, Y568*	not provided|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome	Pathogenic(Last reviewed: Jan 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000655256	5	118862851	5	119527156	655256	632870	rs1038744864	NC_000005.10:119527155:T:A
NM_000441.2(SLC26A4):c.2118C>A (p.Cys706Ter)	SLC26A4	C706*	Pendred syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551315	7	107350527	7	107710082	551315	544449	rs142656144	NC_000007.14:107710081:C:A
NM_000441.2(SLC26A4):c.946G>T (p.Gly316Ter)	SLC26A4	G316*	not provided|Pendred syndrome	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503714	7	107323927	7	107683482	503714	495544	rs1554357231	NC_000007.14:107683481:G:T
NM_004208.4(AIFM1):c.1019T>C (p.Met340Thr)	AIFM1|RAB33A	M340T, M1T, M336T	Combined oxidative phosphorylation deficiency|Charcot-Marie-Tooth Neuropathy X|not provided|Cowchock syndrome|Foot dorsiflexor weakness|Pes planus|Sensorineural hearing loss disorder|Distal muscle weakness	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374094	X	129271109	X	130137134	374094	361080	rs1057518895	NC_000023.11:130137133:A:G
NM_001126108.2(SLC12A3):c.2863C>T (p.Arg955Trp)	SLC12A3	R964W, R955W, R963W	Familial hypokalemia-hypomagnesemia|not provided|Familial hypokalemia-hypomagnesemia|Bartter syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000319919	16	56938313	16	56904401	319919	343470	rs559626481	NC_000016.10:56904400:C:T
NM_000441.2(SLC26A4):c.304+2T>C	SLC26A4		not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189167	7	107303882	7	107663437	189167	186729	rs746238617	NC_000007.14:107663436:T:C
NM_033380.3(COL4A5):c.4631G>A (p.Trp1544Ter)	COL4A5	W1538*, W1544*	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000984067	X	107936080	X	108692850	984067	972396	rs104886293	NC_000023.11:108692849:G:A
NM_033380.3(COL4A5):c.3511C>T (p.Gln1171Ter)	COL4A5	Q1171*	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000974430	X	107909782	X	108666552	974430	962815	rs2068084185	NC_000023.11:108666551:C:T
NM_017780.4(CHD7):c.2238+1G>A	CHD7		CHARGE association|not provided	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000954731	8	61707687	8	60795128	954731	959897	rs1811957737	NC_000008.11:60795127:G:A
NM_017780.4(CHD7):c.3301T>C (p.Cys1101Arg)	CHD7	C1101R	not provided|CHARGE association	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000690306	8	61736498	8	60823939	690306	677982	rs1586393556	NC_000008.11:60823938:T:C
NM_002529.4(NTRK1):c.1804C>T (p.Arg602Ter)	NTRK1	R566*, R596*, R602*	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis|not provided	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620139	1	156846363	1	156876571	620139	611494	rs763758904	NC_000001.11:156876570:C:T
NM_033380.3(COL4A5):c.2237G>A (p.Gly746Glu)	COL4A5	G746E	not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000587146	X	107846284	X	108603054	587146	578157	rs867625069	NC_000023.11:108603053:G:A
NM_002180.3(IGHMBP2):c.1708C>T (p.Arg570Ter)	IGHMBP2	R570*	Charcot-Marie-Tooth disease|Spinal muscular atrophy, distal, autosomal recessive, 1|Distal spinal muscular atrophy|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561032	11	68702842	11	68935374	561032	552154	rs1000091588	NC_000011.10:68935373:C:T
NM_014874.4(MFN2):c.748C>T (p.Arg250Trp)	MFN2	R250W	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000543219	1	12059084	1	11999027	543219	515150	rs373107074	NC_000001.11:11999026:C:T
NM_001540.5(HSPB1):c.404C>A (p.Ser135Tyr)	HSPB1	S135Y	Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533813	7	75933158	7	76303841	533813	523269	rs28939680	NC_000007.14:76303840:C:A
NM_002529.4(NTRK1):c.638T>C (p.Leu213Pro)	NTRK1	L183P, L213P	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV000526734	1	156838360	1	156868568	526734	515140	rs747711259	NC_000001.11:156868567:T:C
NM_017780.4(CHD7):c.5428C>T (p.Arg1810Ter)	CHD7	R1810*	not provided|CHARGE association	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000459555	8	61763075	8	60850516	459555	458975	rs1554603552	NC_000008.11:60850515:C:T
NM_014874.4(MFN2):c.493C>T (p.His165Tyr)	MFN2	H165Y	Charcot-Marie-Tooth disease, type 2|not specified|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439897	1	12057372	1	11997315	439897	433691	rs119103262	NC_000001.11:11997314:C:T
NM_000404.4(GLB1):c.1646C>T (p.Pro549Leu)	GLB1	P549L, P519L, P418L, P597L	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426185	3	33055636	3	33014144	426185	414933	rs776327443	NC_000003.12:33014143:G:A
NM_000404.4(GLB1):c.245+1G>A	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic(Last reviewed: Mar 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417873	3	33114035	3	33072543	417873	404764	rs778423653	NC_000003.12:33072542:C:T
NM_000530.8(MPZ):c.233C>G (p.Ser78Trp)	MPZ	S78W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000411669	1	161277049	1	161307259	411669	390849	rs121913601	NC_000001.11:161307258:G:C
NM_018972.4(GDAP1):c.458C>T (p.Pro153Leu)	GDAP1	P153L, P44L, P85L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000406135	8	75272519	8	74360284	406135	396265	rs538412810	NC_000008.11:74360283:C:T
NM_017780.4(CHD7):c.6148C>T (p.Arg2050Ter)	CHD7	R2050*	not provided|CHARGE association	Pathogenic(Last reviewed: Apr 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000267436	8	61765432	8	60852873	267436	262661	rs886040996	NC_000008.11:60852872:C:T
NM_017780.4(CHD7):c.5833C>T (p.Arg1945Ter)	CHD7	R1945*	not provided|CHARGE association	Pathogenic(Last reviewed: Jun 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000267434	8	61764745	8	60852186	267434	262659	rs757160222	NC_000008.11:60852185:C:T
NM_000404.4(GLB1):c.276G>A (p.Trp92Ter)	GLB1	W92*, W62*, W140*	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264673	3	33110432	3	33068940	264673	244010	rs748830051	NC_000003.12:33068939:C:T
NM_000530.8(MPZ):c.356A>G (p.Tyr119Cys)	MPZ	Y119C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245997	1	161276590	1	161306800	245997	244253	rs879254038	NC_000001.11:161306799:T:C
NM_033380.3(COL4A5):c.2395+1G>A	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222059	X	107850123	X	108606893	222059	223759	rs869025331	NC_000023.11:108606892:G:A
NM_017780.4(CHD7):c.3881T>C (p.Leu1294Pro)	CHD7	L1294P	not provided|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218745	8	61748734	8	60836175	218745	215385	rs864309609	NC_000008.11:60836174:T:C
NM_000530.8(MPZ):c.90C>G (p.Ile30Met)	MPZ	I30M	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217235	1	161277192	1	161307402	217235	213795	rs770546306	NC_000001.11:161307401:G:C
NM_000530.8(MPZ):c.499G>A (p.Gly167Arg)	MPZ	G167R	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000208149	1	161276204	1	161306414	208149	204407	rs121913586	NC_000001.11:161306413:C:T
NM_000404.4(GLB1):c.1768C>T (p.Arg590Cys)	GLB1	R590C, R560C, R459C, R638C	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Mar 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194596	3	33038803	3	32997311	194596	191759	rs794727165	NC_000003.12:32997310:G:A
NM_000288.4(PEX7):c.188+1G>C	PEX7		Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188975	6	137146410	6	136825272	188975	186700	rs267608254	NC_000006.12:136825271:G:C
NM_017780.4(CHD7):c.4480C>T (p.Arg1494Ter)	CHD7	R1494*	not provided|CHARGE association	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158296	8	61750761	8	60838202	158296	168611	rs587783442	NC_000008.11:60838201:C:T
NM_000489.6(ATRX):c.536A>G (p.Asn179Ser)	ATRX	N179S, N141S	not provided|Alpha thalassemia-X-linked intellectual disability syndrome|X-linked intellectual disability-hypotonic face syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093141	X	76944369	X	77688876	93141	99048	rs398123425	NC_000023.11:77688875:T:C
NM_152564.5(VPS13B):c.4745+2T>C	VPS13B		Cohen syndrome	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056669	8	100533240	8	99521012	56669	71308	rs386834091	NC_000008.11:99521011:T:C
NM_000530.8(MPZ):c.670G>T (p.Asp224Tyr)	MPZ	D224Y	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000041024	1	161275743	1	161305953	41024	49446	rs267607247	NC_000001.11:161305952:C:A
NM_033380.3(COL4A5):c.3178G>T (p.Gly1060Ter)	COL4A5	G1060*	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024599	X	107869511	X	108626281	24599	35940	rs104886217	NC_000023.11:108626280:G:T
NM_000399.5(EGR2):c.1225C>T (p.Arg409Trp)	EGR2	R409W, R359W	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1d	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000016750	10	64573173	10	62813413	16750	31789	rs104894159	NC_000010.11:62813412:G:A
m.3256C>T	MT-TL1		Diabetes mellitus, noninsulin-dependent, maternally transmitted|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009591	MT	3256	MT	3256	9591	24630	rs199474659	NC_012920.1:3255:C:T
NM_001540.5(HSPB1):c.406C>T (p.Arg136Trp)	HSPB1	R136W	Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000007482	7	75933160	7	76303843	7482	22521	rs28939681	NC_000007.14:76303842:C:T
NM_001540.5(HSPB1):c.404C>T (p.Ser135Phe)	HSPB1	S135F	Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000007478	7	75933158	7	76303841	7478	22517	rs28939680	NC_000007.14:76303840:C:T
NM_004715.5(CTDP1):c.863+389C>T	CTDP1		Charcot-Marie-Tooth disease|not provided|Congenital cataracts-facial dysmorphism-neuropathy syndrome	Pathogenic(Last reviewed: Jan 1, 2021)	criteria provided, single submitter	VCV000005301	18	77470825	18	79710825	5301	20340	rs113994102	NC_000018.10:79710824:C:T
NM_021830.5(TWNK):c.1001G>A (p.Arg334Gln)	TWNK	R334Q	Infantile onset spinocerebellar ataxia|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Mitochondrial disease	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004623	10	102748968	10	100989211	4623	19662	rs28937887	NC_000010.11:100989210:G:A
NM_152564.5(VPS13B):c.4396G>T (p.Glu1466Ter)	VPS13B	E1491*, E1466*	Cohen syndrome	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002822	8	100523503	8	99511275	2822	17861	rs120074151	NC_000008.11:99511274:G:T
NM_014365.3(HSPB8):c.421A>G (p.Lys141Glu)	HSPB8		Distal hereditary motor neuronopathy type 2A|Charcot-Marie-Tooth disease, type 2L|not provided	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002618	12	119624883	12	119187078	2618	17657	rs104894351	NC_000012.12:119187077:A:G
NM_000404.4(GLB1):c.152T>C (p.Ile51Thr)	GLB1	I51T, I21T, I99T	GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000000926	3	33114129	3	33072637	926	15965	rs72555390	NC_000003.12:33072636:A:G
NM_018344.6(SLC29A3):c.1309G>A (p.Gly437Arg)	SLC29A3	G437R, G359R	Histiocytosis-lymphadenopathy plus syndrome|not provided	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000565	10	73122246	10	71362489	565	15604	rs121912584	NC_000010.11:71362488:G:A
NM_033380.3(COL4A5):c.4706+2T>C	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV001073265	X	107936157	X	108692927	1073265	1065146		NC_000023.11:108692926:T:C
NM_014874.4(MFN2):c.280C>G (p.Arg94Gly)	MFN2	R94G	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000637495	1	12052716	1	11992659	637495	624894	rs119103263	NC_000001.11:11992658:C:G
NM_002529.4(NTRK1):c.574+1G>A	NTRK1		Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000637365	1	156838042	1	156868250	637365	625730	rs1232901259	NC_000001.11:156868249:G:A
NM_018972.4(GDAP1):c.767A>G (p.His256Arg)	GDAP1	H256R, H188R, H198R, H147R	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000618662	8	75276292	8	74364057	618662	609702	rs1476856429	NC_000008.11:74364056:A:G
NM_014874.4(MFN2):c.776G>A (p.Arg259His)	MFN2	R259H	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000577496	1	12059112	1	11999055	577496	556905	rs755065651	NC_000001.11:11999054:G:A
NM_017780.4(CHD7):c.6070C>T (p.Arg2024Ter)	CHD7	R2024*	not provided|CHARGE association	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547195	8	61765232	8	60852673	547195	537835	rs1360515765	NC_000008.11:60852672:C:T
NM_001540.5(HSPB1):c.539C>T (p.Thr180Ile)	HSPB1	T180I	not provided|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447531	7	75933411	7	76304094	447531	441146	rs1422978230	NC_000007.14:76304093:C:T
NM_000091.5(COL4A3):c.4825C>T (p.Arg1609Ter)	COL4A3|MFF-DT	R1609*	not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447174	2	228175561	2	227310845	447174	440687	rs756231749	NC_000002.12:227310844:C:T
NM_006415.4(SPTLC1):c.992C>A (p.Ser331Tyr)	SPTLC1	S331Y, S176Y, S209Y	Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type IA, severe|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372788	9	94809543	9	92047261	372788	359759	rs267607087	NC_000009.12:92047260:G:T
NM_000404.4(GLB1):c.841C>T (p.His281Tyr)	GLB1	H281Y, H329Y, H150Y, H251Y	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372371	3	33093448	3	33051956	372371	359418	rs745386663	NC_000003.12:33051955:G:A
NM_152564.5(VPS13B):c.436C>T (p.Arg146Ter)	VPS13B	R146*	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370440	8	100115204	8	99102976	370440	357680	rs144539572	NC_000008.11:99102975:C:T
NM_017780.4(CHD7):c.4393C>T (p.Arg1465Ter)	CHD7	R1465*	not provided|CHARGE association	Pathogenic(Last reviewed: Mar 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000267430	8	61750674	8	60838115	267430	262655	rs886040991	NC_000008.11:60838114:C:T
NM_000166.6(GJB1):c.112G>A (p.Val38Met)	GJB1	V38M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000245946	X	70443669	X	71223819	245946	245179	rs879254012	NC_000023.11:71223818:G:A
NM_018972.4(GDAP1):c.769C>T (p.Arg257Ter)	GDAP1	R257*, R199*, R148*, R189*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A|not provided|Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245608	8	75276294	8	74364059	245608	244526	rs770501034	NC_000008.11:74364058:C:T
NM_033380.3(COL4A5):c.1780-1G>T	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Apr 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000222057	X	107841931	X	108598701	222057	223758	rs104886338	NC_000023.11:108598700:G:T
NM_018972.4(GDAP1):c.373C>T (p.Arg125Ter)	GDAP1	R125*, R16*, R57*	not provided|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217229	8	75272434	8	74360199	217229	213815	rs745663149	NC_000008.11:74360198:C:T
NM_024577.4(SH3TC2):c.279G>A (p.Lys93=)	SH3TC2		not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV000216120	5	148427425	5	149047862	216120	212513	rs776221160	NC_000005.10:149047861:C:T
NM_000218.3(KCNQ1):c.914G>T (p.Trp305Leu)	KCNQ1	W178L, W305L	not provided|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000200824	11	2594209	11	2572979	200824	197448	rs120074186	NC_000011.10:2572978:G:T
NM_017780.4(CHD7):c.7252C>T (p.Arg2418Ter)	CHD7	R2418*	not specified|CHARGE association|not provided	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158314	8	61769091	8	60856532	158314	168630	rs587783455	NC_000008.11:60856531:C:T
NM_001101.5(ACTB):c.625G>A (p.Val209Met)	ACTB	V209M	Baraitser-Winter syndrome 1|not provided|ACTB-related BAFopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000127172	7	5568089	7	5528458	127172	132670	rs587779777	NC_000007.14:5528457:C:T
NM_018972.4(GDAP1):c.347T>G (p.Met116Arg)	GDAP1	M116R, M48R, M7R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A|not provided	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000038411	8	75272408	8	74360173	38411	46970	rs281865060	NC_000008.11:74360172:T:G
NM_001101.5(ACTB):c.586C>T (p.Arg196Cys)	ACTB	R196C	Baraitser-Winter syndrome 1|not provided	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000029600	7	5568128	7	5528497	29600	38554	rs281875333	NC_000007.14:5528496:G:A
NM_033380.3(COL4A5):c.3319G>A (p.Gly1107Arg)	COL4A5	G1107R	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024617	X	107898633	X	108655403	24617	35958	rs104886225	NC_000023.11:108655402:G:A
NM_000530.8(MPZ):c.393C>A (p.Asn131Lys)	MPZ	N131K	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Roussy-Lvy syndrome|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014186	1	161276553	1	161306763	14186	29225	rs121913599	NC_000001.11:161306762:G:T
m.8356T>C	MT-TK		MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009580	MT	8356	MT	8356	9580	24619	rs118192099	NC_012920.1:8355:T:C
NM_000288.4(PEX7):c.345T>G (p.Tyr115Ter)	PEX7	Y115*	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007786	6	137166758	6	136845620	7786	22825	rs121909154	NC_000006.12:136845619:T:G
NM_000085.5(CLCNKB):c.1830G>A (p.Trp610Ter)	CLCNKB|LOC106501713	W610*, W441*	Bartter syndrome, type 4b|Bartter syndrome type 3|not provided|Bartter syndrome, type 3, with hypocalciuria	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007599	1	16382003	1	16055508	7599	22638	rs121909136	NC_000001.11:16055507:G:A
NM_018972.4(GDAP1):c.469A>C (p.Thr157Pro)	GDAP1	T157P, T48P, T89P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000004199	8	75272530	8	74360295	4199	19238	rs104894079	NC_000008.11:74360294:A:C
NM_152564.5(VPS13B):c.6976C>T (p.Arg2326Ter)	VPS13B	R2351*, R2326*	Cohen syndrome|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002820	8	100733201	8	99720973	2820	17859	rs120074150	NC_000008.11:99720972:C:T
NM_000441.2(SLC26A4):c.249G>A (p.Trp83Ter)	SLC26A4	W83*	not provided|Pendred syndrome	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370650	7	107303825	7	107663380	370650	357528	rs1057516658	NC_000007.14:107663379:G:A
NM_002473.6(MYH9):c.2104C>T (p.Arg702Cys)	MYH9	R702C	MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014078	22	36702031	22	36305985	14078	29117	rs80338826	NC_000022.11:36305984:G:A
NM_000288.4(PEX7):c.120C>G (p.Tyr40Ter)	PEX7	Y40*	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Phytanic acid storage disease|Rhizomelic chondrodysplasia punctata type 1|PEX7-Related Disorders|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007788	6	137143923	6	136822785	7788	22827	rs61753238	NC_000006.12:136822784:C:G
NM_001130823.3(DNMT1):c.1532A>G (p.Tyr511Cys)	DNMT1	Y495C, Y511C, Y390C	Charcot-Marie-Tooth disease|not provided|Hereditary sensory neuropathy type IE	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029682	19	10265693	19	10155017	29682	38637	rs199473690	NC_000019.10:10155016:T:C
NM_000092.5(COL4A4):c.2690G>A (p.Gly897Glu)	COL4A4	G897E	not provided|Benign familial hematuria|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017406	2	227920687	2	227055971	17406	32445	rs121912860	NC_000002.12:227055970:C:T
NM_017780.4(CHD7):c.7803C>G (p.Tyr2601Ter)	CHD7	Y2601*	CHARGE association|not provided	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000935187	8	61773657	8	60861098	935187	934391	rs1563669432	NC_000008.11:60861097:C:G
NM_001540.5(HSPB1):c.250G>A (p.Gly84Arg)	HSPB1	G84R	Charcot-Marie-Tooth disease|not provided|HSPB1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000632006	7	75932279	7	76302962	632006	620269	rs770272088	NC_000007.14:76302961:G:A
NM_000530.8(MPZ):c.245A>G (p.Tyr82Cys)	MPZ	Y82C	Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549681	1	161276701	1	161306911	549681	540438	rs1553259707	NC_000001.11:161306910:T:C
NM_002180.3(IGHMBP2):c.1813C>T (p.Arg605Ter)	IGHMBP2	R605*	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Sep 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000488694	11	68703761	11	68936293	488694	482001	rs991227431	NC_000011.10:68936292:C:T
NM_014874.4(MFN2):c.1252C>T (p.Arg418Ter)	MFN2	R418*	not provided|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372790	1	12064140	1	12004083	372790	359204	rs1057517987	NC_000001.11:12004082:C:T
NM_152564.5(VPS13B):c.6727G>T (p.Glu2243Ter)	VPS13B	E2268*, E2243*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279780	8	100732642	8	99720414	279780	264450	rs146960401	NC_000008.11:99720413:G:T
NM_017780.4(CHD7):c.3655C>T (p.Arg1219Ter)	CHD7	R1219*	not provided|CHARGE association	Pathogenic(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279759	8	61743013	8	60830454	279759	264411	rs372174845	NC_000008.11:60830453:C:T
NM_000166.6(GJB1):c.239A>G (p.Gln80Arg)	GJB1	Q80R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000246096	X	70443796	X	71223946	246096	245182	rs879254097	NC_000023.11:71223945:A:G
NM_000530.8(MPZ):c.106A>T (p.Arg36Trp)	MPZ	R36W	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000221065	1	161277176	1	161307386	221065	221083	rs864622732	NC_000001.11:161307385:T:A
NM_018972.4(GDAP1):c.579+1G>A	GDAP1		not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: May 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220379	8	75274214	8	74361979	220379	221768	rs864622501	NC_000008.11:74361978:G:A
NM_000124.4(ERCC6):c.1526+1G>T	ERCC6		DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome B|Cockayne syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190147	10	50713929	10	49505883	190147	188009	rs371739894	NC_000010.11:49505882:C:A
NM_006158.5(NEFL):c.23C>G (p.Pro8Arg)	NEFL	P8R	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000066688	8	24814007	8	24956493	66688	77585	rs61491953	NC_000008.11:24956492:G:C
NM_152564.5(VPS13B):c.8440C>T (p.Arg2814Ter)	VPS13B	R2839*, R2814*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056694	8	100830757	8	99818529	56694	71333	rs386834113	NC_000008.11:99818528:C:T
NM_152564.5(VPS13B):c.3427C>T (p.Arg1143Ter)	VPS13B	R1143*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056658	8	100454845	8	99442617	56658	71297	rs386834080	NC_000008.11:99442616:C:T
NM_001376.5(DYNC1H1):c.917A>G (p.His306Arg)	DYNC1H1	H306R	not provided|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030029	14	102446843	14	101980506	30029	38984	rs387906738	NC_000014.9:101980505:A:G
NM_033380.3(COL4A5):c.5038C>T (p.Arg1680Ter)	COL4A5	R1674*, R1680*	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024785	X	107939570	X	108696340	24785	36126	rs281874753	NC_000023.11:108696339:C:T
NM_033380.3(COL4A5):c.4315+1G>A	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024725	X	107929360	X	108686130	24725	36066	rs587776403	NC_000023.11:108686129:G:A
NM_033380.3(COL4A5):c.973G>A (p.Gly325Arg)	COL4A5	G325R	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024352	X	107826150	X	108582920	24352	35693	rs104886088	NC_000023.11:108582919:G:A
NM_033380.3(COL4A5):c.385G>A (p.Gly129Arg)	COL4A5	G129R	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024265	X	107814643	X	108571413	24265	35606	rs281874722	NC_000023.11:108571412:G:A
NM_000530.8(MPZ):c.188C>T (p.Ser63Phe)	MPZ	S63F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014177	1	161277094	1	161307304	14177	29216	rs121913585	NC_000001.11:161307303:G:A
NM_000052.7(ATP7A):c.4156C>T (p.Pro1386Ser)	ATP7A	P1386S, P1308S	Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome|Distal spinal muscular atrophy, X-linked 3|Cutis laxa, X-linked|Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000011795	X	77300999	X	78045502	11795	26834	rs267606672	NC_000023.11:78045501:C:T
NM_004637.6(RAB7A):c.484G>A (p.Val162Met)	RAB7A	V162M	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000007346	3	128526470	3	128807627	7346	22385	rs121909079	NC_000003.12:128807626:G:A
NM_025136.4(OPA3):c.143-1G>C	OPA3		3-Methylglutaconic aciduria type 3|Optic atrophy 3|not provided|3-Methylglutaconic aciduria type 3	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004239	19	46057170	19	45553912	4239	19278	rs80356523	NC_000019.10:45553911:C:G
NM_018972.4(GDAP1):c.692C>T (p.Pro231Leu)	GDAP1	P231L, P122L, P173L, P163L	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004202	8	75275286	8	74363051	4202	19241	rs121908114	NC_000008.11:74363050:C:T
NM_000441.2(SLC26A4):c.1001+1G>T	SLC26A4		not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370123	7	107323983	7	107683538	370123	357536	rs80338849	NC_000007.14:107683537:G:T
NM_006005.3(WFS1):c.124C>T (p.Arg42Ter)	WFS1	R42*	Wolfram-like syndrome, autosomal dominant|Autosomal dominant nonsyndromic hearing loss 6|Wolfram syndrome 1|not provided|Type 2 diabetes mellitus|Cataract 41|Wolfram-like syndrome, autosomal dominant|Autosomal dominant nonsyndromic hearing loss 6|Type 2 diabetes mellitus|Wolfram syndrome 1|Wolfram syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189251	4	6279306	4	6277579	189251	187111	rs71530923	NC_000004.12:6277578:C:T
NM_002473.6(MYH9):c.5797C>T (p.Arg1933Ter)	MYH9	R1933*	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|Thrombocytopenia|Abnormal bleeding|MYH9-related disorder|not provided	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014072	22	36678800	22	36282754	14072	29111	rs80338835	NC_000022.11:36282753:G:A
NM_001126108.2(SLC12A3):c.506-1G>A	SLC12A3		Familial hypokalemia-hypomagnesemia|Bartter syndrome|Familial hypokalemia-hypomagnesemia|not provided	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000448398	16	56903640	16	56869728	448398	441908	rs201555148	NC_000016.10:56869727:G:A
NM_000414.4(HSD17B4):c.1369A>T (p.Asn457Tyr)	HSD17B4	N457Y, N317Y, N482Y, N433Y, N439Y	Perrault syndrome|Bifunctional peroxisomal enzyme deficiency|not provided|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|Bifunctional peroxisomal enzyme deficiency|not specified	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007656	5	118844871	5	119509176	7656	22695	rs137853097	NC_000005.10:119509175:A:T
NM_000092.5(COL4A4):c.1402C>T (p.Gln468Ter)	COL4A4	Q468*	not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000948311	2	227954641	2	227089925	948311	922592	rs2059821994	NC_000002.12:227089924:G:A
NM_000371.4(TTR):c.252T>G (p.Phe84Leu)	TTR	F84L	Amyloidogenic transthyretin amyloidosis|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000845368	18	29175134	18	31595171	845368	846811	rs2073510805	NC_000018.10:31595170:T:G
NM_000092.5(COL4A4):c.4623C>G (p.Tyr1541Ter)	COL4A4	Y1541*	not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557998	2	227872920	2	227008204	557998	541878	rs891854419	NC_000002.12:227008203:G:C
NM_000091.5(COL4A3):c.4546C>T (p.Arg1516Ter)	MFF-DT|COL4A3	R1516*	not provided|Alport syndrome|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552261	2	228173698	2	227308982	552261	542170	rs759873621	NC_000002.12:227308981:C:T
NM_000091.5(COL4A3):c.1216C>T (p.Arg406Ter)	MFF-DT|COL4A3	R406*	Alport syndrome, autosomal recessive|not provided|Alport syndrome	Pathogenic(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495548	2	228128561	2	227263845	495548	486961	rs371334239	NC_000002.12:227263844:C:T
NM_002047.4(GARS1):c.794C>T (p.Ser265Phe)	GARS1	S265F, S211F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000476762	7	30649259	7	30609643	476762	457766	rs1554337974	NC_000007.14:30609642:C:T
NM_014874.4(MFN2):c.1091G>A (p.Arg364Gln)	MFN2	R364Q	Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000245944	1	12062091	1	12002034	245944	244195	rs879254011	NC_000001.11:12002033:G:A
NM_001303256.3(MORC2):c.260C>T (p.Ser87Leu)	MORC2	S25L, S87L	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, type 2z|Global developmental delay	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000218308	22	31345795	22	30949809	218308	215004	rs864309504	NC_000022.11:30949808:G:A
NM_000530.8(MPZ):c.181G>A (p.Asp61Asn)	MPZ	D61N	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208146	1	161277101	1	161307311	208146	204409	rs797044845	NC_000001.11:161307310:C:T
NM_017780.4(CHD7):c.7891C>T (p.Arg2631Ter)	CHD7	R2631*, R582*	none provided|not provided|CHARGE association	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158320	8	61774815	8	60862256	158320	168636	rs587783457	NC_000008.11:60862255:C:T
NM_001540.5(HSPB1):c.380G>T (p.Arg127Leu)	HSPB1	R127L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000157529	7	75933134	7	76303817	157529	167391	rs587781250	NC_000007.14:76303816:G:T
NM_152564.5(VPS13B):c.5845C>T (p.Arg1949Ter)	VPS13B	R1949*, R1974*	not provided|Cohen syndrome	Pathogenic(Last reviewed: Sep 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068089	8	100654663	8	99642435	68089	78980	rs180177365	NC_000008.11:99642434:C:T
NM_000530.8(MPZ):c.244T>C (p.Tyr82His)	MPZ	Y82H	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000041017	1	161276702	1	161306912	41017	49439	rs281865124	NC_000001.11:161306911:A:G
NM_033380.3(COL4A5):c.3508G>A (p.Gly1170Ser)	COL4A5	G1170S	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024638	X	107909779	X	108666549	24638	35979	rs104886237	NC_000023.11:108666548:G:A
NM_033380.3(COL4A5):c.2288G>A (p.Gly763Glu)	COL4A5	G763E	not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024503	X	107850015	X	108606785	24503	35844	rs281874689	NC_000023.11:108606784:G:A
NM_000166.6(GJB1):c.556G>A (p.Glu186Lys)	GJB1	E186K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000021086	X	70444113	X	71224263	21086	33938	rs116840821	NC_000023.11:71224262:G:A
NM_000530.8(MPZ):c.242A>G (p.His81Arg)	MPZ	H81R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014179	1	161276704	1	161306914	14179	29218	rs121913594	NC_000001.11:161306913:T:C
NM_000530.8(MPZ):c.293G>C (p.Arg98Pro)	MPZ	R98P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b|none provided	Pathogenic(Last reviewed: Apr 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014174	1	161276653	1	161306863	14174	29213	rs121913589	NC_000001.11:161306862:C:G
NM_000166.6(GJB1):c.415G>A (p.Val139Met)	GJB1	V139M	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV000010433	X	70443972	X	71224122	10433	25472	rs104894812	NC_000023.11:71224121:G:A
m.14487T>C	MT-ND6	M63V	Leigh syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Striatal necrosis, bilateral, with dystonia	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009694	MT	14487	MT	14487	9694	24733	rs199476109	NC_012920.1:14486:T:C
NM_014874.4(MFN2):c.493C>G (p.His165Asp)	MFN2	H165D	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000002275	1	12057372	1	11997315	2275	17314	rs119103262	NC_000001.11:11997314:C:G
NM_000404.4(GLB1):c.1498A>G (p.Thr500Ala)	GLB1	T500A, T369A, T470A, T548A	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000942	3	33055784	3	33014292	942	15981	rs72555368	NC_000003.12:33014291:T:C
NM_057176.3(BSND):c.139G>A (p.Gly47Arg)	BSND	G47R	Bartter disease type 4a|not provided	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004387	1	55464998	1	54999325	4387	19426	rs74315289	NC_000001.11:54999324:G:A
NM_004863.4(SPTLC2):c.1151C>T (p.Ser384Phe)	SPTLC2	S384F	Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type IC|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000637418	14	78021668	14	77555325	637418	625308	rs1594986869	NC_000014.9:77555324:G:A
NM_000091.5(COL4A3):c.391G>T (p.Glu131Ter)	MFF-DT|COL4A3	E131*	not provided|Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive|Benign familial hematuria	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000558496	2	228111404	2	227246688	558496	542010	rs1346138010	NC_000002.12:227246687:G:T
NM_000404.4(GLB1):c.1325G>A (p.Arg442Gln)	GLB1	R442Q, R311Q, R490Q, R412Q	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|GM1 gangliosidosis type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000528328	3	33059962	3	33018470	528328	519256	rs564428355	NC_000003.12:33018469:C:T
NM_022489.4(INF2):c.658G>A (p.Glu220Lys)	INF2	E220K	Focal segmental glomerulosclerosis 5|not provided|Charcot-Marie-Tooth disease|Hypertensive disorder|Focal segmental glomerulosclerosis|Renal insufficiency|Proteinuria	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523533	14	105169782	14	104703445	523533	514037	rs530391015	NC_000014.9:104703444:G:A
NM_018972.4(GDAP1):c.929G>A (p.Arg310Gln)	GDAP1	R310Q, R201Q, R252Q, R242Q	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449535	8	75276454	8	74364219	449535	444306	rs1323153568	NC_000008.11:74364218:G:A
NM_000530.8(MPZ):c.418T>A (p.Ser140Thr)	MPZ	S140T	not specified|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447730	1	161276528	1	161306738	447730	440403	rs572010627	NC_000001.11:161306737:A:T
NM_014845.6(FIG4):c.2467C>T (p.Gln823Ter)	FIG4	Q823*	Charcot-Marie-Tooth disease, type 4J|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease|Yunis-Varon syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447336	6	110117975	6	109796772	447336	440905	rs745790694	NC_000006.12:109796771:C:T
NM_000304.4(PMP22):c.449G>A (p.Gly150Asp)	PMP22	G150D	Charcot-Marie-Tooth disease, type I|not provided|Dejerine-Sottas disease	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245805	17	15134268	17	15230951	245805	245013	rs879253954	NC_000017.11:15230950:C:T
NM_000166.6(GJB1):c.541G>A (p.Val181Met)	GJB1	V181M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000245705	X	70444098	X	71224248	245705	245188	rs879253909	NC_000023.11:71224247:G:A
NM_001163809.2(WDR81):c.3997C>T (p.Arg1333Ter)	WDR81	R1333*, R130*, R106*, R282*	Inborn genetic diseases|Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000224836	17	1634392	17	1731098	224836	226676	rs138358708	NC_000017.11:1731097:C:T
NM_000288.4(PEX7):c.618G>A (p.Trp206Ter)	PEX7	W206*	not provided|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189076	6	137187856	6	136866718	189076	186702	rs61753245	NC_000006.12:136866717:G:A
NM_017780.4(CHD7):c.5458C>T (p.Arg1820Ter)	CHD7	R1820*	CHARGE association|not provided	Pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000158302	8	61763105	8	60850546	158302	168618	rs587783446	NC_000008.11:60850545:C:T
NM_000091.5(COL4A3):c.3499G>A (p.Gly1167Arg)	COL4A3|MFF-DT	G1167R	not provided|Alport syndrome 3, autosomal dominant|Alport syndrome|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017492	2	228159760	2	227295044	17492	32531	rs267606745	NC_000002.12:227295043:G:A
NM_006415.4(SPTLC1):c.398G>A (p.Cys133Tyr)	SPTLC1	C133Y	Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type 1A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000004800	9	94842327	9	92080045	4800	19839	rs119482081	NC_000009.12:92080044:C:T
NM_001008216.2(GALE):c.280G>A (p.Val94Met)	GALE	V94M	not provided|UDPglucose-4-epimerase deficiency|Galactose epimerase deficiency, severe	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003682	1	24124678	1	23798188	3682	18721	rs121908047	NC_000001.11:23798187:C:T
NM_000404.4(GLB1):c.1480-2A>G	GLB1		Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1-gangliosidosis, type I, with cardiac involvement|GM1 gangliosidosis	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000946	3	33055804	3	33014312	946	15985	rs587776526	NC_000003.12:33014311:T:C
NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu)	HSPB1	P39L	HSPB1-related axonal neuropathies|Charcot-Marie-Tooth disease axonal type 2F|Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000533814	7	75932145	7	76302828	533814	522820	rs557327165	NC_000007.14:76302827:C:T
NM_017780.4(CHD7):c.7282C>T (p.Arg2428Ter)	CHD7	R2428*	not provided|CHARGE association	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000523619	8	61769121	8	60856562	523619	514270	rs1320897198	NC_000008.11:60856561:C:T
NM_001614.5(ACTG1):c.1004G>A (p.Arg335His)	ACTG1	R335H	Baraitser-Winter Syndrome 2|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000520655	17	79477840	17	81510814	520655	512336	rs1555666392	NC_000017.11:81510813:C:T
NM_002047.4(GARS1):c.1415A>G (p.His472Arg)	GARS1	H472R, H418R	Charcot-Marie-Tooth disease, type 2|Distal spinal muscular atrophy|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000410314	7	30661064	7	30621448	410314	395634	rs1060502838	NC_000007.14:30621447:A:G
NM_000404.4(GLB1):c.464T>G (p.Leu155Arg)	GLB1	L155R, L203R, L125R	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Aug 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265179	3	33107043	3	33065551	265179	259759	rs376710410	NC_000003.12:33065550:A:C
NM_000530.8(MPZ):c.116A>C (p.His39Pro)	MPZ	H39P	not specified|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: May 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217232	1	161277166	1	161307376	217232	213794	rs371856018	NC_000001.11:161307375:T:G
NM_152564.5(VPS13B):c.2889G>A (p.Trp963Ter)	VPS13B	W963*	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056655	8	100396500	8	99384272	56655	71294	rs386834078	NC_000008.11:99384271:G:A
NM_152564.5(VPS13B):c.11239C>T (p.Gln3747Ter)	VPS13B	Q3772*, Q3747*	not provided|Cohen syndrome|Small hand|Short stature|Microcephaly|Progressive visual loss|Recurrent aphthous stomatitis|Retinal dystrophy|Intellectual disability|Short foot|Neutropenia	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056635	8	100880540	8	99868312	56635	71274	rs386834061	NC_000008.11:99868311:C:T
NM_005236.3(ERCC4):c.1765C>T (p.Arg589Trp)	ERCC4	R589W	Xeroderma pigmentosum, group F|Cockayne syndrome|Fanconi anemia, complementation group Q|Xeroderma pigmentosum, type F/Cockayne syndrome|Xeroderma pigmentosum, group F|XFE progeroid syndrome|Fanconi anemia, complementation group Q	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000055829	16	14029554	16	13935697	55829	70487	rs147105770	NC_000016.10:13935696:C:T
NM_018972.4(GDAP1):c.368A>G (p.His123Arg)	GDAP1	H123R, H55R, H14R	Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000050558	8	75272429	8	74360194	50558	59596	rs397515442	NC_000008.11:74360193:A:G
NM_033380.3(COL4A5):c.3427G>A (p.Gly1143Ser)	COL4A5	G1143S	not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024630	X	107908790	X	108665560	24630	35971	rs104886228	NC_000023.11:108665559:G:A
NM_033380.3(COL4A5):c.1276G>A (p.Gly426Arg)	COL4A5	G426R	not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024393	X	107834398	X	108591168	24393	35734	rs104886111	NC_000023.11:108591167:G:A
NM_000404.4(GLB1):c.1313G>A (p.Gly438Glu)	GLB1	G438E, G408E, G486E, G307E	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000940	3	33059974	3	33018482	940	15979	rs72555367	NC_000003.12:33018481:C:T
NM_001126108.2(SLC12A3):c.2938G>A (p.Gly980Arg)	SLC12A3	G989R, G988R, G980R	not provided|Bartter syndrome|Familial hypokalemia-hypomagnesemia|Familial hypokalemia-hypomagnesemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586605	16	56947189	16	56913277	586605	577557	rs34803727	NC_000016.10:56913276:G:A
NM_000404.4(GLB1):c.175C>T (p.Arg59Cys)	GLB1	R59C, R29C, R107C	GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496895	3	33114106	3	33072614	496895	488319	rs756878418	NC_000003.12:33072613:G:A
NM_024577.4(SH3TC2):c.3511C>T (p.Arg1171Cys)	SH3TC2	R1171C	Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000448370	5	148386608	5	149007045	448370	440868	rs759785462	NC_000005.10:149007044:G:A
NM_017780.4(CHD7):c.6079C>T (p.Arg2027Ter)	CHD7	R2027*	not provided|CHARGE association	Pathogenic(Last reviewed: Dec 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000267435	8	61765241	8	60852682	267435	262660	rs886040995	NC_000008.11:60852681:C:T
NM_001540.5(HSPB1):c.250G>C (p.Gly84Arg)	HSPB1	G84R	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220419	7	75932279	7	76302962	220419	221739	rs770272088	NC_000007.14:76302961:G:C
NM_000166.6(GJB1):c.224G>A (p.Arg75Gln)	GJB1	R75Q	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217167	X	70443781	X	71223931	217167	213892	rs863224972	NC_000023.11:71223930:G:A
NM_000166.6(GJB1):c.-103C>T	GJB1		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Feb 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217166	X	70443099	X	71223249	217166	213890	rs863224971	NC_000023.11:71223248:C:T
NM_152564.5(VPS13B):c.2074C>T (p.Arg692Ter)	VPS13B	R692*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056650	8	100168837	8	99156609	56650	71289	rs180177356	NC_000008.11:99156608:C:T
NM_000399.5(EGR2):c.1142G>A (p.Arg381His)	EGR2	R381H, R331H	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 1d	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041008	10	64573256	10	62813496	41008	49430	rs281865137	NC_000010.11:62813495:C:T
NM_001605.3(AARS1):c.986G>A (p.Arg329His)	AARS1	R329H	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2N|Charcot-Marie-Tooth disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008466	16	70302259	16	70268356	8466	23505	rs267606621	NC_000016.10:70268355:C:T
NM_000304.4(PMP22):c.47T>C (p.Leu16Pro)	PMP22	L16P	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, type IA	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000008428	17	15163998	17	15260681	8428	23467	rs104894617	NC_000017.11:15260680:A:G
NM_000288.4(PEX7):c.694C>T (p.Arg232Ter)	PEX7	R232*	Rhizomelic chondrodysplasia punctata type 1|not provided|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Feb 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007783	6	137191088	6	136869950	7783	22822	rs121909153	NC_000006.12:136869949:C:T
NM_001540.5(HSPB1):c.379C>T (p.Arg127Trp)	HSPB1	R127W	Charcot-Marie-Tooth disease axonal type 2F|not provided|Distal hereditary motor neuronopathy type 2B	Pathogenic(Last reviewed: Jul 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007479	7	75933133	7	76303816	7479	22518	rs29001571	NC_000007.14:76303815:C:T
NM_004637.6(RAB7A):c.385C>T (p.Leu129Phe)	RAB7A	L129F	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2B	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV000007345	3	128525419	3	128806576	7345	22384	rs121909078	NC_000003.12:128806575:C:T
NM_002473.6(MYH9):c.287C>T (p.Ser96Leu)	MYH9	S96L	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|not provided|Autosomal dominant nonsyndromic hearing loss 17|MYH9-related disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014083	22	36744995	22	36348950	14083	29122	rs121913657	NC_000022.11:36348949:G:A
NM_002473.6(MYH9):c.3493C>T (p.Arg1165Cys)	MYH9	R1165C	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|MYH9-related disorder|Thrombocytopenia|Abnormal bleeding|not provided|Autosomal dominant nonsyndromic hearing loss 17	Pathogenic(Last reviewed: Mar 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014074	22	36691115	22	36295069	14074	29113	rs80338829	NC_000022.11:36295068:G:A
NM_024577.4(SH3TC2):c.2642A>G (p.Asn881Ser)	SH3TC2	N881S	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 4C	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377021	5	148406653	5	149027090	377021	363899	rs80338930	NC_000005.10:149027089:T:C
NM_017780.4(CHD7):c.3205C>T (p.Arg1069Ter)	CHD7	R1069*	CHARGE association|CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|not provided	Pathogenic(Last reviewed: Nov 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000267423	8	61736402	8	60823843	267423	262648	rs886040985	NC_000008.11:60823842:C:T
NM_017780.4(CHD7):c.6955C>T (p.Arg2319Cys)	CHD7	R2319C	not provided|CHARGE association	Pathogenic(Last reviewed: Oct 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000235889	8	61768552	8	60855993	235889	237524	rs121434341	NC_000008.11:60855992:C:T
NM_017780.4(CHD7):c.6157C>T (p.Arg2053Ter)	CHD7	R2053*	CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|not provided|CHARGE association	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158307	8	61765441	8	60852882	158307	168623	rs587783450	NC_000008.11:60852881:C:T
NM_001374258.1(BRAF):c.735A>T (p.Leu245Phe)	BRAF	L245F, L211F, L157F, L248F, L193F	Noonan syndrome with multiple lentigines|not provided|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome|Rasopathy	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040348	7	140501337	7	140801537	40348	48818	rs397507466	NC_000007.14:140801536:T:A
NM_006158.5(NEFL):c.64C>T (p.Pro22Ser)	NEFL	P22S	Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, demyelinating, type 1f|Pes cavus|Distal lower limb muscle weakness|Peripheral neuropathy|Peripheral demyelination|Decreased nerve conduction velocity|Hand muscle atrophy|Peripheral neuropathy|Distal muscle weakness|Charcot-Marie-Tooth disease, type 1C|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014029	8	24813966	8	24956452	14029	29068	rs28928910	NC_000008.11:24956451:G:A
NM_002047.4(GARS1):c.880G>C (p.Gly294Arg)	GARS1	G240R, G294R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease type 2D|not provided	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009204	7	30649345	7	30609729	9204	24243	rs137852643	NC_000007.14:30609728:G:C
NM_006415.4(SPTLC1):c.431T>A (p.Val144Asp)	SPTLC1	V144D, V22D	not provided|Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|Neuropathy, hereditary sensory and autonomic, type 1A	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004801	9	94830377	9	92068095	4801	19840	rs119482083	NC_000009.12:92068094:A:T
NM_181882.3(PRX):c.2857C>T (p.Arg953Ter)	PRX	R953*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004787	19	40901402	19	40395495	4787	19826	rs104894714	NC_000019.10:40395494:G:A
NM_018972.4(GDAP1):c.581C>G (p.Ser194Ter)	GDAP1	S194*, S126*, S136*, S85*	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|not provided|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004191	8	75275175	8	74362940	4191	19230	rs104894075	NC_000008.11:74362939:C:G
NM_000082.4(ERCC8):c.37G>T (p.Glu13Ter)	ERCC8|NDUFAF2	E13*	Cockayne syndrome|Cockayne syndrome type A|not provided	Pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001716	5	60240799	5	60944972	1716	16755	rs121434324	NC_000005.10:60944971:C:A
NM_000404.4(GLB1):c.1051C>T (p.Arg351Ter)	GLB1	R351*, R321*, R399*, R220*	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1-gangliosidosis, type I, with cardiac involvement|Infantile GM1 gangliosidosis|Spastic ataxia|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Jan 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000941	3	33087629	3	33046137	941	15980	rs72555372	NC_000003.12:33046136:G:A
NM_001126108.2(SLC12A3):c.2856+1G>T	SLC12A3		Bartter syndrome|Familial hypokalemia-hypomagnesemia|Familial hypokalemia-hypomagnesemia|not provided	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372504	16	56936421	16	56902509	372504	360256	rs199974259	NC_000016.10:56902508:G:T
NM_001126108.2(SLC12A3):c.1964G>A (p.Arg655His)	SLC12A3	R655H, R654H	not provided|Familial hypokalemia-hypomagnesemia|Familial hypokalemia-hypomagnesemia|Bartter syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008588	16	56920314	16	56886402	8588	23627	rs121909380	NC_000016.10:56886401:G:A
NM_014874.4(MFN2):c.1091G>C (p.Arg364Pro)	MFN2	R364P	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000572157	1	12062091	1	12002034	572157	558090	rs879254011	NC_000001.11:12002033:G:C
NM_002047.4(GARS1):c.1000A>T (p.Ile334Phe)	GARS1	I334F, I280F	Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2D|not provided|Charcot-Marie-Tooth disease|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476747	7	30651830	7	30612214	476747	457158	rs1554338260	NC_000007.14:30612213:A:T
NM_000166.6(GJB1):c.64C>T (p.Arg22Ter)	GJB1	R22*	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447441	X	70443621	X	71223771	447441	442441	rs1555937020	NC_000023.11:71223770:C:T
NM_000091.5(COL4A3):c.2371C>T (p.Arg791Ter)	COL4A3|MFF-DT	R791*	Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive|Benign familial hematuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000397514	2	228145303	2	227280587	397514	384400	rs1060499654	NC_000002.12:227280586:C:T
NM_017780.4(CHD7):c.3623T>A (p.Val1208Asp)	CHD7	V1208D	Inborn genetic diseases|not provided|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000267427	8	61742981	8	60830422	267427	262652	rs886040988	NC_000008.11:60830421:T:A
NM_000404.4(GLB1):c.1733A>G (p.Lys578Arg)	GLB1	K578R, K548R, K626R, K447R	not provided|GM1 gangliosidosis type 2|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000252985	3	33055549	3	33014057	252985	247388	rs371582179	NC_000003.12:33014056:T:C
NM_152564.5(VPS13B):c.2410C>T (p.Gln804Ter)	VPS13B	Q804*	Inborn genetic diseases|Cohen syndrome	Pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225000	8	100205180	8	99192952	225000	226909	rs869312923	NC_000008.11:99192951:C:T
NM_033380.3(COL4A5):c.4706G>A (p.Arg1569Gln)	COL4A5	R1563Q, R1569Q	not provided|Alport syndrome 1, X-linked recessive|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024757	X	107936155	X	108692925	24757	36098	rs281874743	NC_000023.11:108692924:G:A
NM_000530.8(MPZ):c.131C>T (p.Ser44Phe)	MPZ	S44F	Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014185	1	161277151	1	161307361	14185	29224	rs121913598	NC_000001.11:161307360:G:A
NM_000288.4(PEX7):c.653C>T (p.Ala218Val)	PEX7	A218V	Rhizomelic chondrodysplasia punctata type 1|not provided|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007781	6	137191047	6	136869909	7781	22820	rs121909151	NC_000006.12:136869908:C:T
NM_003640.5(ELP1):c.2087G>C (p.Arg696Pro)	ELP1	R696P, R347P, R582P	Charcot-Marie-Tooth disease|Familial dysautonomia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006086	9	111662583	9	108900303	6086	21125	rs137853022	NC_000009.12:108900302:C:G
NM_017780.4(CHD7):c.3082A>G (p.Ile1028Val)	CHD7	I1028V	CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association|not provided	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002022	8	61735186	8	60822627	2022	17061	rs121434338	NC_000008.11:60822626:A:G
NM_000404.4(GLB1):c.1369C>T (p.Arg457Ter)	GLB1	R457*, R427*, R326*, R505*	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Infantile GM1 gangliosidosis|GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000924	3	33058311	3	33016819	924	15963	rs72555359	NC_000003.12:33016818:G:A
NM_000404.4(GLB1):c.442C>A (p.Arg148Ser)	GLB1	R148S, R118S, R196S	GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|GM1 gangliosidosis|not provided|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551757	3	33109737	3	33068245	551757	543207	rs192732174	NC_000003.12:33068244:G:T
NM_000166.6(GJB1):c.548G>A (p.Arg183His)	GJB1	R183H	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Mar 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000447435	X	70444105	X	71224255	447435	442450	rs1555937233	NC_000023.11:71224254:G:A
NM_001376.5(DYNC1H1):c.6994C>T (p.Arg2332Cys)	DYNC1H1	R2332C	Inborn genetic diseases|Seizures|Microcephaly|Delayed gross motor development|Delayed speech and language development|Global developmental delay|Charcot-Marie-Tooth disease, axonal, type 2O	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374190	14	102478787	14	102012450	374190	360957	rs1057518961	NC_000014.9:102012449:C:T
NM_152564.5(VPS13B):c.6125T>A (p.Leu2042Ter)	VPS13B	L2042*, L2067*	Inborn genetic diseases|not provided|Cohen syndrome	Pathogenic(Last reviewed: Sep 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280580	8	100711831	8	99699603	280580	264295	rs371364257	NC_000008.11:99699602:T:A
NM_152564.5(VPS13B):c.9472C>T (p.Gln3158Ter)	VPS13B	Q3158*, Q3183*	Cohen syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225027	8	100844738	8	99832510	225027	226911	rs753770252	NC_000008.11:99832509:C:T
NM_000166.6(GJB1):c.305A>G (p.Glu102Gly)	GJB1	E102G	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216038	X	70443862	X	71224012	216038	213501	rs779696968	NC_000023.11:71224011:A:G
NM_014874.4(MFN2):c.775C>T (p.Arg259Cys)	MFN2	R259C	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000155730	1	12059111	1	11999054	155730	165484	rs587777875	NC_000001.11:11999053:C:T
NM_000404.4(GLB1):c.442C>T (p.Arg148Cys)	GLB1	R148C, R118C, R196C	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Infantile GM1 gangliosidosis|GM1 gangliosidosis|GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092907	3	33109737	3	33068245	92907	98814	rs192732174	NC_000003.12:33068244:G:A
NM_006158.5(NEFL):c.1186G>A (p.Glu396Lys)	NEFL	E396K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate G|not provided|Charcot-Marie-Tooth disease type 2E	Pathogenic(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000066671	8	24811293	8	24953779	66671	77568	rs62636503	NC_000008.11:24953778:C:T
NM_014874.4(MFN2):c.1085C>T (p.Thr362Met)	MFN2	T362M	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030738	1	12062085	1	12002028	30738	39695	rs387906991	NC_000001.11:12002027:C:T
NM_021625.5(TRPV4):c.947G>A (p.Arg316His)	TRPV4	R316H, R269H, R282H	not provided|EMG abnormality|Lower limb amyotrophy|Clubfoot|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2C|Neuromuscular disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030473	12	110236624	12	109798819	30473	39430	rs387906905	NC_000012.12:109798818:C:T
NM_033380.3(COL4A5):c.796C>T (p.Arg266Ter)	COL4A5	R266*	not provided|Alport syndrome|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024325	X	107823778	X	108580548	24325	35666	rs104886071	NC_000023.11:108580547:C:T
NM_024577.4(SH3TC2):c.1972C>T (p.Arg658Cys)	SH3TC2	R658C	Charcot-Marie-Tooth disease, type 4C|Mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000021690	5	148407323	5	149027760	21690	34542	rs80338926	NC_000005.10:149027759:G:A
NM_033380.3(COL4A5):c.4964T>G (p.Leu1655Arg)	COL4A5	L1649R, L1655R	not provided|Alport syndrome 1, X-linked recessive|Alport syndrome	Pathogenic(Last reviewed: Nov 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000010466	X	107938639	X	108695409	10466	25505	rs104886303	NC_000023.11:108695408:T:G
NM_000166.6(GJB1):c.491G>A (p.Arg164Gln)	GJB1	R164Q	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Dec 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000543920	X	70444048	X	71224198	543920	535194	rs1241595912	NC_000023.11:71224197:G:A
NM_017780.4(CHD7):c.934C>T (p.Arg312Ter)	CHD7	R312*	Inborn genetic diseases|CHARGE association|not provided	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000279757	8	61654925	8	60742366	279757	264409	rs886041166	NC_000008.11:60742365:C:T
NM_002180.3(IGHMBP2):c.1082T>C (p.Leu361Pro)	IGHMBP2	L361P	Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|not provided|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245627	11	68696672	11	68929204	245627	244678	rs201060167	NC_000011.10:68929203:T:C
NM_017909.4(RMND1):c.1349G>C (p.Ter450Ser)	RMND1		Mitochondrial disease|Inborn genetic diseases|Combined oxidative phosphorylation deficiency 11	Pathogenic(Last reviewed: Aug 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143051	6	151726371	6	151405236	143051	152761	rs115079861	NC_000006.12:151405235:C:G
NM_001354689.3(RAF1):c.1532C>T (p.Thr511Ile)	RAF1	T491I, T511I, T430I, T410I, T458I, T377I	Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Cardiovascular phenotype|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000021342	3	12627244	3	12585745	21342	34194	rs80338799	NC_000003.12:12585744:G:A
NM_000530.8(MPZ):c.188C>G (p.Ser63Cys)	MPZ	S63C	Charcot-Marie-Tooth disease, type I|not provided|Dejerine-Sottas syndrome, autosomal dominant|Dejerine-Sottas disease	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014169	1	161277094	1	161307304	14169	29208	rs121913585	NC_000001.11:161307303:G:C
NM_001005361.3(DNM2):c.1105C>T (p.Arg369Trp)	DNM2	R369W	Charcot-Marie-Tooth disease|Myopathy, centronuclear, 1|Charcot-Marie-Tooth disease, dominant intermediate B|not provided|Centronuclear myopathy	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007280	19	10904508	19	10793832	7280	22319	rs121909090	NC_000019.10:10793831:C:T
NM_021625.5(TRPV4):c.1858G>A (p.Val620Ile)	TRPV4	V560I, V513I, V573I, V586I	Skeletal dysplasia|Neuromuscular disease|Skeletal dysplasia|Charcot-Marie-Tooth disease|Brachyrachia (short spine dysplasia)|not provided|Charcot-Marie-Tooth disease axonal type 2C	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004993	12	110230201	12	109792396	4993	20032	rs121912633	NC_000012.12:109792395:C:T
NM_181882.3(PRX):c.2145T>A (p.Cys715Ter)	PRX	C715*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic/Likely pathogenic(Last reviewed: Aug 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004792	19	40902114	19	40396207	4792	19831	rs104894707	NC_000019.10:40396206:A:T
NM_001126108.2(SLC12A3):c.1928C>T (p.Pro643Leu)	SLC12A3	P643L, P642L	Familial hypokalemia-hypomagnesemia|Familial hypokalemia-hypomagnesemia|Bartter syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000417863	16	56920278	16	56886366	417863	404824	rs140012781	NC_000016.10:56886365:C:T
NM_000166.6(GJB1):c.643C>T (p.Arg215Trp)	GJB1	R215W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000246098	X	70444200	X	71224350	246098	245189	rs879254099	NC_000023.11:71224349:C:T
NM_000166.6(GJB1):c.547C>T (p.Arg183Cys)	GJB1	R183C	Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000216039	X	70444104	X	71224254	216039	213502	rs863224471	NC_000023.11:71224253:C:T
NM_017780.4(CHD7):c.469C>T (p.Arg157Ter)	CHD7	R157*	not provided|not specified|CHARGE association	Pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000195321	8	61654460	8	60741901	195321	192482	rs794727293	NC_000008.11:60741900:C:T
NM_152564.5(VPS13B):c.6657+1G>A	VPS13B		not provided|Cohen syndrome	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056683	8	100729602	8	99717374	56683	71322	rs180177366	NC_000008.11:99717373:G:A
NM_000218.3(KCNQ1):c.1066C>T (p.Gln356Ter)	KCNQ1	Q356*, Q229*	not provided|Long QT syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000052946	11	2606475	11	2585245	52946	67614	rs397508072	NC_000011.10:2585244:C:T
NM_000530.8(MPZ):c.487G>C (p.Gly163Arg)	MPZ	G163R	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000041022	1	161276216	1	161306426	41022	49444	rs281865128	NC_000001.11:161306425:C:G
NM_002834.5(PTPN11):c.1381G>T (p.Ala461Ser)	PTPN11	A461S, A465S, A460S	Noonan syndrome with multiple lentigines|Rasopathy|LEOPARD syndrome 1|not provided	Pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040546	12	112926248	12	112488444	40546	49016	rs121918468	NC_000012.12:112488443:G:T
NM_001854.4(COL11A1):c.3816+1G>A	COL11A1		Inborn genetic diseases|not provided|Marshall syndrome	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039776	1	103381186	1	102915630	39776	48375	rs398122828	NC_000001.11:102915629:C:T
NM_000091.5(COL4A3):c.4441C>T (p.Arg1481Ter)	COL4A3|MFF-DT	R1481*	Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant|Benign familial hematuria|not provided|Alport syndrome, autosomal recessive|Alport syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017484	2	228172614	2	227307898	17484	32523	rs121912824	NC_000002.12:227307897:C:T
NM_000489.6(ATRX):c.109C>T (p.Arg37Ter)	ATRX	R37*	Alpha thalassemia-X-linked intellectual disability syndrome|Mental retardation-hypotonic facies syndrome, X-linked|X-linked intellectual disability-hypotonic face syndrome|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011742	X	76972632	X	77717155	11742	26781	rs122445108	NC_000023.11:77717154:G:A
NM_006214.4(PHYH):c.823C>T (p.Arg275Trp)	PHYH	R275W, R175W, R177W, R277W, R187W	Refsum disease, adult, 1|Phytanic acid storage disease|Retinitis pigmentosa|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007580	10	13325695	10	13283695	7580	22619	rs104894178	NC_000010.11:13283694:G:A
NM_006415.4(SPTLC1):c.399T>G (p.Cys133Trp)	SPTLC1	C133W	Sensorimotor neuropathy|Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type 1A|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004803	9	94842326	9	92080044	4803	19842	rs119482082	NC_000009.12:92080043:A:C
NM_000404.4(GLB1):c.1445G>A (p.Arg482His)	GLB1	R482H, R351H, R452H, R530H	GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000932	3	33058235	3	33016743	932	15971	rs72555391	NC_000003.12:33016742:C:T
NM_152564.5(VPS13B):c.5011C>T (p.Arg1671Ter)	VPS13B	R1696*, R1671*	not provided|Inborn genetic diseases|Cohen syndrome	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056803	8	100587947	8	99575719	56803	71431	rs386834093	NC_000008.11:99575718:C:T
NM_000166.6(GJB1):c.187G>A (p.Val63Ile)	GJB1	V63I	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021081	X	70443744	X	71223894	21081	33933	rs116840818	NC_000023.11:71223893:G:A
NM_000092.5(COL4A4):c.4129C>T (p.Arg1377Ter)	COL4A4	R1377*	Alport syndrome|not provided|Kidney damage|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive|Benign familial hematuria	Pathogenic(Last reviewed: Nov 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017407	2	227886851	2	227022135	17407	32446	rs121912861	NC_000002.12:227022134:G:A
NM_000399.5(EGR2):c.1075C>T (p.Arg359Trp)	EGR2	R359W, R309W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1d|Dejerine-sottas neuropathy, autosomal dominant|Dejerine-Sottas disease	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016752	10	64573323	10	62813563	16752	31791	rs104894161	NC_000010.11:62813562:G:A
NM_001540.5(HSPB1):c.418C>G (p.Arg140Gly)	HSPB1	R140G	Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F|HSPB1-related axonal neuropathies|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007484	7	75933172	7	76303855	7484	22523	rs121909112	NC_000007.14:76303854:C:G
NM_000404.4(GLB1):c.622C>T (p.Arg208Cys)	GLB1	R208C, R178C, R256C	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000939	3	33099692	3	33058200	939	15978	rs72555366	NC_000003.12:33058199:G:A
NM_000414.4(HSD17B4):c.46G>A (p.Gly16Ser)	HSD17B4	G16S	HSD17B4-Related Disorders|Perrault syndrome|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|Bifunctional peroxisomal enzyme deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007655	5	118788316	5	119452621	7655	22694	rs137853096	NC_000005.10:119452620:G:A
NM_017780.4(CHD7):c.1480C>T (p.Arg494Ter)	CHD7	R494*	not provided|CHARGE association	Pathogenic(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000158279	8	61655471	8	60742912	158279	168594	rs587783429	NC_000008.11:60742911:C:T
NM_002834.5(PTPN11):c.767A>G (p.Gln256Arg)	PTPN11	Q256R, Q255R	Noonan syndrome 1|not provided|Noonan syndrome with multiple lentigines|Noonan syndrome|Rasopathy|not specified	Pathogenic(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040518	12	112910758	12	112472954	40518	48988	rs397507523	NC_000012.12:112472953:A:G
NM_000530.8(MPZ):c.233C>T (p.Ser78Leu)	MPZ	S78L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014188	1	161277049	1	161307259	14188	29227	rs121913601	NC_000001.11:161307258:G:A
NM_000530.8(MPZ):c.292C>T (p.Arg98Cys)	MPZ	R98C	Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014175	1	161276654	1	161306864	14175	29214	rs121913590	NC_000001.11:161306863:G:A
NM_000304.4(PMP22):c.36C>A (p.His12Gln)	PMP22	H12Q	Inborn genetic diseases|Charcot-Marie-Tooth disease, type I|Dejerine-Sottas disease|Dejerine-Sottas syndrome, autosomal dominant|Roussy-Lvy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008434	17	15164009	17	15260692	8434	23473	rs104894622	NC_000017.11:15260691:G:T
NM_001374258.1(BRAF):c.721A>C (p.Thr241Pro)	BRAF	T241P, T189P, T244P, T207P, T153P	Noonan syndrome with multiple lentigines|Cardiofaciocutaneous syndrome 1|not provided|LEOPARD syndrome 3|Cardio-facio-cutaneous syndrome|Lung carcinoma|LEOPARD syndrome 3|Noonan syndrome 1|Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029807	7	140501351	7	140801551	29807	38762	rs387906661	NC_000007.14:140801550:T:G
NM_022124.6(CDH23):c.3241C>T (p.Arg1081Ter)	C10orf105|CDH23	R1081*	Inborn genetic diseases|Usher syndrome type 1D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000521399	10	73472442	10	71712685	521399	511873	rs866435331	NC_000010.11:71712684:C:T
NM_017780.4(CHD7):c.6292C>T (p.Arg2098Ter)	CHD7	R2098*	Inborn genetic diseases|not provided|CHARGE association	Pathogenic(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000226115	8	61765576	8	60853017	226115	227917	rs875989879	NC_000008.11:60853016:C:T
NM_002834.5(PTPN11):c.1493G>T (p.Arg498Leu)	PTPN11	R498L, R502L, R497L	not provided|Noonan syndrome with multiple lentigines|Noonan syndrome|Cafe-au-lait spot|Specific learning disability|Scoliosis|Intellectual disability, mild|Abnormal facial shape|Noonan syndrome 1|Rasopathy|LEOPARD syndrome 1	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040554	12	112926873	12	112489069	40554	49024	rs397507542	NC_000012.12:112489068:G:T
NM_033380.3(COL4A5):c.2605G>A (p.Gly869Arg)	COL4A5	G869R	Atypical hemolytic uremic syndrome|Alport syndrome 1, X-linked recessive|Alport syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000024543	X	107863584	X	108620354	24543	35884	rs104886189	NC_000023.11:108620353:G:A
NM_000288.4(PEX7):c.649G>A (p.Gly217Arg)	PEX7	G217R	Rhizomelic chondrodysplasia punctata type 1|not provided|Peroxisome biogenesis disorder 9B	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007782	6	137191043	6	136869905	7782	22821	rs121909152	NC_000006.12:136869904:G:A
NM_000530.8(MPZ):c.371C>T (p.Thr124Met)	MPZ	T124M	not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|Roussy-Lvy syndrome|Congenital hypomyelinating neuropathy 1, autosomal recessive|Dejerine-Sottas disease|Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014181	1	161276575	1	161306785	14181	29220	rs121913595	NC_000001.11:161306784:G:A
NM_001126108.2(SLC12A3):c.1315G>A (p.Gly439Ser)	SLC12A3	G439S, G438S	not provided|Bartter syndrome|Familial hypokalemia-hypomagnesemia|Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586601	16	56913119	16	56879207	586601	577552	rs759377924	NC_000016.10:56879206:G:A
NM_017780.4(CHD7):c.5050G>A (p.Gly1684Ser)	CHD7	G1684S	Inborn genetic diseases|not provided|CHARGE association	Pathogenic(Last reviewed: Dec 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000520773	8	61757622	8	60845063	520773	511761	rs1554602465	NC_000008.11:60845062:G:A
NM_170707.4(LMNA):c.1609-3C>G	LMNA		Primary dilated cardiomyopathy|not provided|Charcot-Marie-Tooth disease|Dilated cardiomyopathy 1A|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066856	1	156107442	1	156137651	66856	77753	rs267607581	NC_000001.11:156137650:C:G
NM_000088.4(COL1A1):c.3076C>T (p.Arg1026Ter)	COL1A1	R1026*	not provided|Infantile cortical hyperostosis|Ehlers-Danlos syndrome, arthrochalasia type, 1|Osteogenesis imperfecta|Osteogenesis imperfecta|Osteogenesis imperfecta type I	Pathogenic(Last reviewed: Apr 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000035920	17	48266126	17	50188765	35920	44584	rs72653173	NC_000017.11:50188764:G:A
NM_000166.6(GJB1):c.223C>T (p.Arg75Trp)	GJB1	R75W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000021082	X	70443780	X	71223930	21082	33934	rs116840819	NC_000023.11:71223929:C:T
NM_033380.3(COL4A5):c.5048G>A (p.Arg1683Gln)	COL4A5	R1677Q, R1683Q	Hematuria|not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000010467	X	107939580	X	108696350	10467	25506	rs104886308	NC_000023.11:108696349:G:A
NM_000166.6(GJB1):c.283G>A (p.Val95Met)	GJB1	V95M	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000010441	X	70443840	X	71223990	10441	25480	rs104894821	NC_000023.11:71223989:G:A
NM_003742.4(ABCB11):c.890A>G (p.Glu297Gly)	ABCB11	E297G	Benign recurrent intrahepatic cholestasis type 2|Progressive familial intrahepatic cholestasis 2|Progressive familial intrahepatic cholestasis|not provided|Cholestasis, intrahepatic, of pregnancy 3	Pathogenic(Last reviewed: Oct 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006590	2	169847329	2	168990819	6590	21629	rs11568372	NC_000002.12:168990818:T:C
NM_001136472.2(LITAF):c.334G>A (p.Gly112Ser)	LITAF	G112S	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 1C	Pathogenic(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006057	16	11647432	16	11553576	6057	21096	rs104894519	NC_000016.10:11553575:C:T
NM_000218.3(KCNQ1):c.914G>C (p.Trp305Ser)	KCNQ1	W305S, W178S	Cardiovascular phenotype|not provided|Long QT syndrome|Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003127	11	2594209	11	2572979	3127	18166	rs120074186	NC_000011.10:2572978:G:C
NM_000166.6(GJB1):c.622G>A (p.Glu208Lys)	GJB1	E208K	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447439	X	70444179	X	71224329	447439	442454	rs1555937270	NC_000023.11:71224328:G:A
NM_000166.6(GJB1):c.65G>A (p.Arg22Gln)	GJB1	R22Q	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X Type 1|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000406228	X	70443622	X	71223772	406228	404289	rs1060501002	NC_000023.11:71223771:G:A
NM_000371.4(TTR):c.290C>A (p.Ser97Tyr)	TTR	S97Y	Charcot-Marie-Tooth disease|not specified|not provided|Amyloidogenic transthyretin amyloidosis	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013422	18	29175172	18	31595209	13422	28461	rs121918071	NC_000018.10:31595208:C:A
NM_006214.4(PHYH):c.135-2A>G	PHYH		not provided|Retinitis pigmentosa|Phytanic acid storage disease|Refsum disease, adult, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007581	10	13337608	10	13295608	7581	22620	rs201578674	NC_000010.11:13295607:T:C
NM_018972.4(GDAP1):c.715C>T (p.Leu239Phe)	GDAP1	L239F, L181F, L171F, L130F	Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, recessive intermediate A|Peripheral axonal neuropathy|Sensory neuropathy|Polyneuropathy|Elevated circulating creatine kinase concentration|Elevated circulating alkaline phosphatase concentration|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 4A|GDAP1-Related Disorders	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004200	8	75276240	8	74364005	4200	19239	rs104894080	NC_000008.11:74364004:C:T
NM_152564.5(VPS13B):c.2911C>T (p.Arg971Ter)	VPS13B	R971*	Cohen syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002823	8	100396522	8	99384294	2823	17862	rs120074152	NC_000008.11:99384293:C:T
NM_000092.5(COL4A4):c.2906C>G (p.Ser969Ter)	COL4A4	S969*	not provided|Alport syndrome|Benign familial hematuria|Alport syndrome, autosomal recessive|Chronic kidney disease	Pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449549	2	227917083	2	227052367	449549	443176	rs35138315	NC_000002.12:227052366:G:C
NM_021625.5(TRPV4):c.694C>T (p.Arg232Cys)	TRPV4	R232C, R198C	Autosomal dominant distal hereditary motor neuropathy|Spondylometaphyseal dysplasia, Kozlowski type|Charcot-Marie-Tooth disease|Distal spinal muscular atrophy, congenital nonprogressive|not provided|Charcot-Marie-Tooth disease axonal type 2C|Neuromuscular disease|Skeletal dysplasia	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030472	12	110240814	12	109803009	30472	39429	rs387906904	NC_000012.12:109803008:G:A
NM_021625.5(TRPV4):c.946C>T (p.Arg316Cys)	TRPV4	R316C, R282C, R269C	Autosomal dominant distal hereditary motor neuropathy|Neuromuscular disease|not provided|Charcot-Marie-Tooth disease|TRPV4-related disorders|Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease axonal type 2C	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005001	12	110236625	12	109798820	5001	20040	rs267607145	NC_000012.12:109798819:G:A
NM_000404.4(GLB1):c.808T>G (p.Tyr270Asp)	GLB1	Y270D, Y318D, Y139D, Y240D	Mucopolysaccharidosis, MPS-IV-B|Inborn genetic diseases|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|GLB1-Related Disorders|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000284172	3	33093481	3	33051989	284172	268409	rs376663785	NC_000003.12:33051988:A:C
NM_006158.5(NEFL):c.293A>G (p.Asn98Ser)	NEFL	N98S	Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease, dominant intermediate G|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, dominant intermediate G|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, demyelinating, type 1f	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000041236	8	24813737	8	24956223	41236	49660	rs58982919	NC_000008.11:24956222:T:C
NM_000166.6(GJB1):c.43C>T (p.Arg15Trp)	GJB1	R15W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth Neuropathy X Type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021084	X	70443600	X	71223750	21084	33936	rs116840815	NC_000023.11:71223749:C:T
NM_000288.4(PEX7):c.903+1G>C	PEX7		PEX7-Related Disorders|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata|not provided	Pathogenic(Last reviewed: Oct 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007785	6	137219380	6	136898242	7785	22824	rs148591292	NC_000006.12:136898241:G:C
NM_000404.4(GLB1):c.602G>A (p.Arg201His)	GLB1	R201H, R171H, R249H	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198077	3	33099712	3	33058220	198077	195238	rs189115557	NC_000003.12:33058219:C:T
NM_017780.4(CHD7):c.7957C>T (p.Arg2653Ter)	CHD7	R2653*, R604*	Inborn genetic diseases|not provided|CHARGE association	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158321	8	61774881	8	60862322	158321	168637	rs587783458	NC_000008.11:60862321:C:T
NM_002834.5(PTPN11):c.1391G>C (p.Gly464Ala)	PTPN11	G464A, G468A, G463A	Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome 1|LEOPARD syndrome 1|not provided	Pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013343	12	112926258	12	112488454	13343	28382	rs121918469	NC_000012.12:112488453:G:C
NM_018972.4(GDAP1):c.487C>T (p.Gln163Ter)	GDAP1	Q163*, Q105*, Q54*, Q95*	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type 4A|Neuropathy, axonal, with vocal cord paresis, autosomal recessive	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004193	8	75274121	8	74361886	4193	19232	rs104894077	NC_000008.11:74361885:C:T
NM_024577.4(SH3TC2):c.3325C>T (p.Arg1109Ter)	SH3TC2	R1109*	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Sep 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002483	5	148389835	5	149010272	2483	17522	rs80338934	NC_000005.10:149010271:G:A
NM_001354604.2(MITF):c.1273G>A (p.Glu425Lys)	MITF	E318K, E419K, E312K, E403K, E402K, E256K, E418K, E425K, E367K, E424K	Melanoma|Cutaneous malignant melanoma 8|Cutaneous malignant melanoma 8|Tietz syndrome|Waardenburg syndrome type 2A|not specified|Cutaneous malignant melanoma 8|Waardenburg syndrome type 2A|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029792	3	70014091	3	69964940	29792	38747	rs149617956	NC_000003.12:69964939:G:A
NM_000218.3(KCNQ1):c.502G>A (p.Gly168Arg)	KCNQ1	G168R, G41R	Cardiovascular phenotype|Arrhythmia|Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000053052	11	2591882	11	2570652	53052	67720	rs179489	NC_000011.10:2570651:G:A
NM_002180.3(IGHMBP2):c.1488C>A (p.Cys496Ter)	IGHMBP2	C496*	Charcot-Marie-Tooth disease|not provided|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S|Spinal muscular atrophy, distal, autosomal recessive, 1|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000234316	11	68701332	11	68933864	234316	231807	rs145226920	NC_000011.10:68933863:C:A
NM_001540.5(HSPB1):c.407G>T (p.Arg136Leu)	HSPB1	R136L	Inborn genetic diseases|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217230	7	75933161	7	76303844	217230	213813	rs863225022	NC_000007.14:76303843:G:T
NM_000218.3(KCNQ1):c.532G>A (p.Ala178Thr)	KCNQ1	A178T, A51T	Congenital long QT syndrome|Long QT syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Cardiovascular phenotype|Long QT syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000053061	11	2591912	11	2570682	53061	67729	rs120074177	NC_000011.10:2570681:G:A
NM_000530.8(MPZ):c.293G>A (p.Arg98His)	MPZ	R98H	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, demyelinating, type 1b|Distal muscle weakness|Pes cavus|Distal lower limb amyotrophy|Decreased nerve conduction velocity|Sensory neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014176	1	161276653	1	161306863	14176	29215	rs121913589	NC_000001.11:161306862:C:T
NM_000304.4(PMP22):c.215C>T (p.Ser72Leu)	PMP22	S72L	Inborn genetic diseases|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease, type IA|Dejerine-Sottas syndrome, autosomal dominant	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008433	17	15142892	17	15239575	8433	23472	rs104894621	NC_000017.11:15239574:G:A
NM_002834.5(PTPN11):c.1517A>C (p.Gln506Pro)	PTPN11	Q506P, Q510P, Q505P	not provided|LEOPARD syndrome 1|PTPN11 Related Disorders|Noonan syndrome with multiple lentigines|Rasopathy	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040563	12	112926897	12	112489093	40563	49033	rs397507548	NC_000012.12:112489092:A:C
NM_018972.4(GDAP1):c.358C>T (p.Arg120Trp)	GDAP1	R120W, R11W, R52W	not provided|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|none provided|Charcot-Marie-Tooth disease, recessive intermediate A|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease axonal type 2K	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004198	8	75272419	8	74360184	4198	19237	rs104894078	NC_000008.11:74360183:C:T
NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser)	MFN2	W740S	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Hereditary motor and sensory neuropathy with optic atrophy|not specified|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002269	1	12071567	1	12011510	2269	17308	rs28940292	NC_000001.11:12011509:G:C
NM_002834.5(PTPN11):c.1529A>C (p.Gln510Pro)	PTPN11	Q510P, Q514P, Q509P	Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome 3|Noonan syndrome 1|LEOPARD syndrome 1|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013344	12	112926909	12	112489105	13344	28383	rs121918470	NC_000012.12:112489104:A:C
NM_000218.3(KCNQ1):c.1760C>T (p.Thr587Met)	KCNQ1	T587M, T460M	Cardiovascular phenotype|Congenital long QT syndrome|not provided|Long QT syndrome|Jervell and Lange-Nielsen syndrome 1	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003138	11	2799233	11	2778003	3138	18177	rs120074189	NC_000011.10:2778002:C:T
NM_014874.4(MFN2):c.281G>A (p.Arg94Gln)	MFN2	R94Q	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002268	1	12052717	1	11992660	2268	17307	rs28940291	NC_000001.11:11992659:G:A
NM_000404.4(GLB1):c.176G>A (p.Arg59His)	GLB1	R59H, R107H, R29H	Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|GM1-gangliosidosis, type I, with cardiac involvement|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000945	3	33114105	3	33072613	945	15984	rs72555392	NC_000003.12:33072612:C:T
NM_001376.5(DYNC1H1):c.1792C>T (p.Arg598Cys)	DYNC1H1	R598C	Inborn genetic diseases|not provided|Hereditary motor and sensory neuropathy|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|Mental retardation, autosomal dominant 13	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139652	14	102452354	14	101986017	139652	143271	rs587780564	NC_000014.9:101986016:C:T
NM_000218.3(KCNQ1):c.692G>A (p.Arg231His)	KCNQ1	R231H, R104H	Long QT syndrome 1|Atrial fibrillation, familial, 3|Long QT syndrome|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Short QT syndrome 2|not provided|Congenital long QT syndrome	Pathogenic(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000053087	11	2593251	11	2572021	53087	67755	rs199472709	NC_000011.10:2572020:G:A
NM_033380.3(COL4A5):c.1871G>A (p.Gly624Asp)	COL4A5	G624D	not provided|Alport syndrome|Alport syndrome 1, X-linked recessive|Hypertensive disorder|Mild proteinuria|Glomerulopathy	Pathogenic(Last reviewed: Dec 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024455	X	107842023	X	108598793	24455	35796	rs104886142	NC_000023.11:108598792:G:A
NM_003640.5(ELP1):c.2204+6T>C	ELP1		Familial dysautonomia|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006085	9	111662096	9	108899816	6085	21124	rs111033171	NC_000009.12:108899815:A:G
NM_001303256.3(MORC2):c.754C>T (p.Arg252Trp)	MORC2	R252W	Inborn genetic diseases|Charcot-Marie-Tooth disease, axonal, type 2z|Charcot-Marie-Tooth disease|not provided|Distal spinal muscular atrophy	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000218307	22	31337490	22	30941503	218307	215003	rs864309503	NC_000022.11:30941502:G:A
NM_017780.4(CHD7):c.5405-17G>A	CHD7		Inborn genetic diseases|not provided|CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195978	8	61763035	8	60850476	195978	193139	rs794727423	NC_000008.11:60850475:G:A
NM_014874.4(MFN2):c.839G>A (p.Arg280His)	MFN2	R280H	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002271	1	12061480	1	12001423	2271	17310	rs28940294	NC_000001.11:12001422:G:A
NM_000218.3(KCNQ1):c.1781G>A (p.Arg594Gln)	KCNQ1	R594Q, R467Q	Congenital long QT syndrome|Long QT syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Cardiovascular phenotype|not provided|Long QT syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000053018	11	2799254	11	2778024	53018	67686	rs199472815	NC_000011.10:2778023:G:A
NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)	FGFR3	P250R	Malignant tumor of urinary bladder|Thanatophoric dysplasia type 1|Carcinoma of colon|Hypochondroplasia|Achondroplasia|Malignant tumor of testis|Epidermal nevus|Cancer of cervix|Levy-Hollister syndrome|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Severe achondroplasia with developmental delay and acanthosis nigricans|Thanatophoric dysplasia, type 2|Muenke syndrome|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Inborn genetic diseases|Craniosynostosis syndrome|Saethre-Chotzen syndrome|not provided|not specified|Achondroplasia|Crouzon syndrome|Generalized non-motor (absence) seizure|Facial asymmetry|Infantile axial hypotonia|Coronal craniosynostosis|Unilateral renal agenesis|Seizures|Hypochondroplasia	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016340	4	1803571	4	1801844	16340	31379	rs4647924	NC_000004.12:1801843:C:G
NM_000218.3(KCNQ1):c.1588C>T (p.Gln530Ter)	KCNQ1	Q530*, Q403*	Arrhythmia|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Short QT syndrome 2|Long QT syndrome|Long QT syndrome 1|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000052996	11	2790147	11	2768917	52996	67664	rs397508097	NC_000011.10:2768916:C:T
NM_014874.4(MFN2):c.1090C>T (p.Arg364Trp)	MFN2	R364W	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease type 4|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002278	1	12062090	1	12002033	2278	17317	rs119103265	NC_000001.11:12002032:C:T
NM_017780.4(CHD7):c.5405-7G>A	CHD7		Inborn genetic diseases|not provided|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Pathogenic(Last reviewed: May 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000095795	8	61763045	8	60850486	95795	101692	rs398124321	NC_000008.11:60850485:G:A
NM_002834.5(PTPN11):c.1381G>A (p.Ala461Thr)	PTPN11	A461T, A465T, A460T	Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not specified|not provided|Noonan syndrome 1|Rasopathy	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013342	12	112926248	12	112488444	13342	28381	rs121918468	NC_000012.12:112488443:G:A
NM_000489.6(ATRX):c.736C>T (p.Arg246Cys)	ATRX	R246C, R208C	not provided|Alpha thalassemia-X-linked intellectual disability syndrome|Acquired hemoglobin H disease|X-linked intellectual disability-hypotonic face syndrome|Alpha thalassemia-X-linked intellectual disability syndrome|Inborn genetic diseases|X-linked intellectual disability-hypotonic face syndrome|Renier-Gabreels-Jasper syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000011735	X	76940012	X	77684520	11735	26774	rs122445105	NC_000023.11:77684519:G:A
NM_000218.3(KCNQ1):c.1615C>T (p.Arg539Trp)	KCNQ1	R539W, R412W	not provided|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Short QT syndrome 2|Long QT syndrome|Long QT syndrome 1|Congenital long QT syndrome	Pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000052998	11	2797214	11	2775984	52998	67666	rs199472795	NC_000011.10:2775983:C:T
NM_001354689.3(RAF1):c.1897C>G (p.Leu633Val)	RAF1	L613V, L633V, L499V, L580V, L552V, L532V	Noonan syndrome with multiple lentigines|Noonan syndrome|Familial hypertrophic cardiomyopathy 1|none provided|Noonan syndrome with multiple lentigines|not provided|Rasopathy|Noonan syndrome|LEOPARD syndrome 2|Noonan syndrome 5	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013960	3	12626123	3	12584624	13960	28999	rs80338797	NC_000003.12:12584623:G:C
NM_000218.3(KCNQ1):c.1766G>A (p.Gly589Asp)	KCNQ1	G589D, G462D	Congenital long QT syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Arrhythmia|Long QT syndrome|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003140	11	2799239	11	2778009	3140	18179	rs120074190	NC_000011.10:2778008:G:A
NM_000218.3(KCNQ1):c.805G>A (p.Gly269Ser)	KCNQ1	G269S, G142S	Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Short QT syndrome 2|not specified|not provided	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003144	11	2594100	11	2572870	3144	18183	rs120074193	NC_000011.10:2572869:G:A
NM_002834.5(PTPN11):c.1492C>T (p.Arg498Trp)	PTPN11	R498W, R502W, R497W	not provided|Rasopathy|Inborn genetic diseases|LEOPARD syndrome 1|Noonan syndrome 1|Noonan syndrome|Noonan syndrome with multiple lentigines	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000040553	12	112926872	12	112489068	40553	49023	rs397507541	NC_000012.12:112489067:C:T
NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp)	LMNA	R482W, R401W, R370W	Charcot-Marie-Tooth disease|Inborn genetic diseases|Familial partial lipodystrophy 2|Familial partial lipodystrophy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014489	1	156106775	1	156136984	14489	29528	rs57920071	NC_000001.11:156136983:C:T
NM_000288.4(PEX7):c.875T>A (p.Leu292Ter)	PEX7	L292*	Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|none provided|Peroxisome biogenesis disorder 9B|Phytanic acid storage disease|Rhizomelic chondrodysplasia punctata type 1|not provided|PEX7-Related Disorders|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Oct 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007780	6	137219351	6	136898213	7780	22819	rs1805137	NC_000006.12:136898212:T:A
NM_014874.4(MFN2):c.280C>T (p.Arg94Trp)	MFN2	R94W	Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided|Microcephaly|Short stature|Failure to thrive|Abnormality of the dentition|Abnormal dental enamel morphology|Hyperpigmentation of the skin|Scarring|EMG abnormality|Decreased body weight|Scarring alopecia of scalp|Abnormal blistering of the skin|Nail dystrophy|Alopecia of scalp|Distal muscle weakness|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002276	1	12052716	1	11992659	2276	17315	rs119103263	NC_000001.11:11992658:C:T
NM_000218.3(KCNQ1):c.1663C>T (p.Arg555Cys)	KCNQ1	R555C, R428C	Congenital long QT syndrome|Long QT syndrome 1|not provided|Prolonged QT interval|Arrhythmia|Long QT syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003126	11	2797262	11	2776032	3126	18165	rs120074185	NC_000011.10:2776031:C:T
NM_002834.5(PTPN11):c.1528C>G (p.Gln510Glu)	PTPN11	Q510E, Q514E, Q509E	not provided|Noonan syndrome 3|Noonan syndrome with multiple lentigines|Noonan syndrome|Cardiovascular phenotype|Noonan syndrome 1|Rasopathy|LEOPARD syndrome 1	Pathogenic(Last reviewed: Jun 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040566	12	112926908	12	112489104	40566	49036	rs397507549	NC_000012.12:112489103:C:G
NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp)	MFN2	R707W	not provided|Peripheral axonal neuropathy|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|MFN2-Related Disorders|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002280	1	12069698	1	12009641	2280	17319	rs119103267	NC_000001.11:12009640:C:T
NM_014874.4(MFN2):c.310C>T (p.Arg104Trp)	MFN2	R104W	Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002281	1	12052746	1	11992689	2281	17320	rs119103268	NC_000001.11:11992688:C:T
NM_003002.4(SDHD):c.242C>T (p.Pro81Leu)	SDHD	P81L, P42L	Paragangliomas 1|Mitochondrial complex II deficiency, nuclear type 1|Pheochromocytoma|Carney-Stratakis syndrome|Pheochromocytoma|Hereditary cancer-predisposing syndrome|none provided|Paragangliomas 1|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Paragangliomas 1 with sensorineural hearing loss|Cowden syndrome 3|Paragangliomas 1|Pheochromocytoma|Carney-Stratakis syndrome	Pathogenic(Last reviewed: Dec 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006896	11	111959663	11	112088939	6896	21935	rs80338844	NC_000011.10:112088938:C:T
NM_021625.5(TRPV4):c.806G>A (p.Arg269His)	TRPV4	R269H, R235H	Charcot-Marie-Tooth disease axonal type 2C|Brachyrachia (short spine dysplasia)|Distal spinal muscular atrophy, congenital nonprogressive|Spondyloepiphyseal dysplasia Maroteaux type|Spondylometaphyseal dysplasia, Kozlowski type|Metatrophic dysplasia|Scapuloperoneal spinal muscular atrophy|Avascular necrosis of femoral head, primary, 2|Charcot-Marie-Tooth disease axonal type 2C|Sodium serum level quantitative trait locus 1|Parastremmatic dwarfism|Digital arthropathy-brachydactyly, familial|Neuromuscular disease|Inborn genetic diseases|Charcot-Marie-Tooth disease|not provided|Distal spinal muscular atrophy, congenital nonprogressive	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000005000	12	110238470	12	109800665	5000	20039	rs267607144	NC_000012.12:109800664:C:T
NM_002834.5(PTPN11):c.844A>G (p.Ile282Val)	PTPN11	I282V, I281V	Rasopathy|none provided|Inborn genetic diseases|Neurodevelopmental abnormality|not provided|Noonan syndrome|Noonan syndrome with multiple lentigines|Noonan syndrome 1	Pathogenic(Last reviewed: Nov 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040525	12	112910835	12	112473031	40525	48995	rs397507529	NC_000012.12:112473030:A:G
NM_024577.4(SH3TC2):c.2860C>T (p.Arg954Ter)	SH3TC2	R954*	not provided|none provided|Charcot-Marie-Tooth disease, type 4C|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 4C|Mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|Mononeuropathy of the median nerve, mild|SH3TC2-Related Disorders|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002482	5	148406435	5	149026872	2482	17521	rs80338933	NC_000005.10:149026871:G:A
NM_000157.4(GBA):c.1342G>C (p.Asp448His)	GBA|LOC106627981	D448H, D361H, D399H	Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Parkinson disease, late-onset|Lewy body dementia|not provided|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease|Hereditary late onset Parkinson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004293	1	155205518	1	155235727	4293	19332	rs1064651	NC_000001.11:155235726:C:G
NM_000371.4(TTR):c.238A>G (p.Thr80Ala)	TTR	T80A	none provided|Cardiomyopathy|Charcot-Marie-Tooth disease|not provided|Amyloidogenic transthyretin amyloidosis	Pathogenic(Last reviewed: Apr 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013421	18	29175120	18	31595157	13421	28460	rs121918070	NC_000018.10:31595156:A:G
NM_001354689.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	S257L, S224L, S143L, S176L	Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome 5|LEOPARD syndrome 2|Cardiomyopathy, dilated, 1NN|Noonan syndrome|Noonan syndrome 5|LEOPARD syndrome 2|Inborn genetic diseases|Neoplasm of the large intestine|Lung adenocarcinoma|Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome 1|not provided|none provided|Malignant melanoma of skin|RAF1-related disorders|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013957	3	12645699	3	12604200	13957	28996	rs80338796	NC_000003.12:12604199:G:A
NM_206933.4(USH2A):c.2276G>T (p.Cys759Phe)	USH2A	C759F	Inborn genetic diseases|Retinitis pigmentosa 39|Retinal dystrophy|Usher syndrome|Usher syndrome, type 2A|USH2A-Related Disorders|Retinitis pigmentosa|not provided|none provided|Retinitis pigmentosa 39|Usher syndrome, type 2A|Autosomal recessive retinitis pigmentosa	Pathogenic(Last reviewed: Jul 28, 2019)	reviewed by expert panel	VCV000002356	1	216420460	1	216247118	2356	17395	rs80338902	NC_000001.11:216247117:C:A
NM_002834.5(PTPN11):c.1403C>T (p.Thr468Met)	PTPN11	T468M, T472M, T467M	Rasopathy|PTPN11-related disorder|Noonan syndrome with multiple lentigines|Inborn genetic diseases|Noonan syndrome 1|Noonan syndrome|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Metachondromatosis|LEOPARD syndrome 1|not specified|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013331	12	112926270	12	112488466	13331	28370	rs121918457	NC_000012.12:112488465:C:T
NM_000371.4(TTR):c.424G>A (p.Val142Ile)	TTR	V142I	Amyloid Cardiomyopathy, Transthyretin-related|ATTRV122I amyloidosis|Cardiomyopathy|Cardiovascular phenotype|Dystransthyretinemic euthyroidal hyperthyroxinemia|Carpal tunnel syndrome|Amyloidogenic transthyretin amyloidosis|Charcot-Marie-Tooth disease|none provided|Postural tremor|Anemia|Bone marrow hypocellularity|Pancytopenia|not provided|Amyloidogenic transthyretin amyloidosis	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013426	18	29178618	18	31598655	13426	28465	rs76992529	NC_000018.10:31598654:G:A
NM_000371.4(TTR):c.148G>A (p.Val50Met)	TTR	V50M	none provided|Charcot-Marie-Tooth disease|Dystransthyretinemic euthyroidal hyperthyroxinemia|Amyloidogenic transthyretin amyloidosis|Carpal tunnel syndrome|not provided|Amyloidogenic transthyretin amyloidosis|Cardiomyopathy	Pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013417	18	29172937	18	31592974	13417	28456	rs28933979	NC_000018.10:31592973:G:A
